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Glossary of Abbreviations 
 
AA Arachidonic Acid 
AAU Arbitrary Absorbance Units 
ABP Actin-Binding Protein 
ACD Acid Citrate Dextrose 
ACF Autocorrelation Function 
ADMIDAS Adjacent to the Metal Ion-Dependent Adhesion Site 
ADP Adenosine Diphosphate 
AFM Atomic Force Microscopy 
APTMS (3-Aminopropyl)trimethoxysilane 
ATP Adenosine Triphosphate 
cAMP Cyclic Adenosine Monophosphate 
cGMP Cyclic Guanosine Monophosphate 
CH Cholesterol 
CMC Critical Micelle Concentration 
DAG Diglyceride 
DLS Dynamic Light Scattering 
DMF Dimethylformamide 
DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
DMPG 1,2-dimyristoyl-sn-glycero-3-phosphorylglycerol 
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine 
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
DOPS 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
DPPE 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine 
DTT Dithiothreitol 
ECM Extracellular Matrix 
FACS Fluorescence-Activated Cell Sorting 
FCS Fluorescence Correlation Spectroscopy 
Fg Fibrinogen 
FITC Fluorescein Isothiocyanate 
FLCS Fluorescence Lifetime Correlation Spectroscopy 
FLIM Fluorescence Lifetime Imaging Microscopy 
FRAP Fluorescence Recovery After Photobleaching 
FRET Förster Resonance Energy Transfer 
FSC Forward Scatter 
GA Glutaraldehyde 
GDP Guanosine Diphosphate 
GPCR G Protein-Coupled Receptor 
GTP Guanosine Triphosphate 
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GUV Giant Unilamellar Vesicle 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
I-EGF Integrin-induced Epidermal Growth Factor 
IP3 Inositol Trisphosphate 
ITO Indium Tin Oxide 
LB Langmuir Blodgett 
LUV Large Unilamellar Vesicle 
MCS Multichannel Scaler 
MIDAS Metal Ion-Dependent Adhesion Site 
MLCK Myosin Light Chain Kinase 
MLV Multilamellar Veiscle 
OgFg Oregon Green Fibrinogen 
PBS Phosphate-Buffered Saline 
PC Phosphocholine 
PDGF Platelet Derived Growth Factor 
PDMS Polydimethylsiloxane 
PE Phosphoethanolamine 
PEG Polyethylene Glycol 
PGI2 Prostacyclin 
PIP2 Phosphatidylinositol 4,5-bisphosphate 
PKC Protein Kinase C 
PLA Phospholipase A 
PLC Phospholipase C 
PLL Poly-L-lysine 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPE 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine 
POPG 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphorylglycerol 
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
PS Phosphoserine 
PSI Plexin Semaphorin Integrin 
SLB Supported Lipid Bilayer 
SM Sphingomyelin 
SPAD Single-Photon Avalanche Diode 
SSC Side Scatter 
STED Stimulated Emission Depletion 
STM Scanning Tunnelling Microscopy 
SUV Small Unilamellar Vesicle 
TCSPC Time-Correlated Single Photon Counting 
THD Talin Head Domain 
THF Tetrahydrofuran 
TIRFM Total Internal Reflection Fluorescence Microscopy 
 10 
TR Thromboxane Receptor 
TRAP Trombin Receptor Activating Peptide 
TxA2 Thromboxane A2 
VASP Vasodilator-Stimulated Phosphoprotein 
VPP Vesicle Prep Pro 
vWF von Willebrand Factor 
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Glossary of Units 
cm Centimetre 
Da Dalton 
℃ Degrees Celcius 
g Gram 
Hz Hertz 
K Kelvin 
kDa Kilodalton 
L Litre 
m Metre 
µg Microgram 
µl Microliter 
µm Micrometre 
µm2/s Micrometres squared per second 
µM Micromolar 
µm Microsecond 
mg Milligram 
ml Millilitre 
mm Millimetre 
mM Millimolar 
mN Millinewtons 
ms Millisecond 
M Molar 
nm Nanometre 
nm Nanosecond 
RPM Revolutions per minute 
s second 
V Volt 
v/v Volume per volume 
w/v Weight per volume 
w/w Weight per weight 
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Glossary of Figures 
Figure 1: Examples of the main components of the lipid membrane. A) A 
phospholipid (DOPC). Phospholipids make up the bulk of the lipid membrane. 
Phospholipids consist of a hydrophilic headgroup and a hydrophobic tail 
composed of two fatty acid chains. These chains may be saturated or 
unsaturated and are covalently linked to a phosphate group via a glycerol 
backbone. To phosphate group, a simple molecule such as choline, serine, 
glycerol or ethanolamine is attached to form the headgroup. B) A sphingolipid 
(spingomylein). Sphingolipids are also composed of a polar head group and 
non-polar tail group. They have a long chain sphingolipid base and, in the case 
in the case of more complex sphingolipids, can form an amide-link to a long 
chain fatty acid. C) A sterol (cholesterol). Cholesterol has a hydrophobic rigid 
ring structure with a short hydrocarbon tail. Cholesterol also has a polar 
hydroxyl group meaning it is also amphipathic in nature. .................................. 42 
Figure 2: Different types of membrane proteins. Transmembrane proteins may 
extend across the lipid bilayer as single a single alpha helix (1), multiple alpha 
helices (2), or as rolled beta-sheets (3). Some membrane proteins are anchored 
to the cytosolic surface by an amphipathic alpha helix that partitions into the 
cytosolic monolayer of the lipid bilayer through the hydrophobic face of the 
helix (4). Others are membrane attached via a covalently attached lipid chain in 
the cytosolic monolayer (5). Some may be membrane attached via an 
oligosaccharide linker, to phosphatidylinositol in the non-cytosolic monolayer 
(6). Finally, peripheral membrane proteins interact with the lipid membrane via 
non-covalent interactions with other membrane proteins intracellularly (7), or 
extracellularly (8). Imaged from “Molecular Biology of the Cell”.11 ................... 44 
Figure 3: A Stokes shift. The Stokes shift is the difference in nm between the peak 
excitation and peak emission wavelengths of a fluorophore. By completely 
filtering out the exciting light without blocking the emitted fluorescence, it is 
possible to see only the objects that are fluorescent. ........................................ 62 
Figure 4: A Jablonski diagram. A fluorophore is excited into a higher energy singlet 
state. The molecule then rapidly undergoes internal conversion and vibrational 
relaxation, before returning to the ground state. This return to the ground state 
may be radiative (fluorescence), or non-radiative (thermal energy, quenching). 
Alternatively, the molecule may transition to an intermediate triplet state 
through inter-system crossing. From here it may return to the ground state 
radiatively (phosphorescence), or non-radiatively. ............................................ 63 
Figure 5: A typical confocal microscopy set-up. The technique uses a spatial pinhole 
placed at the confocal plane of the lens to eliminate out-of-focus light. This 
allows light from a limited optical section to be collected and thus increases 
spatial resolution when compared to standard fluorescence microscopes. ...... 64 
Figure 6: A) An excitation laser profile alongside the donut shaped STED laser profile. 
Emission from overlapping regions is switched off through stimulated emission 
meaning no fluorescence occurs at the periphery of the spot. Therefore, only 
the centre of the STED laser emits fluorescence, thus reducing the interrogated 
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volume. B) The red shifted STED laser is pulsed immediately after the excitation 
laser. DCSP: dichroic mirror (short pass); VPP: vortex phase plate; BPF: 
bandpass filter; P: polarizer; L: lenses; QWP: quarter-wave plate; NF: notch 
filter; DCLP: dichroic mirror (long pass); PH: pinhole; APD: avalanche 
photodiode detector Image from “Review of recent developments in 
stimulated emission depletion microscopy: application on cell imaging”.66 ...... 65 
Figure 7: The basics of the FCS set-up. A) An excitation laser is focused onto a sample 
in order to excite fluorophores. A detector is used to register emitted photons 
from a small focal volume. B) Fluorescence fluctuations are measured over time 
and autocorrelation curve is formed. C) An autocorrelation curve. The data is 
fitted to suitable model (eg 2D or 3D) in order to determine the diffusion co-
efficient of the fluorophore. Figure adapted from “Single molecule techniques 
for the study of membrane proteins”.60 ............................................................. 67 
Figure 8: Left) The amount of time spent in the effective FCS volume is dependent 
on the fluorophore’s diffusion co-efficient. Faster moving molecules will spend 
less time in this volume and the auto-correlation curve will decay towards zero 
faster. Right) The amplitude of the auto-correlation curve is inversely 
proportional to the fluorophore concentration. As the concentration of 
fluorophores increases the ACF begins to move towards zero. ......................... 68 
Figure 9: An approximate focal volume composed of two equal  axes and two 
equal z axes. The ratio between the z and  axes is known as the axial ratio and 
written as k. This value should be between 4 and 7 in a well aligned FCS set-up.
 ............................................................................................................................. 69 
Figure 10: Left) A TCSPC histogram showing FLCS decay alongside contribution from 
afterpulsing. Afterpulsing is constant offset evenly distributed across the 
histogram and can be substracted from the initial decay.  Right) Filters for the 
fluorescence and background decays. Weight for the fluorescence decay is high 
in those channels in which the vast majority of the detected photons come 
from the fluorophore. C) When the filters are applied to the FCS curve, the FLCS 
auto-correlation curve removes unwanted afterpulsing from the data. Image 
from Picoquant. ................................................................................................... 72 
Figure 11: A schematic of a flow cytometry setup. A cell suspension is drawn into a 
stream and created by a surrounding sheath of isotonic fluid that creates 
laminar flow, allowing the cells to pass individually through an interrogation 
point. At the interrogation point a laser intersects the cells. Emitted light is 
given off in all directions. Some of this light is picked by a forward scatter 
detector, while some is picked up by a side scatter detector (1). Meanwhile, the 
system also features multiple fluorescence detectors (2 – 4), used to detect the 
presence of fluorescence molecules (antibodies and other proteins) and the 
interrogated cell’s surface. The signals are amplified and converted to a digital 
format for analysis. Image from “Flow cytometry: principles and clinical 
applications in hematology”.62 ............................................................................ 74 
Figure 12: Left) A scatter plot of various immune cell populations from umbilical cord 
blood separated according to a dot plot of FSC versus SSC. Gates have been 
placed around these separate populations which allows these cells to be 
analysed separately.71 Right) A histogram of anti-CD62P fluorescence in 
platelets. CD62P also known as p-selectin is an adhesion molecule exposed only 
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in activated platelets. The yellow fill is the un-activated platelet population, 
while the red outline is TRAP activated platelets. The shift in fluorescence can 
clearly be seen. .................................................................................................... 75 
Figure 13: A typical AFM setup coupled with an inverted optical microscope. A 
sample is placed on the stage while a cantilever and top comes in close contact 
with the surface. Interaction with the surface deflects the cantilever and this 
motion is monitored by a laser beam. This movement can be analysed and 
express in topographic form. .............................................................................. 76 
Figure 14: A confocal image of phalloidin-FITC-stained platelets activated on a 
fibrinogen-coated glass slide. Phalloidin is a mushroom toxin that binds to 
polymerised actin, one of the main components of the cell cytoskeleton, 
making it any excellent stain for visualising cells. Phalloidin-FITC was excited 
with a 488 nm argon laser line and imaged using a 63x objective. .................... 82 
Figure 15: Initiation of thrombus formation on damaged endothelial tissue. Exposure 
of platelets to vWF bound to collagen leads to transient interaction via the 
GPIb‐IX‐V complex found on platelets, even under high shear stress. This 
interaction reduces platelet velocity sufficiently to allow for direct interaction 
of the platelet to the collagen via the GP VI receptor. This interaction promotes 
a proaggregatory platelet response via intracellular signalling. This leads to the 
release of agonists such as ADP and TxA2, as well as the inside out activation of 
integrin α2β1, transitioning it from a low affinity state to a receptor which 
readily binds to collagen, further strengthening thrombus formation. ............. 84 
Figure 16: Platelet agonists and their respective receptors. A diagram showing just 
some of the important platelet agonists and their receptors that are important 
in the platelet activation process. These agonists promote a pro-aggregatory 
response that involves further agonist release in a positive feedback loop, 
platelet recruitment and the integrin family activation via intracellular 
signalling. ............................................................................................................. 87 
Figure 17: Schematic of the domains present in the alpha and beta chains of αIIbβ3. 
The alpha chain consists of a short cytoplasmic tail and transmembrane 
domain, 2 calf domains, a thigh domain, and 7 β-propeller repeats. The beta 
chain consists of a longer cytoplasmic tail and transmembrane domain, 4 I-EGF 
domains, a PSI domain, a hybrid domain, and the ligand binding domain β-I. 
Self-drawn figure based on “Integrins as therapeutic targets: lessons and 
opportunities”.14 ................................................................................................. 91 
Figure 18: Activation and conformational changes of platelet integrin αIIbβ3. Agonist 
induced inside-out signalling alters αIIbβ3 from its low-affinity state to its high-
affinity state. In this high-affinity state αIIbβ3 may bind to its ligand, in this case 
fibrinogen. Ligand binding leads to outside-in signalling. This involves integrin 
tail separation, signal transmission into the platelet and maturation of the 
platelet plug. ....................................................................................................... 94 
Figure 19: Aggregation of washed platelets in JNL buffer at 37°C after DTT activation 
(0.5 mM to 5 mM). The aggregation response was delayed when compared to 
activation with the positive control TRAP (brown). Additionally, the initiation of 
DTT-mediated aggregation was dose-dependant and even at the highest 
concentration used, never lead to the same degree of aggregation observed 
with TRAP. Unstimulated platelets did not aggregate (red).  Data points were 
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taken at 0.5 second intervals over the 30-minute duration of the experiment in 
a PAP-8E aggregometer and the mean value was obtained at each time-point 
before being plotted. (n=9, where n is the number of different donors) ........ 101 
Figure 20: Lag time of DTT response. It can clearly be seen that as DTT concentration 
increased the lag phase was reduced, with minimal difference between 3, 4 and 
5 mM concentrations of DTT. This lag phase must be taken into account when 
discussing the potency of DTT as an integrin activator. ................................... 102 
Figure 21: Aggregation of washed platelets in JNL buffer at 37°C in response to Mn2+ 
(0.5 mM to 5 mM). The aggregation of platelets in response to Mn2+ at all 
concentrations was negligible over the 30 minutes of observation. The positive 
control TRAP functioned as expected (brown). Unstimulated platelets did not 
aggregate (red). Data points were taken at 0.5 second intervals over the 30 
minute duration of the experiment in a PAP-8E aggregometer and the mean 
value was obtained at each time point. (n=5, where n is the number of different 
donors) .............................................................................................................. 103 
Figure 22: Aggregation of washed platelets in response to Mn2+ after addition of 
fibrinogen at 1 mg/ml. In this case the extra fibrinogen appears to facilitate the 
aggregation of the washed platelet preparation. TRAP results in aggregation as 
expected (brown). Unstimulated platelet aggregation is negligible. Data points 
are taken at 0.5 second intervals over the 30-minute duration of the 
experiment and the mean value is obtained at each time point.  (n=7, where n 
is the number of different donors) ................................................................... 105 
Figure 23: Representative histograms of FITC-labelled PAC-1 fluorescence after 
activation with TRAP, DTT and Mn2+. The unstimulated gate set a 5 % meaning 
that 5 % of the counts for unstimulated platelets fall within this boundary. An 
increase in the number of counts that fall within the gate shows PAC-1 binding. 
A) shows PAC-1 binding in response to DTT (0.5 mM in blue, 3 mM in green) 
and the positive control TRAP (4 μM in red). A shift to the right is evident in all 
three cases when compared with the unstimulated platelets (black with yellow 
fill). B) shows PAC-1 binding in response to Mn2+ (0.5 mM in blue, 3 mM in 
green) and the positive control TRAP (4 μM in red). Once again a shift to the 
right is evident in all three cases when compared with the unstimulated 
platelets (black with yellow fill)......................................................................... 110 
Figure 24: Both DTT and Mn2+-induced integrin activation as assessed using the 
percentage gated of PAC-1 binding. A 5 % gated value was used for 
unstimulated platelets (blue). 4 M TRAP (red) was a surprisingly weak integrin 
activator and only lead to a slight increase in the percentage gated value. DTT 
(green and purple) and Mn2+ (orange and black) were excellent integrin 
activators at 0.5 and 3 mM according to PAC-1 binding. Standard deviation was 
used to represent the error. (n=5, where n is the number of separate donors)
 ........................................................................................................................... 111 
Figure 25: Both DTT and Mn2+-induced integrin activation as assessed using the 
geometric mean of PAC-1 binding. The geometric mean of unstimulated 
platelets is shown in blue. 4 M TRAP (red) was a surprisingly weak integrin 
activator and only lead to a slight increase in the geometric mean. DTT (green 
and purple) and Mn2+ (orange and black) were excellent integrin activators at 
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0.5 and 3 mM according to PAC-1 binding. Standard deviation was used to 
represent the error. (n=5, where n is the number of separate donors) ........... 112 
Figure 26: Representative histograms of Oregon green labelled fibrinogen (OgFg) 
fluorescence after activation with TRAP, DTT and Mn2+. Once again the 
unstimulated gate set a 5 %. A) shows OgFg binding in response to DTT (0.5 mM 
in blue, 3 mM in green) and the positive control TRAP (4 μM in red). A shift to 
the right is evident in all three cases when compared with the unstimulated 
platelets (black with yellow fill). B) shows OgFg binding in response to Mn2+ (0.5 
mM in blue, 3 mM in green) and the positive control TRAP (4 μM in red). In 
contrast to DTT, Mn2+ does not appear to be sufficient for observable 
fibrinogen binding. This is despite the previous findings Mn2+ stimulation leads 
to PAC-1 binding, indicating that αIIbβ3 is in its active confirmation. ................ 115 
Figure 27: DTT but not Mn2+ induced integrin activation as assessed using the 
percentage gated of OgFg binding. A 5 % gated value was used for unstimulated 
platelets (blue). The positive control of 4 M TRAP was also an integrin 
activation as determined by fibrinogen binding. DTT at 3 mM (purple) lead to 
integrin activation according to fibrinogen binding. Mn2+ (orange and black) did 
not lead to activation according to fibrinogen binding. Standard deviation was 
used to represent the error. (n=5, where n is the number of separate donors)
 ........................................................................................................................... 116 
Figure 28: DTT but not Mn2+-induced integrin activation as assessed using the 
geometric mean of OgFg binding. The geometric mean for unstimulated 
platelets is shown in blue. The positive control of 4 μM was an excellent 
integrin activator according to OgFg binding. DTT also lead to integrin activation 
at 3 mM (purple). Mn2+ did not lead to integrin activation at either 
concentration. Standard deviation was used to represent the error. (n=5, where 
n is the number of separate donors) ................................................................ 117 
Figure 29: A representative histogram of anti-CD62P binding to p-selectin in 
unstimulated platelets (yellow), and following stimulation with 4 M TRAP 
(red), 3 mM DTT (blue) and 3 mM Mn2+ (green). It can clearly be seen that TRAP 
stimulation is the only agonist that brings about antibody binding. This shows 
that alpha granules release and thus P-selectin presentation only occurs with 
this agonist and not DTT or Mn2+. ..................................................................... 123 
Figure 30: DTT and Mn2+ failed to lead to alpha granule release according to anti-
CD62P binding as assessed using percentage gated. A gate was set so that 5 % 
of unstimulated platelet counts fall within it (yellow). TRAP at 4 μM (red) was 
sufficient to bring about anti-CD62P binding, meaning that P-selectin was 
expressed on the platelet surface. DTT at 3 mM (green) and Mn2+ at 3 mM 
(blue) did not result in P-selectin expression. Standard deviation was used to 
represent the error. (n=3, where n is the number of donors) .......................... 123 
Figure 31: DTT and Mn2+ failed to cause alpha granule release DTT and Mn2+ failed to 
lead to alpha granule release according to anti-CD62P binding as assessed using 
geometric mean. The geometric mean of unstimulated platelets is shown in 
yellow. TRAP at 4 μM (red) was sufficient to bring about anti-CD62P binding, 
meaning p-selectin was expressed on the platelet surface. DTT at 3 mM (green) 
and Mn2+ at 3 mM (blue) did not result in p-selectin expression. Standard 
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deviation was used to represent the error. (n=3, where n is the number of 
donors) .............................................................................................................. 124 
Figure 32: DTT and Mn2+ fail to cause dense granule release. ATP secretion after 5 
minutes (top) and 30 minutes (bottom) in unstimulated platelets as well as in 
platelets stimulated with TRAP, DTT and Mn2+. ATP release in unstimulated 
platelets is shown in yellow. TRAP at 4 μM (red) was sufficient to bring about 
ATP release. Both DTT at 3 mM (green) and Mn2+ at 3 mM (blue) did not lead to 
ATP release. This was confirmed by ANOVA analysis and a post-hoc Bonferroni 
test. Standard deviation was used to represent the error. (n=3, where n is the 
number of different donors) ............................................................................. 126 
Figure 33: Vesicles can be divided into various populations based on their size and 
morphology. There are no strict definitions of what constitutes these 
descriptions and the nomenclature various from paper to paper.125 Throughout 
this thesis SUVs refers to vesicles with a diameter below 50 nm, GUVs refers to 
vesicles with a diameter of above one micron, while LUVs refers to vesicles with 
a diameter between these two definitions. ...................................................... 131 
Figure 34 Assembly of the electroformation cell. Two ITO-coated slides are 
positioned a number of millimetres apart with the conductive side facing each-
other. Dried lipid is deposited on one or both of the conductive faces. The slides 
are separated by a cell spacer which takes the form of a non-conductive 
material such as PDMS or a rubber O-ring. The cell is filled with buffer before 
being sealed. An electric field is then applied between the ITO glass slides for a 
defined period of time to allow for GUV growth. ............................................. 138 
Figure 35: Assembly of the mini-extruder. The polycarbonate membrane of required 
pore size is place between two Teflon supports and enclosed in a metal outer 
casing as shown. The lipid composition of choice in Tris or HEPES buffer is 
passed through the polycarbonate membrane a number of times using two 
syringes to create vesicles of a required diameter. To confirm vesicle size, DLS 
was used. Figure adapted from Avanti Polar Lipids.136 ..................................... 141 
Figure 36: Amplitude and frequency profile over time of a standard electroformation 
protocol. The protocol runs for 128 minutes with the frequency held constant 
at 5 Hz throughout. The voltage varies during the experiment. The amplitude 
slowly ramps up to 3 V over the first 30 minutes. This ramping step is to avoid 
lipid shearing from the surface. This amplitude is then held constant for the 
next 125 minutes where the majority of the vesicle growth occurs. The final 3 
minutes ramps the voltage back down to zero. If this step occurs to quickly, 
vesicle yield is reduced due to GUV destruction. The values and time-points 
used had been optimised to efficiently create GUVs from lipid deposited in 
chloroform. ........................................................................................................ 142 
Figure 37: Amplitude and frequency profile over time of used to create protein-
containing GUVs in a physiological buffer. This overnight protocol ramps the 
voltage to 1.2 V over the first hour where it remains constant for the next 13 
hours.  The last step ramps the voltage down over the final hour. The most 
important factor in producing GUVs in a high salt before is the use of an 
extremely high frequency when compared with standard electroformation 
protocols. 500 Hz was found to be optimal for such GUV formation. .............. 143 
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Figure 38: Confocal image of GUV growth during an electroformation protocol. After 
approximately 45 minutes, massive GUVs with diameter greater than 100 μm 
become visible. From these massive GUVs, smaller GUVs (diameter between 20 
and 50 μm) begin to bud in vesicle nests. A 10x objective with a suitable 
working distance was used to observe GUV growth (DOPC) in the 
electroformation cell. DOPE-Atto655 was incorporated at 0.1 mol % and excited 
at 633 nm. ......................................................................................................... 154 
Figure 39: Confocal image of GUV growth near the end of an electroformation 
protocol. The massive GUVs originally observed in the electroformation 
protocol have been reduced in size after successive budding. These smaller 
GUVs have a diameter between 20 and 100 μm and occur clumped in vesicle 
nests. They are surface attached and require mechanical agitation or a lowering 
of the frequency of the electric field for removal from the surface. GUVs 
pictured are DOPC with 0.1 mol % DOPE-Atto655 and excited at 633 nm. ..... 155 
Figure 40: GUVs (32 % DOPC, 25 % DOPE, 8 % DOPS, 15 % SM, 25 % CH) following 
completion of the electroformation protocol and subsequent removal to a new 
surface. Many thousands of GUVs are created and these vesicles survive the 
mechanical agitation used to remove them from the electroformation cell. 
DOPE-atto655 was included at 0.1 mol % and excited at 633 nm. ................... 157 
Figure 41: A close-up confocal image of GUVs (32 % DOPC, 25 % DOPE, 8 % DOPS, 15 
% SM, 25 % CH) created via electroformation. The vesicles have been removed 
from the electroformation cell and transferred to new glass surface for imaging. 
The vast majority of GUVs are unilamellar. DOPE-atto655 was included at 0.1 
mol % and excited at 633 nm. ........................................................................... 158 
Figure 42: Confocal image of domain-forming GUVs (40 % DOPC, 40 % SM, and 20 % 
CH). The use of this composition leads to the formation of micron sized lipid 
rafts, domains rich in cholesterol and sphingomyelin. To visualise these 
domains, DiD is included at 0.1 mol %. DiD is a lipophilic tracer dye with affinity 
for the liquid disordered phase. DiD does not partition well into the cholesterol 
and sphingomyelin-rich liquid ordered phase. DiD was excited at 633 nm. .... 160 
Figure 43: A close-up of confocal image of a raft-forming GUV (40 % DOPC, 40 % SM, 
and 20 % CH). DiD was used as a marker for the liquid disordered phase. The 
lipophilic tracer is clearly excluded from certain regions of the GUV. DiD was 
included at 0.1 mol % and excited at 633 nm. .................................................. 161 
Figure 44: DLS measurements of vesicles after extrusion but before integrin insertion 
(blue), and after triton x-100-mediated integrin reconstitution. After extrusion 
vesicles were mono-disperse, around the 100 nm diameter mark. Due to 
detergent solubilisation and then detergent removal, reconstituted vesicles 
were poly-disperse with many proteoliposomes in the micrometer range. .... 163 
Figure 45: Representative histogram of FITC labelled CD41a binding in control 
liposomes (yellow fill, black outline) and reconstituted liposomes (red outline). 
The gate displayed is set so that 5 % of control liposome counts fall within the 
region. A shift in the histogram to the right can clearly be seen for αIIbβ3 
liposomes showing the reconstitution protocol was successful. ..................... 163 
Figure 46: Lipid and protein levels in recovered fractions. A) A graph showing 
detected disintegrations per minute (DPM) for each fraction in black and 
relative density of each fraction (as determined by densitometry) in red. To 
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determine densitometry values, each fraction was run on a polyacrylamide gel 
and later stained with coomasssie blue to highlight any protein present. ImageJ 
was used to analyse each lane and the lane with the highest density value was 
set to 1 (lane 4). From this value the relative density of the other lanes could be 
determined. It is evident that there is a correlation between the lipid 
concentration in each fraction (black) and the protein concentration in each 
fraction (red). B) A coomassie stained polyacrylamide gel from which the 
densitometry values were obtained. A molecular weight marker is also included 
(leftmost lane). αIIbβ3 is reduced into three subunits during the PAGE step. The 
alpha subunit is divided into a heavy (125 kDa, top band) and light chain (25 
kDa, run off gel). The beta subunit is 105 kDa (lower band). ........................... 165 
Figure 47: Atto655-labelled αIIbβ3-reconstituted into nature’s own GUVs. The 
fluorescent labelling of the integrin protein allowed for the identification of it 
within electroformed vesicles. The inclusion of αIIbβ3 in the electroformation 
method did not appear to alter the morphology or success of the 
electroformation process. ................................................................................. 167 
Figure 48: A representative confocal image of atto655 labelled αIIbβ3-reconstituted 
GUVs before (left) and after (right) incubation with proteinase k. A reduction in 
intensity at the GUV membrane is clearly visible following enzyme digestion. A 
line tool in imageJ was used to trace around the GUV membrane in order to 
find the average intensity per pixel at the lipid membrane. ............................ 169 
Figure 49: After the imageJ line tool was used to trace around the GUV membranes, 
the average counts per pixel before and after proteinase k incubation was 
calculated. Before incubation the average count per pixel was found to be 46 ± 
18 counts, while after incubation it was 21 ± 12 counts. A two-tailed unpaired t-
test was performed where the difference between the two data sets was found 
to be significant, where t(14) = 2.90, p < 0.05. This suggests that the enzyme 
digested approximately half of the labelled αIIbβ3 proteins, and thus half the 
labelled αIIbβ3 proteins were orientated outwardly. Therefore, it can be said 
that αIIbβ3 is orientated randomly within the GUV membrane. (n=8) .............. 170 
Figure 50: A typical autocorrelation function and its single component two 
dimensional fit for DOPE-atto532 diffusing in nature’s own GUVs at room 
temperature. GUVs created via the electroformation protocol in a sucrose-
containing buffer were pipetted into an observation buffer of 10 mM HEPES, 
150 mM NaCl, 1 mM CaCl2, 100 mM glucose, pH 7.4, and the GUVs were 
allowed to come to rest on the bottomof a glass slide over a 30-minute period. 
Stationary GUVs were selected before a point measurement was performed on 
the GUV membrane. DOPE-atto532 diffusion in nature’s own GUVs was 
determined to be 7.89  0.42 m2/s at room temperature. ............................ 172 
Figure 51: A typical autocorrelation function and its single component two 
dimensional fit for αIIbβ3-Atto655 diffusing in nature’s own GUVs at room 
temperature. GUVs created via the electroformation protocol in a sucrose-
containing buffer were pipetted into an observation buffer of 10 mM HEPES, 
150 mM NaCl, 1 mM CaCl2, 100 mM glucose, pH 7.4, and the GUVs were 
allowed to come to rest on the bottom of a glass slide over a 30-minute period. 
Stationary GUVs were selected before a point measurement was performed on 
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the GUV membrane. αIIbβ3-Atto655 diffusion in nature’s own GUVs was 
determined to be 2.61  0.35 m2/s at room temperature. ............................ 176 
Figure 52: Representative single component fits (solid lines) to ACFs collected from 
resting αIIbβ3-atto655 (blue) and activated, fibrinogen bound αIIbβ3-Atto655 
(red) in nature’s own GUVs at room temperature. The αIIbβ3-reconstituted 
GUVs were created in a sucrose-containing buffer before being pipetted into an 
observation buffer of 10 mM HEPES, 150 mM NaCl, 1 mM CaCl2, 100 mM 
glucose at pH 7.4. The GUVs were allowed to come to rest on a glass slide over 
a 30-minute period prior to measurement. Stationary GUVs were selected 
before a point measurement was performed on the GUV membrane. αIIbβ3-
Atto655 diffusion in nature’s own GUVs before the addition of activators or 
fibrinogen was determined to be 2.52  0.29 m2/s at room temperature. 
Following integrin activation and addition of fibrinogen, this diffusion co-
efficient reduced to 1.56  0.26 m2/s with DTT and 1.49  0.41 m2/s with 
Mn2+. .................................................................................................................. 180 
Figure 53: Fluctuating photon-counting time traces, binned at 1 ms resolution, from 
single point measurements in the plane of the liposome membrane. The upper 
trace (blue) shows diffusion of un-activated Atto 655 labelled-αIIbβ3 in nature’s 
own GUVs while the lower trace (red) shows diffusion of DTT activated Atto 655 
labelled- αIIbβ3 in nature’s own GUVs following the addition of fibrinogen. The 
un-activated form of αIIbβ3 passes through the focal volume with a regular fairly 
homogeneous frequency. Whereas, fibrinogen bound αIIbβ3 passes through the 
focal volume in heterogeneous, irregular bursts, each burst appears to contain 
clusters of fluorophores migrating together through the focal volume........... 183 
Figure 54: (Left) The liquid disordered probe DiD partitioning into the DOPC rich 
phase of raft-forming GUVs composed of 50 % DOPC, 25 % CH and 25 % SM. 
(Right) TAMRA labelled αIIbβ3 co-localises into the same regions as DiD showing 
that αIIbβ3 also has affinity for the liquid disordered phase in raft-forming GUVs.
 ........................................................................................................................... 185 
Figure 55: Different types of SLB systems within the literature. A) shows a basic SLB 
where a lipid bilayer is formed above a planar substrate. The substrate may be 
made from glass, mica, quartz, amongst others, while the bilayer may be 
formed via vesicle disruption, LB, LS, or a combination of the above. While easy 
to form, these simple systems often suffer from non-specific interactions 
between the substrate and the lipid membrane. This is particularly relevant 
when bulky membrane proteins are also included. B) One of the most common 
means of de-coupling the lipid bilayer from the substrate is via the use of 
polymer cushions. This has been widely used to allow for membrane protein 
mobility. C) With a similar aim, tethered polymer spacers have also been used 
to allow for protein mobility be increasing the distance between the substrate 
and the lipid membrane. D) Bridging the gap between vesicular set-ups and 
planar bilayers, tethered vesicles grants increased stability to liposome 
systems. E) The use of porous substrates is another method by which the lipid 
bilayer may be decoupled from the substrate. These pores have been formed in 
a variety of ways and across a variety of diameters to allow for the free 
diffusion of the lipid membrane as well as any reconstituted proteins. .......... 191 
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Figure 56: Construction of PDMS cavity arrays. Construction began with the gluing of 
a mica spacer to a glass slide. This acts as the platform for deposition of the 
polystyrene spheres. It was important to minimise the thickness of the glued 
mica sheet as this sheet defined the distance between the cavities and the 
opposing cover slip that would later be glued to complete the cell. If the 
distance was too great, then the objective would not have a sufficient enough 
working distance to image the cavity-spanning bilayer. Next, polystyrene 
spheres were deposited on the mica and allowed to air dry overnight. This 
diameter of these spheres controlled the size of the cavities. PDMS was then 
poured atop the spheres and allowed to cure at 150 C. The cured array was 
then pealed from the support and placed in THF to dissolved any remaining 
polystyrene, leaving behind the finish PDMS cavity array. ............................... 196 
Figure 57: A NIMA 120m Langmuir trough. The trough was filled with buffer and the 
lipids of choice were deposited at the air-water interface. After evaporation of 
the solvent, the lipid was compressed to 32-36 mN/m. A buffer-filled cavity-
containing PDMS array was dipped into the trough in order to transfer the lipid 
monolayer to the substrate. Two holes where punched at the extremities of the 
PDMS and at this stage the substrate was glued to a cover glass slide using 
epoxy glue to obtain the flow chamber. Teflon tubing was then attached to the 
PDMS array to allow for buffer circulation. ...................................................... 198 
Figure 58: Examples of typical LB isotherms before PDMS dipping and lipid transfer. 
A) shows an isotherm of a pure DOPC while B) shows an isotherm of the 
nature’s own mixture. The lipids were compressed at a barrier speed of 30 
cm/min to a surface pressure of 32-36 mN/m for the lipid monolayer transfer 
process. ............................................................................................................. 199 
Figure 59: Completion of the PDMS cell. After production of the PDMS array, 
sonication was used to fill the cavities with buffer. LB was then used to transfer 
a lipid monolayer to span the buffer-filled cavities. Teflon tubing was then 
attached to the the array to provide a flow-cell set-up. Here, the cell has been 
flushed with dye so that the flow chamber can be better visualised. .............. 200 
Figure 60: Proteoliposomes separated from un-incorporated protein via sucrose 
gradient ultracentrifugation. The proteoliposomes were easily visible as thin 
white layer within the sucrose solution as shown by the blue arrows. ............ 205 
Figure 61: A DOPC bilayer created above a plasma-cleaned planar glass substrate. 
0.001 % of the lipid was made up of DOPE-Atto655 which allowed for 
fluorescence microscopy to be used to image the lipid bilayer. The completed 
bilayer was continuous and defect free. FCS and FCLS measurements could be 
subsequently carried out on the SLB. ............................................................... 209 
Figure 62: A nature’s own bilayer created above a plasma-cleaned planar glass 
substrate. 0.001 % of the total lipid was made up of DOPE-Atto655 which 
allowed for fluorescence microscopy to be used to image the lipid bilayer. As 
was the case for less complex lipid compositions, the completed nature’s own 
bilayer was continuous and defect free. FCS and FCLS measurements could be 
subsequently carried out on the SLB. ............................................................... 210 
Figure 63: Two-dimensional fits to the ACF trace of DOPE-Atto655 in a DOPC bilayer 
on plasma-cleaned glass at 21, 25, 30 and 37 C. As expected, increasing 
temperature leads to an increase in the lateral diffusion co-efficient of SLBs. 
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This can be seen where the fluorescent molecules spend less time within the 
focal volume and the ACF decays towards zero faster. .................................... 211 
Figure 64: Diffusion of DOPE-Atto655 in a DOPC SLB on plasma-cleaned glass. 
Increasing temperature resulted in an increase in the determined diffusion co-
efficient. Each point is a 60 – 180 seconds FLCS measurement of the lipid 
bilayer fitted to a two-dimensional model. Standard deviation was used to 
report the error. ................................................................................................ 212 
Figure 65: Diffusion of DOPE-Atto655 in a nature’s own SLB on plasma-cleaned glass. 
Increasing temperature resulted in an increase in the determined diffusion co-
efficient. Due to the inclusion of ordered phase lipids, nature’s own was slightly 
less mobile than a DOPC bilayer. Each point is a 60 – 180 seconds FLCS 
measurement of the lipid bilayer fitted to a two-dimensional model. Standard 
deviation was used to report the error. ............................................................ 213 
Figure 66: A fluorescence image of an DOPE-Atto532 in an integrin-reconstituted 
DMPC/DMPG lipid bilayer. The bilayer appeared defect free and was identical 
to a DMPC/DMPG SLB created in the absence of IIb3. Due to the high phase 
transition temperature of DMPC and DMPG (approximately 21 C) the 
experiment was carried out at 25 C. ............................................................... 215 
Figure 67: IIb3-Atto655 in DMPC/DMPG SLB created on glass via the disruption of 
integrin-reconstituted vesicles. Integrin was found well distributed throughout 
the SLB. However, point measurements found that the labelled integrin was 
immobile on the glass substrate as indicated by photobleaching of the lipid 
probe. ................................................................................................................ 216 
Figure 68: MCS trace of atto655 labelled IIb3 in a DMPC/DMPG (1:1) lipid bilayer 
above planar glass. Photobleaching was clearly visible over time indicating that 
the reconstituted integrin was immobilised on the glass surface. This 
photobleaching of a reconstituted transmembrane protein is a key drawback of 
membrane-reconstituted SLB system. It was hoped that our PDMS arrays would 
eliminate this protein immobilisation. .............................................................. 217 
Figure 69: Close up reflectance imaging of the PDMS cavity array following 
sonication. Due to the scattering of the laser light buffer-filled cavities appear 
much brighter than the surrounding PDMS substrate. Measuring the  diameter 
of the cavities using ImageJ suggest that the aperture of the cavities was 
approximately 2 m when constructed from 2.88 m polystyrene spheres. .. 218 
Figure 70: A reflectance image of a PDMS cavity array created with 2.88 m 
polystyrene spheres. Filled cavities are visible as bright white circles. In order to 
attempt to form a lipid bilayer above this PDMS array we used GUVs as the lipid 
source. The GUVs were disrupted via the use of calcium, with the hope the the 
ruptured vesicles would span the buffer-filled cavities. ................................... 219 
Figure 71: A fluorescent image of the DOPC lipid bilayer formed via the disruption of 
GUVs. DOPE-Atto655 was included as a lipid probe for imaging. While the SLB 
formed on planar regions of the PDMS, no bilayer was present above cavities. 
Instead a characteristic fluorescent “halo” was visible around non-spanning 
pores where the labelled lipids were found at high concentrations. ............... 220 
Figure 72: A fluorescent image of the DOPC lipid bilayer that was spanned across the 
PDMS cavity array. DOPE-Atto655 was included at 0.001 % for imaging and 
point measurements. Surface coverage of the bilayer is excellent and the 
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bilayer trans-versed the buffer-filled cavities. Only un-filled cavities prevented 
bilayer coverage. ............................................................................................... 221 
Figure 73: Representative ACFs of DOPE-Atto655 in a DOPC bilayer diffusing on 
planar PDMS (red) and above cavities (blue). It is apparent that lipid above 
cavities is much more mobile than lipid above a planar substrate. This is 
because the lipid bilayer has been decoupled from the PDMS and free-standing. 
As such these diffusion values above cavities are line line with GUV diffusion 
values. ................................................................................................................ 222 
Figure 74: To examine the influence of point measurement positioning within the 
cavities and experiment was designed whereby the cavities were roughly 
divided up into different regions, namely “centre”, “off-centre” and “edge”. 
High resolution images were taken of cavities that appeared to be 
approximately 2 m in diameter and point measurements were taken at the 
aforementioned regions. ................................................................................... 224 
Figure 75: Diffusion of a DOPE-Atto65 in a DOPC bilayer by position. Each point 
represents a 60 second measurement of the lipid bilayer at a particular 
location. Slight deviations from the centre of the cavities lead to a noticeable 
drop in the apparent diffusion co-efficient measured via FLCS. While large 
deviations from the centre of the cavities would be expected to alter the 
diffusion co-efficient, the ease at which this occurred was surprising given the 
width of the confocal volume at its widest point and the apparent dimensions 
of the cavities. Error was reported using standard deviation........................... 225 
Figure 76: AFM of PDMS cavity arrays constructed from 2.88 m polystyrene 
spheres. According to AFM the aperture of the cavities was about 1 m. This 
was in contrast to the apparent size of the aperture obtained via reflectance 
imaging which was approximately 2 m across. This difference in the apparent 
size as obtained via reflectance imaging and the actual size as obtained via AFM 
explained why lipid diffusion co-efficients were reduced when point 
measurements were performed slightly off-centre. ........................................ 227 
Figure 77: Cavity diameter aperture as determined via AFM versus apparent 
diameter determined via reflectance imaging. AFM was used to shows the 
actual aperture of the cavities created with 2.88 m polystyrene spheres. AFM 
measurements show that reflectance imaging had been overestimating the size 
of the cavities due to light scattering within the buffer-filled cavities. ............ 227 
Figure 78: PDMS cavities created using 2.88 m polystyrene spheres. Buffer-filled 
cavities were clearly visible on the PDMS surface. A lipid bilayer was transferred 
to this array using LB and vesicle rupture before annexin V was reconstituted 
within. ................................................................................................................ 229 
Figure 79: Atto547N-labelled annexin V in a DOPC:DOPS (8:2) lipid bilayer formed 
above the PDMS cavities shown in the previous figure. Annexin V appeared to 
aggregate at the locations of un-filled cavities but was also present above 
buffer-filled cavities on in planar PDMS regions. It was these locations that 
were probed with point measurements. .......................................................... 230 
Figure 80: An example of an ACF trace and it accompanying fit for annexin V-
Atto547N above cavities when reconstituted into a DOPC/DOPS (8:2) lipid 
bilayer. A single component fit was used to determine that the protein had a 
diffusion co-efficient of  7.10  0.80 m2/s following reconstitution, a value 
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substantially smaller than the lipid diffusion co-efficient at the same location.
 ........................................................................................................................... 230 
Figure 81: An MCS trace of annexin V-Atto547N on planar PDMS regions when 
reconstituted into a DOPC/DOPS (8:2) lipid bilayer. While annexin V-Atto547N 
was mobile above cavities, it was completely immobile on planar regions of the 
substrate leading to bleaching of the probe during point measurements. This 
contrasting mobility shows the power of our PDMS cavity arrays. .................. 231 
Figure 82: Reflectance image of PDMS array used for lipid-spanning and integrin 
reconstitution experiment. Buffer-filled cavities were visible in white due to the 
scattering of light within the cavities. Un-filled cavities and planar regions did 
not scatter light and there was no refractive index mismatch, and as such, these 
regions were black. ........................................................................................... 234 
Figure 83: Fluorescence image of atto655-labelled IIb3 reconstituted into a cavity-
spanning DOPC bilayer. IIb3 was well distributed throughout the bilayer and 
present above the buffer-filled cavities. Fluorescent “halos” were evident 
around un-filled cavities where no lipid bilayer spanned the cavities. ............ 235 
Figure 84: A representative ACF of integrin super-diffusion above buffer-filled 
cavities. Atto655 labelled IIb3 was found to diffuse at between 16 and 30 
m2/s, values way above the lipid diffusion co-efficient at the same location. 
This data suggests that the integrin protein was not fully inserted into the lipid 
bilayer. ............................................................................................................... 235 
Figure 85: A schematic of the insertion protocol for GUVs and SLBs as well as the 
proposed new method of integrin reconstitution into an SLB (red). In all cases 
the initial protocol is the same whereby the protein is inserted into vesicles via 
the use of detergents to create proteoliposomes. These vesicles can then be 
used as the lipid course for electroformation (left), or as the lipid source for 
bilayer formation (right). Given the fact that direct disruption of the 
proteoliposomes to create an SLB did not result in integrin incorporation it was 
proposed that the successfully reconstituted GUVs be used as the lipid source 
for SLBs instead. ................................................................................................ 238 
Figure 86: Representative ACF for atto655 labelled IIb3 inserted into a cavity-
spanning lipid bilayer using integrin-containing GUVs as an intermediate. In 
contrast to the extremely high diffusion co-efficients witnessed using the 
original integrin reconstitution method, using GUVs as an intermediate resulted 
in a diffusion co-efficient of 3.20  0.33 m2/s above cavities. This value is well 
below the diffusion co-efficient of the surrounding lipid bilayer. .................... 240 
Figure 87: A representative MCS trace of atto655 labelled IIb3 on planar PDMS. 
Photobleaching of the probe is clearly evident over time showing that the 
labelled integrin is immobile above the substrate. This is in contrast to the 
original integrin reconstitution method where IIb3 diffused faster than the 
lipid bilayer at the same position due to loose association with SLB. Such 
protein immobility on planar regions appears to confirm that the use of GUVs 
as an intermediate lead to the proper reconstitution of the integrin protein. 241 
Figure 88: Atto655 labelled IIb3 in a nature’s own bilayer before (left) and after 
(right) proteinase K addition. Following 2 hours of proteinase K incubation, the 
cell was flushed with buffer to leave behind a bilayer where many of the 
extracellular integrin domains have been digested by the enzyme. Only labelled 
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integrin molecules with their headpiece orientated towards the PDMS 
remained. (n=8) ................................................................................................. 244 
Figure 89: Average count per pixel before (left) and after (right) proteinase K 
incubation. Following incubation and buffer flushing the average count per 
pixel was fell to approximately 40 % of its original value, indicating that the 
system slightly favoured “correctly” orientated integrin, with their extracellular 
domain pointed outwards. A two-tailed unpaired t-test was performed where 
the difference between the two data sets was found to be significant, t(14) = 
8.53, p < 0.001. .................................................................................................. 244 
Figure 90: MCS trace before (blue) and after (red) ligand addition. No major changes 
in the characteristics of the time-trace were evident. This is in contrast to the 
findings in our GUV studies before and after fibrinogen addition where large 
fluorescently labelled aggregates were found to diffuse through the focal 
volume. .............................................................................................................. 248 
Figure 91: Left) Reflectance image of a PDMS cavity array. The majority of cavities 
are buffer-filled and appear as a bright white circle due to light scatter. Right) 
An integrin-containing nature’s own lipid bilayer was constructed across the the 
PDMS array. IIb3  was labelled with atto655 to allow for imaging of the 
bilayer. The reconstituted integrin protein was well-distributed throughout the 
bilayer with no defects visible. Un-filled on non spanned cavities were 
highlighted by a fluorescent halo. ..................................................................... 250 
Figure 92: Left) Atto655-labelled IIb3  after DTT activation and fibrinogen 
incubation. Activation and ligand addition lead to large integrin aggregates to 
form on planar regions of the PDMS. Right) The use of atto655-labelled 
fibrinogen showed that fibrinogen appeared to cluster in the same location as 
integrin aggregates. This shows that fibrinogen was mediating the aggregation 
process. ............................................................................................................. 250 
Figure 93: Actin networks may take different architectures, which in turn lends 
different functions. Red arrows show compression, while green arrows show 
tension. A) Branched actin networks push against the cell membrane and 
external barriers as they generate protrusons. B) Filopodia also generate 
protrusive forces as they extend from the cell. C) Cortical networks such as 
those involving filamin crosslinking carry tension loads in multiple directions. D) 
Stress fibres form bundled actin filaments and generate tension against cell 
adhesions to the extracellular matrix. Diagram from “Cell Mechanics and the 
Cytoskeleton”. 187 .............................................................................................. 256 
Figure 94: Microfilaments, microtubules and intermediate filaments within the cell. 
The cytoskeleton is a complex matrix of structures that combine to play a role 
in spatial organisation, while allowing changes in cell morphological in response 
to the external environment. This figure shows the approximate scale of 
microfilaments, microtubules and intermediate filaments, as well their position 
within the cell. Image from ”Molecular Cell Biology”.193 .................................. 257 
Figure 95: The nanoscale architecture of focal adhesions. The integrin proteins span 
the cell’s lipid membrane to provide a link between the ECM and the cell. This 
is mediated by a variety of intracellular proteins including focal adhesion kinase 
and paxillin in an integrin signalling layer, talin and vinculin in an intermediate 
force transduction layer, and an uppermost actin-regulatory layer containing 
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zyxin, vasodilator-stimulated phosphoprotein and a-actinin. Image from 
“Nanoscale architecture of integrin-based cell adhesions”.107 ......................... 260 
Figure 96: SEM images of the three different fibres supplied by Dr Ryadnov’s group. 
According to their SEM data, cyan(+)4 fibres are between 90 and 500 nm in 
length, with a thickness of 5 – 25 nm. Cyan(+)6 has a length between 70 and 90 
nm with a thickness of 4 – 6 nm. SR_EDS_02 has a length in the m range with 
a thickness of approximately 300 nm. This data was supplied by Dr Ryadnov’s 
group, as measured using imageJ from multiple SEM experiments. ................ 267 
Figure 97: A schematic of the constructed PDMS cell used for cytoskeleton and SLB-
based experiments. The glued PDMS cell provided a chamber containing inlets 
and outlets for flow through of buffers, lipids, and proteins used during the 
experiments. ...................................................................................................... 272 
Figure 98: A schematic of the proposed system where a lipid bilayer is formed above 
nanometer wide and micrometer length polypeptide filaments. It was hoped 
that these fibres would act as a sufficient barrier to lipid mobility that would be 
reflected in the diffusional characteristics of the spanning lipid molecules. ... 277 
Figure 99: Phalloidin-TRITC stained bovine actin filaments assembled on a glass 
surface as seen via confocal microscopy. F-actin filaments readily formed under 
the polymerisation conditions used and surface coverage of the glass substrate 
was extremely good. The experiment was carried out at room temperature in a 
PDMS cell. Phalloidin TRITC labelled actin was excited by a 532 nm laser line 
and fluorescence was passed through a 550LP filter onto the SPAD detectors.
 ........................................................................................................................... 278 
Figure 100: Bovine actin on plasma-treated glass following the addition and 
disruption of DOPC lipid vesicles. During the disruption process, which features 
a number of buffer flushes through the cell, the vast majority of actin was 
washed away from the glass. The experiment was carried out at room 
temperature in a PDMS cell. Phalloidin-TRITC labelled actin was excited by a 
532 nm laser line and fluorescence was passed through a 550LP filter onto the 
SPAD detectors. ................................................................................................. 279 
Figure 101: A DOPC bilayer formed above F-actin filaments. DOPE-Atto655 was used 
as the lipid probe. The bilayer appeared formed homogeneously with no 
defects visible due undisrupted vesicles and no perturbation caused by the 
presence of some underlying actin filaments. The experiment was carried out at 
room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser 
line and fluorescence was passed through a 635R filter onto the SPAD 
detectors. .......................................................................................................... 280 
Figure 102: A typical ACF of DOPE-Atto655 diffusion in a DOPC bilayer located above 
a filamentous bovine actin. The fits to a single component model were good, 
and no other diffusing species were evident within the trace. Analogous 
behaviour was observed for lipid above the other actin fibres in rabbit actin and 
human platelet actin, where ACF data could be routinely obtained. The 
experiment was carried out at room temperature in a PDMS cell. DOPE-Atto655 
was excited by a 640 nm laser line and fluorescence was passed through a 635R 
filter onto the SPAD detectors. Point measurements were performed for 
between 1 and 3 minutes. ................................................................................. 281 
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Figure 103: A summary of DOPE-Atto655 diffusion co-efficients in a DOPC bilayer 
above various actin filaments and a lipid only control fitted using a two-
dimensional single species model. Diffusion of lipid above bovine, rabbit, or 
human platelet actin failed to alter the diffusion co-efficient when compared to 
lipid diffusion above plasma-cleaned glass. This was confirmed via a one-way 
ANOVA analysis. Each point refers to the average lipid diffusion co-efficient 
over an individual actin fibre, or in the case of the control, above planar glass. 
The experiment was repeated in triplicate using three separate PDMS flow 
cells. Standard deviation was used to represent the error............................... 282 
Figure 104: Confocal and STED imaging of phalloidin-TRITC labelled human-platelet 
actin. A) A standard confocal image which was routinely used to position point 
measurements above actin filaments. B) A complementary STED image of the 
same actin filaments. STED imaging provided an improvement in resolution 
when compared with confocal imaging. Increased accuracy in positioning point 
measurements above actin filaments did not alter obtained diffusion data. 
Phalloidin-TRITC was excited by the white light laser at 542 nm. Fluorescence 
was detected between 560 and 700 nm. The experiment was carried out at 
room temperature in a PDMS flow cell. ............................................................ 283 
Figure 105: Phalloidin-TRITC stained bovine actin filaments on a PLL-coated glass 
coverslips before bilayer formation. The use of PLL coating massively increased 
the number of actin filaments present on the glass substrate when compared 
to bare glass. The experiment was carried out at room temperature in a PDMS 
cell. Phalloidin-TRITC-labelled actin was excited by a 532 nm laser line and 
fluorescence was passed through a 550LP filter onto the SPAD detectors. ..... 285 
Figure 106: Phalloidin-TRITC-stained bovine actin filaments on a PLL-coated glass 
coverslips following the formation of a spanning DOPC SLB. Unlike non-PLL-
coated glass the vast majority of the F-actin remained on the substrate 
following bilayer formation. The SLB was created via vesicle disruption. The 
experiment was carried out at room temperature in a PDMS cell. Phalloidin-
TRITC-labelled actin was excited by a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors. .................................. 286 
Figure 107: DOPE-Atto655 in a DOPC bilayer that spanned PLL-immobilised F-actin 
filaments. The lipid coverage was high but relatively heterogeneous, as some 
lipid-free defects can be seen on the surface. It was hoped that these defects 
would not negatively influence the fluidity of the lipid bilayer. The experiment 
was carried out at room temperature in a PDMS cell. DOPE-Atto655 was 
excited by a 640 nm laser line and fluorescence was passed through a 635R 
filter onto the SPAD detectors. ......................................................................... 287 
Figure 108: MCS trace of lipid above an actin filament. The image on the left shows 
separate actin filaments immobilised on PLL-coated glass. The red dot shows 
the exact location of the point measurement. This point measurement was 
used to determine the diffusion co-efficient of the lipid bilayer above the actin 
filament. The MCS trace on the right shows the photobleaching of DOPE-
Atto655 at this location showing that no lipid diffusion was apparent above this 
single actin filament. The experiment was carried out at room temperature in a 
PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence 
was passed through a 635R filter onto the SPAD detectors. ............................ 288 
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Figure 109: MCS trace of lipid above an actin bundle. The image on the left shows a 
bundle of F-actin filaments immobilised on PLL-coated glass. The red dot shows 
the exact location of the point measurement. Again this point measurement 
was used to determine the diffusion co-efficient of the lipid bilayer above the 
actin filament. As was the case above a single actin filament, the MCS trace on 
the right shows that photobleaching of DOPE-Atto655 was occurring. 
Therefore, once again the lipid bilayer appeared to be immobile. The 
experiment was carried out at room temperature in a PDMS cell. DOPE-Atto655 
was excited by a 640 nm laser line and fluorescence was passed through a 635R 
filter onto the SPAD detectors. ......................................................................... 288 
Figure 110: A DOPC bilayer formed above PLL coated glass. DOPE-Atto655 was used 
as the lipid probe. No actin was present these experiments. Despite this, the 
homogeneity of the bilayer is less than typically observed on glass alone and a 
number of defects were apparent in the bilayer. The experiment was carried 
out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 
nm laser line and fluorescence was passed through a 635R filter onto the SPAD 
detectors. .......................................................................................................... 290 
Figure 111: An MCS trace of DOPE-Atto655 in a DOPC bilayer on PLL-coated glass. As 
with the PLL immobilised actin on glass, photobleaching of lipid probe was 
evident. This data shows that PLL coating, while an excellent coating to increase 
actin surface coverage, was a poor choice of substrate for an SLB system. The 
experiment was carried out at room temperature in a PDMS cell. DOPE-Atto655 
was excited by a 640 nm laser line and fluorescence was passed through a 635R 
filter onto the SPAD detectors. ......................................................................... 291 
Figure 112: Rabbit actin filaments on APTMS/GA-coated glass before the addition of 
extruded lipid vesicles in order to form a spanning lipid bilayer. As was the case 
with PLL coating, APTMS/GA massively increased the concentration of actin 
filaments present on the glass substrate when compared to bare glass. The 
experiment was carried out at room temperature in a PDMS cell. Phalloidin 
TRITC-labelled actin was excited by a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors. .................................. 293 
Figure 113: Rabbit actin filaments on APTMS/GA-coated glass directly after bilayer 
formation at the same location. Extruded DOPC vesicles were added to the cell 
and incubated above the actin covered glass substrate and allowed to rupture 
over a 30-minute period. The APTMS/GA coating meant that the majority of 
actin filaments remained adhered to the glass with little variation between the 
before and after bilayer formation images. The experiment was carried out at 
room temperature in a PDMS cell. Phalloidin TRITC-labelled actin was excited 
by a 532 nm laser line and fluorescence was passed through a 550LP filter onto 
the SPAD detectors. .......................................................................................... 294 
Figure 114: Confocal luminescence image of DOPE-Atto655 in a DOPC bilayer formed 
above actin, immobilised on a APTMS/GA-coated glass substrate. In contrast to 
the formation of a lipid bilayer above plasma-cleaned glass, the emission was 
considerably less homogeneous. This can be seen where the lipid probe 
appears to be excluded from certain regions and aggregated in others in a 
patchwork fashion. The experiment was carried out at room temperature in a 
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PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence 
was passed through a 635R filter onto the SPAD detectors. ............................ 295 
Figure 115: Photobleaching of DOPE-Atto655 in a DOPC bilayer above actin 
immobilised on glass via an APTMS/GA coating. This bleaching means that the 
lipid bilayer was not diffusive in this sample. At this stage it was unclear 
whether this was due to the actin filaments or the APTMS/GA treatment. The 
experiment was carried out at room temperature in a PDMS cell. DOPE-Atto655 
was excited by a 640 nm laser line and fluorescence was passed through a 635R 
filter onto the SPAD detectors. ......................................................................... 296 
Figure 116: DOPE-Atto655 in a DOPC bilayer above APTMS/GA-coated glass. No actin 
filaments were present in this sample. The lipid bilayer was again not 
continuous. This can clearly be seen where much of the probe was excluded 
from the lower right of the image. Even where the probe was present in the 
upper left its coverage appears patchy when compared to plasma-cleaned 
glass. The experiment was carried out at room temperature in a PDMS cell. 
DOPE-Atto655 was excited by a 640 nm laser line and fluorescence was passed 
through a 635R filter onto the SPAD detectors. ............................................... 297 
Figure 117: Photobleaching of DOPE-Atto655 in a DOPC bilayer above APTMS/GA 
coated glass. No actin was present in this sample, yet the lipid bilayer was not 
diffusive. This suggests that the APTMS/GA coating was responsible for the 
immobilisation of the lipid molecules. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line 
and fluorescence was passed through a 635R filter onto the SPAD detectors.298 
Figure 118: Sulfo-rhodamine B-labelled cyan(+)4 below a DOPC SLB. Some cyan(+)4 
filaments remained adhered to the glass during the vesicle disruption process 
and thus were present below the lipid bilayer. This allowed the bilayer to be 
probed for changes in fluidity directly above individual fibres. The experiment 
was carried out at room temperature in a PDMS cell. Sulfo-rhodamine B-
labelled cyan(+)4 was excited by a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors. .................................. 300 
Figure 119: DOPE-Atto655 in a DOPC bilayer-spanning above cyan(+)4 fibres on 
plasma-cleaned glass. The bilayer was formed by flushing extruded LUVs across 
the surface and allowing the vesicles to rupture over a 30-minute period.  The 
resultant bilayer appeared to form without any defects. Knowing the locations 
of the fibres it was then possible to perform point measurements of the lipid 
bilayer above the peptides. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line 
and fluorescence was passed through a 635R filter onto the SPAD detectors.301 
Figure 120: A typical ACF of DOPE-Atto655 diffusion in a DOPC bilayer above 
cyan(+)4. The fits to a single component model were good and no other species 
were obvious within the trace. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line 
and fluorescence was passed through a 635R filter onto the SPAD detectors. 
Point measurements were carried out above filaments for between 1 and 3 
minutes. ............................................................................................................. 302 
Figure 121: Sulfo-rhodamine B-labelled cyan(+)6 below a DOPC SLB. Some cyan(+)6 
filaments remained adhered to the glass during the vesicle disruption process 
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and thus were present below the lipid bilayer. This allowed the bilayer to be 
probed for changes in fluidity directly above individual fibres. The experiment 
was carried out at room temperature in a PDMS cell. Sulfo-rhodamine B 
labelled cyan(+)6 was excited by a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors. Point measurements for 
the lipid diffusion co-efficients were then carried out above these filaments for 
between 1 and 3 minutes. ................................................................................. 303 
Figure 122: Sulfo-rhodamine B-labelled SR_EDS_02 below a DOPC SLB. SR_EDS_02 
was extremely difficult to polymerise and was only once immobilised on a glass 
slide below a lipid bilayer. Despite this low surface coverage, this again allowed 
the bilayer to be probed for changes in fluidity directly above individual fibres. 
The experiment was carried out at room temperature in a PDMS cell. Sulfo-
rhodamine B-labelled SR_EDS_02 was excited by a 532 nm laser line and 
fluorescence was passed through a 550LP filter onto the SPAD detectors. Point 
measurements for the lipid diffusion co-efficients were then carried out above 
these filaments for between 1 and 3 minutes. ................................................. 304 
Figure 123: A summary of DOPE-Atto655 diffusion co-efficients in a DOPC bilayer 
above cyan(+)4, cyan(+)6 and SR_EDS_02, as well a lipid only control. Data was 
fitted using a two-dimensional single species model. None of the fibres lead to 
a change in the diffusivity of the spanning lipid bilayer when compared to a 
fibre free control. This was confirmed by one-way ANOVA anlysis. Each point 
represents the average diffusion co-efficient of 5 to 10 measurements above an 
individual filament. The experiment was performed in triplicate using three 
separate flow cells, except for SR_EDS_02 where data was obtained from a 
single experiment. Standard deviation was used to represent the error. ........ 305 
Figure 124: In a reversal of the earlier experimental set-up, the various fibre-forming 
polypeptides were added above an already formed DOPC lipid bilayer. This was 
due to the fact that creating a lipid bilayer above immobilised fibres had failed 
to alter the diffusional characteristics of the SLB. ............................................ 306 
Figure 125: Phalloidin-TRITC-labelled bovine actin above a DOPC bilayer on plasma-
cleaned glass. Top shows the initial confocal image of the area. Bottom left 
shows the same area 5 minutes later, while bottom right shows the same area 
10 minutes later. It can clearly be seen that the labelled actin is mobile atop the 
SLB. The experiment was carried out at room temperature in a PDMS cell. 
Phallodin-TRITC was excited by a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors. Point measurements 
were performed for between 12 and 20 minutes to build ACF data................ 308 
Figure 126: Pholloidin-TRITC-labelled rabbit actin above a DOPC bilayer formed on 
plasma-cleaned glass. As was the case with bovine actin these actin filaments 
were mobile atop the SLB and thus only low resolution images could be 
obtained. The experiment was carried out at room temperature in a PDMS cell. 
Phallodin-TRITC was excited by a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors. .................................. 309 
Figure 127: Pholloidin-TRITC-labelled human platelet actin above a DOPC bilayer 
formed on plasma-cleaned glass. In agreement with our bovine and rabbit actin 
results, human platelet F-actin was mobile on top of a SLB and once again only 
low resolution images could be obtained. The experiment was carried out at 
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room temperature in a PDMS cell. Phalloidin-TRITC was excited by a 532 nm 
laser line and fluorescence was passed through a 550LP filter onto the SPAD 
detectors. .......................................................................................................... 310 
Figure 128: A representative ACF of phalloidin-TRIC-labelled rabbit actin diffusing 
above a DOPC bilayer. Fits to ACF trace were often difficult when compared to 
the ease at which lipid data was routinely fitted. Nonetheless diffusion co-
efficients could be obtained for actin filaments above a DOPC bilayer. The 
experiment was carried out at room temperature in a PDMS cell. Phallodin-
TRITC was excited by a 532 nm laser line and fluorescence was passed through 
a 550LP filter onto the SPAD detectors. Point measurements were performed 
for between 12 and 20 minutes to build ACF data. .......................................... 311 
Figure 129: A summary of actin diffusion co-efficients above a DOPC SLB. The actin 
was labelled with phalloidin-TRITC and flushed on top of a preformed lipid 
bilayer. Point measurements were then performed over a 12 to 20 minute 
period and the ACF data was fitted to a two-dimensional model. A lipid probe 
was also included in the form of DOPE-Atto655 to determine whether actin 
presence altered the bilayer’s diffusive properties. It was found that the actin 
filaments diffused much slower than the SLB, while the lipid itself behaved as 
normal with no change in the diffusion co-efficients when compared to 
previous actin free experiments. Standard deviation was used to represent the 
error. .................................................................................................................. 313 
Figure 130: Sulfo-rhodamine B-labelled cyan(+)4 on top of a DOPC SLB. Top shows 
cyan(+)4  after flushing the fibres across the bilayer. Bottom left shows the 
fibres 10 minutes later, while bottom right shows the fibres 30 minutes later. 
The movement of the fibres was negligible over the course of the experiment. 
Sulfo-rhodamine B-labelled fibres were excited with a 532 nm laser line and 
fluorescence was passed through a 550LP filter onto the SPAD detectors. ..... 316 
Figure 131: Sulfo-rhodamine B-labelled cyan(+)6 on top of a DOPC SLB. Top shows 
cyan(+)6  after flushing the fibres across the bilayer. Bottom left shows the 
fibres 10 minutes later, while bottom right shows the fibres 30 minutes later. 
As was the case with cyan(+)4, the movement of the cyan(+)6 was negligible 
over the course of the experiment. Sulfo-rhodamine B labelled fibres were 
excited with a 532 nm laser line and fluorescence was passed through a 550LP 
filter onto the SPAD detectors. ......................................................................... 317 
Figure 132: A typical ACF and its two-dimensional single component fit for DOPE-
Atto655 in a DOPC bilayer “below” a cyan(+)4 fibre. The immobility of the 
cyan(+)4 (and cyan(+)6) fibres may suggest that the filaments are not in fact 
resting above the lipid bilayer but rather have penetrated through the 
membrane to interact with the underlying glass substrate. On the other hand 
the fibres may immobilise a thin length of underlying lipid molecules to remain 
stationary above the SLB. .................................................................................. 319 
Figure 133: A summary of lipid diffusion co-efficients for DOPE-Atto655 in a DOPC 
SLB “below” cyan(+)4 and cyan(+) 6 fibres, as well as a fibre-free control. The 
fact that the fibres remained stationary rather than diffusion in tandem with 
the lipid suggests that the fibres have penetrated through the lipid bilayer to 
interact with the underlying substrate. Nonetheless the fibre’s presence does 
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not appear to provide a sufficient barrier to lipid diffusion to alter DOPE-
Atto655 mobility when compared to a lipid only control. ................................ 320 
Figure 134: By combining cytoskeletal structures with our PDMS cavity arrays we 
would hope to more accurately reflect the cell membrane in an artificial lipid 
model. This top down sketch of one such proposed experiment would involve 
the formation of a cytoskeletal mesh (such as actin) across buffer-filled 
microcavites. By spanning a protein inserted (such as integrin) SLB across the 
microcavity we could better mimic the cell membrane. Here membrane 
proteins could be examined in a biologically-relevant environment. .............. 321 
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Glossary of Tables 
Table 1: The lipid composition of the platelet. The literature is in broad agreement 
with the breakdown of lipid components within the platelet. PC-based 
phospholipids make up the bulk of the lipids, followed by PE and PS containing 
phospholipids. SM is also a major lipid component of the cell. Phospholipids 
outnumber cholesterol approximately 2 to 1. .................................................... 45 
Table 2: Summary of αIIbβ3 integrin reconstitution papers in the literature. The vast 
majority of papers have incorporated αIIbβ3 into DMPC-containing compositions 
using triton x-100 and bio-beads. The papers that feature diffusion 
measurements have all been for SLB systems and utilised FRAP. ...................... 55 
Table 3: The maximum observed aggregation of washed platelets in response to 
DTT, Mn2+ and Mn2+ with the addition of fibrinogen at a final concentration of 1 
mg/ml. While DTT alone is capable of bringing about a sizable degree of 
aggregation, Mn2+ must be co-incubated with fibrinogen for whole platelet 
aggregation to become observable. ................................................................. 107 
Table 4: A summary of the different responses to artificial agonists DTT and Mn2+ 
and the physiologically-relevant agonist TRAP. Both TRAP and DTT readily lead 
to platelet aggregation, albeit the DTT response featured a noticeable lag-
phase. On the other hand, Mn2+ appeared to be a relatively poor agonist where 
fibrinogen supplementation was required to yield noticeable platelet 
aggregation. ....................................................................................................... 108 
Table 5: A summary of the influence of TRAP, DTT, and Mn2+ on PAC-1 binding  and 
fibrinogen binding. While TRAP has been shown to be an excellent agonist in 
terms of platelet aggregation, PAC-1 binding appeared to show that αIIbβ3 
conformational changes were surprisingly minimal. Despite this, labelled 
fibrinogen binding was readily observable. DTT was shown to result in both 
significant PAC-1 and fibrinogen binding. In contrast to this while Mn2+ resulted 
in significant integrin conformational changes, no labelled fibrinogen binding 
was detected. These results hint at a disconnect between conformational 
changes in the integrin protein and ligand binding. ......................................... 120 
Table 6: A summary of integrin αIIbβ3 diffusion in artificial lipid systems. So far 
diffusion measurements have only been performed in SLBs. As such, a massive 
percentage of the protein has been rendered immobile, even when polymer 
cushions were utilised. The αIIbβ3 that was not rendered immobile diffuses 
relatively slowly when compared to free-standing lipid systems such as our 
GUVs. ................................................................................................................. 135 
Table 7: αIIbβ3 saturation of GUVs. The use of varying starting concentrations of 
αIIbβ3appeared to have little influence on the average number of molecules in 
the focal volume during FLCS point measurements, indicating that nature’s own 
GUVs are easily saturated with properly reconstituted αIIbβ3. ......................... 168 
Table 8: The measured diffusion co-efficients for a selection of lipid compositions 
used in GUV experiments. Using lipid probes such as DOPE-Atto532 or DOPE-
Atto655 FLCS point measurements were recorded at room temperature. At the 
ratios used, the inclusion of DOPE and DOPS appeared to have no influence on 
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the diffusion of the GUV lipid bilayer. Only when cholesterol and sphingomyelin 
were included in the vesicle membrane such as in nature’s own could a change 
in the diffusion co-efficient by identified. This was verified by a one-way ANOVA 
with Bonferroni post-hoc test (p < 0.001). The alpha value appeared to be 
unchanged by cholesterol and sphingomyelin presence and remained 1 
throughout. Standard deviation was used to report the error. ........................ 173 
Table 9: The measured diffusion co-efficients for a fluorescently-labelled αIIbβ3 in a 
variety of lipid compositions. Integrin in the cholesterol and sphingomyelin-
containing nature’s own composition diffused slower than in the other 
examined compositions. The alpha value, regardless of lipid composition, was 
1. All point measurements took place at room temperature. Standard deviation 
was used to report the error. ............................................................................ 177 
Table 10: Lipid and integrin αIIbβ3 diffusion in nature’s own GUVs. The table shows 
the diffusion coefficient before activation in the presence and absence of 
fibrinogen, and after activation in the presence and absence of fibrinogen. 
Activation or ligand addition alone was not sufficient to bring about a 
measurable change in αIIbβ3 diffusion. The combination of activation and ligand 
addition was sufficient to bring about a reduction in diffusion of αIIbβ3 
attributed to integrin aggregation. This was confirmed by a one-way ANOVA 
and post-hoc Bonferroni test where p < 0.001. Furthermore, the combination of 
activation and ligand addition led to anomalous diffusion of αIIbβ3 as indicated 
by the alpha values. Error was reported used standard deviation. .................. 182 
Table 11: The lateral diffusion co-efficient of DOPE-Atto655 in DOPC versus nature’s 
own bilayers on plasma-cleaned glass at 21, 25, 30 and 37 C. Increasing the 
experimental temperature lead to an increase in the diffusion co-efficient of 
the lipid bilayer. The nature’s own lipid composition was slightly less mobile 
than a pure DOPC bilayer due to the inclusion of cholesterol and 
sphingomyelin. Standard deviation was used to report the error. .................. 214 
Table 12: Summary of diffusion co-efficients obtained by positon. Slight deviations 
from the centre of cavities lead to a considerable fall in the apparent diffusion 
co-efficient owing to influence from the slower moving lipid above planar 
PDMS regions. This sudden fall off in diffusion co-efficients was unexpected in 
the “off-centre” regions given the apparent dimensions of the cavities and the 
focal volume of the point measurements. Error was reported used standard 
deviation. ........................................................................................................... 225 
Table 13: Summary of diffusion co-efficients of components in a DOPC/DOPS (8:2) 
lipid bilayer reconstituted with annexin V. The protein was highly mobile above 
cavities although the diffusion co-efficient was below that found for lipid at the 
same location. On the other and, while the lipid was mobile on planar PDMS 
regions, annexin V was immobile at these locations where photo-bleaching was 
evident. Standard deviation was used to report the error. .............................. 231 
Table 14: Summary of diffusion co-efficients in a DOPC lipid bilayer reconstituted 
with IIb3 using the Müller et al. method. The reconstituted IIb3 protein was 
found to have a diffusion co-efficient well in excess of the surrounding lipid 
phase indicating that protein was not properly inserted into the bilayer in our 
SLB system. This is in contrast to our GUV results were IIb3 was found to 
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diffuse much slower than the lipid membrane. Standard deviation was used to 
report the error. ................................................................................................ 236 
Table 15: Summary of diffusion co-efficients in a DOPC lipid bilayer reconstituted 
with IIb3 using the GUV intermediate method. In contrast to the high diffusion 
values witnessed using the original integrin insertion method, this new 
reconstitution method delivered IIb3 diffusion co-efficient well below the lipid 
diffusion co-efficient above cavities. On planar regions the integrin protein was 
immobile where bleaching was evident. Standard deviation was used to report 
the error. ........................................................................................................... 240 
Table 16: A summary of diffusion co-efficients in a Nature’s own lipid bilayer 
reconstituted with IIb3 using the GUV intermediate method. As with a pure 
DOPC bilayer the IIb3 diffused much slower than the lipid value above cavities. 
Likewise the IIb3 was immobile above planar PDMS. Of particular note is that 
the integrin protein diffused slower in this composition than in a pure DOPC 
bilayer. Standard deviation was used to report the error. ............................... 242 
Table 17: The influence of integrin activators alone on the diffusion co-efficient of 
IIb3 above cavities in a nature’s own bilayer. No change in the mobility of the 
integrin protein was recorded as confirmed via ANOVA analysis. This was to be 
expected given our results in GUVs. Standard deviation was used to display the 
error. .................................................................................................................. 245 
Table 18: The influence of integrin activators in the presence of the integrin ligand 
fibrinogen. No change in the mobility of the integrin protein was detected. This 
was shown via one-way ANOVA analysis. This was unexpected given our results 
in GUVs where the use of an integrin activator in the presence of fibrinogen 
lead to measureable reduction in the mobility of IIb3. Standard deviation was 
used to display the error. .................................................................................. 247 
Table 19: A table describing the characteristics of Dr Ryadnov’s group’s fibre-forming 
peptides. Three different self assembling peptides known as cyan(+)4, cyan(+)6, 
and SR_EDS_02 were provided. ........................................................................ 268 
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Abstract 
The cell membrane is complex mixture of phospholipids, sphingolipids, sterols and 
proteins that combine to provide a semi-permeable barrier between the 
extracellular and intracellular environments, while also providing a functional role in 
cell-signalling, cell adhesion, and membrane transport. This complexity means that it 
is often better to study both the lipid and protein constituents of the cell membrane 
using artificial membrane models. Here, the transmembrane protein integrin αIIbβ3 
was used as a model protein to be reconstituted into physiologically-relevant 
artificial lipid systems. αIIbβ3 is an integral membrane protein found in platelets and 
is a key mediator of thrombosis. Upon activation αIIbβ3 undergoes significant 
conformational rearrangement, clustering, and ligand-binding to enable complex 
bidirectional signalling. It is this structural rearrangement, aggregation and ligand 
binding that was the key focus of this project.  
 
In chapter 2, and before reconstitution into artificial lipid models, αIIbβ3 was first 
studied in its native environment, the platelet. Here, DTT and Mn2+ were used to 
induce the activated form of αIIbβ3. It was found that both activators lead to 
structural changes in the integrin protein and varying degrees of platelet 
aggregation, without the full range of response normally associated with 
physiological agonists. Chapter 3 focused on the production of αIIbβ3-reconstituted 
liposomes. It was found that integrin-ligand binding lead to a reduction in αIIbβ3 
mobility, as well as integrin clustering. αIIbβ3 was also found to preferentially 
excluded from cholesterol rich regions of lipid vesicles. Chapter 4 focused on the 
insertion of αIIbβ3 into a novel, cavity-spanning, lipid bilayer. Here, it was possible to 
determine αIIbβ3 diffusion co-efficients and induce protein aggregation. Finally, in 
chapter 5, cytoskeletal mimics were incorporated alongside a supported lipid bilayer 
in order to better imitate the conditions encountered by the cell membrane. 
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1. The Cell Membrane and 
Artificial Models 
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1.1. The Cell Membrane 
At its most basic level, the cell membrane is a fluid lipid bilayer composed of 
constituent phospholipids, glycolipids, and cholesterols, interspersed with a range of 
proteins with varying biological roles. Cell membranes are semi-permeable 
membranes that enclose the cell cytoplasm to separate the cell from its outside 
environment. Over the years, a number of models have been proposed to explain 
how lipid molecules organise themselves in cell membranes. The first membrane 
model, proposed by Danielli et al. in 1935, built on the knowledge that lipids 
organise themselves into bilayers and suggested that a protein layer is tightly 
associated to the polar heads of lipids in the membrane.1 This was further expanded 
on in 1972 when Singer and Nicolson put forward the “fluid mosaic model”. In it, the 
cell membrane was described as a bilayer consisting of a homogenous mixture of 
diffusing macromolecules (lipids, proteins, glycoproteins, etc).2 Since then this 
model has evolved and expanded to better describe the composition and 
organisation of the cell membrane. The biggest change in the model is the that this 
membrane is no longer thought to a homogenous mixture, but rather the various 
lipids and proteins are compartmentalised in heterogeneous phases, or domains. 
These domains are dynamic, restless, and cooperative molecular assemblies, which 
constantly form and disband within the plasma membrane over various timescales.3 
Of particular interest is the separation of lipids into the liquid disordered phase and 
liquid ordered phase. As the name suggests, the liquid ordered phase is a rigid and 
well-organised region, rich in sphingolipids and sterols. These nanoscale detergent 
resistant phases are often referred to as lipid rafts. It is believed these rafts function 
to serve as platforms for proteins that are involved in cell signalling.4,5 In addition to 
these liquid disordered and liquid ordered phases, membrane invaginations, 
adhesive structures, and lectin-glycoprotein lattices are some of the features that 
have been added to the original fluid mosaic model.6 
 
The dominant components of cell membranes are phospholipids. Phospholipids are 
amphiphiles and contain a hydrophilic headgroup and a hydrophobic tail composed 
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of two fatty acid chains. These chains may be saturated or unsaturated and are 
covalently linked to a phosphate group via a glycerol backbone. To the phosphate 
group, a simple molecule such as choline, serine, glycerol or ethanolamine is 
attached to form the headgroup. The amphipathic nature of phospholipids gives rise 
to their structural role. When exposed to an aqueous environment they readily self-
assemble into bilayers with the hydrophilic heads orientated outwards and the 
hydrophobic tails buried within the interior.7 Pure phospholipids have an intrinsic 
phase transition temperature, the temperature at which the phospholipid changes 
from a freely diffusing liquid phase to a rigid solid or gel phase. The temperature at 
which this occurs is dependent on the structure of the phospholipid. Longer fatty 
acid chain lengths exhibit higher phase transition temperatures, owing to increased 
Van der Waals interaction along their tails, and thus decreased lipid mobility. As well 
as the effect of chain length on phase transition temperature, the degree of 
unsaturation of the tails also influences the phase behaviour. The more double 
bonds present in the tail, the lower phase transition temperature. This is due to the 
fact that unsaturated tails interrupt the “packing” of phospholipids in the bilayer 
resulting in greater lipid mobility.8     
 
Sphingolipids, like phospholipids, are composed of a polar head group and non-polar 
tail group. They have a long chain sphingoid base, generally 18 carbons in length. In 
the case of more complex sphingolipids they can form an amide-link to a long chain 
fatty acid.9 The sphingolipid sphingomyelin, which is used throughout this thesis, is 
also composed of a phosphocholine or phosphoethanolamine head group. Owing to 
their long, largely saturated acyl chains, sphingolipids pack tightly in a bilayer, 
allowing for very little lateral movement. They are predominantly found in the outer 
leaflet of cell membranes and contribute to the stability of the bilayer.9 As well as its 
role in signal transduction, sphingolipids plays an important role in the formation of 
lipid rafts.  
 
The most well-known of the water insoluble sterols, cholesterol has a hydrophobic 
rigid ring structure with a short hydrocarbon tail. Cholesterol also has a polar 
hydroxyl group meaning it is also amphipathic in nature. In bilayers, the hydrophobic 
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ring of cholesterol positions itself adjacent to fatty acid tails of phospholipids, while 
the hydroxyl group of cholesterol forms hydrogen bonds with polar phospholipid 
head groups. Cholesterol has quite contrasting roles in the cell membrane, in that its 
rigidity decreases the mobility of phospholipid hydrocarbon tails, but its structure 
also serves to interfere with close packing of fatty acid tails. As such, cholesterol 
serves as a buffer between extremes of fluidity in the cell membrane. As previously 
mentioned, cholesterol also has an important role in the formation of lipid rafts. It 
associates primarily with lipids that feature long saturated fatty acyl chains, such as 
sphingomyelin. This non-random clustering forms the ordered raft domains that 
may have roles in membrane trafficking, cell-signalling and endocytosis.10 
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Figure 1: Examples of the main components of the lipid membrane. A) A phospholipid (DOPC). Phospholipids 
make up the bulk of the lipid membrane. Phospholipids consist of a hydrophilic headgroup and a hydrophobic 
tail composed of two fatty acid chains. These chains may be saturated or unsaturated and are covalently 
linked to a phosphate group via a glycerol backbone. To phosphate group, a simple molecule such as choline, 
serine, glycerol or ethanolamine is attached to form the headgroup. B) A sphingolipid (spingomylein). 
Sphingolipids are also composed of a polar head group and non-polar tail group. They have a long chain 
sphingolipid base and, in the case in the case of more complex sphingolipids, can form an amide-link to a long 
chain fatty acid. C) A sterol (cholesterol). Cholesterol has a hydrophobic rigid ring structure with a short 
hydrocarbon tail. Cholesterol also has a polar hydroxyl group meaning it is also amphipathic in nature. 
  
While the basic structure of the cell membrane is provided by the aforementioned 
lipid constituents, membrane proteins perform the majority of the specific functions 
of membranes.  The different classifications of membrane protein are summarised in 
Figure 2. Membrane proteins enable the cell to interact with the extracellular 
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environment and allows for a cell’s characteristic functional properties. Due to this 
specificity, the proteins found within the cell membrane are numerous and diverse. 
Membrane bound proteins are typically classified as either integral; in which a 
portion of the protein is embedded within the bilayer, or peripheral, where the 
protein interacts with the exterior of the membrane or through binding via one of its 
constituents. For example, transmembrane proteins are integral proteins which 
extend through the lipid bilayer. Like the lipids themselves, transmembrane proteins 
are amphipathic and contain both hydrophilic and hydrophobic regions, the 
hydrophobic, spanning portion of such proteins are typically either α-helical or -
barrel structures. Other integral membrane proteins do not span through the bilayer 
but rather interact with a lipid monolayer of the cell membrane. This interaction 
may be through the hydrophobic face of an alpha helix or via covalent attachment 
to the lipid chains for example. This may occur on either the extracellular or 
intracellular side of the lipid bilayer. Finally, peripheral proteins do not interact 
directly with the lipid bilayer but rather act through membrane associated 
intermediates. Again these proteins may be found both extracellularly or 
intracellularly.11 This thesis primarily focuses on a membrane protein αIIbβ3. αIIbβ3 is 
member of the integrin family of transmembrane receptors. Integrins are receptors 
found ubiquitously in metazoan cells. They facilitate cell migration and extracellular 
matrix assembly and are involved in a wide range of activities, including immune 
response, cell proliferation and apoptosis.12 Like all 24 members of the integrin 
family, αIIbβ3 is a heterodimer of an alpha and beta subunit that spans the platelet 
plasma membrane once.13 αIIbβ3 is found solely within the platelet lipid membrane, 
and numbers 50,000 to 80,000 copies per platelet making it the most abundant 
receptor on the cell fragment’s surface. It’s main role is in thrombosis where it 
undergoes significant conformational rearrangement, inducing complex 
bidirectional signalling and protein recruitment leading to platelet activation.14 
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Figure 2: Different types of membrane proteins. Transmembrane proteins may extend across the lipid bilayer 
as single a single alpha helix (1), multiple alpha helices (2), or as rolled beta-sheets (3). Some membrane 
proteins are anchored to the cytosolic surface by an amphipathic alpha helix that partitions into the cytosolic 
monolayer of the lipid bilayer through the hydrophobic face of the helix (4). Others are membrane attached 
via a covalently attached lipid chain in the cytosolic monolayer (5). Some may be membrane attached via an 
oligosaccharide linker, to phosphatidylinositol in the non-cytosolic monolayer (6). Finally, peripheral 
membrane proteins interact with the lipid membrane via non-covalent interactions with other membrane 
proteins intracellularly (7), or extracellularly (8). Imaged from “Molecular Biology of the Cell”.11 
 
This thesis focuses on the lipid bilayer and transmembrane components of the 
platelet membrane. While the lipid composition of the platelet is discussed here, 
many of the membrane proteins are discussed in chapter 2. Within the literature, a 
number of different studies exist on the platelet lipid composition.15–17 These are 
summarised in Table 1. Of the phospholipids, the majority have a 
phosphatidylcholine (PC) headgroup. The second most common headgroup is 
phosphatidylethanolamine (PE), while the third most common headgroup is 
phosphatidylserine (PS). All reports also agree that sphingomyelin (SM) is the 
primary sphingolipid found in platelets. This PC dominant lipid makeup is in contrast 
to some other cells; for example, in erythrocytes, PC, PE, and SM are found in almost 
equal parts.15 Data also exists on the chain length of these lipid components. Owen 
et al. state that 20:4, 18:0, 18:1, and 16:0 fatty acids dominate the lipid make up of 
the platelet.15 Hamid et al. highlights the same fatty acids types as well as 22:1. They 
later go on to breakdown this further: The relative majority of PC lipids are 16:0 fatty 
acids. The relative majority of PE lipids are 20:4 and 22:1 fatty acids. The relative 
majority of PS lipids are 18:0 fatty acids.16 This breakdown of fatty acid content is 
also in agreement with Marcus et al.17 Turning attention to the sterol composition in 
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platelets, phospholipids outnumber cholesterol 1.75 to 1 (mol/mol) according to 
Owen et al.15 Hamid et al. give the ratio in weight, stating that the ratio is 4.42 to 1 
(mg/mg).16 Given that cholesterol has a molecular weight of 386 g/mol, and taking 
DOPC as a model phospholipid with a molecular weight of 786 g/ml we can 
approximate that phospholipids are twice the molecular weight of cholesterol. 
Taking this into account we can say that ratio of phospholipids to cholesterol is 
approximately 2.2 to 1, roughly in line with Owen’s work. Similarly, Marcus et al. 
found a ratio of approximately 2 phospholipids for every 1 cholesterol molecule. For 
comparison, they state that liver plasma membranes have an approximate molar 
ratio of 3.8 to 1, erythrocytes have an approximate molar ratio of 1.1 to 1, and brain 
myelin has an approximate molar ratio of 0.76 to 1 (phospholipid:cholesterol).17  
 
Table 1: The lipid composition of the platelet. The literature is in broad agreement with the breakdown of lipid 
components within the platelet. PC-based phospholipids make up the bulk of the lipids, followed by PE and PS 
containing phospholipids. SM is also a major lipid component of the cell. Phospholipids outnumber cholesterol 
approximately 2 to 1. 
 Owen et al.15 Hamid et al.16 Marcus et al.17 
Lipid type Approximate % of phosphorus containing lipids in platelets 
PC 40 39 39 
PE 28 26 26 
PS 9 9 10 
SM 19 18 18 
 Approximate phospholipid to cholesterol ratio (mol/mol) 
PL:CH 1.75 2.2 2 
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1.2. Biomimetic Models 
As previously described, the cell membrane is a complex and dynamic mixture of 
lipids and proteins interacting with one another. Due to this complexity, it is often 
desirable to create biomimetic models of the lipid membrane where constituents 
can be included or excluded at will. To this end, a range of biomimetic systems have 
been used within the the literature but they can generally be divided into two 
categories: lipid vesicles, and supported lipid bilayers (SLBs). Lipid vesicles (also 
known as liposomes) are free-standing, quasi-spherical, structures formed from an 
enclosed lipid bilayer. SLBs are planar lipid bilayers formed above a solid substrate 
such as glass or mica. Both lipid vesicles and SLBs may be formed from a wide range 
of techniques each with their own advantages and disadvantages.1 In this thesis we 
sought to produce both vesicle-based (chapter 3) and SLB-based biomimetic models 
(chapter 4). One of the key goals of the project was to expand on the existing work 
within the literature by utilising more physiologically-relevant lipid compositions in 
order to more accurately mimic the cell membrane. Indeed, one of the striking 
features of existing models is reliance on unary or binary lipid compositions. Here, 
we explored more complex lipid mixtures including a composition adopted from the 
Lentz group at the University of North Carolina at Chapel Hill; known as nature’s 
own, and various domain-forming lipid compositions.  
 
While purely lipid models have their role, biomimetic systems are particularly 
powerful when membrane proteins are reconstituted within the lipid bilayer. This 
allows for the study of said protein in controlled isolation, away from the complexity 
of the cell membranes and any exogenous agents. For example, drug interactions, 
ligand binding, and diffusional studies may be carried out on reconstituted proteins, 
away from the multitude of other membrane constituents that would otherwise 
complicate such measurements. Given that we wanted to insert membrane proteins 
into our biomimetic models we needed to explore and understand various 
reconstitution techniques. A search of the literature shows that a number of general 
strategies may be used: 
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Perhaps the simplest method of membrane protein reconstitution is the 
spontaneous insertion of proteins into preformed unilamellar vesicles. A number of 
membrane proteins have been bilayer inserted via this method, such as cytochrome 
c oxidase, cytochrome b5, bacteriorhodopsin, and F0F1-ATPase.18 Such reconstitution 
appears to more successful where impurities are introduced into the lipid (eg short 
chain myristic acids or cholesterol).19 An additional factor that appears to influences 
direct incorporation is vesicles size, where insertion occurred preferentially in 
liposomes with a small diameter (approximately 20 nm).18 
 
Organic solvents have also been successfully used to reconstitute membrane 
proteins in artificial lipid bilayers. Based on reverse phase evaporation, a method 
utilised to prepare large unilamellar and multilamellar vesicles20, membrane 
proteins are added to the lipid-solvent mixture before the solvent is evaporated and 
the vesicles formed from the dried protein and lipid film. This protocol has been 
used to successfully insert a wide range of membrane proteins into liposomes, such 
as rhodopsin21, bacteriorhodopsin22, acetylcholine receptor (AcChR)23, and 
cytochrome c oxidase.24 The biggest and most obvious drawback to this insertion 
protocol is the usage of harsh organic solvents in direct contact with often delicate 
and easily denatured membrane proteins. 
 
A rather crude approach to membrane protein insertion is the use of mechanical 
means to reconstitute the protein. Such mechanical means are routinely used to 
produce Small Unilamellar Vesicles (SUVs) or Large Unilamellar Vesicles (LUVs) from 
a lipid-buffer solution.25 Sonication of such a mixture in the presence of membrane 
protein is one such method to incorporate transmembrane proteins into SUVs, 
although this method is obviously hindered by protein inactivation during the 
sonication process.18 A slight modification to this protocol utilises a freeze thaw 
cycle to reduce the sonication time. Here, preformed vesicles are mixed with the 
membrane protein of choice before undergoing the freeze-thaw step before a short 
sonication phase. This technique has been used to reconstitute erythrocytes D-
glucose transporter into lipid vesicles.26 
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By far the most common and successful method of membrane protein 
reconstitution utilises detergent-mediated reconstitution. In its simplest form, this 
approach begins with the creation of a lipid-protein-detergent mixture, followed by 
the removal of said detergent to leave behind a lipid-protein assembly. The exact 
protocol of reconstitution may vary between choice of protein and choice of 
detergent. Some groups use preformed SUVs27 or LUVs28 as the target for 
reconstitution. Others have used a solubilised lipid suspension as the lipid source 
rather than preformed lipid vesicles.29–31 It is also possible to directly target 
preformed GUVs during the insertion process,32,33 although this is harder to scale up 
and also runs the risk of vesicle destruction. In all cases, the end result is the 
formation of membrane protein reconstituted lipid vesicles, or proteoliposomes.  
 
In similar fashion, detergent-mediated reconstitution can also be used to form 
membrane protein inserted SLBs. This can be achieved via the deformation of 
proteoliposomes to form a supported planar bilayer.34 Alternatively, detergent-
mediated insertion of membrane proteins into an SLB can be achieved in situ. In this 
case a preformed SLB may be created by whatever means before being partially 
solubilised by a detergent. By carefully controlling the detergent concentration, the 
SLB can be weakened to allow for membrane protein insertion without bilayer 
destruction. Subsequently, the detergent may be removed to leave behind an SLB 
containing properly inserted transmembrane proteins.35 
 
To achieve this solubilisation process a wide range of detergents have been used, 
including, but not limited to, triton x-10030, β-OG27, CHAPS36, and octyl-POE33. While 
some groups have sought to use minimal detergent concentrations to simply bring 
preformed lipid vesicles to the onset of solubilisation, other groups have sought to 
fully solubilise the lipid vesicles to allow for protein insertion. There is no general 
consensus on what detergent to use in the solubilisation process where the main 
concern is minimising protein aggregation and any other deleterious effects to the 
membrane protein. To this end, Rigaud and Lévy have proposed that glycosylated 
detergents (such as β-OG or dodecylmaltoside), polyoxyethylenic detergents (such 
as triton x-100 or C12E8), as well as ionic detergents (such as cholate) all be explored 
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as possible candidates for membrane protein insertion.37 Interestingly, Müller et al. 
reported that lipid composition influenced detergent choice. In the reconstitution of 
αIIbβ3 they reported that triton-x 100-mediated insertion into DMPC and 
DMPC/DMPG vesicles was successful, while triton-x 100-mediated insertion into 
POPC/POPS vesicles was unsuccessful. On the other hand, β-OG-mediated insertion 
into DMPC and DMPC/DMPG vesicles was unsuccessful, yet β-OG-mediated 
insertion into POPC/POPS was successful (although not as successful as triton-x 100 
and DMPC or DMPC/DMPG). However, it must be noted that the detergents were 
removed via different means in this case, where triton x-100 was removed by 
detergent adsorbent beads, and β-OG removed be extensive dialysis.34 Thus it is 
unclear whether the differing observations are as a result of detergent choice or 
means of detergent removal. To date there is no definitive guide for membrane 
protein reconstitution, where most successful insertions appear to have been 
achieved through a trial and error process. In this thesis both triton x-100 and β-OG 
were explored in the detergent-mediated reconstitution process. 
 
Whatever the means of formation of the lipid-protein-detergent mixture, the 
detergent must subsequently be removed from the micellar solution, allowing 
formation of closed lipid bilayers in which the proteins are incorporated. Once again 
the strategies for this step are wide ranging. Perhaps the simplest way detergent 
removal may be achieved is via dilution. Whilst not capable of completely removing 
detergent from the solution, dilution with a detergent-free buffer can reduce the 
initial surfactant below its critical micelle concentration, (CMC). The CMC is defined 
as the concentration at which detergent monomers form micellar aggregates18, and 
reduction of detergent concentration below its CMC allows for the spontaneous 
formation of closed proteoliposomes. Practically speaking, this particular technique 
is limited to use with detergents with high CMCs such as cholate or β-OG and even 
so will normally require some later concentration step in order to obtain a solution 
with a workable protein concentration. As well as this, because the detergent is not 
actually removed from the solution, residual surfactants may influence downstream 
experiments. This particular method has been used to reconstitute sarcoplasmic 
reticulum Ca2+ ATPase and cytochrome oxidase38, as well as bovine rhodopsin.39 
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Dialysis is a common and effective method for removing detergent from the 
solution. Here the lipid-protein-detergent mixture is dialysed against a detergent-
free buffer. Only the detergent monomers diffuse through the dialysis tubing leaving 
behind a closed proteoliposome assembly. Again this method of detergent removal 
is best suited to remove detergents with high CMCs. It is also more difficult to 
reproduce and control the rate of dialysis, is relatively time consuming, and may 
leave trace amounts of surfactant behind. On the other-hand it is a simple, low-cost, 
and low-maintenance method of detergent removal.37 Dialysis has been used in the 
insertion of many membrane proteins including, but not limited to, SNARE 
proteins27, bovine rhodopsin39, and spinach aquaporin SoPIP2;1.40 Dialysis was one 
of the detergent removal processes utilised in this thesis, specifically for the removal 
of the detergent β-OG. 
 
Perhaps the most common method of detergent removal is the use of detergent-
adsorbent beads such Bio-Beads SM-2 or Amberlite XAD. The key advantage of this 
method is that detergent-adsorbent beads can be used regardless of the detergents 
CMC. The beads may be added directly to the lipid-protein-detergent solution, may 
be added to the outside of a dialysis bag to speed up the transfer process or may be 
used on a filtration column. Other major advantages of adsorbent beads is that the 
rate of surfactant removal can be controlled by varying the concentration of beads 
added, the fact that the beads ensure full detergent removal, as well as its high rate 
of reproducibility.37 Detergent-adsorbent beads have been used for surfactant 
removal in the reconstitution process of platelet integrin αIIbβ330, the lactose 
transporter LacS41, and the porin OmpF33, amongst many others. In this thesis Bio-
Beads were routinely used for the removal of triton x-100 after protein insertion. 
 
Therefore, in summary, one of the key goals of this project was to explore these 
reconstitution techniques in order to insert membrane proteins into both liposome 
and SLB models, while maintaining the biological relevance of the lipid environment.  
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1.3. αIIbβ3 reconstitution 
While a number of membrane proteins were explored by the group, the primary 
model protein used for reconstitution in this thesis was platelet integrin αIIbβ3. Prior 
to this work, there existed a number of relevant studies where αIIbβ3 had been 
reconstituted in a number of different artificial lipid systems. The first mention of 
αIIbβ3 reconstitution in lipid vesicles is found in work by Parise and Philips where 
αIIbβ3 was added to variety of egg yolk PC and bovine brain PS compositions in the 
presence of octyl glucoside. The lipid-protein-detergent solution was well mixed 
before a brief sonication period. To remove the detergent, the mixture was dialysed 
against a detergent-free buffer. It was found that a using a mixture of 30 % PC and 
70 % PS (mol/mol) lead to the highest degree of integrin reconstitution and that the 
vast majority of integrin was orientated with its extracellular domain on the outside 
of the lipid vesicles as determined by cryoelectron microscopy.42 
 
More in-depth work was done by Müller et al. where αIIbβ3 was incorporated into 
lipid vesicles using two different reconstitution methods, several detergents, and 
differing lipid compositions. All of these criteria reportedly influenced success of the 
αIIbβ3 insertion process as examined via cryoelectron microscopy. For example, using 
triton x-100 and bio-beads SM-2 to insert αIIbβ3 into POPC/POPS vesicles did not 
result in successful reconstitution. However, changing the lipid composition to 
DMPC or DMPC/DMPG (1:1) did result in successful reconstitution. Intriguingly, 
changing the detergent to octyl glucoside and the removal method to dialysis lead to 
almost the exact opposite result. Here, DMPC or DMPG vesicles could not be αIIbβ3-
reconstituted, while POPC/POPS vesicles could be αIIbβ3-reconstituted. In this case 
the protocol and the ratio of POPC/POPS was almost exactly the same as the earlier 
work by Parise and Philips (30/70 versus 25/75) although interestingly this update 
reported the αIIbβ3 insertion as “partial” as well as stating that “incorporation was 
not homogeneous” suggesting that αIIbβ3 had a tendency to aggregate under these 
conditions. They did not further expand on why these results differed with choice of 
detergent and lipid composition. This work also highlighted the fact that colocation 
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of lipid and integrin was not a reliable measure of correct incorporation but instead 
a sign that αIIbβ3 had a tendency to strongly adhere to the lipid, an association that 
could not be removed by sucrose-gradient centrifugation.34 In hindsight this perhaps 
brings into question the earlier work Parise and Philips where they had concluded 
that αIIbβ3 was fully reconstituted in their PC/PS mix.42 Following the Müller 
reconstitution process the group went on to form a DMPC/DMPG SLB above a 
quartz substrate. Here they performed Total Internal Reflection Fluorescence 
Microscopy (TIRFM) and found that the bilayer inserted integrin was capable of 
binding both fibrinogen and RGD containing peptides. They concluded that 
fibrinogen binding occurred in a two-step process where binding was initially fast 
and reversible (via a buffer wash) but over longer timescales was “essentially 
irreversible” after 2 hours.34 
 
Erb et al. were the first group to look at the mobility of αIIbβ3 in an artificial lipid 
system. In an integrin insertion protocol based on Müller’s earlier work, αIIbβ3 was 
reconstituted into DMPC/DMPG (1:1) vesicles, which were later disrupted above a 
quartz substrate to form an SLB. Using Fluorescence Recovery After Photobleaching 
(FRAP), it was concluded that the αIIbβ3 protein diffused at a rate of 0.70 ± 0.06 
μm2/s at 33 °C, a value well below the diffusion co-efficient of the lipid itself (4.40 ± 
0.40 μm2/s). Of note was the fact that much of the αIIbβ3 protein was immobile 
(approximately 40 %) and so this diffusion co-efficient refers to a second round of 
photobleaching that discounts immobile and, therefore, bleached labelled αIIbβ3 
molecules. As mentioned previously such protein immobility is a common problem 
with reconstituted systems above planar substrates. It was also found that addition 
of fibrinogen to the system lead to an increase in the number of immobile αIIbβ3 
proteins (approximately 70 %) while the remaining mobile αIIbβ3 proteins showed a 
decreased diffusion co-efficient (0.58 ± 0.06 μm2/s at 33 °C). From this Erb 
concluded that the protein was non-clustered in its reconstituted state but clusters 
upon fibrinogen binding. Smaller ligands (an RGD containing peptide and a 
fibrinogen γ-chain dodecapeptide) did not alter the aggregation state of αIIbβ3 in the 
system, perhaps not surprising given the fact these molecules did not provide a 
bridge between adjacent integrin proteins.30 
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In an update on the earlier Erb work, Goennenwein et al. initially attempted to 
recreate these reported results. Again DMPC/DMPG was used as the target of 
reconstitution, mediated by triton x-100 and bio-beads SM-2. However, in this case 
the disruption of the proteoliposomes above a planar substrate lead to completely 
immobilised αIIbβ3, a result that contradicts Erb’s findings. This problem was 
overcome by the formation of ultrathin cellulose films above a glass substrate to 
create a polymer cushion. Such a polymer cushion provided enough space between 
the lipid bilayer and the glass to allow for the diffusion of the bulky reconstituted 
protein.  Here they again used FRAP to yield a diffusion co-efficient of 0.60 ± 0.2 
μm2/s for the mobile fraction, a value in close agreement with Erb, albeit with the 
prior requirement of a polymer cushion. Despite the necessity for such a cushion 
they reported a large percentage of proteins remained immobile within the system 
(75 %).31 This paper again emphasises the main drawback of membrane protein 
reconstitution in planar SLBs, where even the use of a polymer cushion did not fully 
decouple the bilayer and membrane proteins from the underlying substrate.   
 
Purrucker et al. provided an alternative system that used polymer-tethered lipid 
membranes instead of a cellulose film to separate an αIIbβ3 containing bilayer from 
the underlying substrates. Again this insertion protocol followed Müller’s work 
whereby integrin was first inserted into DMPC/DMPG vesicles although in this case 
the proteo-liposomes were disrupted above an SOPC LB transferred monolayer 
(with varying concentrations of lipopolymers) to form an asymmetric lipid bilayer. In 
this system only 20 % of the αIIbβ3 were mobile and the reported diffusion co-
efficient was given as 0.03 μm2/s according to FRAP, a value well below Erb’s and 
Goennenwein’s reported values.43 A second follow up paper by Purrucker et al. used 
a different set of polymer tethers but again reported a similarly small mobile 
fraction (16 – 24 %) and low diffusion co-efficient (0.08 – 0.13 μm2/s) for membrane-
reconstituted αIIbβ3.44  
 
Feng Ye et al. avoided the use of vesicles and SLBs by synthesising DMPC/DMPG 
nanodiscs, each bearing a single lipid embedded αIIbβ3 protein. With access to the 
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intracellular domain of αIIbβ3 they were able to activate the protein without the use 
of DTT or Mn2+. This was achieved via the use of the talin head domain (THD), part of 
the integrin-associating protein talin. They confirmed this activated state via the use 
of an antibody specific to the activated form of αIIbβ3, PAC-1. Interestingly, and in 
contrast to nanodisc-embedded αIIbβ3, detergent-solubilised αIIbβ3 was not readily 
activated by THD showing the requirement for αIIbβ3 to be lipid bilayer inserted. They 
also examined the structural status of activated and un-activated αIIbβ3 in their 
system. It was found that the addition of THD leads to an extended conformation; 
molecular extension of the integrin, in the absence of other proteins, ligands, or 
imposed forces. This was determined via cryoelectron microscopy.45  
 
In a subsequent report, Streicher et al. were able to reconstitute αIIbβ3 into Giant 
Unilamellar Vesicles (GUVs) and monitor the spreading dynamics of the giant 
vesicles on a surface coated with fibrinogen, the primary ligand of αIIbβ3. 
Interestingly this is one of the few modern papers to feature a non-DMPC containing 
lipid composition. Instead they utilised 85 % egg PC, 10 % egg PA, and 5 % DPPE-
PEG2000 to firstly create integrin-containing SUVs. They later emphasised the 
requirement for egg PA and DPPE-PEG2000 in the lipid mixture although it was not 
clarified whether this was to ensure αIIbβ3 reconstitution or improve the yield of 
GUVs. In any case this choice of lipid composition is no more biomimetically relevant 
than combinations of DMPC and DMPG when considering the platelet membrane. In 
order to validate the insertion process and confirm biological activity of the integrin 
RGD-containing quantum dots were used. Modelling the spreading kinetics of the 
GUVs on the adhesive surfaces they were able to break the process down into a 2-
step process. Firstly, small adhesive patches begin to grow before fusing and to form 
an adhesive ring. Secondly, the ring closes with a radius decreasing linearly with 
time before it eventually forms an adhesive disk.46 While αIIbβ3 appears to be 
biologically active under these conditions it is noteworthy that no cryoelecton 
microscopy or diffusion measurements carried out to ensure that the integrin 
protein was fully membrane-inserted and not just membrane-associated. This is 
especially relevant given the fact that αIIbβ3 has been highlighted to strongly adhere 
to the lipid bilayer in non DMPC containing compositions.29,34  
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One of the few other modern papers to feature αIIbβ3 liposome-reconstituted into a 
non-DMPC containing lipid composition is by Sloan et al. Here, a mixture of egg PC, 
bovine PS and cholesterol (60:15:25) was used for insertion. Again, biological 
relevance is minimal. Of note was also the use of β-OG in the αIIbβ3 detergent 
reconstitution process instead of the common use of triton x-100 in the literature. 
They used flow cytometry that their membrane-reconstituted integrin was capable 
of binding fibrinogen but did not undergo fibrinogen-mediated clustering. 47 This 
finding that no clustering occurred upon fibrinogen binding is in contrast to Erb’s 
observations and Goennenwein’s observations in integrin reconstituted SLBs.30,31 As 
was the case with Streicher et al., Sloan et al.  did not carry out any cryoelecton 
microscopy or diffusion measurements to ensure that the integrin protein was fully 
membrane-inserted and not just membrane-associated. This means that of the two 
recent papers where αIIbβ3 has been membrane-reconstituted into DMPC-free 
compositions, neither has been able to provide proof of full transmembrane 
insertion.  
 
Table 2: Summary of αIIbβ3 integrin reconstitution papers in the literature. The vast majority of papers have 
incorporated αIIbβ3 into DMPC-containing compositions using triton x-100 and bio-beads. The papers that 
feature diffusion measurements have all been for SLB systems and utilised FRAP. 
Paper Year Platform Composition Integrin 
Diffusion 
Notes 
Parise and 
Philips42 
1985 Lipid vesicles Egg PC and 
Bovine PS 
n/a First 
reconstitution of 
αIIbβ3 
Müller et al.34 1993 SLB DMPC and 
DMPC/DMPG 
n/a DMPC required 
for proper 
reconstitution 
Erb et al.30 1997 SLB DMPC/DMPG 0.70 μm2 
according to 
FRAP 
First diffusion 
measurements 
for αIIbβ3 
Sloan et al.47 2000 Lipid vesicles Egg PC, Bovine 
PS and 
Cholesterol 
n/a Unusual use of a 
non-DMPC 
containing 
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composition 
Goennenwein et 
al.31 
2003 SLB DMPC/DMPG 0.60 μm2 
according to 
FRAP 
A cellulose 
cushion was 
required for αIIbβ3 
diffusion 
Purrucker et al.43 2004 SLB Asymmetric 
bilayer of 
DMPC/DMPG 
and POPC 
0.03 μm2/s 
according to 
FRAP 
A polymer tether 
used for αIIbβ3 
diffusion 
Purrucker et al.44 2007 SLB Asymmetric 
bilayer of 
DMPC/DMPG 
and POPC 
0.08 – 0.13 
μm2/s 
according to 
FRAP 
A different 
polymer tether 
used for αIIbβ3 
diffusion 
Streicher et al.46 2009 Lipid vesicles Egg PC, Egg PA 
and DPPE-
PEG200 
n/a Unusual use of a 
non-DMPC 
containing 
composition 
Feng Ye et al45 2010 Nanodiscs DMPC/DMPG n/a Nanodiscs used 
as an alternative 
to vesicles/SLBs 
 
Summarised in Table 2, a number of things are evident about the current standing of 
αIIbβ3 reconstitution in the literature. Firstly, the majority of reconstitution 
experiments have taken place in SLBs rather than lipid vesicles. Indeed, all αIIbβ3 
diffusion-based experiments have taken place in SLBs. Erb was able to report 
laterally diffusing αIIbβ3 directly on a planar substrate30 but Goennenwein31 and 
Purrucker43,44 required a polymer cushion to allow for mobile αIIbβ3. Of particular 
note is that in all cases, with or without polymer cushions, a high percentage still 
rendered immobile on the underlying substrate. These values ranged from 40 %30 to 
84 %44 of the bilayer-reconstituted integrin remaining immobile. We were therefore 
very interested to create platforms that allowed for free diffusion of αIIbβ3 away 
from the restrictions of standard planar systems and the non-specific interactions 
they bring. To do so, we decided to utilise two separate systems, namely a free-
standing GUV set-up, and a cavity-spanning lipid bilayer array.  
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Another noteworthy aspect of the literature to date is the fact that the diffusional 
studies have been limited to FRAP-based experiments. FRAP interrogates relatively 
large volumes (several m3) via destructive photobleaching to infer diffusion co-
efficients based on the fluorescent recovery of the lipid bilayer. In the work 
described herein, we sought to utilise the single molecule techniques of 
Fluorescence Correlation Spectroscopy (FCS) and Fluorescence Lifetime Correlation 
Spectroscopy (FLCS) to gain insight into the diffusional characteristics of integrin-
reconstituted bilayer systems. FCS/FLCS has a number of key advantages over FRAP. 
These methods are described in detail in the following section but of note is the fact 
that FCS/FLCS is non-destructive to the fluorescent molecules in the sample, can be 
readily used in multicolour experiments, and can be used to infer additional data 
about the sample such as probe concentration and kinetic data.48 Another key 
advantage of FCS/FLCS over FRAP is the requirement for much lower concentrations 
of fluorophore in the sample. This limits any influences exogenous agents may have 
on the dynamics of the lipid membrane. Finally, the femotolitre volume required for 
FCS/FLCS is well suited to the GUV and cavity-spanning lipid bilayers we sought to 
create, and is in contrast to the large volume required in FRAP.49 Of course, FCS/FLCS 
does have some drawbacks when compared to FRAP. For example, FRAP is more 
suited measuring slower moving molecules, it probes larger areas of a lipid system, 
is more robust when probing systems that contain a large fraction of immobile 
fluorophores, and is experimentally easier to carry out and interpret.50 Nonetheless, 
with regards to our two designated systems of a free-standing GUV set-up and a 
cavity-spanning planar lipid bilayer the advantages of FCS/FLCS are clear. Therefore, 
this work attempts to be the first not only to characterise αIIbβ3 diffusion in vesicles 
but also to characterise αIIbβ3 diffusion by FCS/FLCS in any platform.  
 
Another striking feature of the literature is the dependence on DMPC to be utilised 
in the lipid composition. This requirement for DMPC was first noted by Müller34 and 
later re-emphasised by Erb in two separate papers29,30 Due to this recommendation, 
the majority of  αIIbβ3 reconstitutions have since taken place in DMPC-based 
compositions. The two exceptions to this rule are by Sloan47 and by Streicher46. 
However, given neither of these papers address the diffusion co-efficient of αIIbβ3 in 
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their respective systems, nor do they provide cryoelectron microscopy data of αIIbβ3 
in the vesicles there is doubt as to whether the αIIbβ3 has been fully inserted into the 
lipid bilayer. This is further highlighted by the fact that association of αIIbβ3 with the 
lipid is not proof of full reconstitution. For example, Müller stated that “Co-
migration of lipid and integrin in a sucrose gradient was not a reliable measure of 
correct incorporation. Especially during dialysis, non-incorporated integrin formed 
large protein aggregates which adhered so strongly to the vesicles that they could 
not be separated on a sucrose gradient.”34 In our work we sought to overcome this 
apparent limitation by inserting αIIbβ3 into DMPC-free lipid compositions and strive 
towards a physiologically-relevant lipid mixture.   
 
 
1.4. Diffusion of 
transmembrane proteins 
 
One of the key goals of this thesis was to characterise the diffusion co-efficients of 
transmembrane proteins, with emphasis on reconstituted αIIbβ3 in liposomes and 
SLBs. We were particularly interested in determining whether conformational 
changes in the structure of αIIbβ3 and/or ligand binding would alter the diffusion of 
the integrin protein. To this end FCS and FLCS were major techniques utilised and 
these are discussed in more detail below. Before going into more detail about these 
experimental techniques we must first discuss diffusion and in particular 
transmembrane protein diffusion. Throughout this thesis much of the work focuses 
on obtaining the diffusion co-efficients (D, usually in m2/s) of molecules, that is, the 
distance a particle may reach due to its diffusive motion. The larger the diffusion co-
efficient, the faster the particle moves. The diffusion of a molecule in solution may 
be described as a random walk. For example, a protein freely diffusing in water 
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collides with water molecules, receiving a series of small kicks in random directions. 
The protein then takes on a random trajectory, characterised as the mean squared 
displacement (MSD).50 According to the Stokes-Einstein equation, in Brownian 
motion, the diffusion of spherical particles through a liquid with a low Reynolds 
number may be described by: 
 
 
𝐷 =  
𝑘𝐵𝑇
6𝜋𝜂𝑟
  
 
 
Where kB is the Boltzmann constant, T is the absolute temperature,  is the dynamic 
viscosity, and r is the radius of the diffusing spherical particle. However much of our 
work does not relate to three dimensional diffusion of particles, but rather the 
diffusion of transmembrane protein in two dimensions within a thin lipid 
membrane. To explain this type of diffusion we turn to the Saffman–Delbrück 
model.51 This modification to 3D diffusion describes the transmembrane protein as a 
cylindrical object diffusing within a thin layer of viscous fluid of defined height (the 
lipid membrane), and surrounded by a less viscous fluid (the bulk fluid). In said 
model the diffusion co-efficient is described by: 
 
 
𝐷 =  
𝑘𝐵𝑇
4𝜋𝜇𝑚ℎ
(𝑙𝑛 (
𝜇𝑚ℎ
𝜇𝑤𝑅
) − 𝛾) 
 
 
Where h is the thickness of the lipid bilayer, μm is the viscosity of the lipid bilayer, μw 
is the viscosity of the surrounding aqueous phase, R is the hydrodynamic radius of 
the transmembrane protein, and  is the Euler–Mascheroni constant. The Saffman–
Delbrück model is the standard model for transmembrane diffusion and widely 
utilised within the literature. Indeed, various papers have shown that this model of 
membrane protein diffusion can be used to accurately predict the diffusion of 
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transmembrane proteins.41,52–54 One of the key observations that may be made 
about this model is the fact that predicts a weak, logarithmic dependence of the 
diffusion coefficient (D) with the radius (R) of the protein. In practice this means that 
radius of a transmembrane protein has little influence on its diffusion co-efficient. 
For example, increasing the protein radius from 1 to 10 nm only reduces the 
protein’s mobility by 30 %.55 However, despite the widespread use of the Saffman–
Delbrück model, challenges do exist as to its veracity.52 For example, Gambin et al. 
suggested that a transmembrane protein’s diffusion coefficient is in fact strongly 
linked to its dimensions. They state, in contrast to the Saffman–Delbrück assumption 
that the lipid bilayer is homogenous layer of viscous fluid, that the bilayer is not a 
featureless continuum. Instead they emphasise the heterogeneity of the membrane, 
with lipid chains of varying sizes, undergoing internal degrees of freedom, and 
featuring packing defects. To combat this they proposed an alternative model for 
transmembrane protein diffusion where the diffusion coefficient is inversely 
proportional to the radius of the diffusing object.55 Naji et al. made further 
advancements on this when they argued that protein-lipid interactions within the 
bilayer deforms the membrane leading to new hydrodynamic stresses and a 
suppression of mobility.56 This was later disputed by Guigas and Weiss’ calculations 
where their data found that while hydrophobic mismatch between transmembrane 
proteins and the lipid membrane did alter the membranes viscosity, it had minimal 
influence on protein diffusion.57 It is therefore suggested that the Saffman–Delbrück 
model is applicable for particles with a radius below 10 nm, dimensions well suited 
to the study of transmembrane proteins.52 
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1.5. Background to key 
techniques 
 
 
1.5.1. Fluorescence microscopy 
Fluorescence is the platform for most of the methods used in this work. Therefore, 
to understand these techniques we must first understand fluorescence. In its 
simplest terms, fluorescence is the property of a molecule to molecule to absorb 
light at a given wavelength and, after a brief interval, emit light at a longer 
wavelength. The difference between the absorption and emission wavelengths is 
known as the Stokes shift. Photophysical properties of a fluorophore can be 
described by a Jablonski diagram. Starting in the ground state, the fluorophore is 
excited into a higher energy singlet state by absorption of light (approximately 10-15 
seconds). The molecule then rapidly undergoes internal conversion, and vibrational 
and rotational relaxation (approximately 10-14 – 10-11 seconds), to an intermediate 
semi-stable, excited state in a process described by Kasha’s rule. The molecule may 
return to the ground state non-radiatively, by emitting thermal energy through 
vibrational/rotational relaxation. Alternatively, this return to the ground state may 
occur radiatively via the emission of a photon under appropriate molecular 
conditions (approximately 10-9 seconds). This process is known as fluorescence. Of 
key importance is the fact that the emitted photon has less energy than the 
absorbed photon, since fluorescence occurs after the molecule has already relaxed 
to its lowest vibrational level within the excited state. This means that the emission 
occurs at longer wavelengths than the absorption, i.e. it is red-shifted (or Stokes 
shifted) in comparison with absorption. In an alternative relaxation pathway, the 
excited molecules may in some circumstances, undergo inter-system crossing 
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(approximately 10-8 – 10-3 seconds) to form a triplet state. From the triplet state the 
molecule may return to the ground state, again either radiatively, or non-radiatively. 
The radiative relaxation from the triplet state is known as phosphorescence 
(approximately 10-4 – 10-1 seconds). This process occurs on a noticeably longer time-
scale than fluorescence because it originates from a spin-forbidden process.58,59  
 
Fluorescence has wide ranging scientific applications. For example, the use of 
fluorescently-labelled proteins and peptides allows for the tracking and monitoring 
of biological molecules using fluorescence microscopy and confocal microscopy.58 
Furthermore, diffusion dynamics of single molecules can be examined via FCS60, 
while the lifetime of a fluorescent molecule can inform us about environmental 
conditions via Fluorescence Lifetime Imaging Microscopy (FLIM)61. Additionally, the 
selectivity of fluorescently-labelled antibodies can be exploited for cell identification 
and sorting via flow cytometry.62 These are just some of the many applications of 
fluorescence widely used in life sciences. 
 
 
 
Figure 3: A Stokes shift. The Stokes shift is the difference in nm between the peak excitation and peak 
emission wavelengths of a fluorophore. By completely filtering out the exciting light without blocking the 
emitted fluorescence, it is possible to see only the objects that are fluorescent. 
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Figure 4: A Jablonski diagram. A fluorophore is excited into a higher energy singlet state. The molecule then 
rapidly undergoes internal conversion and vibrational relaxation, before returning to the ground state. This 
return to the ground state may be radiative (fluorescence), or non-radiative (thermal energy, quenching). 
Alternatively, the molecule may transition to an intermediate triplet state through inter-system crossing. 
From here it may return to the ground state radiatively (phosphorescence), or non-radiatively. 
 
Fluorescence microscopy allows for the observation of labelled molecules within a 
focal volume, such as within a cell or artificial lipid bilayer. In conventional wide-field 
fluorescence microscopy, the entire sample is bathed in light meaning the sample’s 
fluorescent molecules are excited in a wide focal plane. This means that large 
unfocused background regions are picked up by the microscope’s detector. This 
side-effect can be overcome via confocal microscopy. Confocal microscopy is used to 
acquire images selecting from within a thin focal plane, while rejecting out of focus 
fluorescent light. This allows for high resolution images of a defined depth of field to 
be obtained. Confocal microscopy directs the laser beam of desired wavelength 
through an aperture, focusing it on a small focal volume via an objective lens in 
order to excite a given fluorophore. Fluorescent light from the sample as well as any 
other reflected light is then recollected via the objective, filtered with a mirror to 
exclude the original excitation wavelength and passed through a detector pinhole. 
This aperture only allows light from the selected focal plane through, while 
obstructing any out of focus light. Thus only light from a limited optical section is 
picked up by the detector and converted to an electrical signal to be recorded.63 In 
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this thesis confocal microscopy was routinely used to image platelets, liposomes, 
SLBs and cytoskeletal filaments.    
 
 
 
Figure 5: A typical confocal microscopy set-up. The technique uses a spatial pinhole placed at the confocal 
plane of the lens to eliminate out-of-focus light. This allows light from a limited optical section to be collected 
and thus increases spatial resolution when compared to standard fluorescence microscopes.  
 
 
1.5.2. STED microscopy 
Stimulated emission depletion (STED) microscopy is a form of super resolution 
microscopy that allows for the acquisition of fluorescence images below the 
diffraction limit that restricts resolution in standard confocal microscopy set-ups. 
First proposed in 199464, and later demonstrated in 200065, STED uses selective 
elimination of emission of fluorophores to minimise the focal area of illumination 
and thus increases the resolution of the imaging process. In a typical STED 
measurement, an excitation laser is used to excite a fluorophore in a sample in the 
same manner as confocal microscopy. The excitation pulse is immediately followed 
by a pulse from a red-shift depletion (STED) laser. The STED laser is shaped to a 
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donut profile within the focal plane which overlaps the profile of the excitation laser 
(Figure 6). The STED laser is of high intensity and instigates stimulated emission of 
the fluorophore at these overlapping peripheral regions. The result is that 
fluorescence from the probe is switched off at the rim of the focal spot, reducing the 
interrogated volume and thus enhanced resolution.66 In practice this allows for the 
imaging of structures with diameters in the tens of nanometers, i.e. much smaller 
than achievable using standard confocal microscopy because of the diffraction limit 
which applies to these methods. In this thesis STED was utilised to provide super 
resolution images of micrometer long, nanometer wide filamentous proteins.  
 
 
 
Figure 6: A) An excitation laser profile alongside the donut shaped STED laser profile. Emission from 
overlapping regions is switched off through stimulated emission meaning no fluorescence occurs at the 
periphery of the spot. Therefore, only the centre of the STED laser emits fluorescence, thus reducing the 
interrogated volume. B) The red shifted STED laser is pulsed immediately after the excitation laser. DCSP: 
dichroic mirror (short pass); VPP: vortex phase plate; BPF: bandpass filter; P: polarizer; L: lenses; QWP: 
quarter-wave plate; NF: notch filter; DCLP: dichroic mirror (long pass); PH: pinhole; APD: avalanche 
photodiode detector Image from “Review of recent developments in stimulated emission depletion 
microscopy: application on cell imaging”.66  
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1.5.3. FCS and FLCS 
Fluorescence correlation spectroscopy 
Fluorescence correlation spectroscopy (FCS) and Fluorescence Lifetime Correlation 
Spectroscopy (FLCS) are two related techniques used to determine dynamic 
processes and molecular interactions through the analysis of fluorescence 
fluctuations in a given focal volume. Of key interest in the context of this work is the 
application of FCS to determine diffusion dynamics of particular molecules via these 
fluorescence fluctuations. To do so, an excitation laser is focused onto a sample in 
order to excite fluorophores. A confocal pinhole rejects light emission outside a thin 
focal plane and emitted photons are spectrally filtered before being detected on a 
suitably sensitive detector such as a SPAD, or hybrid detector (Figure 7 A). 
Therefore, only fluorophores within a well-defined femtoliter focal volume are 
registered. This process is carried over a time-period (10s of seconds to minutes) in 
order to form a fluctuating time-intensity trace (Figure 7 B). Using these 
fluorescence fluctuations, an autocorrelation curve can be calculated as follows: 
 
 
 
𝐺(𝜏) =  
〈𝛿𝐹(𝑡)𝛿𝐹(𝑡 + 𝜏)〉
〈𝐹〉2
 
 
Where F is the fluorescence intensity, t is the time and τ is the lag time. The brackets 
“<” and “>” indicate the time averaged over the fluorescence signal. This allows the 
signal at time t to be compared with the signal at time t + τ, and the similarity is 
averaged over all times. Over short time intervals, fluorophores in the detection 
volume have not moved far and thus the fluorescence signal will not have changed 
much. This leads to a degree of high self-similarity of the intensity trace, and a high 
value of the auto-correlation curve for small lag times. Over longer time intervals, 
fluorophores will have moved much further distances, leading to large changes in 
the fluorescence signal. As a result, there will be a lack of self-similarity of the 
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intensity trace and a low value of the auto-correlation curve for large lag times as 
the curve decays towards zero (Figure 7 C). Faster moving molecules will spend less 
time within the focal volume and thus the auto-correlation curve will decay quicker 
than for slow moving molecules.60 
 
 
Figure 7: The basics of the FCS set-up. A) An excitation laser is focused onto a sample in order to excite 
fluorophores. A detector is used to register emitted photons from a small focal volume. B) Fluorescence 
fluctuations are measured over time and autocorrelation curve is formed. C) An autocorrelation curve. The 
data is fitted to suitable model (eg 2D or 3D) in order to determine the diffusion co-efficient of the 
fluorophore. Figure adapted from “Single molecule techniques for the study of membrane proteins”.60   
 
The amplitude of the autocorrelation curve is dependent on the concentration of 
fluorophores. At low concentrations, the relative fluctuations in the fluorescence 
signal are large, and thus the amplitude of the auto-correlation curve is high. 
Therefore, the opposite is also true and it can be said that the amplitude of the 
auto-correlation curve is inversely proportional to the fluorophore concentration 
(Figure 8). Using this knowledge, key parameters such as diffusion co-efficients and 
concentrations can be determined by fitting the autocorrelation data to an equation 
suitable for the experimental parameters.60 For example, for a molecule freely 
diffusing in solution, a three-dimensional fit is best applied to the autocorrelation 
data, while in a planar lipid bilayer, a two-dimensional fit is best applied owing the 
inherent spatial restrictions of the system. Furthermore, if the fluorophore has a 
tendency to transition to an intermediate dark triplet-state or more than one 
species is present in the fluorophore population, additional parameters may be 
included in the fitting equation to account for this.49 The amount of time a 
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fluorophore spends within the instrument’s effective detection volume (Veff), is 
dependent on how fast the molecule is diffusing. Therefore quickly diffusing 
molecules spend less time in the Veff which results in an auto-correlation curve 
decaying towards zero faster than for a relatively slowly diffusing fluorophore 
(Figure 8). 
 
 
 
Figure 8: Left) The amount of time spent in the effective FCS volume is dependent on the fluorophore’s 
diffusion co-efficient. Faster moving molecules will spend less time in this volume and the auto-correlation 
curve will decay towards zero faster. Right) The amplitude of the auto-correlation curve is inversely 
proportional to the fluorophore concentration. As the concentration of fluorophores increases the ACF begins 
to move towards zero. 
 
Of course the amount of time a fluorophore resides in the Veff is also dependent on 
the dimensions of said volume. The Veff is not identical to the confocal volume 
(Vconf). If the volumes are approximated using a 3-dimesional Gaussian shape 
function, then Veff is larger than Vconf by a factor of 23/2. To obtain this Veff value FCS 
setups must be regularly calibrated due to slight misalignments and changes in the 
optical system. To do so a number of options are available. For example, by using a 
freely-diffusing dye of known concentration, using a freely-diffusing dye with a 
known diffusion co-efficient, or via imaging fluorescent beads with a well-defined 
diameter. In our work a freely diffusing dye with a well-defined diffusion co-efficient 
was used for this calibration step. Assuming that the confocal volume can be 
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approximated by a three-dimensional Gaussian function, the dimensions of the 
confocal volume can be derived from the fit parameters using: 
 
 
 
𝑮(𝝉) =
𝟏
𝑵
[𝟏 +
𝟒𝑫𝝉
𝝎𝟐
]
−𝟏
[𝟏 +
𝟒𝑫𝝉
𝒛𝟐
]
−𝟏/𝟐
 
 
 
(1) 
 
Where G(τ) is the autocorrelation function of fluorescence fluctuations, N is the 
average number of fluorophores in the focal volume, τ is the lag-time, ω is the 
lateral radius of the confocal volume, z is the axial radius of the confocal volume, 
and D is the diffusion co-efficient. It must be remembered that the effective focal 
volume is an ellipsoid with two equal  axes and z axes as shown in Figure 9. 
 
 
Figure 9: An approximate focal volume composed of two equal  axes and two equal z axes. The ratio 
between the z and  axes is known as the axial ratio and written as k. This value should be between 4 and 7 in 
a well aligned FCS set-up. 
 
The ratio between the height and width of this ellipsoid and is known as the axial 
ratio (k) and can be described by: 
 
 𝑘 =
𝑧
𝜔
  
(2) 
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Therefore, equation 1 can be rewritten with a slight modification to the z 
component: 
 
 
 
 
𝐺(𝜏) =
1
𝑁
[1 +
4𝐷𝜏
𝜔2
]
−1
[1 +
4𝐷𝜏
𝑘2𝜔2
]
−1/2
 
 
 
(3) 
Equation 3 can be further rewritten in terms of the average retention-time of the 
fluorophore, or diffusion time (τD) where: 
 
 
τ𝐷  =  
ω2
4D
 
 
 
(4) 
Taking this into account, equation 3 becomes: 
 
 
𝐺(𝜏) =  
1
𝑁
[1 +  
𝜏
𝜏𝐷
]
−1
[1 +
𝜏
𝑘2𝜏𝐷
]
−1 2⁄
 
 
(5) 
 
Using a dye with a known diffusion co-efficient, equations 5 and 6 can be combined 
to experimentally determine the spatial values of the volume, ie the lateral radius of 
the confocal volume, the axial radius of the confocal volume, and thus the axial ratio 
between the two. This means that the effective volume can be determined as 
follows: 
 
 𝑉𝑒𝑓𝑓 = (𝜋)
3 2 ⁄ ω2𝑧 = (𝜋)3 2 ⁄ ω3𝑘 (6) 
However, if FCS is applied to a two-dimensional system, a separate 2D Veff must be 
used. In this case the effective value is the area of intersection between the confocal 
volume and a planar (2D) object. In practice this occurs at the widest point of the 
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focal volume’s ellipsoid shape. Knowing the lateral radius of the beam as 
determined experimentally above, the 2D Veff of FCS interrogation can be 
determined by finding the area of a circle: 
 
 2𝐷 𝑉𝑒𝑓𝑓 = 𝜋𝜔
2 (7) 
 
 
Fluorescence Lifetime Correlation Spectroscopy 
While FCS has been routinely used in the literature to determine diffusion co-
efficients in both 2D and 3D systems, the technique does suffer from a number of 
problems. For example, during conventional FCS a number of unwanted signal 
components, or background contributions, are incurred in the auto-correlation 
curve. This background noise includes Rayleigh and Raman scattered excitation light, 
detector thermal noise and detector afterpulsing.67  FLCS is a modification to the 
standard FCS technique as described above. FLCS combines FCS with Time-
Correlated Single Photon Counting (TCSPC) in order to separate the autocorrelation 
function of various signal components. In TCSPC, the sample is excited with a short 
pulse of light and the temporal delay between the excitation pulse and the arrival of 
a photon emitted by the sample at the detector is recorded. This procedure is 
repeated many times in order to obtain a statistically significant distribution of time 
differences. The data is captured as a histogram in which the x-axis is the time 
difference between the excitation pulse and the detection of the emitted photon, 
and the y-axis is the frequency with which each time difference is observed. Hence, 
this histogram describes the decay of the excited-state population following pulsed 
excitation of the sample, and it can be fit to an exponential decay function to obtain 
the luminescent lifetime of the probe. Due to the fact that the unwanted signal 
components (scattered light, detector afterpulsing, etc) occur on a different 
timescale than the lifetime of the fluorophore, this noise can be removed from the 
auto-correlation curve in order to improve the accuracy of the fitting model. For 
example, Figure 10 shows how FLCS can be applied to the removal of detector 
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afterpulsing, a constant offset across the experiment in order to provide more 
accurate diffusional data. Furthermore, this TCSPC aspect of FLCS can even be used 
to separate auto-correlation curves of two different fluorophores with 
indistinguishable emission spectra, as long as their respective fluorescent lifetimes 
are sufficiently different.  
 
 
Figure 10: Left) A TCSPC histogram showing FLCS decay alongside contribution from afterpulsing. Afterpulsing 
is constant offset evenly distributed across the histogram and can be substracted from the initial decay.  Right) 
Filters for the fluorescence and background decays. Weight for the fluorescence decay is high in those 
channels in which the vast majority of the detected photons come from the fluorophore. C) When the filters 
are applied to the FCS curve, the FLCS auto-correlation curve removes unwanted afterpulsing from the data. 
Image from Picoquant. 
 
Within the literature, FCS and FLCS have been used for a variety of applications in a 
wide range of environments, for example, to study the influence of lipid composition 
on lipid diffusion co-efficients in liposomes68, to examine the anomalous diffusion of 
proteins due to molecular crowding69, or to determine the efficiency of cytosolic 
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transport within cells.70 In this thesis FCS and FLCS were routinely used to determine 
both lipid and protein diffusion co-efficients in a variety of lipid compositions in both 
vesicle and SLBs systems.  
 
1.5.4. Flow Cytometry 
Flow cytometry is a commonly used method for identifying different cell populations 
based on cell size, cell granularity and protein expression. To achieve differentiation, 
cells are passed through the flow cytometer instrument in a stream of fluid and 
separated particle by particle. At an interrogation point a laser intersects with the 
cells. Emitted light is given off in all directions and collected by a series of detectors. 
Flow cytometry setups contain two important detectors known as the forward 
scatter (FSC) and side scatter (SSC) detector. The FSC is used to detect particle size 
while the SSC is used to determine particle granularity. This is a key component of a 
flow cytometry and it allows for the identification of cell populations by plotting one 
parameter against another. This can be seen in Figure 12 where granulocytes, 
lymphocytes, and monocytes can be differentiated on the scatter plot. As well as the 
FSC and SSC detectors, flow cytometry also utilises a number of fluorescence 
emission detectors. This means that in addition to determination of particle size and 
granularity, the laser can be used to excite a cell-bound fluorophore. The emitted 
light is then picked up the relevant detector. This means the presence or absence of 
a probe, such as a labelled antibody or other protein, on the cell can be ascertained. 
The resulting fluorescence information may then be displayed on a histogram where 
the horizontal axis represents the parameter’s signal value in channel numbers and 
the vertical axis represents the number of events per channel. To quantify the 
histogram data a percentage gated, mean, or geo-mean value be used. Another key 
feature of flow cytometry is the ability to analyse selected cell populations and 
subpopulations. For example, using the FSC and SSC detectors the presence of a 
labelled antibody may be analysed for only monocytes (or any other cell 
population).62 This is known as gating. This ability to analyse multiple parameters of 
cells is a powerful feature of flow cytometry. In this thesis the technique was applied 
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to both platelets and vesicles. This allowed use to determine the activation status of 
platelets, the conformation of αIIbβ3 in the platelet membrane, and the presence of 
reconstituted αIIbβ3 in lipid vesicles.  
 
 
 
Figure 11: A schematic of a flow cytometry setup. A cell suspension is drawn into a stream and created by a 
surrounding sheath of isotonic fluid that creates laminar flow, allowing the cells to pass individually through 
an interrogation point. At the interrogation point a laser intersects the cells. Emitted light is given off in all 
directions. Some of this light is picked by a forward scatter detector, while some is picked up by a side scatter 
detector (1). Meanwhile, the system also features multiple fluorescence detectors (2 – 4), used to detect the 
presence of fluorescence molecules (antibodies and other proteins) and the interrogated cell’s surface. The 
signals are amplified and converted to a digital format for analysis. Image from “Flow cytometry: principles 
and clinical applications in hematology”.62 
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Figure 12: Left) A scatter plot of various immune cell populations from umbilical cord blood separated 
according to a dot plot of FSC versus SSC. Gates have been placed around these separate populations which 
allows these cells to be analysed separately.71 Right) A histogram of anti-CD62P fluorescence in platelets. 
CD62P also known as p-selectin is an adhesion molecule exposed only in activated platelets. The yellow fill is 
the un-activated platelet population, while the red outline is TRAP activated platelets. The shift in 
fluorescence can clearly be seen.    
 
1.5.5. Atomic Force Microscopy  
Atomic Force Microscopy, or AFM, is technique that allows for the attainment of 
high atomic resolution topographic data. AFM can be used to analyse a wide range 
of samples from relatively hard glass and mica substrates to soft biological samples. 
AFM is a type of scanning probe microscopy that uses a tip to probe a surface rather 
than electrons or beam of light. Although it is an invasive method, it is not 
diffraction-limited and thus is capable of characterising surface roughnesses and 3D 
topographical data at sub-wavelength dimensions, unlike confocal microscopy. 
Scanning Tunnelling Microscopy (STM) was the precursor to AFM and was 
developed in the early 1980s. SPM allowed the high resolution imaging of surfaces 
but could only be applied to conductive or semi-conductive surfaces. The STM later 
evolved in the AFM which allowed for the probing of a much wider range of 
surfaces.72 The basic set up behind AFM features a probing tip mounted on a flexible 
cantilever. The tip is placed in contact or close to the sample. Interactions with the 
surface deflect the cantilever, and this motion is monitored by a laser beam. The 
beam is reflected towards a split photodetector configuring an optical lever which 
amplifies cantilever deflections. A feedback circuit, connected to the cantilever 
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deflection sensor keeps tip–sample interaction at a fixed value controlling the tip–
sample distance. The amount of feedback signal, measured at each scanning point of 
a 2D matrix, concurs to form a 3D reconstruction of the sample topography which is 
usually displayed as an image.73 An example of an AFM setup is given in Figure 13. 
 
 
Figure 13: A typical AFM setup coupled with an inverted optical microscope. A sample is placed on the stage 
while a cantilever and top comes in close contact with the surface. Interaction with the surface deflects the 
cantilever and this motion is monitored by a laser beam. This movement can be analysed and express in 
topographic form. 
 
A number of modes of operation exist for AFM. In contact mode, for example, the 
tip is kept in gentle contact with the sample surface. As the tip raster scans the 
surface, images are created by recording the piezo-vertical position required to keep 
the force constant.73 In this mode, the interaction forces between the tip and the 
sample are mainly van der Waals repulsive forces. Another popular mode of 
operation is tapping mode. In this mode the cantilever is oscillated at a frequency 
near its resonance and the oscillation amplitude is monitored. By recording the 
feedback signal required to keep the amplitude constant, the topography of the 
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sample surface can be obtained.73 As the tip is only intermittently in contact with 
the sample it overcomes problems such as friction and adhesion that are usually 
associated with conventional AFM imaging systems. The intermittent contact also 
means that tapping mode is particularly useful for soft biological samples such as 
supported lipid bilayers.74 AFM has played a role in a large number of fields such as 
characterising materials for electronics, semi-conductors, materials and 
manufacturing, polymers, biology and biomaterials.74 One of the biggest advantages 
of AFM in comparison to other high resolution techniques, such as SEM and TEM, is 
the fact the AFM allows for the imaging of biological samples in physiological like 
conditions. This also means that minimal sample preparation is required.73 The 
technique can be used monitor mechanical properties of a sample, cell stiffness and 
cell viscoelasticity, adhesion forces and Young’s modulus.72 In this thesis AFM was 
used to obtain topographic data of PDMS surfaces at far higher resolution than was 
possible using optical microscopy.  
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1.6. Key Aims and 
Objectives 
 
The key objective of this work was to provide biologically-relevant platforms to 
study transmembrane proteins away from the chaos and complexity of the native 
cell membrane. While our platforms are compatible with any number of 
transmembrane proteins we chose to use platelet integrin αIIbβ3 as the primary 
model protein in much of this work. As such, chapter 2 is devoted to study of the 
αIIbβ3 protein in the platelet membrane in order to better understand its 
physiological role in ligand binding and platelet aggregation. Emphasis was placed 
on inducing the activated ligand bound form of αIIbβ3 via the use of artificial integrin 
activators dithiothreitol (DTT) and Mn2+, and comparing these activated states to 
more biologically-relevant agonist pathways. DTT and Mn2+ were studied as integrin 
activators as we later wanted to induce conformational changes in αIIbβ3 within our 
artificial lipid platforms, systems lacking the signalling machinery required for 
physiological agonist activation.  
 
After characterising DTT and Mn2+-mediated activation of αIIbβ3 in platelets, we next 
sought to characterise αIIbβ3 within liposomes in chapter 3. As such, various 
reconstitution protocols were explored to insert the protein into more 
physiologically-relevant lipid compositions than what currently exists within the 
literature. Next we wanted to to determine the diffusional abilities of the 
reconstituted protein in its un-activated, activated and ligand bound forms as well as 
its preference for phospholipid rich or cholesterol rich microdomains.  
 
While liposome-based systems have their advantages over planar SLB models, we 
wanted to combine the best attributes of these systems in chapter 4 via the use of a 
novel cavity-spanning bilayer. Developed by our group over a number of years, such 
a system combines the stability of planar SLBs with the free-standing nature of 
liposomes. This was hoped to provide a planar lipid bilayer away from the non-
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specific lipid-substrate interactions that plague traditional SLB platforms. Utilising 
the knowledge gained in our liposome work it was hope to reconstitute αIIbβ3 into 
our physiologically-relevant cavity-spanning SLB to compare and contrast the 
diffusional characteristics of αIIbβ3 in its un-activated, activated and ligand bound 
forms.  
 
Finally, in preliminary work, chapter 5 focuses on increasing the complexity and 
physiological relevance of SLB models even further by including cytoskeletal fibres 
alongside the planar lipid membrane. It was hoped that such cytoskeletal structures 
would alter the diffusional characteristics of the SLB and that such lipid-protein 
interactions would more accurately mimic the intracellular-cell membrane interface 
found within the cell. 
 
  
 
 
 
  
 80 
2. Integrin in Platelets 
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2.1. Introduction 
Given that we wanted to later reconstitute the platelet protein αIIbβ3 into our various 
biomimetic models it made sense to first characterise the function of αIIbβ3 in its 
native environment, the platelet membrane. Therefore, this chapter seeks to 
examine the activation of αIIbβ3 using DTT and Mn2+ while comparing and contrasting 
this activation to more physiological platelet agonists. DTT and Mn2+ were chosen as 
activators due to their direct actions on integrin conformation, and thus ligand-
binding ability. This is in contrast to physiological agonists which induce integrin 
conformational changes indirectly through complex platelet signalling pathways, 
pathways that will not be available in our later biomimetic models. Thus this chapter 
seeks to examine both DTT and Mn2+ as suitable αIIbβ3 activators for later integrin-
reconstituted lipid platforms. Before looking at the structure and function of αIIbβ3 in 
more detail, we must first examine the physiological role of the platelet.    
 
Platelets are small non-nucleated cell-fragments formed from the fragmentation of 
precursor megakaryocytes. There are approximately one trillion platelets in 
circulation at any one time in the human body. Their primary role is the 
maintenance of haemostasis.75 Under normal physiological conditions, platelets 
remain in their resting discoid form. Understandably, this resting state of platelets 
must be properly maintained so as to avoid inappropriate thrombosis. Activated 
platelets form thrombi in response to tissue trauma and the associated exposure of 
the subendothelial matrix. Thrombus formation occurs in a number of stages that 
involve platelet adhesion, shape change, release of pro-aggregatory regulators and 
aggregation. To illustrate this, activated platelets can be seen in Figure 14. To initiate 
the thrombus formation, platelets firstly localise to the site of vascular injury before 
forming a platelet monolayer. Secondly, the release of platelet agonists activates 
and recruits additional platelets to the site. Finally, the platelet plug is stabilised in 
order to halt blood loss and to prevent the premature dis-aggregation of the 
thrombus.76 Throughout this process, the platelet response is governed by a variety 
of membrane proteins that act as receptors for signalling molecules and/or as 
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functional adhesion molecules. These receptors are typical integral membrane 
proteins present within the lipid bilayer. They sense the extracellular environment 
and control the platelet response to stimuli, thus initiating the pro-aggregatory 
platelet response. The membrane receptors include the selectins, integrins, and 
immunoglobulin superfamily, as well as receptors specific for ADP, collagen, 
epinephrine and thrombin, amongst others.77  
 
 
 
Figure 14: A confocal image of phalloidin-FITC-stained platelets activated on a fibrinogen-coated glass slide. 
Phalloidin is a mushroom toxin that binds to polymerised actin, one of the main components of the cell 
cytoskeleton, making it any excellent stain for visualising cells. Phalloidin-FITC was excited with a 488 nm 
argon laser line and imaged using a 63x objective. 
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2.1.1. Thrombus initiation 
The platelet response to endothelial damage is controlled by receptors present on 
the platelet cell surface. GPIb‐IX‐V is a receptor complex, which is important in the 
initial stages of thrombus formation.78 This complex primarily associates with von 
Willebrand factor (vWF) becomes immobilised to the subendothelial matrix 
following endothelial damage. vWF itself is a multimeric protein containing variable 
numbers of identical subunits, each over 2000 amino acids in length. The protein is 
produced exclusively by megakaryocytes, the precursor to platelets, and endothelial 
cells, and may be produced by two divergent pathways, a “regulated pathway” or a 
“constitutive pathway”. The regulated pathway involves the storage of the protein 
for secretion in response to agonist stimulation in intracellular vesicles, for example, 
within the alpha granules of platelets. On the other-hand, in the constitutive 
pathway the vWF is released as soon as synthesis is complete. The key feature of the 
vWF is its ability to act as a ligand for a wide range of other proteins at distinct 
functional sites. For example, it may bind to FVIII, integrin αIIbβ3, collagen, and as 
mentioned previously, GPIb‐IX‐V.79 Exposure to damaged endothelium allows vWF 
to act as bridge between exposed collagen and GPIb‐IX‐V. Of key importance is the 
ability for this interaction to take place under high shear stress, something which is 
problematic for other direct platelet-collagen receptors. This first transient 
interaction between the platelet and the damaged endothelium reduces platelet 
velocity and allows for interactions between other receptors and their ligands that 
can otherwise only occur at lower shear rates.80 The next step in providing a more 
stable platelet-ECM interaction is mediated by the platelet receptor GP VI. GP VI is a 
65 kDa platelet-specific collagen receptor that plays a significant role at lower shear 
stresses. It functions in conjunction with an FcR γ-chain dimer transmembrane 
protein which acts as the intracellular signalling subunit of the receptor.81 
Phosphorylation of this FcR γ-chain dimer, which is mediated by members of the Src 
family, recruits another Src family member in the form of Syk, which in turn 
activates an enzyme known as PLC2. PLC2 converts phosphatidylinositol 4,5-
bisphosphate, a phospholipid component of the cell membrane also known as PIP2, 
to inositol 1,4,5-trisphosphate (IP3) and diacyl glycerol (DAG).82 IP3 is responsible for 
 84 
the release of Ca2+ from the platelet dense tubular system, while DAG activates 
Protein Kinase C (PKC). Both Ca2+ and PKC are responsible for upcoming platelet 
activity including platelet aggregation and the secretion of pro-aggregatory 
factors.83,84 Indeed, this intracellular signalling is important because it is required for 
the next integrin-mediated platelet-collagen interaction, namely by integrin α2β1. 
Like other members of the integrin family, α2β1 is restrained in its low affinity state. 
Intracellular signalling events promoted by GP VI-collagen interaction following 
platelet activation promotes conformational changes in α2β1, thus transitioning the 
integrin into its high affinity state. As such, activated α2β1 is now free to undergo its 
own collagen interactions further strengthening the platelet-ECM interaction.85  
  
 
Figure 15: Initiation of thrombus formation on damaged endothelial tissue. Exposure of platelets to vWF 
bound to collagen leads to transient interaction via the GPIb‐IX‐V complex found on platelets, even under high 
shear stress. This interaction reduces platelet velocity sufficiently to allow for direct interaction of the platelet 
to the collagen via the GP VI receptor. This interaction promotes a proaggregatory platelet response via 
intracellular signalling. This leads to the release of agonists such as ADP and TxA2, as well as the inside out 
activation of integrin α2β1, transitioning it from a low affinity state to a receptor which readily binds to 
collagen, further strengthening thrombus formation.         
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2.1.2. Thrombus extension 
Following the vWF and collagen driven initiation stage of platelet adhesion, the 
extension phase is distinguished by the recruitment of additional platelets to the site 
of vascular injury in response to various platelet agonists. These agonists may be 
released by the platelets themselves in response to activation and act to promote 
the continuation of thrombus formation. While some of the agonists are synthesised 
de-novo following platelet activation, others are stored in the cell. To store agonists, 
platelets make use of intracellular vesicles. Alpha granules (α-granules), for example, 
are vesicles that contain a wide variety of proteins including platelet factor 4, 
platelet derived growth factor (PDGF), beta-thromboglobulin, fibrinogen, vWF, 
fibronectin and P-selectin, amongst other clotting factors. Upon platelet activation 
these contents may be secreted by the platelet or, in the case of P-selectin, 
transferred to the platelet membrane for presentation. Most of these molecules are 
not specific to platelets (such as vWF, which is also secreted by endothelial cells), 
while some are already found in the plasma (such as fibrinogen), yet some are 
platelet specific (such as beta-thromboglobulin). A second type of intracellular 
vesicle found in platelets are known as dense granules (δ-granules). Dense granules 
also contain a wide range of components such as calcium, histamine, serotonin and 
nucleotides, such as adenosine diphosphate (ADP) and adenosine triphosphate 
(ATP).76,77 The exact role of these secreted molecules varies but the general 
consequence of their secretion is clear. As a whole they function to further support 
the pro-aggregatory response by promoting vasoconstriction, encouraging platelet 
morphological changes, the recruitment of additional platelets to the site of vascular 
injury, increasing the adhesive properties of the platelets, as well as upholding 
continued agonist secretion.  
 
In order to respond to these pro-aggregatory molecules there exists a wide range of 
complementary receptors on the platelet membrane. For example, ADP interacts 
with its receptors P2Y1 and P2Y12,75 while thromboxane A2 (TxA2) is an agonist 
directed agonist the TxA2 receptor (TR).86 Thrombin is particularly interesting in that 
it is a serine protease with a number of roles in the pro-aggregatory response. 
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Converted from prothrombin by cleavage at two sites by a plasma protease known 
as activated factor X, the major proteolytic action of thrombin is the conversion of 
the blood-soluble glycoprotein fibrinogen to fibrin, an insoluble and fibrous protein 
that may be polymerised to form a hemostatic plug in conjunction with platelets at 
the site of vascular injury. It also has another key role in the pro-aggregatory 
response where it acts on the platelet receptors PAR-1 and PAR-4 (and also on GPIb‐
IX‐V). Here, thrombin binds to and proteolytically cleaves the extracellular N-
terminal domain of the receptor unmasking a new N-terminus with the amino acids 
sequence SFLLRN for PAR-1 or GYPGKF for PAR-4. This newly exposed sequence is a 
tethered ligand and is capable of self-activating the PAR receptor. It binds to to the 
second extracellular loop of the receptor to initiate intracellular signalling.87  
 
Many, though not all, of the platelet agonist receptors are G-protein coupled 
receptors (GPCR). GPCRs are seven-transmembrane domain receptors that can bind 
to a cytoplasmic guanine nucleotide-binding G-protein. The G-protein segment can 
be thought of as the on/off switch of the receptor and is composed of an , , and  
subunit. Binding of an agonist to the GPCR leads to an enzymatic exchange of GTP 
for GDP on the  subunit and its subsequent dissociation from the  subunits. 
Much of the platelet response is governed by the form of  subunit that associates 
with the GPCR.88 For example ADP may act on either of its receptors P2Y1 or P2Y12. 
P2Y1 interacts with the Gq alpha subunit and signalling via this pathway leads to 
phospholipase C beta (PLC) activation, which in turn generates IP3 from PIP2.89 IP3 is 
then responsible for the release of intracellular Ca2+ and thus Phospholipase A2 
activation (PLA2). PLA2 releases Arachidonic Acid (AA) from membrane 
phospholipids. AA is subsequently converted to thromboxane, another important 
platelet agonist, via the sequential actions of COX and thromboxane synthase. On 
the other hand, the alternative ADP receptor P2Y12 interacts with the Gi2 alpha 
subunit and thus operates via a different signalling pathway. This pathway inhibits 
cyclic adenosine monophosphate (cAMP) production in platelets, a messenger which 
would otherwise down-regulate the platelet pro-aggregatory response.90  
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One of the many effects of agonist-receptor interaction and platelet activation is 
seen in the morphology of the platelet. Previously discoid in shape, platelets 
become irregular spheres in solution, ready to spread outwards when in contact 
with a surface. This shape change is driven by cytoskeletal rearrangements of the 
actin filaments and proteins such as myosin, filamin, spectrin and ankyrin.7,91 Again, 
this cytoskeletal rearrangement is driven by agonist-mediated signalling pathways. 
For example, myosin light chain kinase (MLCK) phosphorylates myosin in a Ca2+-
dependent manner.92  
  
 
Figure 16: Platelet agonists and their respective receptors. A diagram showing just some of the important 
platelet agonists and their receptors that are important in the platelet activation process. These agonists 
promote a pro-aggregatory response that involves further agonist release in a positive feedback loop, platelet 
recruitment and the integrin family activation via intracellular signalling.  
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2.1.3. Thrombus stabilisation  
Another response to agonist driven activation and maturation of the platelet 
response is seen in the integrin family of receptor proteins. In particular the integrin 
molecule αIIbβ3, undergoes conformational changes that alters its affinity for its 
primary ligand, fibrinogen. This transformation from a low-affinity state to a high-
affinity state allows the formation of stable fibrinogen bridges between platelets 
and thus promotes plug formation. Once again intracellular signalling pathways are 
the key to integrin activation. For example, agonist driven mobilisation of PLC and 
PLC leads to a rise in intracellular Ca2+ levels and liberation of DAG. These converge 
to activate the protein CalDAG-GEFI which in turn leads to the triggering of Rap1, a 
precursor to integrin αIIbβ3 activation.93 This activation of the αIIbβ3 molecule from a 
low-affinity state to a high-affinity state allows the integrin protein to bind to its 
ligands, of which fibrinogen is its primary target. This transition to a high-affinity 
state is mediated by conformational changes within the integrin molecule, a process 
known as “inside-out signalling”. 
 
 Fibrinogen binding to αIIbβ3 causes further conformational changes and cell 
signalling, this time directed from the extracellular domain of the integrin protein 
towards the platelet. This is known as “outside-in signalling” and this functions to 
perpetuate the thrombus growth. This is achieved in a number of ways. Firstly, it 
allows for cytoskeletal reorganisation in the form of focal adhesions. Here, an array 
of structural proteins assemble in an ordered fashion to provide a link between the 
ECM and the intracellular environment. These proteins may be adaptors with a 
structural function, adaptors with catalytic activity, or adaptors that fulfil scaffolding 
function. Via this method, a link between the ECM and the platelet intracellular 
machinery is formed in order to facilitate cell signalling and thus aid thrombus 
stabilisation.94 Secondly, this thrombus growth is perpetuated by an increase in size 
of the platelet aggregates. The congregation of these platelets results in an increase 
in soluble platelet agonists such as ADP, released from platelet dense granules, and 
TXA2, synthesised in platelets in response to primary activation, which function in a 
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positive feedback loop to allow for development of a procoagulant surface and clot 
retraction that helps to narrow the gaps between platelets.76  
       
 
2.1.4. Control of thrombus formation 
Due to the fact that thrombus formation may be highly damaging if improperly 
initiated, the control of platelet aggregation must be highly regulated. One of the 
best understood mechanisms of negative control of thrombus formation involves 
nitric acid (NO). NO is produced by endothelial cells and diffuses across platelet 
membranes where it induces a rise in cytoplasmic levels of cGMP. This is achieved 
via the activation of guanylate cyclase which converts guanosine triphosphate (GTP) 
into cGMP. cGMP activates the protein kinase PKG, which in turn, reduces 
intracellular Ca2+ levels.95,96 High levels of intracellular Ca2+ are normally required for 
platelet activation. A second mechanism of negative thrombus formation is 
expression of PGI2. Similarly to NO, PGI2 is produced by endothelial cells, but it 
regulates platelet responses via a seven transmembrane domain receptor, the 
prostacyclin (PGI2) receptor. Occupancy of the PGI2 receptor results in increased 
activity of adenyate cyclase, via the Gs cytoplasmic protein, causing a rise in platelet 
cytoplasmic levels of cyclic adenosine monophosphate (cAMP). cAMP functions 
though the activation of the protein kinase PKA, which causes a reduction in 
intracellular Ca2+ levels, similar to the actions of PKG.97 In addition to the 
aforementioned mechanisms, the membrane proteins PECAM-182 and ESAM98 may 
provide an attenuating role in thrombus formation. Finally, the previously 
mentioned activation of αIIbβ3 is not an irreversible feature. αIIbβ3 is capable of  
returning to its un-activated form which no longer has affinity for its ligands such as 
vWF and fibrinogen.76 
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2.1.5. Platelet Integrin αIIbβ3 
As previously mentioned, the αIIbβ3 protein, also known as GPIIb/IIIa, is a key 
receptor molecule in maturation of thrombus formation. αIIbβ3 is a member of the 
integrin family of cell surface receptor molecules. Integrins are essential adhesion 
receptors found ubiquitously in metazoan cells. They function to facilitate cell 
migration and extracellular matrix assembly and are thus involved in a wide range of 
activities, including immune response, cell proliferation and apoptosis.12 Like all 24 
members of the integrin family, αIIbβ3 is a heterodimer of an alpha and beta subunit 
that spans the cytoplasmic membrane once.13 The alpha subunit of αIIbβ3 is 
composed of a short cytoplasmic tail and transmembrane domain that crosses the 
cell membrane. Following this region is two calf-domains and the thigh-domain. 
Finally, there exists seven β-propeller repeats. The beta subunit has a longer 
cytoplasmic domain, a transmembrane domain that once again crosses the cell 
membrane once, and four cysteine-rich I-EGF (integrin epidermal growth factor-like) 
domains. Following this is the beginning of the PSI (plexin semaphorin integrin) 
domain, which features the hybrid-domain inserted into it. In turn, the β-I domain is 
inserted into the hybrid domain. The subunit is terminated by the PSI-domain. This 
region and the adjoining hybrid region fold over to expose the β-I domain.14 (Figure 
17) 
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Figure 17: Schematic of the domains present in the alpha and beta chains of αIIbβ3. The alpha chain consists of 
a short cytoplasmic tail and transmembrane domain, 2 calf domains, a thigh domain, and 7 β-propeller 
repeats. The beta chain consists of a longer cytoplasmic tail and transmembrane domain, 4 I-EGF domains, a 
PSI domain, a hybrid domain, and the ligand binding domain β-I. Self-drawn figure based on “Integrins as 
therapeutic targets: lessons and opportunities”.14     
 
αIIbβ3 is the most abundant receptor on the platelet surface, numbering between 
50,000 to 80,000 copies per platelet.99 Its primary ligand is the soluble plasma 
glycoprotein fibrinogen, which is found abundantly in the plasma. Fibrinogen is a 
hexamer containing two sets of three different chains, namely an α, β and γ chain. 
αIIbβ3’s affinity for fibrinogen is mediated by the RGD sequence present on the α-
chain of fibrinogen, as well as the AGD sequence present on the γ chain.100,101 The 
symmetrical fibrinogen structure bridges platelets via their αIIbβ3 surface proteins, 
thus promoting platelet aggregation. Other cell adhesion molecules present on 
endothelial cells also have affinity for fibrinogen and allow localisation of a clot to 
the activated, or injured endothelium. While fibrinogen is αIIbβ3’s primary ligand, this 
integrin also has affinity for vWF, fibronectin, and vitronectin, amongst others.102 As 
such an important facilitator in the platelet aggregation process, activation of the 
protein must be strictly regulated to prevent the formation of thrombi under normal 
physiological conditions. For example, the recognition of fibrinogen by αIIbβ3 is 
dependent on intracellular proteins that interact with the cytoplasmic domain of the 
integrin protein in order to initiate inside-out signalling of αIIbβ3. In typical thrombus 
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formation, initial interaction of platelets with the ECM at the site of vascular injury is 
mediated by glycoprotein (GP) Ib/IX/V complex and collagen receptors, GP VI and 
integrin α2β1 on the platelet surface, and by vWF and fibrillar collagen at the vascular 
site. This initiates the release soluble agonists such as ADP, and TxA2 as previously 
mentioned. Occupancy of receptors by these agonists then initiates an intracellular 
signalling pathway within the platelet, ultimately leading to αIIbβ3 activation via its 
cytoplasmic tail in a process known as inside-out signalling.76 This leads to a change 
in conformation of the αIIbβ3 molecule, enabling it to bind to fibrinogen. Thus αIIbβ3 is 
said to have transitioned from a low-affinity to a high-affinity state. Upon ligand 
interaction an additional signal is sent inside the cell, a process known as outside-in 
signalling. As such αIIbβ3 is capable of bidirectional signalling. Outside-in signalling 
leads to reinforcement of the thrombus via integrin clustering and downstream 
activation of kinases that stabilize the integrin-mediated links between ECM proteins 
and actin filaments.103 Throughout this process a variety of proteins are known to 
associate with the cytoplasmic tails of αIIbβ3 to participate in the bidirectional 
signalling process. These include paxillin, talin, filamin and kindilin.94  
 
 
2.1.6. Inside out signalling 
To bring about the aforementioned large scale structural changes, αIIbβ3 must be 
activated via inside-out signalling. Normally the two subunit tails of the integrin 
molecule keep the protein constrained in its resting state. This is maintained via a 
salt bridge between two conserved regions of the cytoplasmic tail, namely the HDRK 
sequence of the beta tail (via the aspartate [D]) and the GFFKR sequence of the 
alpha tail (via the arginine [R]).94 Interruption of this clasp is required for inside-out 
signalling, and as the cytoplasmic tails have no known enzymatic activities, they 
must rely on adapter proteins to relay functionality. In this case the β3 subunit is 
best recognised as the target of these adapter proteins, while the  αIIb subunit is 
more enigmatic.14 Approximately 20 intracellular proteins are known to directly 
interact with integrin beta tails while a number of times this quantity are believed to 
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be indirectly involved. For example, the proteins paxillin, skelemin, FAK and Fyn all 
interact with the aforementioned HDRK motif of the β3 subunit. While the proteins 
talin, filamin, Src, tensin and kindilin have affinity for the membrane-proximal NPxY 
motif and/or the membrane-distal NxxY motif.94 In platelet activation, inside-out 
signalling owing to agonist-receptor interaction and thus intracellular signalling 
events, leads to separation of the lower legs of the ectodomain via the help of these 
adapter proteins. This separation leads to a “switchblade” like extension of the 
inactive bent integrin, releasing the hybrid domain from its restraining interface with 
the calf domains. In turn the head of the integrin may swing outwards in its high-
affinity state.13 Alternatively, the “deadbolt” model proposes that the increase in 
affinity for it ligand is a step that precedes the extension of the integrin molecule. In 
this case no change in integrin height is required for the ligand-binding and the 
integrin extension is in fact a post-activation event.104 (Figure 18) 
 
2.1.7. Outside-in signalling 
Whatever the degree of integrin extension and conformational change, αIIbβ3 in its 
activated state has an increased affinity for its ligands. The β-I domain of αIIbβ3 
contains a metal ion which interacts with the integrin’s ligand. This is known as the 
metal ion dependant adhesion site (MIDAS). As an integrin lacking a corresponding 
α-I domain, the ligand binding of αIIbβ3 occurs between β-I domain (of the β-subunit) 
and the β-propeller domain (of the α-subunit). Ligand binding is believed to cause 
further structural modifications to the integrin mediated by movements in the α7 
and α1 helices in the α-I and β-I domains. The piston like displacement of the 
integrin legs is thought to promote the formation of the extended αIIbβ3 structure 
and transmission of signals intracellularly.105 This causes an indirect connection 
between the extracellular matrix and the platelet cytoskeletal proteins via the 
interaction of talin with the cytoplasmic tail of the integrin molecule. As these 
adhesions mature, a multitude of cytoskeletal and signalling proteins converge on 
clustered, ligand bound integrin molecules.106 Proteins of these focal adhesions 
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include FAK, actin, paxillin, vinculin, VASP and actin, which combine to form the well 
organised molecular architecture of the platelet cytoskeleton.107 (Figure 18) 
 
 
Figure 18: Activation and conformational changes of platelet integrin αIIbβ3. Agonist induced inside-out 
signalling alters αIIbβ3 from its low-affinity state to its high-affinity state. In this high-affinity state αIIbβ3 may 
bind to its ligand, in this case fibrinogen. Ligand binding leads to outside-in signalling. This involves integrin 
tail separation, signal transmission into the platelet and maturation of the platelet plug.        
 
 
2.1.8. Activation of αIIbβ3 
In order to bring about platelet or integrin activation, a variety of activators are 
commonly used. Thrombin, ADP, collagen, thromboxane A2, are just some of the 
agonists used to bring about platelet activation, αIIbβ3 conformational changes and 
αIIbβ3 ligand binding.108 In the case of these agonists, they do not directly interact 
with the integrin molecule but rather act on their respective receptor molecules to 
bring about an intracellular signalling cascade involving a rise in cytosolic calcium, 
activation of PKC and PI3K, as well as engagement of talin with αIIbβ3.76 In addition to 
these physiological activators of αIIbβ3, a number of synthetic integrin activators are 
available that bring about integrin activation. In contrast to the physiological 
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activators mentioned, these artificial activators act directly on the integrin molecule 
itself rather than signalling through intracellular pathways. The reducing agent 
dithiothreitol (DTT) is one such artificial activator used to mimic αIIbβ3 
conformational change. DTT functions to reduce two disulphide bonds within the 
integrin’s cysteine-rich domain which leads to a structural and allosteric change in 
αIIbβ3. This change in conformation opens up the integrin headpiece to allow for 
ligand binding.109 A second artificial integrin activator is the divalent cation Mn2+. In 
contrast to DTT, Mn2+ does not bring about the same global conformational changes 
in the integrin molecule. Conflicting explanations exist on the exact structural 
changes observed in integrins when subjected to Mn2+, with some reports 
suggesting a “switchblade” like extension of the integrin molecule110, while others 
suggest that no extension of the integrin molecule occurs.104 The differences 
observed with these two mimics of integrin activation once again suggest the 
multiple structural configurations can exist in αIIbβ3, but how close these are to 
physiological conformations is a matter for debate. In this chapter we sought to 
compare and contrast the use of the artificial activators DTT and Mn2+ with a 
physiologically-relevant activator in thrombin receptor activating peptide (TRAP). 
The purpose of this was to characterise the efficacy of DTT and Mn2+ as activators of 
αIIbβ3. This was examined in platelets before attention moved to the activation of 
αIIbβ3 in artificial lipid systems such as integrin-reconstituted liposomes, or integrin-
reconstituted supported lipid bilayers.  
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2.2. Experimental 
2.2.1. Washed platelet preparation 
Venous whole blood was drawn from volunteers by a qualified phlebotomist with a 
Butterfly© 16 gauge needle. Volunteers were healthy and free from aspirin or other 
drugs that may knowingly affect platelet function. Ethical approval was given by the 
RCSI research ethics committee. To prevent coagulation, Acid-Citrate-Dextrose 
(ACD) (38mM citric acid anhydrous, 5 mM sodium citrate, 124mM glucose) at 15 % 
(v/v) was present in the syringe during withdrawal. The blood was aliquoted into 15 
ml tubes and centrifuged at 150 g for 12 minutes in order to fractionate the blood. 
The majority of the top fraction which is known as the platelet rich plasma (PRP) is 
removed from the tube. The PRP is transferred to a 50 ml tube and the pH reduced 
to approximately 6.5 with a few drops of ACD. Prostaglandin E1 (PGE1) (Sigma 
Aldrich) was added at a final concentration of 1 μM to prevent premature platelet 
activation. The PRP was centrifuged at 720 g for 10 minutes to pellet the platelets. 
The supernatant was removed and platelets were re-suspended gently in JNL buffer 
(10 mM Tris, 130 mM NaCl, 9 mM NaHCO3, 10 mM sodium citrate, 3 mM KCl, 0.81 
mM KH2PO4, 0.9 mM MgCl26H2O, 6 mM glucose, pH 7.35) before bring left to rest at 
room temperature for 45 minutes. CaCl2 was added to the platelets at a final 
concentration of 1.8 mM before activation studies. 
 
2.2.2. Platelet Aggregometry 
Platelet aggregometry is a technique that uses light transmission through a platelet-
containing glass cuvette to determine the degree of aggregation of a platelet 
population. Washed platelets were placed in an aggregometry cuvette and stirred at 
a defined speed (1100rpm) and a controlled temperature (37oC). Light was passed 
through the cell and much of the light was absorbed by the platelets before it 
reaches a detector. The addition of an agonist to the cuvette caused the platelets to 
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aggregate and fall to the bottom of the cell. This aggregation allowed for the 
increased transmission of light through the cell. This increase in light transmission 
corresponded to the degree of platelet aggregation and can be monitored over a set 
period of time. To perform the aggregation experiments, washed platelets were 
counted with a Sysmex KX-21 haematology analyser and adjusted to 3 x 106  
platelets per μl via the addition of more JNL buffer. CaCl2 was added at a final 
concentration of 1 mM. Platelets were added to the aggregation tubes of a PAP-8E 
aggregometer from BioData Corporation. At 37 °C and under constant stirring, the 
platelets were stimulated with varying concentrations of DTT or MnCl2 (0.5 to 5 mM) 
(both Sigma Aldrich). Thrombin receptor activating peptide (TRAP) (Bachem) was 
used as a positive control throughout (4 M). Physiologically, thrombin acts by 
cleaving its receptor’s N-terminus revealing a tethered ligand, SFLLRN, which in turn 
acts as an agonist on itself. TRAP is a short peptide sequence (SFLLRN) that potently 
mimics this response without the additional serine protease actions of thrombin, ie 
the conversion of fibrinogen to fibrin. In some experiments additional fibrinogen 
(Calbiochem) was added at a final concentration of 1 mg/ml to aid platelet 
aggregation. The percentage aggregation was monitored with the in-built software 
of the PAP-8E aggregometer and the data was exported for analysis in GraphPad 
Prism (GraphPad Software Inc, CA, USA). 
 
2.2.3. Flow cytometry 
Experimentally, platelets were transferred to fluorescence-activated cell sorting 
(FACS) tubes and incubated at room temperature in the presence of the required 
antibody or protein. The final platelet concentration was always 3 x 105  platelets per 
μl as determined by a Sysmex KX-21 haematology analyser. Calcium was added at a 
final concentration of 1 mM to ensure that platelets were responsive. Platelets were 
stimulated with either DTT or MnCl2 (both at 3 mM) for 30 minutes at room 
temperature to induce αIIbβ3 conformation or platelet activation. Thrombin receptor 
activating peptide (TRAP) at 4 μM was used as the positive control. Platelets were 
passed through the FACScalibur flow cytometer (Becton Dickinson, NJ, USA) and the 
 98 
platelet population was identified by a dot plot of forward scatter versus side 
scatter. A population gate was made around this area and 10,000 acquisitions are 
made. Data was analysed using CellQuest Pro software from Becton Dickinson or 
Flowing Software from Turku Bioimaging. Data was graphed using GraphPad Prism. 
αIIbβ3 conformational studies 
For αIIbβ3 conformational studies, FITC labelled mouse anti-human PAC-1 antibody 
(BD Pharmingen) or Oregon Green® 488 conjugated fibrinogen from human plasma 
(OgFg) (Molecular Probes) was used. PAC-1 is an antibody specific to the activated 
conformation of αIIbβ3, while OgFg is a labelled fibrinogen which should also only 
bind to activated αIIbβ3. The final concentration of PAC-1 was 0.1 mg/ml, while the 
final concentration of OgFg was 0.15 mg/ml.  
Alpha granules release (p-selectin expression) 
As mentioned in section 2.1.2 , activated platelets mobilise alpha granules in 
response to pro-aggregatory signals. One of the constituents of these granules is P-
selectin, also known as CD62P. P-selectin is a cell adhesion molecule that is 
presented on the cell membrane in activated platelets. In resting platelets, P-
selectin is stored in alpha granules. Therefore, the activation state of platelets can 
be determined by the expression of this molecule on the platelet surface. 
Experimentally this expression was identified via the antibody PE mouse anti-human 
CD62P (BD Pharmingen). The antibody was incubated with the platelets at 0.1 
mg/ml for 30 minutes at room-temperature.    
 
2.2.4. ADP/ATP assay 
As mentioned in section 2.1.2, activated platelets secrete the contents of their 
dense granules in response to platelet agonist stimulation. These components 
include histamine, serotonin, ADP and ATP. In order to investigate whether dense 
granule secretion has occurred, ATP release by platelets was measured. Due to the 
fact that ATP:ADP release occurs in the ratio of 2:3,111 this measure can be used as a 
surrogate for ADP release. In order to measure ATP release in response to various 
agonists, platelets were incubated with DTT, MnCl2 (both at 3 mM) or TRAP (at 4 
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M) for a given time (5 or 30 minutes) in a 96 well plate. The final platelet 
concentration was always 3 x 106  platelets per μl as determined by a Sysmex KX-21 
haematology analyser. The volume of each well was 100 μl. An ADP standard was 
also prepared and pipetted into the 96 well-plate. The plate was gently shaken at 37 
°C during the experiment runtime. In order to detect ATP levels for each well, 10 µl 
of the detection reagent Chronolume (Chronolog; Labmedics Limited, UK) was 
dispensed in the requisite wells at the end of the experimental time and the plate 
was shaken for 5 seconds as per the manufacturer’s instructions. Luminescence 
from each well was detected using a Wallac 1420 Multilabel Counter (Perkin Elmer). 
Data was exported to GraphPad Prism and expressed as arbitrary absorbance units 
(AAU). 
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2.3. Results 
2.3.1. Platelet Aggregation 
Perhaps the most straightforward method of determining the effectiveness of the 
artificial agonists DTT and Mn2+ as integrin αIIbβ3 activators is through the use of 
platelet aggregometry. Here the activators can be added to cuvettes containing 
platelets and the degree of aggregation can be monitored over time and compared 
to a positive control in the form of TRAP. Although platelet aggregation is not 
controlled by integrin αIIbβ3 activation alone, it is one of the primary players in the 
aggregation process.   
  
Platelet Aggregation in Response to DTT 
The first artificial activator to be examined was DTT. Washed platelets (3 x 106  
platelets per μl) were incubated with DTT concentrations ranging from 0.5 to 5 mM, 
or a positive control of 4 M TRAP and light transmission through the cell was 
monitored over time. Washed platelets were prepared from 9 different donors, 
across separate days. As expected, the well-characterised positive control TRAP lead 
to immediate and large degree of platelet aggregation. After reaching maximum 
aggregation, the percentage of aggregated platelets proceeded to slowly decrease 
over the course of the experiment. In contrast to this response, DTT addition 
resulted in a prolonged lag phase in a concentration dependent manner. Using a 
percentage aggregated of 1 % as the start of this aggregation process, the lag time 
for each concentration of DTT is given in Figure 20. At the highest DTT 
concentrations (5 mM) aggregation was not visible until the 4 or 5-minute mark. At 
the lowest concentration (0.5 mM) this lag-phase was extended to approximately 12 
– 15 minutes. As well as this lag in platelet response, the rate of platelet aggregation 
was also much slower than the positive control. Instead of reaching a plateau within 
2 minutes as with TRAP, DTT-mediated aggregation had still not reached its zenith 
30 minutes into the experiment. The different dynamics of DTT versus TRAP-
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mediated aggregation can be seen in Figure 19. A one-way ANOVA was performed 
on this data at three different timepoints. After 500 seconds, TRAP, 5 mM DTT, 4 
mM DTT (all p < 0.001) and 3 mM (p < 0.01) were all found to be significantly 
different than the negative control. After 1000 seconds, all the activators were 
found to be significantly different than the negative control (p < 0.001, except for 
0.5 mM DTT where p < 0.05). At 1500 seconds all activators were also found to be 
significantly different than the negative control, where p < 0.001. It is clear from this 
that although DTT is indeed a good platelet aggregator, consideration must be 
placed on the fact that the platelet response is not instantaneous.  
 
 
 
Figure 19: Aggregation of washed platelets in JNL buffer at 37°C after DTT activation (0.5 mM to 5 mM). The 
aggregation response was delayed when compared to activation with the positive control TRAP (brown). 
Additionally, the initiation of DTT-mediated aggregation was dose-dependant and even at the highest 
concentration used, never lead to the same degree of aggregation observed with TRAP. Unstimulated 
platelets did not aggregate (red).  Data points were taken at 0.5 second intervals over the 30-minute duration 
of the experiment in a PAP-8E aggregometer and the mean value was obtained at each time-point before 
being plotted. (n=9, where n is the number of different donors)  
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Figure 20: Lag time of DTT response. It can clearly be seen that as DTT concentration increased the lag phase 
was reduced, with minimal difference between 3, 4 and 5 mM concentrations of DTT. This lag phase must be 
taken into account when discussing the potency of DTT as an integrin activator.  
 
 
 
Platelet Aggregation in Response to Mn2+ 
To investigate Mn2+ as an integrin activator in a platelets, washed platelets (3 x 106  
platelets per μl) were incubated with Mn2+ at concentrations ranging from 0.5 mM 
to 5 mM, as well as incubated with a positive control in TRAP (at 4 M), and the 
degree of light transmission through the platelet aggregation cell was monitored 
over time. Washed platelets were prepared from 5 different donors on separate 
days. As before, the well-characterised positive control TRAP lead to immediate and 
extensive platelet aggregation before slowly declining over the course of the 
experiment. On the other hand, Mn2+-mediated aggregation in washed platelets 
appeared to be negligible at all concentrations used. This can be seen in Figure 21. 
To confirm this a one, way ANOVA and post-hoc Bonferroni test was performed at 
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500, 1000, and 1500 seconds. Only TRAP was found to be significantly different than 
the negative control, where p < 0.001. This result was somewhat surprising given the 
wide use of Mn2+ as an integrin activator within the literature.  
 
 
Figure 21: Aggregation of washed platelets in JNL buffer at 37°C in response to Mn2+ (0.5 mM to 5 mM). The 
aggregation of platelets in response to Mn2+ at all concentrations was negligible over the 30 minutes of 
observation. The positive control TRAP functioned as expected (brown). Unstimulated platelets did not 
aggregate (red). Data points were taken at 0.5 second intervals over the 30 minute duration of the experiment 
in a PAP-8E aggregometer and the mean value was obtained at each time point. (n=5, where n is the number 
of different donors) 
 
Platelet Aggregation in Response to Mn2+ and Additional Fibrinogen 
Due to the fact that Mn2+ has been widely described as an integrin 
activator,13,110,112,113 it was unexpected that platelet aggregation was negligible using 
this agonist. In order to promote Mn2+-induced aggregation it was later decided to 
supplement the washed platelets with fibrinogen. Fibrinogen is the primary ligand of 
αIIbβ3 and acts as bridge between platelets to aid aggregation and promote 
thrombus formation. Therefore, the additional of fibrinogen to our washed platelets 
was hoped to enable the aggregation process. It should be noted that prepared 
washed platelet solutions already contain a quantity of free fibrinogen, while 
platelets also contain fibrinogen within their alpha granules. This fibrinogen may be 
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released in response to to intracellular signalling events in order to promote the 
platelet aggregatory process.89 As such, under these conditions, the washed 
platelets were simply put in solution with fibrinogen at a higher concentration then 
a standard washed platelet population. Experimentally the platelets were 
supplemented by the addition of fibrinogen at final concentration of 1 mg/ml. To 
this fibrinogen-augmented platelet population, Mn2+ was added as before at 
concentrations ranging from 0.5 mM to 5 mM. Once again 4 M TRAP was used as a 
positive control. The experiment was carried out on washed platelets prepared from 
7 different donors on separate days.  Figure 22 shows the platelet aggregation 
profile within the aggregation cell following agonist addition.  
 
Under these conditions TRAP was once again an excellent agonist for promoting 
platelet aggregation. In fact, the fibrinogen supplementation had increased the rate 
at which maximum aggregation was achieved, although no increase in the maximum 
percentage aggregated value was detected, when compared to a standard washed 
platelet preparation  (Figure 19 and Figure 21).  As before, using TRAP, the 
percentage of aggregated platelets began to slowly decrease over the course of the 
experiment after initially plateauing. Turning attention to Mn2+ it can clearly be seen 
that the cation does increase the aggregation response in fibrinogen-supplemented 
washed platelets. This is in contrast to results in a standard washed platelet 
population where no aggregation response was obvious (Figure 19 and Figure 21). 
However, the aggregatory response to Mn2+ was not as significant when compared 
to TRAP or DTT and did not exceed 20 % aggregation in any of the experiments. 
Interestingly, in contrast to DTT, no lag-phase was apparent, thus showing very 
different dynamics when compared with the reducing agent. A one-way ANOVA and 
post-hoc Bonferroni test was performed after 500, 1000, and 1500 seconds to 
determine how statistically significant this aggregation was. At all three time-points 
p < 0.001 for all activators, expect 0.5 mM Mn2+, where p < 0.01 throughout. 
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Figure 22: Aggregation of washed platelets in response to Mn2+ after addition of fibrinogen at 1 mg/ml. In this 
case the extra fibrinogen appears to facilitate the aggregation of the washed platelet preparation. TRAP 
results in aggregation as expected (brown). Unstimulated platelet aggregation is negligible. Data points are 
taken at 0.5 second intervals over the 30-minute duration of the experiment and the mean value is obtained 
at each time point.  (n=7, where n is the number of different donors) 
From our platelet aggregometry experiments it can clearly be seen that each of the 
agonists, TRAP, DTT and Mn2+, show very different aggregation profiles. The positive 
control TRAP used at a half-maximal dose consistently lead to a measurable degree 
of aggregation within seconds and reached its maximum percentage aggregation 
value with 2 to 3 minutes, before a gradual decline in aggregation was seen as 
platelets slowly returned to solution. On the other-hand, the response to DTT was 
distinguished by a relatively long lag phase. This lag occurred in a concentration-
dependent manner which varied from from 4 minutes (5 mM DTT) to 15 minutes 
(0.5 mM DTT). Despite this lag-phase the magnitude of aggregation was significant, 
while not as substantial as TRAP. Another noteworthy observation is the fact that 
the maximum percentage aggregation plateaued at approximately 40 % aggregated. 
For example, at 3, 4 and 5 mM DTT the same percentage aggregated value of 
approximately 40 % was reached. Over the time-course of the experiment no 
decrease in the percentage aggregation was detected, although this could be due to 
the length of the experiment (30 minutes). For Mn2+, it was surprising to see no 
platelet aggregatory response in washed platelets. This was despite the fact the 
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Mn2+ has been widely used as an integrin activator.45,46,114 In order to combat this 
lack of aggregation it was decided to supplement the washed platelets with extra 
fibrinogen. To do so fibrinogen was added at 1 mg/ml (2.9 μM) , a value which did 
not include any fibrinogen already present in the washed platelets, nor any 
fibrinogen that may or may not be released from the platelet’s alpha granules during 
the activation response. As platelets were at a concentration of 3 x 106 platelets per 
μl and assuming between 50,000 and 80,000 αIIbβ3 molecules per platelet the 
concentration of αIIbβ3 in the aggregation experiments was anticipated to be 
between 0.249 and 0.399 μM. This meant we are working with an approximate 
tenfold excess of fibrinogen molecules when compared with αIIbβ3 molecules. It was 
found that only under these fibrinogen saturated conditions was Mn2+-mediated 
aggregation observable. Using Mn2+ concentrations between 0.5 and 5 mM this 
aggregation occurs more quickly than DTT-mediated aggregation but never reaches 
the same degree of percentage aggregation. Fibrinogen addition without the 
presence of Mn2+ does not lead to aggregation showing the requirement for both 
the divalent cation and the αIIbβ3 ligand. The maximum percentage of platelet 
aggregation reached under these conditions and at varying agonist concentrations is 
shown in Table 3. Together, these results suggest that DTT is a much more potent 
activator of αIIbβ3 than Mn2+, with the caveat that DTT activation includes a lag-
phase. As previously mentioned, there is believed to be at least one intermediate 
partially activated state of αIIbβ3115, and Mn2+ does not bring about the same global 
conformational changes with when integrin is subjected to DTT.104,110 It is therefore 
interesting to speculate that Mn2+ stimulation results in an intermediate state αIIbβ3 
molecule with lower affinity for its ligands, while DTT stimulation leads to an αIIbβ3 
with high affinity for its ligands. In this case the partially-activated αIIbβ3 molecule 
may be continually moving between a ligand bound and unbound state whereby the 
low levels of soluble fibrinogen found in washed platelets is unable to support 
platelet bridging. The addition of extra fibrinogen at the concentration used in the 
experiments results in an approximate tenfold excess of fibrinogen in comparison to 
αIIbβ3, plus the fibrinogen already present in washed platelet preparations. This 
would mean that αIIbβ3 spends less time in its ligand unoccupied state and enough 
time in its ligand occupied state to facilitate some degree of platelet aggregation as 
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observed. Of course it these platelet aggregation experiments observe whole cell 
response to agonist stimulation rather than an integrin αIIbβ3 specific response. It 
must be remembered that the platelet membrane contains a variety of receptor 
molecules with affinity for a wide range of ligands involved in the aggregation 
response. For example, GPVI and integrin α2β1 and their shared ligand; collagen85, 
integrin αVβ3 and its primary ligand vitronectin116, and the GPIb-IX-V complex and its 
ligand vWF76, amongst others. Indeed integrin αIIbβ3 itself has specificity for a 
number of RGD and AGD peptide containing ligands including fibrinogen, vWF, 
fibronectin, and vitronectin, amongst others.102 Furthermore, both DTT and Mn2+ 
are not specific to αIIbβ3 activation alone, but rather general integrin activators.117–119 
Given the fact the αIIbβ3, is one of five different integrins present at the platelet 
membrane116, a simple whole cell platelet aggregation response to DTT and Mn2+ 
does not tell us the whole picture of how these two agonists influence integrin 
αIIbβ3’s structural response and ligand binding ability with particular emphasis on 
fibrinogen-binding. It was therefore decided to use flow cytometry to get more αIIbβ3 
specific information following activation with DTT and Mn2+. 
   
 
Table 3: The maximum observed aggregation of washed platelets in response to DTT, Mn2+ and Mn2+ with the 
addition of fibrinogen at a final concentration of 1 mg/ml. While DTT alone is capable of bringing about a 
sizable degree of aggregation, Mn2+ must be co-incubated with fibrinogen for whole platelet aggregation to 
become observable. 
Agonist Concentration Maximum mean aggregation in response to agonist (%) 
mM DTT Mn2+ Mn2+ + Fg 
0 1 2 3 
0.5 14*** 2 7** 
1 24*** 3 12*** 
2 31*** 3 16*** 
3 43*** 3 16*** 
4 40*** 4 16*** 
5 40*** 3 16*** 
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Table 4: A summary of the different responses to artificial agonists DTT and Mn2+ and the physiologically-
relevant agonist TRAP. Both TRAP and DTT readily lead to platelet aggregation, albeit the DTT response 
featured a noticeable lag-phase. On the other hand, Mn2+ appeared to be a relatively poor agonist where 
fibrinogen supplementation was required to yield noticeable platelet aggregation.   
Agonist Platelet aggregation Lag phase 
TRAP Extremely significant 
aggregation 
No 
DTT Significant aggregation Concentration dependent 
lag phase 
Mn2+ Negligible aggregation n/a 
Mn2+ and fibrinogen Aggregation No 
 
2.3.2. Direct probing of αIIbβ3 
PAC-1 binding to integrin αIIbβ3 
The first method we used to directly probe the integrin αIIbβ3 conformational state 
was through the use of the antibody PAC-1 in a flow cytometry set-up. This antibody 
has specificity for the “activation-induced conformational epitope of the integrin 
αIIbβ3”, according to the supplier120, while having no affinity for the resting form of 
the protein. Therefore, if agonist-driven stimulation transitioned the αIIbβ3 protein 
from its low-affinity activation state to its high-affinity activation state, PAC-1 
binding should be apparent. The experiment was repeated 5 times on separate 
donors. To gauge FITC-labelled PAC-1 binding to αIIbβ3, un-stimulated platelets were 
firstly analysed by flow cytometry for the binding of FITC–PAC-1. The platelet 
population was identified by forward scatter (particle size) and side scatter (particle 
granularity). Counts for the fluorescence data channel were piled on lowest values 
of the logarithmic x-axis of a histogram as the negative control. Subsequently, TRAP, 
DTT and Mn2+-treated platelets were passed through the flow cytometer and the 
fluorescence data channels were plotted on the same histogram. Therefore, any 
PAC-1 binding is apparent as a shift in the counts to the right of the histogram. 
Figure 23 shows representative results for DTT (top) and Mn2+ (bottom) activation. 
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Four M TRAP was used as the positive control and is visible in both histograms as a 
yellow fill. It can clearly be seen that TRAP, DTT and Mn2+ all lead to a shift in the 
counts to the right of the histogram showing that PAC-1 binding was occurring. 
Therefore, according to PAC-1 binding, all three agonists are capable of causing 
αIIbβ3 conformational changes and transition of the integrin protein from its low-
affinity to its high-affinity state.  
 
There are a number of ways to quantify PAC-1 binding. One such method is to use a 
gate on the histogram. Here, a gate was placed on the data so that 5 % of the total 
counts for the un-stimulated platelets were found within this gate. This way, any 
shift in counts to the right of the histogram results in more counts being 
encompassed within the gate. Figure 23 shows this gate, while Figure 24 shows the 
percentage gated values following agonist addition. Somewhat surprisingly, the 
positive control of 4 M TRAP only lead to a small histogram shift, whereby the 
percentage gated value increased from 5 % to 16 ± 2 %. Using 0.5 mM and 3 mM 
DTT resulted in percentage gated value of 56 ± 17 % and 59 ± 8 %, respectively. 
Whereas, 0.5 mM and 3 mM Mn2+ resulted in percentage gated value of 33 ± 10 % 
and 35 ± 5 %, respectively. A one-way ANOVA and post-hoc Bonferroni test found all 
activators to lead to a significant degree of PAC-1 binding, where p < 0.01 for TRAP 
and p < 0.001 for DTT and Mn2+ at both concentrations.  
 
An alternative method of quantifying PAC-1 binding is using the geometric mean of 
the counts under each condition. The geometric means of PAC-1 binding are shown 
in Figure 25. Using this measure, the geometric mean for unstimulated platelets was 
1.55 ± 0.15. TRAP stimulation increased this value to 1.91 ± 0.28. The use of 0.5 mM 
DTT resulted in a geometric mean of 3.45 ± 0.97, while at 3 mM DTT the geometric 
mean was 3.67 ± 0.60. The use of 0.5 mM Mn2+ resulted in a geometric mean of 2.82 
± 0.36, while at 3 mM Mn2+ the geometric mean was 2.97 ± 0.41. ANOVA analysis 
and post-hoc Bonferroni test revealed that the agonists lead to significantly different 
PAC-1 binding, where p < 0.001 for both DTT concentrations, p < 0.01 for 3 mM 
Mn2+, and p < 0.05 for 0.5 mM Mn2+. Strangely, TRAP did not lead to significant PAC-
1 binding according the geometric mean data. 
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All in all, these results are quite surprising. TRAP was a surprisingly poor integrin 
αIIbβ3 activator according to PAC-1 binding. On the other-hand, DTT appeared to be 
an excellent αIIbβ3 activator, while Mn2+ was also a good αIIbβ3 activator. Weak 
activation by TRAP can perhaps be explained by the fact that TRAP acts on the 
thrombin receptor rather than directly on the αIIbβ3 protein. This in turn leads to the 
activation of various intracellular pathways which include but most importantly are 
not limited to inside-out activation of integrin αIIbβ3. Thus, platelet aggregation is 
driven by a multitude of platelet response and not merely conformational changes 
in the αIIbβ3 protein. Taken together with our earlier platelet aggregometry 
experiments this may highlight the disconnect between what constitutes platelet 
activation (platelet aggregation) and αIIbβ3 activation (αIIbβ3 conformational changes). 
 
 
 
Figure 23: Representative histograms of FITC-labelled PAC-1 fluorescence after activation with TRAP, DTT and 
Mn2+. The unstimulated gate set a 5 % meaning that 5 % of the counts for unstimulated platelets fall within 
this boundary. An increase in the number of counts that fall within the gate shows PAC-1 binding. A) shows 
PAC-1 binding in response to DTT (0.5 mM in blue, 3 mM in green) and the positive control TRAP (4 μM in red). 
A shift to the right is evident in all three cases when compared with the unstimulated platelets (black with 
yellow fill). B) shows PAC-1 binding in response to Mn2+ (0.5 mM in blue, 3 mM in green) and the positive 
control TRAP (4 μM in red). Once again a shift to the right is evident in all three cases when compared with the 
unstimulated platelets (black with yellow fill).  
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Figure 24: Both DTT and Mn2+-induced integrin activation as assessed using the percentage gated of PAC-1 
binding. A 5 % gated value was used for unstimulated platelets (blue). 4 M TRAP (red) was a surprisingly 
weak integrin activator and only lead to a slight increase in the percentage gated value. DTT (green and 
purple) and Mn2+ (orange and black) were excellent integrin activators at 0.5 and 3 mM according to PAC-1 
binding. Standard deviation was used to represent the error. (n=5, where n is the number of separate donors) 
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Figure 25: Both DTT and Mn2+-induced integrin activation as assessed using the geometric mean of PAC-1 
binding. The geometric mean of unstimulated platelets is shown in blue. 4 M TRAP (red) was a surprisingly 
weak integrin activator and only lead to a slight increase in the geometric mean. DTT (green and purple) and 
Mn2+ (orange and black) were excellent integrin activators at 0.5 and 3 mM according to PAC-1 binding. 
Standard deviation was used to represent the error. (n=5, where n is the number of separate donors) 
 
Fibrinogen binding to integrin 
An alternative method of directly probing the activation state of integrin αIIbβ3 in a 
flow cytometry setup is via the use of a labelled fibrinogen molecule, in this case, 
Oregon green fibrinogen (OgFg). As only the high affinity conformation is capable of 
binding to fibrinogen so this experiment can be seen as proxy for the activation state 
of αIIbβ3.In this experimental setup it we sought to investigate whether fibrinogen 
binding could be brought about by the artificial agonists DTT and Mn2+. The earlier 
PAC-1 binding results suggest that both agonists lead to the high-affinity activation 
state of integrin αIIbβ3. Given that this high-affinity activation state allows for ligand 
binding and has previously been shown to lead to platelet aggregation, it would be 
 113 
expected that fibrinogen binding should occur. In order to gauge labelled fibrinogen 
binding to αIIbβ3, un-stimulated platelets were firstly passed through the flow 
cytometer and the population was identified by forward scatter (cell size) and side 
scatter (cell granularity). Counts for the fluorescence data channel were piled on 
lowest values of the logarithmic x-axis of a histogram as the negative control. 
Subsequently, TRAP, DTT and Mn2+-activated platelets were passed through the flow 
cytometer and the fluorescence data channels were plotted on the same histogram. 
Therefore, any OgFg binding is apparent as a shift in the counts to the right of the 
histogram. The experiment was repeated using washed platelets from 5 separate 
donors. Figure 26 shows typical results for DTT (top) and Mn2+ (bottom) activation. 4 
M TRAP was used as the positive control and is visible in both cases. It is clear that 
TRAP leads to a massive histogram shift for OgFg binding. Interestingly, this is in 
contrast to the earlier PAC-1 results. DTT also brought about a histogram shift in a 
concentration-dependant fashion (top). Whereas, Mn2+ did not appear to bring 
about a histogram shift at either concentration (bottom). This is unusual given the 
fact that PAC-1 binding had earlier shown that Mn2+ leads to the activated high 
affinity form of αIIbβ3. In order to quantify these results two separate analysis 
methods were used once again applied.  
 
Using percentage gated in the same manner as last time where a baseline gate was 
placed on the data so that 5 % of the total counts for the un-stimulated platelets 
were found within. Figure 26 shows this gate, while Figure 27 shows the percentage 
gated values following agonist addition. In this case, TRAP activation lead to 
substantial increase in the percentage gated value where 56 ± 7 % of events were 
found to occupy the gated region, up from the 5 % baseline in unstimulated 
platelets. For DTT the percentage gated value increased in a concentration-
dependent manner. At 0.5 mM DTT it was found to be 14 ± 4 %, while 3 mM DTT it 
was found to be 86 ± 9 %. On the other-hand the percentage gated value for Mn2+ 
stimulated platelets failed to deviate from the baseline gated value at either 
concentration used. In this case both 0.5 and 3 mM Mn2+ resulted in 6 ± 1 % of 
events falling within the gate. ANOVA analysis and a post-hoc Bonferroni test 
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showed that only TRAP and DTT at 3 mM lead to significant OgFg binding, where p < 
0.001 in both cases. 
 
Following this analysis using a gated histogram, the geometric mean was also used 
to quantify OgFg binding. Using this method, un-stimulated platelets had a 
geometric mean of 1.80 ± 0.06 The geometric mean of TRAP stimulated platelets 
was 7.01 ± 0.94. For DTT stimulation, the geometric means were 2.39 ± 0.24 and 
10.48 ± 2.92 at 0.5 and 3 mM, respectively. Using Mn2+, the geometric means were 
1.91 ± 0.27 and 1.87 ± 0.16 at 0.5 and 3 mM, respectively.  ANOVA analysis and a 
post-hoc Bonferroni test showed that only TRAP and DTT at 3 mM lead to significant 
OgFg binding, where p < 0.01 and p <0.001, respectively. 
 
Figure 26 shows that the positive control TRAP (at 4 M), despite earlier leading to 
limited PAC-1 binding, was an excellent agonist for fibrinogen binding. DTT lead to 
fibrinogen binding as shown in Figure 26A. Whereas, interestingly, Mn2+ did not 
appear to result in any degree of fibrinogen binding as shown in Figure 26B. This is 
despite the fact that PAC-1 binding had showed that αIIbβ3 was in its activated state 
and thus should be available for ligand-binding. These fibrinogen binding 
experiments are extremely interesting considering our earlier PAC-1 binding 
experiments that informed us of the activation state of integrin αIIbβ3. While this 
PAC-1 binding had shown that both DTT and Mn2+ transitioned the αIIbβ3 protein to 
its active ligand-available configuration, OgFg binding has shown that only DTT 
allowed for fibrinogen binding to the αIIbβ3 protein. This highlights the intricacies of 
αIIbβ3 activation and points to varying degrees of activation states which may or may 
not be suitable for ligand-binding. It is plausible to suggest that Mn2+ leads to some 
degree of αIIbβ3 conformational changes to allow for PAC-1 binding but not the 
extent where αIIbβ3 is fully available for fibrinogen binding, ie, a partially activated 
state. As a whole, these results suggest that both the positive control TRAP and the 
reducing agent DTT are good integrin αIIbβ3 activators in terms of fibrinogen binding. 
Contrary to this, Mn2+ stimulation does not appear to lead to fibrinogen binding.    
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Figure 26: Representative histograms of Oregon green labelled fibrinogen (OgFg) fluorescence after activation 
with TRAP, DTT and Mn2+. Once again the unstimulated gate set a 5 %. A) shows OgFg binding in response to 
DTT (0.5 mM in blue, 3 mM in green) and the positive control TRAP (4 μM in red). A shift to the right is evident 
in all three cases when compared with the unstimulated platelets (black with yellow fill). B) shows OgFg 
binding in response to Mn2+ (0.5 mM in blue, 3 mM in green) and the positive control TRAP (4 μM in red). In 
contrast to DTT, Mn2+ does not appear to be sufficient for observable fibrinogen binding. This is despite the 
previous findings Mn2+ stimulation leads to PAC-1 binding, indicating that αIIbβ3 is in its active confirmation. 
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Figure 27: DTT but not Mn2+ induced integrin activation as assessed using the percentage gated of OgFg 
binding. A 5 % gated value was used for unstimulated platelets (blue). The positive control of 4 M TRAP was 
also an integrin activation as determined by fibrinogen binding. DTT at 3 mM (purple) lead to integrin 
activation according to fibrinogen binding. Mn2+ (orange and black) did not lead to activation according to 
fibrinogen binding. Standard deviation was used to represent the error. (n=5, where n is the number of 
separate donors) 
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Figure 28: DTT but not Mn2+-induced integrin activation as assessed using the geometric mean of OgFg 
binding. The geometric mean for unstimulated platelets is shown in blue. The positive control of 4 μM was an 
excellent integrin activator according to OgFg binding. DTT also lead to integrin activation at 3 mM (purple). 
Mn2+ did not lead to integrin activation at either concentration. Standard deviation was used to represent the 
error. (n=5, where n is the number of separate donors) 
 
Taken separately these PAC-1 and fibrinogen binding results are relatively 
straightforward. However, taken together their contradictory nature is intriguing. 
TRAP leads to a small degree of conformational changes in αIIbβ3, yet a large degree 
of fibrinogen binding. DTT leads to both large scale αIIbβ3 structural changes and 
fibrinogen binding. Mn2+ also leads to large scale αIIbβ3 structural changes, yet fails to 
elicit fibrinogen binding.  
 
In these flow cytometry experiments it can be said that DTT behaved as expected, 
based on our earlier light aggregometry experiments. DTT induced platelet 
activation resulted in enhanced PAC-1 binding, indicating that integrin αIIbβ3 had 
transitioned to its ligand available high affinity activated state. In addition, DTT 
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causes enhanced fibrinogen binding as seen in the OgFg experiments. These two 
results combine to agree with our earlier observation that DTT was a capable of 
supporting whole platelet aggregation as seen via light aggregometry. This is 
relatively unsurprising given the blunt nature of the reducing agent DTT as an 
integrin activator. Yan and Smith have reported that DTT reduces two disulfide 
bonds within the integrin’s cysteine-rich domain and it is these reductions that are 
responsible for the global conformational changes in αIIbβ3 which make the integrin 
protein available for ligand binding.109 This ability of DTT to function as general 
integrin was further backed up by Zhang et al. where the reducing agent was 
capable of bringing about conformational changes within integrin 57, again via 
reduction in two disulphide bonds at the integrin knees. This disulphide bond 
reduction did not occur via inside-out activation or Mn2+ activation.117                          
 
TRAP was, as expected, an excellent activator of αIIbβ3 at least in terms of fibrinogen 
(OgFg) binding. This would be expected given our earlier aggregometry experiments 
where TRAP was an extremely potent agonist, leading to a high degree of platelet 
aggregation. However, the fact that PAC-1 was relatively low contrasts with this.  
This can be explained in a number of ways. The TRAP peptide acts on the thrombin 
receptor and thus signals intracellularly with all the associated responses 
accompanying thrombin activation. As such TRAP stimulation leads to a whole-
platelet response that may include the transitioning of all five platelet present 
integrins121 to their high-affinity conformation, the expression of P-selectin on the 
platelet surface76, and the release of pro-aggregatory factors.88 Thus although αIIbβ3 
activation is a major feature of platelet activation it is not the only feature. It must 
also be remembered that αIIbβ3 is not the only receptor for fibrinogen. Indeed 
integrin αVβ3 is also capable of binding to fibrinogen.122 Thus, at least some OgFg 
binding is possible in the absence of αIIbβ3 conformational changes. Of course these 
conclusions are based on the reliability of the PAC-1 antibody as a sign that αIIbβ3 is 
in its active conformation. As discussed below, the difference between resting and 
activated αIIbβ3 does not appear to be binary.   
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The final artificial integrin activator, Mn2+, facilitated PAC-1 binding. This shows that 
structural changes in αIIbβ3 have occurred and according to the literature, αIIbβ3 
should now be in its active, high-affinity ligand-binding conformation. However, 
contrary to this expectation, no fibrinogen (OgFg) binding occurred. This may 
suggest that PAC-1 binding occurs independently of the ligand-binding site for 
fibrinogen becoming available. For example, integrin αIIbβ3 is believed to have a 
number of intermediate activation states that may help to explain this discrepancy.  
 
Indeed, there exists inconsistent data in the literature about the exact structural 
changes undergone by integrins in the presence of Mn2+. Takagi et al. report that 
Mn2+ lead to large scale conformational changes in purified integrin αVβ3, in a 
“switchblade-like opening to an extended structure”110, while Ye et al. report that 
αIIbβ3 in liposomes showed no change in height in the presence of Mn2+, indicating 
that no integrin extension occured.104 Furthermore, FRET-based measurements in 
live cells have also provided conflicting results. For example, Chigaev et al. found 
that α4β1 appeared to undergo large scale structural changes due to Mn2+, albeit not 
the same as those induced by chemokines. Meanwhile, Kim et al. found that αLβ2 did 
not appear to alter its conformation in response to Mn2+.123 Yan and Smith stated 
that Mn2+ increased purified αIIbβ3’s affinity for ligands without fully activating the 
integrin protein.112 Kamata et al. reported that conformational changes in response 
to Mn2+ is an integrin isoform specific response. Here αIIbβ3 was highlighted as 
partially resistant to Mn2+ when compared to αVβ3. While αVβ3 showed robust ligand 
binding after Mn2+ activation, αIIbβ3 showed limited ligand binding, and failed to 
achieve full activation. Interestingly, by constructing a series of αIIb/αV domain 
swapped chimeras, αIIbβ3’s partial resistance to Mn2+ activation was shown to stem 
from its calf-2 domain, a domain which does not contain any divalent cation-binding 
sites. Swapping this region of αIIbβ3 allowed for robust ligand-binding after Mn2+ 
activation.113 This result suggests that different integrin isoforms respond to Mn2+ in 
different manners, rather than being simply general integrin activators 
 
As can be seen the relationship between integrins and Mn2+-induced activation is 
complex. The complexity is summed by Ye et al. where it was stated that “Mn2+ re-
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created integrin activation has multiple forms depending on the integrin isoforms 
and the context. It is probable that Mn2+-induced integrin activation is somewhat 
different from the physiologic inside-out integrin signalling process. The debates 
about the nature of Mn2+-induced integrin activation and its relevance to physiologic 
inside-out integrin signalling process will probably continue”.119      
  
Table 5: A summary of the influence of TRAP, DTT, and Mn2+ on PAC-1 binding  and fibrinogen binding. While 
TRAP has been shown to be an excellent agonist in terms of platelet aggregation, PAC-1 binding appeared to 
show that αIIbβ3 conformational changes were surprisingly minimal. Despite this, labelled fibrinogen binding 
was readily observable. DTT was shown to result in both significant PAC-1 and fibrinogen binding. In contrast 
to this while Mn2+ resulted in significant integrin conformational changes, no labelled fibrinogen binding was 
detected. These results hint at a disconnect between conformational changes in the integrin protein and 
ligand binding. 
Agonist Integrin conformational 
changes (PAC-1 binding) 
Ligand binding 
(OgFg binding) 
TRAP Yes, albeit surprisingly 
minimal 
Significant 
DTT Extremely significant Significant 
Mn2+ Significant None 
 
 
2.3.3. Whole platelet response 
The previous sections have focuses on whether DTT and Mn2+ could support washed 
platelet aggregation, induce conformational changes in integrin αIIbβ3, and/or result 
in measureable binding of labelled fibrinogen. Of course the platelet reaction is not 
limited to these responses. In vivo activation includes platelet morphological 
changes91, phosphorylation of intracellular proteins124, an increase in cytosolic 
calcium levels82, and granule secretion91. Given the general literature description of 
DTT and Mn2+ as integrin activators119, combined with αIIbβ3’s bidirectional signalling 
ability14, and the fact the other integrins have shown a ligand independent outside 
in response to these artificial modulators117, we were keen to determine whether 
DTT or Mn2+ stimulation results in a whole-platelet response, and not just αIIbβ3 
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localised extracellular conformational changes and alterations in affinity for 
fibrinogen binding. For example, Zhang et al. used DTT to mimic activation in 
integrin α4β7 and found that breakage of two disulphide bonds near the integrin 
knees lead lead to integrin downstream signalling independently of ligand 
occupancy. This was measured via the activation of FAK and paxillin, two 
downstream molecules of integrin outside-in signalling.117 As such we were keen to 
see whether DTT or Mn2+ could elicit similar platelet response via αIIbβ3 
conformational changes. To do so two different platelet assays were conducted, one 
based on the release of alpha granule contents, and one based on the release of 
dense granule contents, two events associated with the whole platelet activation 
response.     
 
Alpha granule secretion  
As previously mentioned, α-granules are one of the secretory granules found in the 
platelet cytoplasm. They contain a variety of contents including PDGF, fibrinogen, 
and vWF. In platelets, α–granules fuse with the plasma membrane upon activation, 
releasing their cargo and increasing platelet surface area. Another factor found in α–
granules is the adhesion molecule P-selectin. Prior to platelet activation this protein 
is confined to α–granules, but following granule mobilisation P-selectin is trafficked 
to the platelet membrane for presentation. Therefore, display of P-selectin can be 
used as a measure of α–granule secretion and whole platelet activation. By using 
TRAP, DTT and Mn2+ as integrin activators it was therefore possible to gauge the 
whole-platelet response to these agonists via the presence or absence of is P-
selectin on the platelet membrane. To determine this presence a PE-labelled CD62P 
antibody was used in a flow cytometry. Again, unstimulated platelets were used as 
the negative control where counts for the fluorescence data channel were piled on 
lowest values of the logarithmic x-axis of a histogram. Subsequently, TRAP, DTT and 
Mn2+-activated platelets were passed through the flow cytometer and the 
fluorescence data channels were plotted on the same histogram. Therefore, any P-
selectin binding could be visualised as shift in the counts to the right of the 
histogram. A typical histogram is shown in Figure 29. It is clear from this histogram 
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that only TRAP stimulation lead to anti-CD62P binding. Nonetheless, to quantify this 
we again used two different analysis tools in percentage gated and geometric mean 
in order to quantify this anti-CD62P binding. Using percentage gated in the same 
manner as last time where a baseline gate was placed on the data so that 5 % of the 
total counts for the un-stimulated platelets were found within this gate. This 
histogram gate is visible in Figure 29. In this case TRAP stimulation lead to a massive 
increase in the percentage gated value where 52 ± 17 % of events were found to 
occupy the gated region up from the 5 % baseline in unstimulated platelets. In the 
case of 3 mM DTT stimulation the percentage gated value was found to be 6 ± 1 %, 
while in the case of 3 mM Mn2+ stimulation the percentage gated value was found to 
be 5 ± 1 %. This data is shown in Figure 30. A one-way ANOVA analysis and post-hoc 
Bonferroni test was performed on this data where only TRAP stimulation was found 
to lead to a significant degree of P-selectin expression, where p < 0.001. Following 
this analysis using a gated histogram, the geometric mean was also used to quantify 
anti-CD62P binding. Using this method, un-stimulated platelets had a geometric 
mean of 1.69 ± 0.31. The geometric mean of TRAP stimulated platelets was found to 
be 5.83 ± 0.64. The geometric mean of 3 mM DTT and 3 mM Mn2+ stimulated 
platelets was found to be 1.77 ± 0.35 and 1.62 ± 0.27 respectively. This data is 
shown in Figure 31. Once again, a one-way ANOVA analysis and post-hoc Bonferroni 
test was performed on this data. In agreement with our previous analysis, only TRAP 
stimulation was found to lead to a significant degree of P-selectin expression, where 
p < 0.01. Therefore, according to the absence of P-selectin on the platelet surface, 
no alpha granule secretion has occurred due to DTT or Mn2+ stimulation. This 
suggests that the conformational changes that occur in αIIbβ3 due to these integrin 
modulators does not lead to the full range of platelet activation normally associated 
with physiological agonists. 
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Figure 29: A representative histogram of anti-CD62P binding to p-selectin in unstimulated platelets (yellow), 
and following stimulation with 4 M TRAP (red), 3 mM DTT (blue) and 3 mM Mn2+ (green). It can clearly be 
seen that TRAP stimulation is the only agonist that brings about antibody binding. This shows that alpha 
granules release and thus P-selectin presentation only occurs with this agonist and not DTT or Mn2+.  
 
 
 
Figure 30: DTT and Mn2+ failed to lead to alpha granule release according to anti-CD62P binding as assessed 
using percentage gated. A gate was set so that 5 % of unstimulated platelet counts fall within it (yellow). TRAP 
at 4 μM (red) was sufficient to bring about anti-CD62P binding, meaning that P-selectin was expressed on the 
platelet surface. DTT at 3 mM (green) and Mn2+ at 3 mM (blue) did not result in P-selectin expression. 
Standard deviation was used to represent the error. (n=3, where n is the number of donors) 
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Figure 31: DTT and Mn2+ failed to cause alpha granule release DTT and Mn2+ failed to lead to alpha granule 
release according to anti-CD62P binding as assessed using geometric mean. The geometric mean of 
unstimulated platelets is shown in yellow. TRAP at 4 μM (red) was sufficient to bring about anti-CD62P 
binding, meaning p-selectin was expressed on the platelet surface. DTT at 3 mM (green) and Mn2+ at 3 mM 
(blue) did not result in p-selectin expression. Standard deviation was used to represent the error. (n=3, where 
n is the number of donors) 
 
 
Dense granules secretion 
The other primary secretory vesicles found in platelets are known as dense granules. 
Similar to alpha granules, dense granules are released by platelets during the 
activation process. They contain a variety of contents including histamine, serotonin, 
ADP and ATP.89 In order to quantify dense granule secretion an ATP releases assay. 
This assay can, therefore, be used as a proxy for whole platelet response to various 
agonists. Normally this assay is done within 5 minutes of agonist stimulation but due 
to the lag-phase seen with the platelet aggregation in response to DTT, the assay 
was also repeated at the 30-minute time point in case dense granule secretion was 
dependent on this lag-phase. The experiment was carried out on 3 separate donors 
across different days. Figure 32 shows ADP/ATP release in AAU following stimulation 
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with TRAP, DTT and Mn2+ at these time points. It was immediately clear that 4 μM 
TRAP stimulation leads to a large degree of ATP release from dense granules at the 5 
minute and 30 minute mark. On the other hand the use of DTT and Mn2+ at 3 mM 
failed to alter ATP from the unstimulated platelet baseline. This observation was 
confirmed by ANOVA anlysis and post-hoc Bonferroni test where only TRAP 
activation was found to lead to significant ATP release where, p < 0.001. This 
indicates that our artificial activators did not result in dense granules secretion in an 
outside-in signalling manner. This result is consistent with our earlier alpha granule 
release assay and again suggests that DTT and Mn2+ does not lead to the full degree 
of platelet activation normally associated with physiological agonists.  
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Figure 32: DTT and Mn2+ fail to cause dense granule release. ATP secretion after 5 minutes (top) and 30 
minutes (bottom) in unstimulated platelets as well as in platelets stimulated with TRAP, DTT and Mn2+. ATP 
release in unstimulated platelets is shown in yellow. TRAP at 4 μM (red) was sufficient to bring about ATP 
release. Both DTT at 3 mM (green) and Mn2+ at 3 mM (blue) did not lead to ATP release. This was confirmed by 
ANOVA analysis and a post-hoc Bonferroni test. Standard deviation was used to represent the error. (n=3, 
where n is the number of different donors) 
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As a whole these results show the complexity of the platelet response to 
physiological and non-physiological agonists. In the literature DTT and Mn2+ are 
widely described as integrin activators, with recognition that Mn2+ is a weaker 
integrin agonist. Our results show that while DTT and Mn2+ do share some 
similarities with TRAP-mediated activation, they do not not accurately replicate 
physiological activation particularly with regards to a whole platelet response. For 
example, DTT and Mn2+ failed to lead to either alpha or dense granule secretion.  
 
Platelet aggregometry experiments show that all three agonists, TRAP, DTT and 
Mn2+ were capable of supporting platelet aggregation, with some reservations. For 
example, DTT appears to possess a concentration dependent lag-phase, while Mn2+ 
required additional fibrinogen to be added to washed platelets so that aggregation 
was readily apparent, testament to its description as a weaker integrin activator 
than DTT.  
 
Moving attention to direct probing of the αIIbβ3 protein, all three activators lead to 
varying degrees of PAC-1 binding indicating that some degree of structural changes 
had occurred in αIIbβ3. As such, all three activators would be expected to lead to 
fibrinogen binding as measured with a labelled fibrinogen molecule in OgFg. On the 
contrary, only TRAP and DTT facilitated this binding. This again highlights Mn2+ as a 
weaker integrin activator.  
 
Given that PAC-1 binding occurred in all three cases showing some degree of 
conformational changes in αIIbβ3 it could perhaps be expected that outside-in 
signalling would be the expected downstream result, perhaps mediated by tail 
separation within the integrin protein. Physiologically this outside-in signalling 
strengthens the platelet aggregation response. Therefore, it was hoped that these 
agonists could mobilise a downstream whole-cell response. To detect whether a 
whole cell response to DTT and Mn2+ was occurring, two granule release assays were 
used,: (1) P-selectin membrane presence indicative of  alpha granule release, and (2) 
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ATP release assay to indicate dense granule release. In both assays the artificial 
agonists failed to mobilise a whole-platelet response via their influence on integrin 
conformation. This is in contrast to the TRAP-mediated response, a positive control, 
which does not act directly on the αIIbβ3 protein but rather via the thrombin 
receptor. This may indicate that DTT and Mn2+ activation of integrin is not sufficient 
to induce a full outside-in signalling response or perhaps only partial outside-in 
signalling occurs. For example, it is possible that prior inside-out activation is a 
requirement for later outside-in activation, whereby protein machinery is primed 
and localised at the cytoplasmic tails of αIIbβ3. Alternatively, the results may indicate 
that granule release is not an attribute of outside-in signalling but rather is confined 
to the earlier stages of the physiological platelet activation response. Nonetheless, 
the fact that DTT and Mn2+ are capable of bringing about some degree of positive 
activation response in αIIbβ3 brings hope to the future use of these agonists in our 
upcoming platelet-free, αIIbβ3-reconstituted systems.            
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3. Integrin in GUVs 
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3.1. Introduction 
3.1.1. Liposomes 
Due to the complex nature of cell membranes, it is frequently better to examine 
transmembrane proteins in a simplified artificial lipid model. With varying degrees 
of complexity, these systems seek to recreate the physiological conditions of the cell 
membrane. The systems may make use of a wide range of lipids (phospholipids, 
cholesterol, sphingomyelin, etc.) and may also include any number of membrane-
incorporated proteins. A number of different systems exist to accomplish this and 
we can roughly divide these systems into two categories; supported lipid bilayers 
and liposomes. While supported lipid systems are covered in chapter 4, this chapter 
focuses on liposomes. Liposomes are quasi-spherical lipid vesicles composed of a 
lipid bilayer. Such lipid vesicles may be created in a range of sizes as well as 
morphologies (unilamellar or multilamellar). The nomenclature of these vesicles 
varies from paper to paper but generally unilamellar vesicles with a diameter of less 
than 50 nm are referred to as SUVs, those with a diameter of a micron or above are 
categorised as GUVs. Vesicles that fall between these two classifications are referred 
to as LUVs. Lipid vesicles have been used for a diverse range of applications 
including use in drug delivery125, the study of membrane proteins in biologically-
relevant conditions126 as well as their use in lipid bilayer assembly.127 One of the 
main advantages of liposomes over SLB systems is the fact they are free-standing 
structures meaning that they are not subjected to the same frictional and non-
specific lipid-substrate interactions that occur in SLB models. To create liposomes a 
variety of protocols are available, each with their own advantages and 
disadvantages. For example, sonication is a commonly used method to create SUVs 
via the disruption of a multilamellar vesicle (MLV) suspension using a tip or bath 
sonicator.25 Extrusion is mechanical process by which an MLV containing solution is 
forced through a porous membrane of a defined pore diameter in order to create 
unilamellar vesicles (SUVs or LUVs) of a desired size.128 These vesicles may be 
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increased in size by the fusion of vesicles to form GUVs. This can be promoted by the 
addition of calcium.129 Dehydration-rehydration is a simple GUV creation method 
that takes advantage of the fact that dried lipid bilayers may spontaneously form 
liposomes upon rehydration.130  In a related technique, an electric field can be used 
to promote such vesicle swelling, in a process known as electroformation.131 These 
procedures and various others combine to create a wide range of possible methods 
to create vesicles of different size distributions. (Figure 33) 
 
 
 
Figure 33: Vesicles can be divided into various populations based on their size and morphology. There are no 
strict definitions of what constitutes these descriptions and the nomenclature various from paper to paper.125 
Throughout this thesis SUVs refers to vesicles with a diameter below 50 nm, GUVs refers to vesicles with a 
diameter of above one micron, while LUVs refers to vesicles with a diameter between these two definitions.     
 
3.1.2. αIIbβ3 reconstitution in the literature 
A review of the literature shows that prior to this work, papers that use αIIbβ3 in 
artificial lipid systems share a number of common characteristics; namely the limited 
use of free-standing GUV systems, the use of FRAP for diffusion measurements, and 
the use of a limited range of lipid compositions.29–31,34,43,44,46,47 The vast majority of 
papers that have reconstituted αIIbβ3 in artificial lipid systems have done so in planar 
SLB systems rather than free-standing GUV systems.29–31,34 Indeed, prior to this 
work, no diffusion-based experiments had been performed in vesicle systems. Due 
to this limitation these pieces of literature were limited by the problems normally 
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associated with planar bilayers such as non-specific interaction between the 
lipid/protein and the underlying substrate. For example, Erb et al. reported that in 
its un-clustered form approximately 40 % of the reconstituted αIIbβ3 was immobilised 
on a glass substrate.30 In order to eliminate these difficulties some papers have 
incorporated polymer cushions into their systems in order to improve αIIbβ3 mobility. 
Goennenwein et al. reported that αIIbβ3 was completely immobilised on the 
substrate in the absence of surface modification. The addition of a cellulose cushion 
to the substrate was required for protein mobility, yet up to 75 % of the αIIbβ3 
remained immobile.31 Purrucker et al. used a variety of polymers to decouple the 
bilayer from the substrate. Even so they stated that between 76 and 84 % of 
reconstituted αIIbβ3 remained immobile.43,44 One of the biggest advantages to GUV 
systems is their free-standing nature. It was, therefore, hoped that successful 
reconstitution of αIIbβ3 into GUVs would alleviate these major drawbacks that exist in 
other works.  
 
Prior to this work, all diffusion-based measurements of αIIbβ3 in artificial lipid 
systems have used FRAP as the investigative method. Here we sought to utilise the 
single molecule techniques, FCS and FLCS, to gain diffusion data. In contrast to FCS 
and FLCS, FRAP uses much larger volumes, typically several m3 for its 
measurements. An intense laser pulse photobleaches the fluorescent probe within 
this large volume before the recovery of fluorescence is monitored as labelled lipid 
molecules diffuse into the bleached area. Our use of FCS and FLCS has a number of 
advantages over FRAP. For example FCS/FLCS is non-destructive to the fluorescent 
molecules in the sample, can be readily used in multicolour experiments, and can be 
used to infer additional data about the sample such as probe concentration and 
kinetic data.48 This data can be extremely useful in a number of ways. For example, 
the alpha value allows for the determination of whether a molecule undergoes 
Brownian diffusion or not. An alpha value of 1 represents this unhindered diffusion. 
A value below 1 shows anomalous hindered sub-diffusion while a value above 1 
shows super-diffusion. Additionally, the fact that FCS/FLCS experiments provide a 
direct means of measuring probe concentration means that integrin concentration 
within GUVs can be measured, something not possible in FRAP. Another major 
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advantage of FCS/FLCS over FRAP is the requirement for much lower concentrations 
of fluorophore in the sample. This reduces any influences exogenous agents may 
have on the dynamics of the lipid membrane. Finally, the femotolitre volume 
required for FCS/FLCS is well suited to the curvature of GUV bilayers when 
compared to the large volume required in FRAP.49 Erb, Goennenwein and Purricker 
all utilised FRAP to report their diffusion data.30,31,43,44 Therefore to the best of our 
knowledge this is the first work to use the single molecule techniques of FCS and 
FLCS in αIIbβ3 focused experiments.  
 
As previously mentioned, another striking feature of the literature is the use of a 
very limited number of lipids in artificial systems. The vast majority of papers utilise 
DMPC as a major component in artificial lipid systems. Beginning with Müller et al., 
it was highlighted that αIIbβ3 had a tendency to strongly bind to the vesicle surface in 
large aggregates depending on the method of insertion and vesicle composition. 
Müller only reported full insertion, as determined by electron microscopy, for DMPC 
and DMPC:DMPG (1:1) mixtures. The use of other compositions lead to non-
insertion or “partial” insertion.34 This was later advanced upon by Erb and Engel 
where they stated that various combinations of POPC, POPE, POPG and POPS did not 
lead to good αIIbβ3 reconstitution. They also reiterated the need for DMPC or 
DMPC/DMPG in order to ensure full insertion.29 Owing to this issue, the available 
literature that has presented diffusion data on αIIbβ3 has utilised DMPC and 
DMPG30,31 or an asymmetric bilayer of DMPC/DMPG (1:1) and SOPC.43,44 More 
recent pieces of literature that stray from the assertion that DMPC is an absolute 
requirement for full αIIbβ3 reconstitution, for example Sloan47 (60 % egg PC, 15 % 
bovine PS, 25 % cholesterol) and Streicher46 (85 % egg PC, 10 % egg PA, 5 % DPPE-
PEG2000), perhaps somewhat tellingly did not perform any diffusion-based 
measurements, nor did they perform any cryoelectron experiments to verify that 
the integrin protein was bilayer inserted and not simply bilayer associated. Given 
αIIbβ3’s propensity to strongly associate with the membrane to give the impression of 
insertion, on the basis of the data they presented it is difficult to strongly state that 
their respective reconstitution protocols were successful. Therefore this work 
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sought to be first to characterise reconstituted αIIbβ3 diffusion in a DMPC-free 
system. 
 
In contrast to this existing literature, we wanted to reconstitute αIIbβ3 into more 
physiologically-relevant lipid compositions that aimed to better mimic the platelet 
membrane. Then, in these GUVs, we sought to determine the diffusion co-efficient 
of the reconstituted protein in its un-activated, DTT activated, Mn2+ activated, and 
ligand bound forms, as well as to determine whether we could initiate activation 
dependant clustering of the integrin molecules. The use of free-standing vesicles 
was hoped, would eliminate non-specific interaction between the substrate and 
bilayer that hinders existing SLB work. To obtain the diffusional data, we wanted to 
utilise the single molecule techniques of FCS/FLCS, in contrast to the use of FRAP 
within the literature. Finally, in novel work, we wanted to utilise confocal 
microscopy to determine whether αIIbβ3 preferentially partitioned into the 
phospholipid rich disordered phase or cholesterol rich ordered phase of raft-forming 
GUVs. 
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Table 6: A summary of integrin αIIbβ3 diffusion in artificial lipid systems. So far diffusion measurements have 
only been performed in SLBs. As such, a massive percentage of the protein has been rendered immobile, even 
when polymer cushions were utilised. The αIIbβ3 that was not rendered immobile diffuses relatively slowly 
when compared to free-standing lipid systems such as our GUVs. 
Paper Composition Integrin 
Diffusion 
(μm2/s) 
Percentage of 
immobile 
integrin 
Notes 
Erb et al. 
(1997)30 
DMPC/DMPG 0.70 40 % First diffusion 
measurements for αIIbβ3. 
Fibrinogen addition lead to 
decreased diffusion and 
increased immobility 
Goennenwein 
et al. (2003)31 
DMPC/DMPG 0.60 75 % Contrary to Erb, αIIbβ3 was 
completely immobile on 
bare substrate. A cellulose 
cushion was required for 
αIIbβ3 diffusion 
Purrucker et 
al. (2004)43 
Asymmetric 
bilayer of 
DMPC/DMPG 
and POPC 
0.03 80 % A polymer tether used for 
αIIbβ3 diffusion. Very slow 
diffusion recorded 
Purrucker et 
al. (2007)44 
Asymmetric 
bilayer of 
DMPC/DMPG 
and POPC 
0.08 – 
0.13 
76 – 84 % A different polymer tether 
used for αIIbβ3 diffusion. 
Again very slow diffusion 
recorded 
 
3.1.3. Proteoliposome Preparation 
Throughout this thesis a number of techniques were used to create vesicles of 
varying sizes. SUVs were generally formed via sonication while LUVs were formed 
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via extrusion. Generally, these sub-micron size vesicles were not directly 
experimented upon but were rather used as the target during membrane protein 
reconstitution. In the literature a number of different reconstitution techniques exist 
and can be roughly divided into four different strategies; mechanical, freeze-
thawing, use of organic solvents, or detergent-mediated reconstitution. In this work 
we primarily used detergents to reconstitute integrin in lipid vesicles. The basic 
premise for this is destabilisation or partial destabilisation of liposomes using a 
detergent, the addition of a membrane protein to this mixture and the subsequent 
removal of this detergent to leave behind protein-incorporated vesicles, or 
proteoliposomes.37 We used two different techniques to create integrin-containing 
proteoliposomes. The first method was based on work by Müller et al.34, and used 
triton x-100 to fully solubilise liposomes before IIb3 was added and the detergent 
was quickly removed via the addition of detergent-absorbent beads. The second 
method was based on work by Moses et al.27, and used β-OG (Octyl-beta-Glucoside) 
to partially solubilise liposomes before IIb3 was added and the detergent was 
slowly removed by dialysis. Both of these techniques appeared to successfully 
produce proteoliposomes although the Erb method was preferred due to its speed.  
 
In order to use confocal microscopy and FLCS measurements we required vesicles in 
the micrometre range so that the liposomes were easily resolved. We examined a 
number of ways to produce these GUVs: calcium induced fusion of smaller vesicles, 
dehydration and subsequent rehydration of a dried lipid film, gentle hydration of a 
lipid film to swell giant vesicles and finally, electroformation. Each of these 
techniques had their own advantages and disadvantages. For example, it was found 
that both calcium-induced fusion and gentle hydration regularly produced 
multilamellar vesicles as opposed to the unilamellar vesicles we sought to produce 
for microscopy experiments. The dehydration-rehydration protocol was sometimes 
successfully used to create GUVs but the protocol was unreliable and only produced 
surface tethered vesicles. In the end it was found that electroformation was the 
most reliable method of routinely producing GUVs. Electroformation is a technique 
used to produce a relatively monodisperse population of giant (20 μm plus) 
unilamellar vesicles. The protocol utilises an electric field to “grow” GUVs from lipid 
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deposited on a solid surface. This solid surface functions as the working electrode 
and normally takes the shape of either a platinum wire/sheet or ITO coated glass. 
The technique was first used by Angelova and Dimitrov in the 1980s to produce 
GUVs using a DC electric field.131 This protocol was later updated to produce GUVs 
using an AC electric field.132 The basic premise of this technique sees lipid in 
chloroform, or sometimes a mixture of chloroform and methanol, deposited on the 
electrode surface. A counter electrode is positioned perpendicular to the electrode 
and a cell is assembled around the two conductors. (Figure 34) This cell is then filled 
with buffer before an electric field is applied between the two electrodes. Over the 
course of a number of hours, the lipid begins to form GUV “nests” where hundreds 
of GUVs congregate. These GUVs often remain tethered to the electrode surface 
until removal via mechanical agitation or the use of a low frequency electric field. 
The exact mechanism of GUV formation is unknown, but according to Politano et al., 
the process involves both bilayer separation and bending. To initiate bilayer 
separation of the deposited lipid film electrostatic and osmotic forces are believed 
to play a key role. This allows for the transport of water molecules between the 
stacks of lipid films driven by the electric field. Secondly, defects in the lipid films 
due to the irregular stacking of bilayers contribute to bilayer bending. These defects 
expose the hydrophobic interior of the bilayers to the aqueous buffer stressing the 
film to correct this by bulging outwards. These bulges swell further into the tethered 
GUVs.133 Most electroformation protocols in the literature have been limited to GUV 
creation in salt-free buffers, however more recent adaptions have been made to the 
electroformation protocol to allow for GUV growth in a salt-containing buffer. This 
particular upgrade to the standard electroformation was developed by Pott, 
Bouvrias and Méleard and allows for the electroformation of GUVs in electrolyte-
containing buffers.134,135 While not as reliable as the standard electroformation 
method we found this adaption particularly useful given the fact we were dealing 
with membrane-reconstituted proteins throughout much of the experimentation 
process. By combining the aforementioned proteoliposomes reconstitution 
processes and the electroformation technique a protocol was developed that used 
the proteoliposomes solution as the lipid source for GUV growth. This allowed for 
the production of GUVs from a variety of lipid compositions where integrin αIIbβ3 
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was successfully reconstituted within. These αIIbβ3 containing GUVs were then used 
to explore protein and lipid diffusion, ligand binding, protein aggregation and 
protein partitioning.  
 
 
 
 
Figure 34 Assembly of the electroformation cell. Two ITO-coated slides are positioned a number of millimetres 
apart with the conductive side facing each-other. Dried lipid is deposited on one or both of the conductive 
faces. The slides are separated by a cell spacer which takes the form of a non-conductive material such as 
PDMS or a rubber O-ring. The cell is filled with buffer before being sealed. An electric field is then applied 
between the ITO glass slides for a defined period of time to allow for GUV growth. 
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3.2. Experimental 
 
3.2.1. Multilamellar Vesicle (MLV) Creation 
MLVs were prepared by the hydration of a lipid film. Firstly, lipid in chloroform (or in 
the case of DMPG, chloroform: methanol in the ratio 3:1) was evaporated in a glass 
vial under a steady stream of N2. The lipid was then placed under vacuum for at least 
2 hours to fully ensure solvent removal. To rehydrate the lipid film, Tris buffer (10 
mM Tris, 150 mM NaCl, 1 mM CaCl2, pH 7.4) or HEPES buffer (10 mM HEPES, 150 
mM NaCl, 1 mM CaCl2, pH 7.4) was warmed to a number of degrees above the 
highest phase transition temperature present in the lipid composition before being 
added to the vial. The lipid suspension was left to stand above the highest phase 
transition temperature for at least 45 minutes with occasional vortexing. 
 
3.2.2. Small Unilamellar Vesicle (SUV) 
creation 
In order to prepare SUVs, the sonication method was utilised. This process began 
with the preparation of MLVs via the hydration of a lipid film as described above. 
The probe of a tip sonicator (Heat Systems Ultrasonic model W350 Sonicator) was 
positioned into the MLV containing solution and using a predefined protocol, the 
solution was subjected to sonication for 20 minutes. The solution was kept in an ice 
bath throughout to prevent over heating of the solution which may occur to 
sonication. During the sonication process, pieces of the titanium probe may break 
off and as such, the solution was subjected to centrifugation. Centrifugation 
occurred at 72,000 rpm for 25 min at 15°C in a Beckman TL100 centrifuge (using a 
TLA100.3 rotor). This centrifugation step also removes larger vesicles that have not 
been successfully broken down in the sonication step. 
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3.2.3. Large Unilamellar Vesicle Creation 
LUVs were prepared by extrusion using the Avanti mini-extruder extruder (Avanti 
Polar Lipids, Alabaster, AL). Two filter supports were pre-wetted with dH2O and 
placed over the orifice of a Teflon internal membrane support. The internal 
membrane support was placed into the extruder outer casing with the filter 
supports facing upwards. A polycarbonate membrane with a pore size of 100 nm 
was placed on top of the filter supports. A second pair of filter supports was pre-
wetted as before and placed over the orifice of the second Teflon internal 
membrane support. The internal membrane support was then placed face down on 
top of the polycarbonate membrane so that the polycarbonate membrane was 
separated by two filter supports on either side. A Teflon bearing is then placed into 
the retainer nut and the retainer nut was then tightened on the threaded end of the 
extruder outer casing. This was done by hand to ensure that the nut is not over-
tightened. The extruder outer casing with retainer nut is placed into the supplied 
heating block and heated at least 5°C above the phase transition temperature of all 
lipids present in the lipid composition. A schematic of the extruder assembly is 
shown below. (Figure 35) MLVs, prepared using the film hydration method 
previously described, were first loaded into one of the gas-tight syringes and 
carefully place into one end of the mini-extruder. The second gas-tight syringe, with 
the plunger fully engaged, was placed into the opposing end of the mini-extruder. 
The lipid in buffer was then passed through the polycarbonate membrane in order 
to fill the other syringe. This was done a total of eleven times so that the final 
sample was collected from the originally empty syringe. The vesicles were then 
examined by DLS to evaluate the size distribution of the LUVs. 
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Figure 35: Assembly of the mini-extruder. The polycarbonate membrane of required pore size is place 
between two Teflon supports and enclosed in a metal outer casing as shown. The lipid composition of choice 
in Tris or HEPES buffer is passed through the polycarbonate membrane a number of times using two syringes 
to create vesicles of a required diameter. To confirm vesicle size, DLS was used. Figure adapted from Avanti 
Polar Lipids.136 
 
3.2.4. Giant Unilamellar Vesicle (GUV) 
creation in salt free buffer 
GUVs were created using the Vesicle Prep Pro (VPP) (Nanion Technologies, Munich, 
Germany) or a homemade conductive cell composed of two ITO slides separated by 
a PDMS spacer connected to a function generator and oscilloscope. Lipid in 
chloroform at 5mM was placed on the conductive sides of a pair of ITO glass slides in 
a number of 2 µl droplets. Depositing lipid at higher concentrations or larger droplet 
sizes appeared to reduce the final yield of GUVs, perhaps owing to over-stacking of 
lipid layers. The organic solvent was allowed to evaporate at room temperature for 
45 minutes before the electroformation cell is assembled. The cell was filled with 
dH2O, or 100mM sucrose in dH2O if required for later imaging. As soon as the cell 
was filled with buffer the voltage was applied to prevent spontaneous swelling. This 
voltage was ramped up over 10 minutes from 0V to 3V and held at this amplitude 
for another 125 minutes before being ramped down to 0V over a 3-minute period. 
The frequency was held constant at 5 Hz throughout. (Figure 36) The protocol was 
carried out at 37 °C. This entire process was controlled by the VesicleControl 
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software supplied with the Vesicle Prep Pro (VPP), or manually when using the 
homemade cell. 
  
 
Figure 36: Amplitude and frequency profile over time of a standard electroformation protocol. The protocol 
runs for 128 minutes with the frequency held constant at 5 Hz throughout. The voltage varies during the 
experiment. The amplitude slowly ramps up to 3 V over the first 30 minutes. This ramping step is to avoid lipid 
shearing from the surface. This amplitude is then held constant for the next 125 minutes where the majority 
of the vesicle growth occurs. The final 3 minutes ramps the voltage back down to zero. If this step occurs to 
quickly, vesicle yield is reduced due to GUV destruction. The values and time-points used had been optimised 
to efficiently create GUVs from lipid deposited in chloroform. 
 
3.2.5. GUV creation in physiological buffer 
In order to perform electroformation in a high-salt buffer (greater than 10 mM total 
salt), the electroformation protocol was altered. After depositing the lipid mixture of 
interest (in a salt free buffer, with or without protein reconstitution) and partially 
dehydrating the composition, the cell was filled with a high-salt buffer and sealed. 
The voltage ramps up over 1 hour from 0 to 1.2 V, before remaining at this voltage 
for the next 13 hours. Importantly, these stages of the protocol took place at 500 Hz 
instead of between 2 and 12 Hz as normally associated with electroformation. The 
final stage of the protocol sees the voltage ramped down to zero over an hour. To 
begin with this step took place at 50 Hz as recommended in the literature134,135, but 
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this step was later altered to remain at 500 Hz as better results were obtained at this 
frequency. (Figure 37) The protocol was carried out at room temperature. 
 
 
Figure 37: Amplitude and frequency profile over time of used to create protein-containing GUVs in a 
physiological buffer. This overnight protocol ramps the voltage to 1.2 V over the first hour where it remains 
constant for the next 13 hours.  The last step ramps the voltage down over the final hour. The most important 
factor in producing GUVs in a high salt before is the use of an extremely high frequency when compared with 
standard electroformation protocols. 500 Hz was found to be optimal for such GUV formation. 
 
3.2.6. Integrin reconstitution  
 
A number of different protocols for IIb3 reconstitution into liposomes were 
explored. Below are the 2 most commonly used methods for integrin reconstitution 
into liposomes. Both of these protocols yielded liposomes below the size associated 
with GUVs and therefore for microscopy work these proteoliposomes had to be 
converted to GUVs via electroformation.  
Lentz β-OG-mediated insertion of integrin αIIbβ3 into liposomes 
SUVs of the required composition were firstly created via sonication at a lipid 
concentration of 2 mg/ml in HEPES buffer. αIIbβ3 at 0.5 mg/ml in HEPES buffer with 
β-OG was added to the SUVs so that final concentration of β-OG was 20 mM. This 
optimal detergent concentration was determined experimentally by monitoring 
absorbance at 600 nm. Here, the partitioning of detergent into the bilayer of 
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liposomes until it saturates the liposomes causes an increase in turbidity which is 
reflected in the OD. As the liposomes begin to solubilise, the turbidity of the solution 
begins to decrease until the solution is optically transparent.37 Due to the fact that 
detergent-saturated vesicles retain their structural integrity, the identification of the 
point where vesicles are fully saturated allows for efficient protein reconstitution 
without altering vesicle size.  Using 20 mM β-OG, the detergent-lipid solution which 
was now at the onset of solubilisation was incubated at room temperature for 45 
minutes to allow for the integrin-detergent micelles to fully partition into the SUV 
membrane. The removal of β-OG was facilitated via dialysis of the SUV-integrin-
detergent mixture against a detergent free buffer of 500 times the sample buffer 
volume. The dialysis proceeded for 24 hours at 4 °C with one buffer exchange after 6 
hours, and a second exchange after 18 hours. In order to determine whether the 
reconstitution was successful, reconstituted SUVs were firstly separated from free 
αIIbβ3 on a sephadex G-200 size exclusion column. The fractions were analysed for 
radiolabelled lipid (trace amounts of C14 DOPE) to determine which fractions contain 
the SUVs and then these lipid-containing fractions were run on a polyacrylamide gel 
to separate protein via its molecular weight. The gel was then stained with 
Coomassie brilliant blue for a number of hours to visualise any protein bands for 
each SUV-containing fraction. 
 
Modified Erb Triton X-100-mediated insertion of integrin αIIbβ3 into liposomes 
The initial protocol for the reconstitution of IIb3 in a supported lipid bilayer was 
based on a method developed by Müller et al.34 The desired lipids were firstly mixed 
and evaporated in a glass vial under a stream of nitrogen. The lipids were completely 
solubilised in a HEPES reconstitution buffer (10 mM HEPES, 150 mM NaCl, 1 mM 
CaCl2, 0.1% Triton X-100 (w/v), pH 7.4) with a final detergent:lipid ratio of 2:1 (w/w). 
The final lipid concentration was normally 1 mM. αIIbβ3 in HEPES reconstitution 
buffer was then added to the detergent-lipid solution at the required concentration, 
normally 1 integrin molecule for every 8000 lipid molecules. The protein-containing 
solution was shaken at room temperature for 30 minutes to fully ensure that all lipid 
has been solubilised and that the solution was homogenous. The solution was then 
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incubated at 37 °C for 1 hour 30 minutes. Detergent was removed by the addition of 
100 mg of biobeads per ml of solution for 3 hours 30 minutes in a slow shaken vial. 
The biobeads were then removed and replaced by a fresh batch of 100 mg biobeads 
per ml of solution for 30 minutes (slowly shaken). Flow cytometry was used to 
determine successful reconstitution of αIIbβ3 into liposomes. Proteoliposomes in the 
reconstitution buffer were pipetted into a FACS tube and incubated at room 
temperature with the anti-human CD41a antibody at a concentration of 0.1 mg/ml 
for 30 minutes. This antibody has affinity for both the resting and activated forms of 
αIIbβ3.  The proteoliposomes were passed through the flow cytometer until 10,000 
acquisitions had been acquired in a gated region that corresponds to the 
reconstituted vesicles. Data was analysed using CellQuest Pro software from Becton 
Dickinson or Flowing Software from Turku Bioimaging. 
 
3.2.7. Proteoliposome conversion to GUVs 
Instead of a lipid in chloroform solution normally used for deposition in standard 
electroformation protocols, proteoliposmes created from the β-OG-mediated 
insertion or the triton x-100-mediated insertion methods were used as the lipid 
source. However, due to the presence of salt in these proteoliposme containing 
buffers, direct electroformation was not possible. This was due to the osmotic shock 
that occurs when the lipid comes in contact with the electroformation buffer. 
Instead we required that the salt buffer be removed from the protein-containing 
vesicles. This was achieved through an ultracentrifugation step. Integrin-
reconstituted vesicles were loaded into an ultracentrifuge tube and centrifuged at 
100,000 g for 1 hour. This resulted in the pelleting of the protein-reconstituted 
liposomes. The supernatant was removed and the pellet was gently washed in dH2O 
to eliminate any remaining salts. This pellet was then re-suspended in dH2O at a lipid 
concentration of 10 mM. The re-suspended vesicles could then be stored at -20 °C 
for a number of weeks. When required, the solution was thawed and 2 μl droplets 
were placed on the conductive side of an ITO glass slide of the Vesicle Prep Pro. The 
slides were placed in a vacuum desiccator in the presence of a saturated sodium 
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chloride solution resulting in a relative air humidity of 73%. The lipid in buffer was 
left to partially dehydrate for between 2 and 20 hours. Once complete the 
electroformation cell of the VPP was assembled as before, filled 100 mM sucrose in 
HEPES buffer, and the electroformation protocol was started. In order to 
successfully create GUVs in a salt buffer the voltage was ramped up over 1 hour 
from 0 to 1.2 V, before being held constant at 1.2 V for 13 hours. This took place at 
500 Hz in comparison to the frequency of between 2 and 12 Hz normally used for 
electroformation in a salt-free buffer. The voltage was then ramped down from 1.2 
to 0 V over the final hour while the frequency was held constant at 500 Hz. The 
electroformation process was carried out at room temperature. This process was 
effective in yielding GUVs from a wide range of lipid compositions with IIb3 
successfully reconstituted within.  
 
3.2.8. Integrin labelling 
 
Integrin labelling with Atto655 
In order to label αIIbβ3 with atto655 NHS ester, the probe (which was supplied in 
powder form) was re-suspended in DMF at 2 mg/ml. The integrin protein which is 
supplied in a Tris-based buffer (20 mM Tris, 100 mM NaCl, 1 mM CaCl2, 0.05% NaN3, 
0.1% triton x-100 (w/v), 50% glycerol (v/v), pH 7.4) was dialysed into HEPES 
reconstitution buffer. This was necessary due to the fact that atto655 NHS ester is 
amine reactive. This buffer exchange was achieved via dialysis against 1000 times 
the original volume over a 24-hour period with buffer exchanges after 6 and 18 
hours. For efficient labelling, the protein concentration should be above 1 mg/ml. 
The dialysis process may dilute the αIIbβ3 concentration and as such it may be 
necessary to concentrate the protein to above this threshold. Therefore, if required, 
αIIbβ3 was concentrated using centrifuge filter columns (Amicon® Ultra-4 Centrifugal 
Filter Units, 100 kDa cut-off). For labelling, αIIbβ3 was incubated with a five-fold 
molar excess of atto655 NHS ester for 3 hours. This occurred at room temperature 
under gentle stirring. 
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Integrin labelling with 5(6)-TAMRA SE 
TAMRA labelling was achieved in a similar manner to atto655 labelling. Using αIIbβ3 
at more than 1 mg/ml in a HEPES reconstitution buffer, 5(6)-TAMRA SE (in DMF at 2 
mg/ml) at a five-fold molar excess is co-incubated for 1 hour at room temperature 
under gentle stirring. This was in contrast to the 3 hours used for atto655 labelling. 
Separation of integrin from free dye 
In order to separate labelled αIIbβ3 from unbound dye, size exclusion 
chromatography was used. Firstly, sepharose beads (Sephadex G-25) were left to 
swell overnight in dH2O. These beads were then loaded onto a disposable column 
(20 ml Econo-Pac Chromatography Column) and the beads were allowed to pack 
tightly at the bottom of the column under gravity. Excess dH2O was removed and 
more beads were added to the column until the packed beads filled the column 
entirely. Approximately 250 ml of HEPES reconstitution buffer was flushed through 
the column to equilibrate the beads. The labelled integrin solution was added to the 
top of the column where it begins to migrate through the beads. After a number of 
minutes two separate fluorescent bands can be resolved in the column. The first 
band was labelled protein as it migrates quickly through the beads. The second band 
was the unbound dye that moves slower through the beads. The column was 
flushed with detergent containing buffer throughout. The first band was collected 
and dialysed against HEPES reconstitution buffer for 24 hours to fully ensure all free 
dye had been removed. 
Determination of labelling ratio 
The degree of labelling (DOL) between dye and protein was obtained from the 
spectrum of the conjugated probe and the concentration of protein as determined 
by the Bradford assay or the 2-D Quant Kit assay. This is achieved after all free dye 
had been removed from the solution via size exclusion chromatography and dialysis. 
The concentration of bound dye was firstly determined by measuring the 
absorbance spectra of the solution in a 1 cm path length cuvette.  
𝑀𝑜𝑙𝑎𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 =
𝐴𝑚𝑎𝑥
𝜀𝑚𝑎𝑥
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Where Amax is the absorbance of the dye at its absorption maximum (λabs) and εmax is 
the extinction coefficient of the dye. The respective Amax and εmax values for atto655 
and TAMRA are given below. From this formula, the molar concentration of bound 
dye can easily be determined. Normally the concentration of protein can be 
determined via a similar method using absorbance at 280 nm (A280), but due to the 
fact the detergent triton X-100 absorbs strongly in this region, an alternative 
method was used. For the determination of αIIbβ3-atto655 concentration, the 2-D 
Quant Kit assay method was used. For the determination of αIIbβ3-TAMRA 
concentration, the Bradford assay method was used. From these assays the molar 
concentration of labelled αIIbβ3 can be determined. As the molar concentration of 
dye is also known, the DOL was determined using: 
 
𝐷𝑂𝐿 =  
𝑚𝑜𝑙𝑎𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑑𝑦𝑒
𝑚𝑜𝑙𝑎𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛
 
 
3.2.9. Determination of protein 
concentration 
Bradford Assay 
To perform the Bradford assay, standard solutions were prepared by dissolving BSA 
in the required buffer at 2, 1, 0.5, 0.25, 0.125 and 0.0625 mg/ml, as well as a blank 
of buffer alone. Bradford reagents were prepared by added 20 μl of Bradford 
solution S to Bradford solution A to create A*. 25 μl of A* was added to each well of 
a 96 well plate where the experiment was to take place. 5 μl of each standard 
solution was added to separate wells alongside the unknown(s). The standard curve 
and unknowns were prepared in triplicate. The plate was incubated at room-
temperature for approximately 15 minutes before absorbance was measured at 690 
nm in a plate reader. Data was analysed in by plotting the standard curve and 
extrapolating the unknown(s).  
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2-D Quant Kit assay 
To perform the 2-D Quant Kit assay, standard solutions were prepared using the BSA 
solution supplied with the kit. To the tubes 0, 5, 10, 15, 20 and 25 μl of the 2 mg/ml 
BSA solution were added. To another tube, 25 μl of the unknown was added. These 
tubes were prepared in triplicate. To each tube, 500 μl of precipitant solution was 
added before vortexing and incubation at room temperature for 2 minutes. 500 μl of 
co-precipitant solution was then added to each tube before an additional vortexing. 
The tubes were centrifuged at 10,000 g for 5 minutes in order to sediment the 
protein. The supernatant was removed without disturbing the protein pellet. 100 μl 
of copper solution was added to each tube and the volume was brought to 500 μl 
with the addition of dH2O. The solution was briefly vortexed in order to re-suspend 
the protein. 1 ml of working colour reagent was added to each tube before mixing 
and incubation at room temperature for 20 minutes. The absorbance of each sample 
was read at 480 nm using dH2O as a reference. By plotting the standard curve and 
extrapolating the unknown(s). It should be noted that in contrast to most protein 
assays, the absorbance of the assay solution decreases with increasing protein 
concentration.  
 
3.2.10. Integrin detection in proteoliposomes 
Flow cytometry was used to determine successful reconstitution of αIIbβ3 into 
liposomes. Proteoliposomes in the reconstitution buffer were pipetted into a FACS 
tube and incubated at room temperature with the anti-human CD41a antibody at a 
concentration of 0.1 mg/ml for 30 minutes. This antibody has affinity for both the 
resting and activated forms of αIIbβ3.  The proteoliposomes were passed through the 
flow cytometer until 10,000 acquisitions had been acquired in a gated region that 
corresponds to the reconstituted vesicles. Data was analysed using CellQuest Pro 
software from Becton Dickinson or Flowing Software from Turku Bioimaging. 
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3.2.11. Confocal Microscopy of GUVs 
For confocal microscopy studies, a fluorescent probe was included in lipid 
compositions at 0.1 % (mol/mol). Two fluorescently labelled lipids that were 
routinely used in these studies were DOPE-BODIPY and DOPE-atto655. Alternatively, 
the lipophilic tracer dyes DiL (excitation max 549 nm) or DiD (excitation max 644 nm) 
were used.  These lipophilic tracer dyes were particularly useful to identify domain-
forming GUVs due to the fact they fail to fully partition into SM and CH rich rafts. In 
compositions that had lower concentrations of SM and CH they appeared to 
partition homogenously throughout the GUV bilayers.  
 
A number of different methods were employed for observing GUVs prepared via 
electroformation. GUVs may be examined within their electroformation cell by using 
a 10x objective with a suitable working distance (due to the thickness of the cell 
glass). This allows for the observation of vesicle growth, helped by the fact that the 
first GUVs in electroformation may be hundreds of microns in diameter. 
Alternatively, GUVs may be removed from their cell and pipetted onto a borosilicate 
glass coverslip for observation. In this case, a 63x objective was normally used. To 
aid GUV observation it was generally advantageous to create GUVs in a sucrose-
containing buffer before transfer to a glucose-containing buffer. This meant that the 
inner medium of GUVs was sucrose while the exterior medium was a mixture of 
sucrose and glucose. This yielded two benefits. Firstly, the difference in refractive 
indexes between the inner and outer mediums allowed for the ready identification 
of GUVs under light a light microscope. Secondly, the sucrose-containing GUVs fall 
to the bottom of solution thus making confocal imaging easier. Care was taken to 
ensure the glucose and sucrose mediums were of equal osmolarity. This was 
important as failure to do so resulted in the rupturing of GUVs due to the osmotic 
gradient. If the GUVs were not created in a sucrose-containing buffer, the continual 
movement of vesicles made microscopy experiments difficult.  The image data was 
analysed with LSM image browser (Carl Zeiss, Germany) or ImageJ (National 
Institutes of Health, USA).  
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3.2.12. FLCS measurements 
Diffusion coefficients for labelled integrin or lipid were obtained using Fluorescence 
Lifetime Correlation Spectroscopy, FLCS. The autocorrelation functions obtained 
using FLCS are less prone to noise and distortion caused by scattered excitation light, 
detector thermal noise and detector afterpulsing than conventional Fluorescence 
Correlation Spectroscopy (FCS). FLCS measurements were performed using a 
MicroTime 200 confocal fluorescence lifetime microscope system. For FLCS 
experiments, the fluorophores were excited as described for confocal imaging and 
the sample fluorescence was also collected as described for confocal microscopy. 
The autocorrelation functions (ACF) were fit using SymphoTime software (PicoQuant 
GmbH, Berlin, Germany): 
 
𝐺(𝜏) = 1 +  [
1
𝑁
] [
1
1 + (𝜏 𝜏𝐷⁄ )
𝛼
] 
 
For simple single component diffusion, or in the case of the presence of a triplet 
state: 
 
𝐺(𝜏) = 1 + [1 − 𝑇 + 𝑇𝑒𝑥𝑝(−𝜏 𝜏𝑇⁄ )] [
1
𝑁(1 − 𝑇)
] [
1
1 + (𝜏 𝜏𝐷⁄ )
𝛼
] 
 
where G(τ) is the autocorrelation function of fluorescence fluctuations; N is the 
number of fluorophores in the effective volume; T is the fraction of the molecules in 
the triplet state; τT is the relaxation time for the singlet–triplet crossing;  is the 
anomalous parameter; and τD is the diffusion time, which is related to the lateral 
diffusion coefficient (D) of the labelled tracer by the expression: 
 
τ𝐷  =  
ω2
4D
 
 
In the latter equation, the radius ω is the distance at which the excitation intensity 
profile decreases to e-2 of its maximum value. This parameter was determined 
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experimentally, by measuring the translational diffusion of Rhodamine 6G (532 nm 
laser) and Atto655 (640 nm laser) in water at room temperature (approximately 21 
°C).137 These dyes, have well characterized diffusion coefficients and so were used as 
standards to determine the working confocal volume for FLCS measurements. 
Before performing FLCS measurements on the GUV membrane, confocal images 
were collected to identify and locate suitable vesicles for study. In order to avoid the 
sharp curvature of smaller GUVs or undulations in larger GUVs, only single 
unilamellar vesicles with diameters within the range 20 and 40 μm were selected for 
FLCS measurements. This selection criteria was based on that recommended by 
Ramadurai et al.53 To precisely locate the lipid bilayer of the liposome where FLCS 
measurements were to be taken, fluorescence intensity measurements were 
performed by Z-scanning near the GUV membranes until the site of maximum 
intensity was located. Point FLCS measurements were then recorded at these 
precise positions for up to 3 minutes. Throughout the measurement, the MCS trace 
was monitored to ensure that the GUVs remained stationary during FLCS recording. 
Recordings from GUVs that exhibited drift during the measurement were eliminated 
from the analysis.  
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3.3. Results 
 
3.3.1. Electroformation 
Before we attempted to create integrin-reconstituted GUVs we first needed to 
establish an easy and reliable method of GUV production. A number of techniques 
were explored for this reason, such as dehydration-rehydration, calcium-induced 
swelling and electroformation. Of these techniques, electroformation was chosen as 
the primary method GUV production method used throughout this work owing to its 
reliability and its high GUV yield. In following the literature, our first attempts to 
produce giant vesicles via this method used relatively simple unary or binary 
compositions such as pure DOPC or DOPC:DOPS (9:1). These compositions were 
chosen to first establish a reliable protocol for GUV production. It was found that by 
using a microscope objective with suitably long working distance we could use 
confocal imaging to observe the GUV growth within the cell of the electroformation 
cell of the vesicle prep pro. Due to the thickness of the ITO glass used in the 
electroformation cell only the 10x air objective was suitable for GUV observation 
during this growth phase. Upon initiation of the electroformation protocol all that 
was visible on the ITO glass was a thick layer of fluorescently-labelled lipid that had 
been deposited prior to the electroformation process. After about 45 minutes of the 
protocol the first GUVs began to become visible. Some of these vesicles were up to 1 
mm in diameter and from these “parent” vesicles many smaller GUVs (20 μm to 100 
μm in diameter) began to bud. A confocal image of this is shown in Figure 38. Over 
the length of the electroformation process the size of the parent vesicles reduces as 
more and more GUVs begin to bud. By the end of the protocol many thousands of 
GUVs are visible, clustered together in vesicle “nests” on the glass surface. A 
confocal image of this is shown in Figure 39. 
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Figure 38: Confocal image of GUV growth during an electroformation protocol. After approximately 45 
minutes, massive GUVs with diameter greater than 100 μm become visible. From these massive GUVs, smaller 
GUVs (diameter between 20 and 50 μm) begin to bud in vesicle nests. A 10x objective with a suitable working 
distance was used to observe GUV growth (DOPC) in the electroformation cell. DOPE-Atto655 was 
incorporated at 0.1 mol % and excited at 633 nm. 
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Figure 39: Confocal image of GUV growth near the end of an electroformation protocol. The massive GUVs 
originally observed in the electroformation protocol have been reduced in size after successive budding. These 
smaller GUVs have a diameter between 20 and 100 μm and occur clumped in vesicle nests. They are surface 
attached and require mechanical agitation or a lowering of the frequency of the electric field for removal from 
the surface. GUVs pictured are DOPC with 0.1 mol % DOPE-Atto655 and excited at 633 nm. 
 
Once the electroformation process was complete these GUVs could be removed 
from the ITO surface by gently pipetting the solution up and down. It was noted that 
some of the larger GUVs visible within the electroformation cell appeared to be 
destroyed during the transfer process. The average diameter of the GUVs was 
approximately 30 μm although this value varied from batch to batch. It was also 
noted that GUVs created from cholesterol and sphingomyelin containing 
compositions appeared more polydisperese when compared to GUVs created purely 
from phospholipids. GUVs were stable for a number of days at 4 °C although due to 
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the ease of creation, new batches were generally created as required on a day-to-
day basis.  
 
As mentioned previously, initial electroformation experiments used simple 
phospholipid mixtures to perform the GUV growth process as these compositions 
were the most widely used in the literature. It was only after a routine and reliable 
protocol for electroformation had been established that we looked to use more 
complex and physiologically-relevant compositions. The most widely used of these 
physiologically-relevant compositions applied throughout this thesis was adopted 
from the Lentz group at the University of North Carolina at Chapel Hill. Titled 
“nature’s own” this particular mixture has been regularly used by the Lentz group in 
their work to better model the cell membrane. Previously the Lentz group had only 
used nature’s own in their sonicated SUV work and due to the fact that such 
complex compositions were not regularly used in the literature (most of the 
literature features quite simple unary or binary lipid composiitons,138 although some 
may be ternary139) we first needed to establish whether the mixture was suitable for 
electroformation. Using the electroformation protocol we found that GUVs could be 
regularly formed using the nature’s own composition. Examples of these 
electroformed GUVs are given in Figure 40 and Figure 41. As can be seen, the 
electroformation process allowed for the high-yield production of primarily defect-
free, unilamellar giant vesicles which can be easily visualised by confocal 
microscopy. The conformation that nature’s own could be successfully used to 
create GUVs was required before advancing the process to include a reconstituted 
membrane protein in the form of integrin αIIbβ3. 
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Figure 40: GUVs (32 % DOPC, 25 % DOPE, 8 % DOPS, 15 % SM, 25 % CH) following completion of the 
electroformation protocol and subsequent removal to a new surface. Many thousands of GUVs are created 
and these vesicles survive the mechanical agitation used to remove them from the electroformation cell. 
DOPE-atto655 was included at 0.1 mol % and excited at 633 nm. 
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Figure 41: A close-up confocal image of GUVs (32 % DOPC, 25 % DOPE, 8 % DOPS, 15 % SM, 25 % CH) created 
via electroformation. The vesicles have been removed from the electroformation cell and transferred to new 
glass surface for imaging. The vast majority of GUVs are unilamellar. DOPE-atto655 was included at 0.1 mol % 
and excited at 633 nm. 
 
3.3.2. Electroformation of raft-forming GUVs 
Following on from the successful production of GUVs composed of both simple and 
physiologically-relevant lipid compositions, we later sought to create lipid raft-
forming GUVs via electroformation. While physiologically, lipid rafts are believed to 
occur on the nanoscale, too small to be visible via confocal experiments, it is 
possible to create GUVs with microscale domains by using high concentrations of 
both cholesterol and sphingomyelin. We investigated a number of different 
cholesterol and sphingomyelin rich mixtures but one particular composition that 
was regularly used to form GUVs with large visible ordered and disordered phases 
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was the domain-forming DOPC:CH:SM (4:2:2) composition. By utilising this 
composition in conjunction with an appropriate lipid probe it was possible to 
visualise lipid rafts within GUVs via confocal microscopy.140 For example we regularly 
used the lipophilic tracer dyes DiD and DiL in our lipid raft experiments. These 
particular dyes are known to favourably partition into the liquid disordered, 
phospholipid rich phase of domain-forming bilayers.139 Figure 42 and Figure 43 show 
the successful production of domain-forming vesicles using the aforementioned 
DOPC:SM:CH (4:2:2) mixture where DiD was used as the disordered phase probe. 
The un-labelled regions of the GUV membranes correspond to the cholesterol and 
sphingomyelin-rich liquid ordered phases. As well as the aforementioned 4:2:2 ratio 
of DOPC:SM:CH, various other GUV compositions were explored in domain-forming 
experiments using different DOPC:SM:CH ratios. While many of these mixtures did 
produce raft-forming GUVs it was found that increasing the cholesterol 
concentration much above 30 % resulted in domains that were poorly defined by 
phase separating dyes. As well as the use of the disordered phase probes DiD and 
DiL we also attempted to utilise an ordered phase probe, DSPE-NBD, in order to 
visualise the lipid rafts directly. According to the supplier, Avanti Polar Lipids, DSPE-
NBD “preferentially partitions, although not entirely, into the more ordered 
cholesterol and sphingolipid-enriched microdomain known as a lipid raft”. However, 
using the raft-forming mixture DOPC:SM:CH (4:2:2) as well as other raft-forming 
compositions we were unable to visualise this preference for the liquid ordered 
phase of GUVs. However in our hands DSPE-NBD appeared to have no particular 
affinity for either liquid ordered and disordered phases. Thus the dye was evenly 
distributed throughout the GUV membrane. As such, for all our raft-forming GUV 
experiments we were limited to the use of liquid disordered phase probes. 
Nonetheless the ability to create raft-forming GUVs via electroformation was a 
promising basis before we attempted to reconstitute αIIbβ3 within such 
compositions.  
 
 
 
 
 160 
 
Figure 42: Confocal image of domain-forming GUVs (40 % DOPC, 40 % SM, and 20 % CH). The use of this 
composition leads to the formation of micron sized lipid rafts, domains rich in cholesterol and sphingomyelin. 
To visualise these domains, DiD is included at 0.1 mol %. DiD is a lipophilic tracer dye with affinity for the 
liquid disordered phase. DiD does not partition well into the cholesterol and sphingomyelin-rich liquid ordered 
phase. DiD was excited at 633 nm. 
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Figure 43: A close-up of confocal image of a raft-forming GUV (40 % DOPC, 40 % SM, and 20 % CH). DiD was 
used as a marker for the liquid disordered phase. The lipophilic tracer is clearly excluded from certain regions 
of the GUV. DiD was included at 0.1 mol % and excited at 633 nm. 
 
3.3.3. Integrin Reconstitution 
Due to the difficulty in reconstituting membrane proteins directly into preformed 
GUVs we found that the best, most reproducible approach was to firstly create 
smaller proteoliposomes before later “growing” these to GUVs. To create these 
smaller αIIbβ3-reconstituted proteoliposomes, two different methods were regularly 
utilised. The first method utilised a protocol based on Müller et al.34 whereby lipid 
was fully solubilised by the detergent triton x-100 and the surfactant later removed 
by the addition of bio-beads. Alternatively a protocol based on Dennison et al.27 was 
used whereby sonicated SUVs were brought to the onset of solubilsation with β-OG 
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and the surfactant removed later removed via dialysis. Because of these different 
protocols for integrin αIIbβ3 reconstitution, two different methods were used to 
detect the presence of αIIbβ3 in the liposomes.  
 
Detection of integrin in Triton X-100 created proteo-liposomes 
While the extruded vesicles used for integrin reconstitution were of uniform 
dimater, DLS measurements showed that the use of triton x-100 and biobeads to 
insert αIIbβ3, as per the Müller protocol, had lead to a shift in the dispersity of the 
resultant proteoliposomes. Proteoliposomes produced via Müller’s full solubilisation 
method were found to have a diameter in the micrometer range. This change in 
vesicle size can be seen in Figure 44. Due to this increased vesicle diameter it was 
decided to use flow cytometry in order to detect the presence of αIIbβ3 in the 
proteoliposomes. Control liposomes were prepared via the same detergent 
solubilisation method but in the absence of integrin αIIbβ3 in order to yield protein-
free liposomes of equivalent size. In order to identify integrin in the lipid membrane 
the anti-αIIbβ3 antibody CD41a was used. This antibody has general affinity for αIIbβ3 
and will bind the protein’s extracellular domain regardless of integrin activation 
state. To detect the presence of αIIbβ3 in the reconstituted proteoliposomes, flow 
cytometry was first performed on control liposomes using FITC labelled CD41a. To 
act as a negative control, αIIbβ3 free vesicles were passed through the flow cytometer 
and counts for the fluorescence data channel were piled on the lowest values of the 
logarithmic x-axis of the histogram. Using a gate 5 % of these counts were located 
within this region. Therefore, any CD41a binding leading to a shift in the histogram 
to the right can be quantified by the percentage gated value increasing within the 
region. After the control liposomes, αIIbβ3-reconstituted liposomes were passed 
through the flow cytometer and the counts were overlayed on the same histogram. 
A typical histogram for CD41a-FITC featuring both control and αIIbβ3-reconstituted 
liposomes is given in Figure 45. A shift in the histogram to the right can clearly be 
seen in the αIIbβ3-reconstituted liposomes due to the CD41a binding. Using this 
method, it was determined that the percentage gated value increased from a 
baseline of 5 % to 35.47 % ± 5.74 % in αIIbβ3-reconstituted liposomes showing the 
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presence of the integrin protein within the vesicle lipid membrane in 
proteoliposomes produced via the Müller method. 
 
Figure 44: DLS measurements of vesicles after extrusion but before integrin insertion (blue), and after triton x-
100-mediated integrin reconstitution. After extrusion vesicles were mono-disperse, around the 100 nm 
diameter mark. Due to detergent solubilisation and then detergent removal, reconstituted vesicles were poly-
disperse with many proteoliposomes in the micrometer range. 
  
 
 
Figure 45: Representative histogram of FITC labelled CD41a binding in control liposomes (yellow fill, black 
outline) and reconstituted liposomes (red outline). The gate displayed is set so that 5 % of control liposome 
counts fall within the region. A shift in the histogram to the right can clearly be seen for α IIbβ3 liposomes 
showing the reconstitution protocol was successful. 
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Detection of integrin in β-OG created proteoliposomes 
When compared to proteoliposomes produced via the Müller method, 
proteoliposomes produced via the Dennison method were relatively small. In fact, 
no change in vesicle diameter was detected by DLS before and after detergent 
treatment where the mean vesicle diameter was 31 nm ± 5 nm throughout. This was 
likely due to the fact that sonicated SUVs were only brought to the onset of 
solubilisation in this protocol, rather than being fully solubilised. Due to their SUV 
size it was not possible to use flow cytometry to detect the presence of αIIbβ3 within 
the vesicle membrane. Instead an alternative assay had to be used. To do so, newly 
reconstituted proteoliposomes that had been separated from detergent via dialysis 
were run on a size exclusion column to remove free integrin. The fractions were 
collected and analysed for lipid concentration and the presence of protein. The lipid 
concentration of each fraction was quantified by the presence of radiolabelled lipid. 
The protein (integrin αIIbβ3) concentration of each fraction was quantified by running 
each fraction on a polyacrylamide gel. Densitometry was subsequently used on each 
lane of the gel. Combined these two assays showed that the lipid and αIIbβ3 were 
present in the same fractions and that the concentration of each component in the 
fractions was roughly correlated. This is shown in Figure 46. Due to the fact that free 
integrin had previously been removed through a size exclusion column and only the 
vesicle-containing fractions collected, this co-association of lipid and protein in the 
same fractions showed that αIIbβ3 had been reconstituted in SUVs created using the 
Dennison protocol.  
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Figure 46: Lipid and protein levels in recovered fractions. A) A graph showing detected disintegrations per 
minute (DPM) for each fraction in black and relative density of each fraction (as determined by densitometry) 
in red. To determine densitometry values, each fraction was run on a polyacrylamide gel and later stained 
with coomasssie blue to highlight any protein present. ImageJ was used to analyse each lane and the lane with 
the highest density value was set to 1 (lane 4). From this value the relative density of the other lanes could be 
determined. It is evident that there is a correlation between the lipid concentration in each fraction (black) 
and the protein concentration in each fraction (red). B) A coomassie stained polyacrylamide gel from which 
the densitometry values were obtained. A molecular weight marker is also included (leftmost lane). αIIbβ3 is 
reduced into three subunits during the PAGE step. The alpha subunit is divided into a heavy (125 kDa, top 
band) and light chain (25 kDa, run off gel). The beta subunit is 105 kDa (lower band). 
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3.3.4. Proteoliposome to GUV conversion 
Conformation of insertion in GUVs 
In order to confirm the presence of αIIbβ3 within GUVs electroformed from smaller, 
αIIbβ3-containing proteoliposomes, confocal microscopy was used. The 
proteoliposomes used as the lipid source for GUV production could be produced by 
either the Müller or the Dennison method of reconstitution without negatively 
influencing the resultant GUVs. In a typical preparation, αIIbβ3 was fluorescently 
labelled with an appropriate probe such as Atto532, Atto655 or TAMRA in order to 
visualise integrin presence in the electroformed GUVs. Figure 47 gives a typical 
result of the inclusion of αIIbβ3 in the electroformation protocol, where the nature’s 
own mixture was used as the lipid composition and the reconstituted αIIbβ3 was 
labelled with Atto655 . As can be seen, using αIIbβ3-containing proteoliposomes as 
the lipid source in the electroformation process was capable of producing defect 
free GUVs indistinguishable from protein free GUVs produced from a lipid in 
chloroform solution, as is normally the case in electroformation. This result shows 
that αIIbβ3-containing GUVs could be routinely created and serve as a platform for 
later diffusion-based measurements.  
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Figure 47: Atto655-labelled αIIbβ3-reconstituted into nature’s own GUVs. The fluorescent labelling of the 
integrin protein allowed for the identification of it within electroformed vesicles. The inclusion of αIIbβ3 in the 
electroformation method did not appear to alter the morphology or success of the electroformation process.  
 
Integrin concentration in GUVs 
In seeking to control the loading of integrin αIIbβ3 into liposomes, a number of 
starting concentrations of labelled αIIbβ3 were used to firstly create integrin-
containing proteoliposomes. This ranged from 1 integrin per 8000 lipid molecules, to 
1 integrin molecule per 80,000 lipid molecules. Surprisingly, the starting 
concentration of integrin used had little effect on the final concentration of αIIbβ3 
embedded in the GUVs. To reach this conclusion, point measurements were 
performed on the GUV membrane and the average number of fluorescently labelled 
αIIbβ3 molecules in the focal volume was recorded over the length of the experiment. 
This capability to infer the number of fluorescently labelled molecules is one of the 
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major advantages of FCS/FLCS when compared to FRAP. The value itself, referred to 
as N, remained relatively constant for the GUVs regardless of the starting 
concentration of labelled αIIbβ3 used to create αIIbβ3-containing proteoliposomes. 
This can be seen in Table 7 where the N number is given during point measurements 
alongside the starting lipid to αIIbβ3 ratio. From this data it appears that the proteo-
GUVs appear to reach an integrin saturation point relatively quickly. While this 
concentration is low compared to native membrane concentrations, N values such 
as these are absolutely ideal for FCS measurements.   
 
 
Table 7: αIIbβ3 saturation of GUVs. The use of varying starting concentrations of αIIbβ3appeared to have little 
influence on the average number of molecules in the focal volume during FLCS point measurements, indicating 
that nature’s own GUVs are easily saturated with properly reconstituted αIIbβ3.  
Starting lipid:protein ratio Average number of molecules in the focal 
volume (N) 
8,000:1 1.55 ± 0.17 
20,000:1 1.67 ± 0.20 
40,000:1 1.60 ± 0.22 
80,000:1 1.34 ± 0.25 
 
Integrin orientation in GUVs 
In order to estimate the orientation of αIIbβ3 in GUVs, integrin-reconstituted nature’s 
own GUVs were constructed as normal. GUVs were then incubated with the serine 
protease proteinase k for 2 hours at 37 °C. This enzyme only had access to outwardly 
orientated atto655-labelled αIIbβ3 and thus inwardly orientated atto655-labelled 
proteins could not be digested. Confocal images (Figure 48) were taken before and 
after proteinase k incubation and using a tracing tool in imageJ, the average count 
per pixel at the GUV membrane was determined. Before incubation the average 
count per pixel was found to be 46 ± 18 counts, while after incubation it was 21 ± 12 
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counts. (Figure 49) A two-tailed unpaired t-test was performed where the difference 
between the two data sets was found to be significant, where t(14) = 2.90, p < 0.05. 
This approximate halving of the intensity suggests that αIIbβ3 is orientated 
symmetrically within the lipid membrane. This result was somewhat predicted given 
the uncontrolled and seemingly random nature of αIIbβ3 reconstitution. 
 
 
Figure 48: A representative confocal image of atto655 labelled αIIbβ3-reconstituted GUVs before (left) and after 
(right) incubation with proteinase k. A reduction in intensity at the GUV membrane is clearly visible following 
enzyme digestion. A line tool in imageJ was used to trace around the GUV membrane in order to find the 
average intensity per pixel at the lipid membrane. 
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Figure 49: After the imageJ line tool was used to trace around the GUV membranes, the average counts per 
pixel before and after proteinase k incubation was calculated. Before incubation the average count per pixel 
was found to be 46 ± 18 counts, while after incubation it was 21 ± 12 counts. A two-tailed unpaired t-test was 
performed where the difference between the two data sets was found to be significant, where t(14) = 2.90, p 
< 0.05. This suggests that the enzyme digested approximately half of the labelled αIIbβ3 proteins, and thus half 
the labelled αIIbβ3 proteins were orientated outwardly. Therefore, it can be said that αIIbβ3 is orientated 
randomly within the GUV membrane. (n=8) 
 
3.3.5. Diffusion in GUVs 
Lipid diffusion 
Following characterisation of αIIbβ3 within the GUV membrane where integrin 
presence, concentration, and orientation was examined, attention was turned to 
single molecule techniques in order to determine the rate of diffusion of integrin 
and lipid within GUVs. For these diffusion measurements, Fluorescence Lifetime 
Correlation Spectroscopy (FLCS) was used. Integrin-containing vesicles were created 
as described and located via confocal microscopy for their XY co-ordinates. A Z-scan 
was then performed in order to then identify the upper most pole of the GUV 
membrane. This was achieved by locating the position of most fluorescence 
intensity, which corresponded to the GUV lipid membrane that contained a 
percentage of labelled lipid and protein. At these positions point measurements 
were carried for between 60 and 180 seconds to yield an autocorrelation function 
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for the lipid or protein. Initial FLCS experiments simply characterised the lipid 
diffusion co-efficents of various lipid compositions. For example, a typical 
autocorrelation function and its fit to a single component, two-dimensional diffusion 
model for a lipid probe (DOPE-atto532) in a GUV composed of nature’s own is given 
in Figure 50. Using this fitting model we determined that the diffusion co-efficient of 
DOPE-Atto532 within the nature’s own bilayer was found to be 7.89  0.42 m2/s at 
room temperature, with an alpha value of 1.01  0.04, i.e., the mean-squared 
displacements of the lipid scale as a power law of time with an exponent a of 1 
indicating that the lipid is undergoing normal Brownian diffusion at the liposome 
interface. Alpha values of greater or less than one, indicate anomalous diffusion, 
which in the case of a value less than 1 is usually attributed to hindered diffusion 
due to barriers within the membrane.69 This lipid diffusion value is consistent with 
values reported previously for GUVs as determined by FCS,48,141 but well in excess of 
reported lipid diffusion values for planar SLBs.30,31 As well as nature’s own other 
simpler lipid compositions were characterised by FLCS. Lacking cholesterol and 
sphingomyelin, these mixtures such as DOPC and DOPC/DOPS at varying ratios were 
generally indistinguishable from one another and diffused slightly faster than the 
nature’s own composition. Again the alpha value remained consistently at 1, as 
expected for the lateral diffusion of lipids in free standing GUV systems. A summary 
of the diffusion values for a variety of lipid compositions is given in Table 8. A one-
way ANOVA to compare the means of each data set against one another, P(4, 100) = 
71.15, p < 0.001. A post-hoc Bonferroni test was performed where the nature’s own 
composition was the only composition found to show significant variation from the 
other compositions, p < 0.001. Therefore, it can be said that altering the ratios of 
phospholipids had a negligible influence on the rate of diffusion within the GUV 
membrane. Only when ordered phase lipids such as cholesterol and sphingomyelin 
were included, as in the case of nature’s own, was membrane fluidity altered.  
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Figure 50: A typical autocorrelation function and its single component two dimensional fit for DOPE-atto532 
diffusing in nature’s own GUVs at room temperature. GUVs created via the electroformation protocol in a 
sucrose-containing buffer were pipetted into an observation buffer of 10 mM HEPES, 150 mM NaCl, 1 mM 
CaCl2, 100 mM glucose, pH 7.4, and the GUVs were allowed to come to rest on the bottomof a glass slide over 
a 30-minute period. Stationary GUVs were selected before a point measurement was performed on the GUV 
membrane. DOPE-atto532 diffusion in nature’s own GUVs was determined to be 7.89  0.42 m2/s at room 
temperature. 
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Table 8: The measured diffusion co-efficients for a selection of lipid compositions used in GUV experiments. 
Using lipid probes such as DOPE-Atto532 or DOPE-Atto655 FLCS point measurements were recorded at room 
temperature. At the ratios used, the inclusion of DOPE and DOPS appeared to have no influence on the 
diffusion of the GUV lipid bilayer. Only when cholesterol and sphingomyelin were included in the vesicle 
membrane such as in nature’s own could a change in the diffusion co-efficient by identified. This was verified 
by a one-way ANOVA with Bonferroni post-hoc test (p < 0.001). The alpha value appeared to be unchanged by 
cholesterol and sphingomyelin presence and remained 1 throughout. Standard deviation was used to report 
the error. 
Lipid Composition Diffusion Co-efficient 
(m2/s) 
Alpha Value 
DOPC 9.89  0.80 0.99  0.02 
DOPC:DOPS (9:1) 10.05  0.78 1.01  0.03 
DOPC:DOPS (8:2) 9.65  0.71 1.00  0.02 
DOPC:DOPE (9:1) 10.11  1.02 1.00  0.03 
Nature’s Own 7.89  0.42 0.99  0.02 
 
αIIbβ3 diffusion 
After characterisation of the diffusion co-efficients of various lipid compositions in 
our free-standing GUV system attention turned to the diffusion of fluorescently 
labelled αIIbβ3 in the giant vesicles. αIIbβ3 was membrane-inserted as described 
previously and the location of the integrin-reconstituted bilayer was identified by a 
combination of XY imaging and Z-scanning, as was the case for lipid diffusion 
experiments. Again point measurements were taken for between 60 and 180 
seconds. A typical autocorrelation function and its fit to a single component, two-
dimensional diffusion model for αIIbβ3–atto655 in nature’s own GUVs is shown in 
Figure 51. The ACF fits well to a single-component model with no evidence for 
slower diffusing components, associated, for instance, with aggregated protein. 
Analysis of the ACF traces shows that αIIbβ3 was diffusing at a rate of 2.52  0.29 
m2/s within nature’s own GUVs. Again the alpha value showed that diffusion was 
Brownian. In lipid compositions lacking cholesterol and sphingomyelin, a slightly 
 174 
faster αIIbβ3 diffusion coefficient was recorded due to the fact that these GUVs were 
composed of liquid disordered phase phospholipids and lacking the rigid liquid 
ordered sterols and sphingolipids of nature’s own. A summary of diffusion co-
efficients for fluorescently labelled αIIbβ3 in various GUV compositions is given in   
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Table 9. A one-way ANOVA was carried out, which found that lipid composition 
appeared to alter the diffusion of αIIbβ3 within the lipid membrane, F (3, 54) = 12.68, 
p < 0.001. A post-hoc Bonferroni test showed that αIIbβ3 in DOPC:DOPS and nature’s 
own diffused significantly slower than αIIbβ3 in DOPC (p < 0.001) and DOPC:DOPE (p 
< 0.01).  To the best of our knowledge, these diffusion values are the first to be 
recorded for αIIbβ3 in a GUV system, but are in line what would be expected based 
on the reconstitution of other membrane proteins into GUVs.53,142 The fact that 
these diffusion values are in line with other literature values suggests that the 
integrin protein has been properly inserted into the lipid membrane in our lipid 
compositions, something not investigated in other GUV-αIIbβ3 models.46,47 This 
aspect is particularly relevant given our use of a range of lipid compositions, where 
other groups have asserted that that non-DMPC-containing lipid compositions do 
not facilitate αIIbβ3 insertion.29 Therefore, not only is our work the first to confirm 
proper αIIbβ3 reconstitution into GUVs, it is also the first to confirm proper αIIbβ3 
reconstitution into a DMPC-free system.  
 
Another key feature of the use of a free-standing GUV system is the increased 
diffusion values for membrane proteins when compared to SLB systems. For 
example Erb and Goennenwein both reported similar αIIbβ3 lateral diffusion co-
efficients of 0.70 and 0.60 m2/s, respectively30,31, while Purricker gives a much 
slower diffusion co-efficient of between 0.03 and 0.13 m2/s.43,44 This is in contrast 
to our αIIbβ3 diffusion values of between 2.5 and 3.4 m2/s, depending the lipid 
composition used. This mirrors the increased lipid diffusion co-efficients in GUVs, 
when compared to SLBs, as previously mentioned. However, and more importantly, 
this free standing nature of GUVs manifests itself in the unencumbered lateral 
mobility of membrane proteins when compared to SLBs. While existing αIIbβ3-
reconstituted SLBs suffer from major protein immobility (Erb et al.; 75 %, 
Goennenwein et al.; 40 %, Purrucker et al.; > 75 %)30,31,43,44,  no αIIbβ3 immobility was 
apparently in our system. This can be inferred from the lack of photobleaching 
during point measurements at the lipid membrane. If fluorescently-labelled αIIbβ3 
had been immobile, ie stationary, within the focal volume during point 
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measurements this would have obvious as a decrease in the fluorescence intensity 
over time, and the failure to obtain an ACF trace.  
 
 
 
 
Figure 51: A typical autocorrelation function and its single component two dimensional fit for αIIbβ3-Atto655 
diffusing in nature’s own GUVs at room temperature. GUVs created via the electroformation protocol in a 
sucrose-containing buffer were pipetted into an observation buffer of 10 mM HEPES, 150 mM NaCl, 1 mM 
CaCl2, 100 mM glucose, pH 7.4, and the GUVs were allowed to come to rest on the bottom of a glass slide over 
a 30-minute period. Stationary GUVs were selected before a point measurement was performed on the GUV 
membrane. αIIbβ3-Atto655 diffusion in nature’s own GUVs was determined to be 2.61  0.35 m2/s at room 
temperature. 
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Table 9: The measured diffusion co-efficients for a fluorescently-labelled αIIbβ3 in a variety of lipid 
compositions. Integrin in the cholesterol and sphingomyelin-containing nature’s own composition diffused 
slower than in the other examined compositions. The alpha value, regardless of lipid composition, was 1. All 
point measurements took place at room temperature. Standard deviation was used to report the error. 
Lipid Composition Diffusion Co-efficient 
(m2/s) 
Alpha Value 
DOPC 3.40  0.66 0.98  0.02 
DOPC:DOPS (9:1) 2.99  1.04 0.99  0.02 
DOPC:DOPE (9:1) 3.46  1.21 0.98  0.03 
Nature’s Own 2.52  0.29 1.00  0.02 
 
αIIbβ3 activation state 
Following conformation that αIIbβ3 had been successfully incorporated within the 
GUV membrane, and the establishment of a baseline diffusion co-efficient, we next 
sought to infer whether the integrin protein remained in its un-activated 
conformation, or had transitioned to its ligand binding conformation during the 
membrane reconstitution process. This was important as, for example, Erb et al. 
found that αIIbβ3 incorporated into a planar bilayer system was capable of binding to 
ligands in the absence of any integrin activators.30 In a similar experiment we 
decided to incubate the liposome-protein assembly with the integrin’s primary 
ligand, fibrinogen. It was hoped that if αIIbβ3 was in its activated ligand binding state 
then formation of an integrin-fibrinogen complex could be identified via a reduction 
in the diffusion co-efficient or a change in the alpha value for fluorescently labelled 
αIIbβ3. To do so, reconstituted GUVs were incubated with fibrinogen at 0.1 mg/ml for 
1 hour before the diffusion co-efficient was determined. However, according to our 
analysis, the diffusion co-efficient of αIIbβ3 in the nature’s own composition 
remained constant with a value of 2.52  0.29 m2/s. The alpha also remained 
constant with a value of 0.99  0.02. These values, indistinguishable from those 
observed prior to incubation with fibrinogen, appeared to show that αIIbβ3 had not 
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bound to its ligand. Thus, we concluded that αIIbβ3-reconstituted in electroformed 
GUVs via our novel insertion method was present in it ligand unavailable un-
activated conformation.  
 
 
3.3.6. Diffusion of αIIbβ3 in GUVs after 
activation 
DTT and Mn2+ activation  
Knowing that αIIbβ3-reconstituted into nature’s own GUVs appeared to remain in its 
un-activated state, we wanted to know whether conformational changes induced by 
nominally activating αIIbβ3 lead to a measurable change to its diffusion co-efficient as 
determined by FLCS. To do so the integrin activators DTT or Mn2+ were applied to 
the GUV-protein assembly. In the experimental procedure, DTT or Mn2+ solutions 
were carefully pipetted into the observation chamber containing the αIIbβ3-
reconstituted GUVs to a final activator concentration of between 0.5 and 5 mM. The 
integrin and activator were incubated at room temperature for 1 hour before FLCS 
measurement commenced. Following incubation with 3 mM DTT, the diffusion co-
efficient of liposome-bound αIIbβ3 was determined by FLCS to be 2.59  0.24 m2/s, 
whilst for liposome-bound αIIbβ3 incubated with 3 mM Mn2+, a diffusion co-efficient 
of 2.51  0.19 m2/s was obtained. In both cases, the alpha values were found to be 
approximately 1. Together these results indicate that the conformational 
(hydrodynamic volume) changes induced in αIIbβ3 by DTT or Mn2+ are not alone 
sufficient to induce a measurable change in the integrin diffusion coefficient. 
Furthermore, the ACFs fit well to a single component model with no evidence for 
slower diffusing components in the ACF which might suggest integrin clustering. 
These results were repeated with a range of activator concentrations with no 
change in the reported diffusion co-efficient.  
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DTT and Mn2+ activation in the presence of fibrinogen 
Following on from the activation of membrane-reconstituted αIIbβ3 in the absence of 
a ligand, we later sought to repeat this activation in the presence of αIIbβ3’s primary 
ligand, fibrinogen. While we had established that conformational changes alone 
were not capable of bringing about a change in integrin diffusion it was hoped that 
DTT or Mn2+-mediated fibrinogen binding would be sufficient to lead to a change in 
αIIbβ3’s diffusion co-efficient. Using 3 mM DTT or 3 mM Mn2+ in conjunction with 
fibrinogen at a concentration of 0.1 mg/ml it was found that the diffusion co-
efficient of αIIbβ3-Atto655 was altered in nature’s own GUVs. The co-addition of DTT 
and fibrinogen reduced the diffusion coefficient to 1.56  0.26 m2/s. Similarly, co-
addition of Mn2+ and fibrinogen to αIIbβ3-reconstituted into liposome resulted in a 
diffusion co-efficient of 1.49  0.41 m2/s.  
 
A one-way ANOVA was was performed on αIIbβ3 diffusion in nature’s own under the 
previous conditions (before activation, before activation in the presence of 
fibrinogen, after DTT and Mn2+ activation, DTT and Mn2+ activation in the presence 
of fibrinogen) where significance was found within the data (F(5, 134) = 100.10, p < 
0.001). A post-hoc Bonferroni test between all the variables revealed that this 
significance was only found when fibrinogen was added to DTT and Mn2+ activated 
integrin, where p < 0.001. These results suggest that the DTT or manganese 
activated integrin binds fibrinogen and the resulting complex diffuses more slowly. 
An example of an ACF trace and its fit to a single component, two dimensional 
diffusion model before and after fibrinogen binding it given in Figure 52.  
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Figure 52: Representative single component fits (solid lines) to ACFs collected from resting αIIbβ3-atto655 
(blue) and activated, fibrinogen bound αIIbβ3-Atto655 (red) in nature’s own GUVs at room temperature. The 
αIIbβ3-reconstituted GUVs were created in a sucrose-containing buffer before being pipetted into an 
observation buffer of 10 mM HEPES, 150 mM NaCl, 1 mM CaCl2, 100 mM glucose at pH 7.4. The GUVs were 
allowed to come to rest on a glass slide over a 30-minute period prior to measurement. Stationary GUVs were 
selected before a point measurement was performed on the GUV membrane. αIIbβ3-Atto655 diffusion in 
nature’s own GUVs before the addition of activators or fibrinogen was determined to be 2.52  0.29 m2/s at 
room temperature. Following integrin activation and addition of fibrinogen, this diffusion co-efficient reduced 
to 1.56  0.26 m2/s with DTT and 1.49  0.41 m2/s with Mn2+. 
 
In order to interrogate the change in integrin diffusion we turned to the Saffman–
Delbrück model of protein diffusion. The Saffman–Delbrück model51, is one of the 
most widely used models used to describe the 2-dimensional diffusion of protein 
bound to a membrane. According to this the model, the diffusion co-efficient of a 
membrane protein integrated into a lipid membrane exhibits logarithmic 
dependence on the reciprocal of the hydrodynamic radius R, of the protein as 
expressed by53: 
 
 
𝐷 =  
𝑘𝐵𝑇
4𝜋𝜇𝑚ℎ
(𝑙𝑛 (
𝜇𝑚ℎ
𝜇𝑤𝑅
) − 0.5772) 
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where D is the lateral diffusion co-efficient of the protein, kB is Boltzmann constant, 
T is the absolute temperature, h is the thickness of the lipid bilayer, μm is the 
viscosity of the lipid bilayer and μw is the viscosity of the surrounding aqueous 
phase. Although there have been challenges to the broad veracity of the SD model55, 
there are numerous convincing studies which demonstrate its applicability across 
membrane proteins with hydrodynamic radii up to approximately 10 nm.52,53 The 
integrin within both resting and activated conformational ranges have 
hydrodynamic radii below this value.143 According to the SD model, the only 
parameter of the protein exerting an influence on its diffusion coefficient is its 
hydrodynamic radius and this value weakly affects the diffusion co-efficient. For 
example, increasing the protein radius from 1 nm to 10 nm only changes the 
mobility by 30 %.55 Here, upon fibrinogen binding, the diffusion coefficient of αIIbβ3 
decreases by approximately 40 % when compared with unbound, resting αIIbβ3. This 
suggests, relying on the Saffman–Delbrück model as a first approximation, a 20-fold 
increase in the radius of the diffusing protein following ligand binding. Such an 
increase is too large to be accounted for by the formation of 1:1 or even 1:2 
fibrinogen–αIIbβ3complexes. Rather, it strongly suggests that significant aggregation 
of the integrin is occurring on fibrinogen binding following αIIbβ3 activation by either 
DTT or Mn2+. In turn, fibrinogen binding and aggregation only occur after treatment 
of the integrin with the activator. 
 
Another factor that could be examined and used to explain the diffusional 
characteristic of our αIIbβ3 protein was the alpha value from our two-dimensional 
fits. In our initial set-ups where integrin was in its un-activated or activated but un-
liganded states, analysis of the ACFs had shown that Brownian diffusion was 
occurring, ie the alpha value remained at 1. We found that when the integrin protein 
was activated with DTT or Mn2+ and incubated in the presence of fibrinogen at 0.1 
mg/ml a reduction in the alpha value was witnessed alongside the aforementioned 
reduction in the diffusion co-efficient. These values were 0.87  0.03 and 0.88  0.03 
for DTT (and fibrinogen) and Mn2+ (and fibrinogen), respectively. This reduction in 
the alpha value suggests that the diffusion of labelled αIIbβ3 is hindered under the 
ligand-binding conditions and can therefore the diffusion can now be described as 
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anomalous. This same phenomena of anomalous protein diffusion has previously 
been described in cells due to molecular crowding for example.69 A summary of the 
diffusion co-efficients and their associated alpha values can be seen in Table 10. 
 
Table 10: Lipid and integrin αIIbβ3 diffusion in nature’s own GUVs. The table shows the diffusion coefficient 
before activation in the presence and absence of fibrinogen, and after activation in the presence and absence 
of fibrinogen. Activation or ligand addition alone was not sufficient to bring about a measurable change in 
αIIbβ3 diffusion. The combination of activation and ligand addition was sufficient to bring about a reduction in 
diffusion of αIIbβ3 attributed to integrin aggregation. This was confirmed by a one-way ANOVA and post-hoc 
Bonferroni test where p < 0.001. Furthermore, the combination of activation and ligand addition led to 
anomalous diffusion of αIIbβ3 as indicated by the alpha values. Error was reported used standard deviation.  
Condition Diffusion co-efficient 
(m2/s) 
Alpha value 
Lipid (DOPE-Atto532) 7.89  0.42 1.01  0.04 
αIIbβ3 2.52  0.29 0.99  0.03 
αIIbβ3 + fibrinogen 2.61  0.35 0.99  0.02 
αIIbβ3 + DTT 2.59  0.24 1.02  0.03 
αIIbβ3 + Mn2+ 2.51  0.19 1.02  0.04 
αIIbβ3 + DTT + fibrinogen 1.56  0.26 0.87  0.03 
αIIbβ3 + Mn2+ + 
fibrinogen 
1.49  0.41 0.88  0.03 
 
 
In combination, this large reduction in the lateral diffusion co-efficient and fall in the 
recorded alpha values all pointed toward the formation of large protein aggregates 
within the GUV bilayer when αIIbβ3 becomes ligand bound. Further exploration of 
this phenomenon was possible via examination of the MCS trace over time. The MCS 
trace displays fluorescence fluctuations over time during the point measurements 
and can be used to visualise the movement of fluorescently-labelled integrin 
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molecules passing through the focal volume over the timescale of the FLCS 
experiment. An example of the MCS traces before and after assembly incubation 
with activator and fibrinogen is given Figure 53. Un-activated atto655 labelled αIIbβ3 
diffuses through the focal volume regularly with evenly distributed fluorescence 
bursts during point measurement. (blue) Addition of DTT or Mn2+ did not alter the 
pattern of the MCS trace, nor did fibrinogen alone. However, the addition of 
fibrinogen to either DTT or Mn2+ treated αIIbβ3 dramatically altered the MCS trace 
during point measurements. The regular, high frequency of bursts in fluorescence 
intensity was replaced with less frequent, clustered bursts in the MCS trace (red). 
This indicates that groups of the labelled proteins are diffusing together through the 
confocal volume. It is important to note that the sum of fluorescent intensity before 
and after activation and on fibrinogen addition does not change, so although the 
integrin proteins diffuse through the focal volume in clusters, the total integrin 
number remains unchanged.  
 
 
Figure 53: Fluctuating photon-counting time traces, binned at 1 ms resolution, from single point 
measurements in the plane of the liposome membrane. The upper trace (blue) shows diffusion of un-activated 
Atto 655 labelled-αIIbβ3 in nature’s own GUVs while the lower trace (red) shows diffusion of DTT activated Atto 
655 labelled- αIIbβ3 in nature’s own GUVs following the addition of fibrinogen. The un-activated form of αIIbβ3 
passes through the focal volume with a regular fairly homogeneous frequency. Whereas, fibrinogen bound 
αIIbβ3 passes through the focal volume in heterogeneous, irregular bursts, each burst appears to contain 
clusters of fluorophores migrating together through the focal volume. 
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3.3.7. Integrin in Raft-Forming GUVs 
We had earlier established that it was possible to create raft-forming GUVs via 
electroformation through the use of lipid compositions with high concentrations of 
cholesterol and sphingomyelin. These raft-forming GUVs were visualised using lipid 
probes with affinity for the cholesterol poor liquid disordered phase. Combining this 
raft-forming composition (50 % DOPC, 25 % CH and 25 % SM (mol/mol)) with our 
integrin reconstitution method we sought to understand whether αIIbβ3 favourably 
associated with the liquid ordered or liquid disordered phase of these GUVs. In the 
literature this technique has previously been used to investigate the preferential 
partitioning of other membrane proteins into lipid domains. For example, syntaxin, 
synaptobrevin and bacteriorhodopsin have been shown to associate with the liquid 
disordered phase,36,144 while the GPI-anchored human prion protein, involved in 
Creutzfeld–Jakob disease associates with the liquid ordered phase.145 Whereas αIIbβ3 
has been shown in platelets to exhibit low affinity for detergent resistant 
(cholesterol rich domains),124 other integrins have been shown in both artificial 
membrane models and in cells, to exhibit variable affinity for cholesterol rich 
domains depending on their activation and ligand binding status.146,147 To data no 
such investigation has taken place for integrin αIIbβ3 in artificial lipid systems. Using 
dual colour confocal microscopy we created raft-forming GUVs with αIIbβ3 
reconstituted within. Figure 54 shows one such dual colour experiment where the 
lipid has been labelled with the disordered phase probe DiD (left), while the integrin 
αIIbβ3 has been labelled with TAMRA (right). As can clearly be seen both probes co-
localise. This indicates that αIIbβ3 has affinity for the phospholipid rich and 
cholesterol poor liquid disorder phase of raft-forming GUVs. 
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Figure 54: (Left) The liquid disordered probe DiD partitioning into the DOPC rich phase of raft-forming GUVs 
composed of 50 % DOPC, 25 % CH and 25 % SM. (Right) TAMRA labelled αIIbβ3 co-localises into the same 
regions as DiD showing that αIIbβ3 also has affinity for the liquid disordered phase in raft-forming GUVs. 
 
This observation in raft-forming GUVs is consistent with previous reports on αIIbβ3 in 
platelets124 and with a recent report by Siegel et al. on polymer-tethered lipid 
bilayers of ternary lipid mixtures where they observed that the integrins; αVβ3 and 
α5β1, also sequestered into Ld (cholesterol poor) domains.146 However, interestingly, 
this paper also found that exposing these integrins to their native ligands; 
vitronectin and fibronectin respectively, led to integrin sequestering to liquid 
ordered (Lo) phase domains or loss of specific sequestering respectively for each 
integrin. Therefore, we were interested to see if molecular activation and fibrinogen 
binding of αIIbβ3 induced similar changes in its domain preference. In an analogous 
experiment to the FLCS experiment described previously, the integrin activators DTT 
and Mn2+ (0.5 mM to 5 mM) were incubated with αIIbβ3 reconstituted into raft-
forming GUVs in the absence of fibrinogen. Confocal fluorescence microscopy 
showed this did not alter the partitioning of αIIbβ3 in the liposomes where the 
integrin remained sequestered in the Ld regions along with DiD. Furthermore, the 
addition of integrin activators DTT and Mn2+ to αIIbβ3 in the presence of fibrinogen 
(0.1 mg/ml) similarly failed to alter its preference for the Ld phase. Therefore, in 
contrast to Siegel et alia. observation of integrins αVβ3 and α5β1, αIIbβ3 does not 
change its affinity for the Ld phase following either activation or ligand binding in a 
model membrane. 
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4. Integrin in SLBs 
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4.1. Introduction 
4.1.1. SLBs 
Due to the complexity of the cell membrane an important research objective has 
been to model this lipid interface in vitro to enable study of the unit functions of the 
membrane and its constituents in a simpler, more controllable system. One of the 
first attempts to create fluidic planar lipid bilayer systems were black lipid 
membranes (BLMs). Developed in the 1960s, BLMs consist of phospholipid 
molecules painted across a small orifice between two solution-filled chambers, 
rather than above a solid supported substrate used in SLBs.148 It was not until the 
1980s that model systems began to resemble the supported lipid bilayers we 
recognise today. In one of the earliest papers, simply entitled “Supported 
Phospholipid Bilayers”, Tamm and McConnell were able to form a laterally diffusing 
lipid bilayer on glass, quartz, and silicon surfaces using a variety of lipids.149 
Supported Lipid Bilayers, or SLBs, are now a commonly used means of mimicking the 
cell membrane. SLBs can be deposited on a range of different substrates including 
glass150, mica151, silicon wafer152 and PDMS153, amongst others. The biggest 
advantage of SLBs over vesicles systems is their mechanical stability. This allows for 
a wide range of experimental techniques to be utilised on the bilayer, such as 
Fluorescence Correlation Spectroscopy153, Fluorescence Recovery After 
Photobleaching30, Atomic Force Microscopy127, Surface Plasmon Resonance154 and 
Ellipsometry155. These techniques range from difficult to impossible in freestanding 
vesicle systems.  
 
SLBs can be formed via a number of methods, perhaps the simplest of which is the 
spontaneous disruption of SUVs or LUVs onto the substrate surface. Such a protocol 
involved the creation of vesicles via extrusion or sonication as normal and the later 
introduction of these vesicles to the surface of a substrate. Vesicles are left in 
contact with the substrate from minutes to hours where they spontaneously disrupt 
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to form lipid bilayers. The bilayer itself is not in direct contact with the underlying 
substrate, but rather separated by an approximate 1 to 2 nm water layer which 
allows for the diffusion of lipid within the bilayer.152 Another method of SLB 
formation utilises the transfer of amphiphilic monolayer films from a water-air 
interface to a solid substrate. This method is known as the Langmuir-Blodgett (LB) 
method and can be used to create monolayers, bilayers or even multilayers of lipid 
(or other amphiphilic molecules).156  Alternatively, the LB method can be used in 
conjunction with the vesicle disruption method to form lipid bilayers whereby the 
first monolayer is formed via the LB transfer of a lipid monolayer and the bilayer is 
completed via the disruption of SUVs/LUVs to form an SLB.157 
 
SLBs have been formed from a wide range of lipid compositions and have been used 
to for a number of in vitro applications. For example, Montero et al. used SLBs to 
study drug interactions with lipid bilayers158, Richter et al. used SLBs to insert 
membrane proteins within159, while Mingeot-Leclercq et al. describe a method to 
study lipid raft formation in an SLB.160 This diverse range of applications for SLBs has 
in turn lead to the need for a wide range of modifications from standard SLB 
formation on planar substrates. One of the driving forces behind this diversification 
is the need for more sophisticated biomimetic models of lipid and protein diffusion, 
which eliminate the restrictions of non-specific substrate interactions. One such 
modification is the use of polymer cushions. Polymer cushions provide a soft and 
deformable layer that separates the lipid bilayer from the underlying substrate. The 
role of the cushion is to allow for diffusion of the bilayer without non-specific 
interaction from the planar surface. This can be particularly important in studying 
membrane proteins as large intracellular (or extracellular) domains of these proteins 
will interact with the underlying substratein turn leading to protein immobilisation 
or even protein denaturation. To date polymer cushions have been produced from a 
number of materials including, but not limited to, polyethyleneglycol161, cellulose31 
and polydopamine.162  
 
Polymer-tethered bilayers have a similar aim to decouple the lipid bilayer from the 
substrate. They utilise linear polymers to link yet separate the bilayer from the 
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surface. Wagner et al. used polyethyleneglycol as a covalent linker between silane 
and lipid that allowed for the diffusion of both the lipid bilayer and the diffusion of 
membrane-reconstituted Annexin V and cytochrome b5, proteins which were found 
to be immobile in the absence of the polymer linker.163 Purrucker et al. developed a 
range of well-defined lipopolymers with a proximal silane coupling group and a 
distal lipid anchor. The intermediate hydrophilic polymer tether length could be 
controlled allowing for determination of the distance between the substrate and the 
bilayer. Using this system they were able to create protein-reconstituted tethered 
bilayers whereby the membrane proteins (integrin IIb3) were freely diffusing.43,44 
 
Supported vesicular systems bridge the gap between SLBs and vesicle systems. For 
example, Yoshina-Ishii and Boxer created a system in which a lipid bilayer is firstly 
created using vesicle disruption. This bilayer contained a short oligonucleotides 
sequence. Subsequently fresh vesicles displaying the antisense oligonucleotide were 
flushed over the bilayer. This lead to specific tethering of the intact vesicles to the 
supported bilayer.164 Similarly Svedhem et al. used cDNA-immobilised on gold to 
spatially direct DNA labelled vesicles to specific locations on the substrate. The now 
immobilised vesicles remained intact on the gold surface and available for 
experimentation.165 
 
Another way in which planar lipid bilayers are dissociated from non-specific 
interactions with the underlying surface is the use of porous substrates where 
surfaces can be patterned with nano- or micro-cavities and a lipid bilayer can be 
formed across the cavity-containing surface whereby some regions of the lipid 
bilayer or in contact with the planar substrate but other regions span the cavities. 
For example, Romer et al. developed a system whereby a lipid bilayer was 
suspended across a porous alumina substrate allowing decoupling of the lipid 
membrane from the otherwise planar surface. They utilised this system for 
electrochemical impedance measurements where they were able to insert 
membrane proteins into the pore-spanning bilayer.166 Kumar et al. explored 
methods to create nanopore-spanning lipid bilayers using vesicle disruption. They 
found that to successfully span bilayers across their nanopore system a number of 
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criteria had to be met including a minimum liposome to pore diameter ratio, high-
curvature pore edges, and a sufficiently strong liposome-substrate adhesion 
energy.167 Urban et al. presented a method whereby they produced a membrane on 
nanopore chip containing tens of thousands of nanocavities. The membrane was 
reconstituted with membrane proteins and was stable across their silicon dioxide 
substrate. Using this system they studied transport events across the lipid bilayer.168 
 
Our novel cavity-spanning bilayer system has a number of advantages of existing 
systems. For example, many porous systems are limited by their nanoscale 
size.167,169 Our PDMS cavities range in size from hundreds of nanometres to 8 m in 
diameter. This pore size opens up the system to a new range of experiments such as 
diffusion measurements via FCS and FLCS, something impossible in nanoscale 
cavities. Furthermore, our cavities are buffer-filled. This is in contrast to the use of 
un-filled pores within the literature, which means the spanning lipid bilayer (and any 
incorporated membrane proteins) are interfaced by an air-filled pocket.170–172 Our 
use of buffer-filled cavities therefore has more biologically relevance, particularly in 
relation to the diffusion of spanning molecules. Both the substrate construction and 
the bilayer construction are also advantageous. For example, while other other 
pore-containing systems utilise more complex and labour intensive preparations173, 
our PDMS cavities are easily produced in bulk. Likewise, while some techniques 
utilise high shear stresses and harsh pHs to form spanning bilayers,174 our method of 
bilayer construction is well suited to membrane protein inclusion. Our novel system 
to decouple the bilayer from the underlying substrate has been developed within 
the group over a number of years. Mallon et al. describes the initial steps in the 
construction of our system whereby polystyrene nanospheres were dropcast onto a 
glass slide before PDMS was cured above to form a closely packed array of voids 
imprinted on the PDMS surface.175 Using this substrate as a base, we were 
successfully able to expand on this knowledge to produced suspended lipid bilayers 
with and without the inclusion of various membrane proteins.  
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Figure 55: Different types of SLB systems within the literature. A) shows a basic SLB where a lipid bilayer is 
formed above a planar substrate. The substrate may be made from glass, mica, quartz, amongst others, while 
the bilayer may be formed via vesicle disruption, LB, LS, or a combination of the above. While easy to form, 
these simple systems often suffer from non-specific interactions between the substrate and the lipid 
membrane. This is particularly relevant when bulky membrane proteins are also included. B) One of the most 
common means of de-coupling the lipid bilayer from the substrate is via the use of polymer cushions. This has 
been widely used to allow for membrane protein mobility. C) With a similar aim, tethered polymer spacers 
have also been used to allow for protein mobility be increasing the distance between the substrate and the 
lipid membrane. D) Bridging the gap between vesicular set-ups and planar bilayers, tethered vesicles grants 
increased stability to liposome systems. E) The use of porous substrates is another method by which the lipid 
bilayer may be decoupled from the substrate. These pores have been formed in a variety of ways and across a 
variety of diameters to allow for the free diffusion of the lipid membrane as well as any reconstituted 
proteins.  
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4.1.2. Protein incorporation into our set-up 
The ultimate goal of our cavity-containing system was to incorporate integrin IIb3 
into the spanning lipid bilayer. Similar goals have previously been achieved in a 
number of different ways. For example, glycophorin A is capable of self-
incorporation into lipid bilayers176, and this may be exploited to insert said protein 
into preformed SLBs in situ.153 In a modification to this method, protein 
incorporation into preformed SLBs may also be promoted by the use of membrane 
weakening detergents. For example, using specific concentrations of the detergent 
-OG, Hussain et al. were able to allow for the partitioning of integrins V3 and 
51 into a bilayer without the destruction of the SLB.35 On the other hand, the 
incorporation of membrane proteins into planar bilayers may also be achieved via 
an intermediate proteoliposomes formation step. In this protocol, membrane 
proteins are reconstituted into lipid vesicles, before these lipid-protein assemblies 
are disrupted on a substrate in order to form an SLB.163 Indeed it is via this scheme 
that the majority of integrin IIb3-reconstituted bilayers have been formed.29–
31,34,43,44,46,154 
 
Given that we had successfully reconstituted integrin IIb3 into vesicles (Chapter 3), 
it would appear natural that this method would be ideal for the formation of a cavity 
spanning, integrin-containing, supported lipid bilayer system. While this IIb3 
reconstitution was eventually achieved, the process was more challenging than first 
thought and so in the meantime and alternative membrane protein was sought as a 
proof of concept for our novel cavity-spanning bilayer system. For this role annexin 
V, also known as annexin A5, was selected. Annexin V was chosen for a number of 
reasons. For example, it is well characterised in the literature, it is widely 
commercial available, and the reconstitution process is relatively straightforward. 
The protein itself is a member of the conserved Annexin multigene protein family. 
Annexins are characterised by their ability to interact with biological membranes in a 
calcium dependent manner.177 They are believed to play a role in exocytosis, 
endocytosis, cell signalling and may also act as ion channels,178 at least in vitro.179 
Like other members of the protein family, Annexin V features a core domain made 
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up of four similar repeats, each approximately 70 amino acids long. This core region 
controls annexin V’s ability to bind membranes that contain negatively charged 
phospholipids in a calcium dependant manner.180 Interestingly, annexin V is also 
capable of functioning as a transmembrane protein. At mildly acidic pH, annexin V 
transitions from its soluble form (in the absence of calcium) or membrane 
associated form (in the presence of calcium) to its transmembrane form where it 
functions as an ion channel.177 It was this characteristic of annexin V to become 
membrane inserted at mildly acidic pHs that could be exploited in our cavity-
spanning system. This insertion process contrasts with protocols required for 
integrin αiibβ3 insertion, where the use of detergents was necessary for 
reconstitution. Owing to this relatively straightforward method of reconstitution, 
Annexin V was an ideal candidate to evaluate protein diffusion within a cavity-
spanning lipid bilayer. 
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4.2. Experimental 
4.2.1. Lipid bilayer formation on a planar 
substrate 
In order to form an SLB via vesicle disruption it was firstly necessary to prepare 
extruded LUVS. To do so, the desired lipid composition in chloroform was 
evaporated under a steady stream of nitrogen in a glass vial. A fluorescent lipid 
probe was usually included for imaging or single molecule techniques. For FRAP 
experiments the labelled lipid made up 0.1 % of the lipid molecules (molar 
percentage), while for point measurement experiments such as FLCS the labelled 
lipid made up 0.001 % of the total lipid molecules (molar percentage). The lipid was 
then placed under vacuum for at least 2 hours to fully ensure solvent removal. To 
rehydrate the lipid film, the buffer of choice (Tris, HEPES, or PBS) was added to the 
glass vial and mixed so that the rehydrated lipid was at a concentration between 1 
and 2 mM. The lipid suspension was left to stand above the highest phase transition 
temperature for at least 45 minutes with occasional vortexing. The lipid solution was 
extruded through an Avanti mini-extruder extruder (Avanti Polar Lipids, Alabaster, 
AL) that was assembled as before. Once the lipid solution was extruded 11 times the 
LUVs could be stored for up to 5 days at 4 °C. The bilayer could be formed on a 
number of substrates such as glass, mica, or PDMS. In all cases the substrate was 
firstly placed in Harrick PDC-002 plasma cleaner at 1000 mT for 5 minutes. The 
substrate was then assembled as part of a temperature control cell (Focht Chamber 
System 2) or “home-made” PDMS cell. The LUVs were diluted to a concentration of 
approximately 0.3 mM and then injected into the now assembled flow cell. The LUVs 
were left in contact with the substrate for at least 30 minutes to allow for the 
spontaneous rupture of the vesicles and thus the formation of a lipid bilayer. In 
order to remove any remaining un-disrupted LUVs or other lipid fragments the flow 
cell was then flushed with buffer leaving behind only the SLB. In order to confirm the 
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formation of the SLB the substrate surface was examined via confocal microscopy 
for fluorescently labelled lipid. 
 
4.2.2. PDMS fabrication 
In order to construct PDMS cavities, mica was freshly cleaved to provide an ultraflat 
surface for later polystyrene sphere deposition. This mica was then carefully glued 
to a glass slide to provide a platform for PDMS pouring. It was important to minimise 
the thickness of the glued mica sheet as the working distance of the microscope 
objective needed to be greater than this thickness for later confocal and FCS 
experiments. If required, the mica, glued to the glass slide, was carefully cleaved 
with sticky tape to further reduce its thickness. Once the mica thickness was judged 
to be sufficiently thin, polystyrene spheres at 0.1 % w/v were pipetted onto the mica 
surface. Our group has used a variety of polystyrene spheres with diameters ranging 
from hundreds of 100 nm to 10 μm in various experiments. However, for simplicity 
this thesis only focuses on PDMS cavities constructed from polystyrene spheres with 
a diameter of 2.88 μm. The volume of the 2.88 μm polystyrene sphere solution, now 
at 0.1 % w/v, varied in accordance with the size of the mica sheet, but 
approximately 150 μl of the sphere solution was used per 1cm2 mica sheet. The 
solution was subsequently allowed to evaporate over a 24-hour period in order to 
yield a mica surface with immobilised polystyrene spheres left behind. In order to 
prepare the PDMS solution, 10 parts PDMS elastomer to 1 part PDMS curing agent 
were mixed (w/w). Approximately 3 g of final solution was required per PDMS cavity 
array. The PDMS was thoroughly mixed and then placed in a vacuum desiccator for 
30 minutes to ensure that all air bubbles were removed. Meanwhile, an aluminium 
foil “boat” was folded around the mica-glass slide platform. The now bubble free 
PDMS solution was then carefully poured into this foil. The array was then placed on 
hotplate which had been preheated to 150 °C and cured over a 15-minute period. 
Once complete the PDMS arrays were removed and left to cool before the 
aluminium foil was peeled from the substrate. Using a scalpel, the PDMS was then 
cut from the glass-mica platform to yield an imprinted PDMS array. The PDMS was 
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then immersed in a THF solution for 10 – 15 minutes in order to dissolve any 
remaining polystyrene spheres. During this time the THF was stirred and the PDMS 
pieces were occasionally removed from the solution to detach any remaining mica. 
Once the time had elapsed the THF was poured off and the PDMS was left in the 
fume hood overnight. During the THF treatment the PDMS swelled and warped but 
returned to its original dimensions a number of hours later. These cavity arrays 
could be kept in a dust free environment for an indefinite period of time. A diagram 
of these PDMS fabrication process is shown below in Figure 56. 
 
 
Figure 56: Construction of PDMS cavity arrays. Construction began with the gluing of a mica spacer to a glass 
slide. This acts as the platform for deposition of the polystyrene spheres. It was important to minimise the 
thickness of the glued mica sheet as this sheet defined the distance between the cavities and the opposing 
cover slip that would later be glued to complete the cell. If the distance was too great, then the objective 
would not have a sufficient enough working distance to image the cavity-spanning bilayer. Next, polystyrene 
spheres were deposited on the mica and allowed to air dry overnight. This diameter of these spheres 
controlled the size of the cavities. PDMS was then poured atop the spheres and allowed to cure at 150 C. The 
cured array was then pealed from the support and placed in THF to dissolved any remaining polystyrene, 
leaving behind the finish PDMS cavity array. 
 
4.2.3. Cavity spanning 
Due to the hydrophobic nature of PDMS, buffer filling of the cavities for lipid bilayer 
spanning required that the substrate be rendered hydrophilic. This was achieved via 
air-plasma treatment of the PDMS array. To do so, the PDMS was placed in a Harrick 
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PDC-002 plasma cleaner at 1000 mT for 5 minutes. Immediately following plasma 
treatment, the PDMS was sonicated for 1 hour in the buffer of choice. This 
combination of plasma treatment and sonication was essential for the majority of 
cavities to be buffer filled.  
 
In order to then create a cavity-spanning lipid bilayer across the buffer-filled cavities, 
a number of different techniques were explored. The first of these was the direct 
disruption of extruded LUVs atop the PDMS surface. It was hoped that the buffer 
filling of the cavities would allow for the formation of a continuous bilayer. This was 
later changed to the disruption of electroformed GUVs via the incubation of these 
giant vesicles in contact with the PDMS surface and in the presence of a buffer 
containing 30 mM CaCl2. Finally, and most successfully, a 2-step protocol that 
combined both Langmuir Blodgett (LB) and vesicle disruption was utilised to create a 
continuous bilayer. 
 
This 2-step protocol was based on the work by Klab et al.157 Firstly, a monolayer of 
the desired lipid composition was formed onto the air-water interface of a NIMA 
120m Langmuir trough by spreading 150 μL of a chloroform solution of the 
appropriate lipids at 50 mg/mL.  For single molecule measurements, DOPE-Atto532, 
DOPE-Atto655 or another appropriate probe was included at a concentration of 
approximately 0.001 mol %. The chloroform was allowed to evaporate for at least 30 
minutes, after which the lipids where compressed at a barrier speed of 30 cm/min 
to a surface pressure of 32-36 mN/m. (Figure 58) Surface pressure was measured 
using a paper Wilhemy plate. Holding the surface pressure constant, the substrate 
was rapidly lowered into the dipping well at a dipper speed of 67 mm/min and 
slowly withdrawn at a dipper speed of 5 mm/min to allow the transfer of a 
monolayer onto the surface. Once the monolayer was formed, two holes where 
punched at the extremities of the PDMS and at this stage the substrate was glued to 
a cover glass slide using epoxy glue to obtain the flow chamber. Teflon tubing was 
attached to the two holes to allow the circulation of solution into the flow chamber.  
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Figure 57: A NIMA 120m Langmuir trough. The trough was filled with buffer and the lipids of choice were 
deposited at the air-water interface. After evaporation of the solvent, the lipid was compressed to 32-36 
mN/m. A buffer-filled cavity-containing PDMS array was dipped into the trough in order to transfer the lipid 
monolayer to the substrate. Two holes where punched at the extremities of the PDMS and at this stage the 
substrate was glued to a cover glass slide using epoxy glue to obtain the flow chamber. Teflon tubing was then 
attached to the PDMS array to allow for buffer circulation.  
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Figure 58: Examples of typical LB isotherms before PDMS dipping and lipid transfer. A) shows an isotherm of a 
pure DOPC while B) shows an isotherm of the nature’s own mixture. The lipids were compressed at a barrier 
speed of 30 cm/min to a surface pressure of 32-36 mN/m for the lipid monolayer transfer process. 
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Figure 59: Completion of the PDMS cell. After production of the PDMS array, sonication was used to fill the 
cavities with buffer. LB was then used to transfer a lipid monolayer to span the buffer-filled cavities. Teflon 
tubing was then attached to the the array to provide a flow-cell set-up. Here, the cell has been flushed with 
dye so that the flow chamber can be better visualised.   
 
To complete the bilayer, the vesicle disruption method was utilised. Extruded LUVs 
of the desired composition were created via extrusion as normal using the required 
buffer. The LUVs were then diluted to a concentration of 0.3 mM before being 
injected into the cell via the Teflon tubings. The LUVs were incubated at room 
temperature for 30 minutes to allow for the vesicles to distrust above the LB 
transferred monolayer. After the elapsed time un-disrupted LUVs and excess lipid 
were flushed from the cell with additional buffer. This protocol yields a lipid bilayer 
that spans the PDMS cavities. 
 
4.2.4. Microscopy of cavities 
Due to the refractive index difference between the PDMS (n ≈ 1.45) and the buffer 
(n ≈ 1.33), as well as the way in which incident laser light scatters at the site of 
cavities, reflectance images could be used to identify cavities. In fact, filled and un-
filled cavities could readily be differentiated due to the degree of scattering where 
buffer-filled cavities were more intense than un-filled cavities in reflectance images. 
Cavities were imaged using a MicroTime 200 fluorescence lifetime microscope 
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system (PicoQuant GmbH, Berlin, Germany). For imaging of reflectance an OD3 filter 
was used to attenuate the signal obtained by the detectors 1000 fold. 
 
4.2.5. Fluorescent imaging of the bilayer 
Enabled by the inclusion of a fluorescently lipid probe, confocal microscopy was 
used to observe the lipid bilayer. This also allowed for confirmation that the lipid 
bilayer spanned the cavities of the PDMS arrays. Confocal images were taken using 
the same MicroTime 200 fluorescence lifetime microscope system. Fluorophores 
were excited with 532 nm PicoTA or 640 nm light from a LDH-P-C-640B diode laser. 
The laser was directed toward a z532/635rpc dichroic mirror and focused on a water 
immersion objective (NA 1.2 UPlanSApo 60 x 1.2 water/ CC1.48, Olympus). The 
sample fluorescence was collected through the same objective and filtered by the 
aforementioned dichroic mirror, as well as by an HQ550lp AHF/Chroma filter 
(Olching, Germany) for the 532 nm laser, or a BLP01-635R-25 Semrock filter (New 
York, USA) for the 640 nm laser. Finally, the sample fluorescence was passed 
through a 50 mm pinhole onto a MPD SPAD detector. 
 
4.2.6. Single molecule experiments 
Diffusion coefficients for labelled integrin or lipid were obtained using Fluorescence 
Lifetime Correlation Spectroscopy, FLCS. The autocorrelation functions obtained 
using FLCS are less prone to noise and distortion caused by scattered excitation light, 
detector thermal noise and detector afterpulsing than conventional FCS.67 FLCS 
measurements were performed using a MicroTime 200 confocal fluorescence 
lifetime microscope system. For FLCS experiments, the fluorophores were excited as 
before and the sample fluorescence was also collected as described for confocal 
microscopy. The autocorrelation functions (ACF) were fit using SymphoTime 
software (PicoQuant GmbH, Berlin, Germany): 
 
𝐺(𝜏) = 1 +  [
1
𝑁
] [
1
1 + (𝜏 𝜏𝐷⁄ )
𝛼
] 
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For simple single component diffusion, or in the case of the presence of a triplet 
state: 
 
𝐺(𝜏) = 1 + [1 − 𝑇 + 𝑇𝑒𝑥𝑝(−𝜏 𝜏𝑇⁄ )] [
1
𝑁(1 − 𝑇)
] [
1
1 + (𝜏 𝜏𝐷⁄ )
𝛼
] 
 
where G(τ) is the autocorrelation function of fluorescence fluctuations; N is the 
number of fluorophores in the effective volume; T is the fraction of the molecules in 
the triplet state; τT is the relaxation time for the singlet–triplet crossing;  is the 
anomalous parameter; and τD is the diffusion time, which is related to the lateral 
diffusion coefficient of the labelled tracer by the expression: 
 
τ𝐷  =  
ω2
4D
 
 
In the latter equation, the radius ω0 is the distance at which the excitation intensity 
profile decreases to e-2 of its maximum value. This parameter was determined 
experimentally, by measuring the translational diffusion of Rhodamine 6G (532 nm 
laser) and Atto655 (640 nm laser) in water at room temperature (approximately 21 
°C).137 These dyes, have well characterized diffusion coefficients and so were used as 
standards to determine the working confocal volume for FLCS measurements. 
Before performing point measurements on bilayers the surface was imaged in the 
XY direction for both fluorescence and reflectance in order to better target MCS or 
FLCS measurements (ie to differentiate between planar and cavity regions of PDMS). 
This allowed for selection of the XY coordinates for upcoming measurements. On 
the other-hand, the Z-position was firstly roughly tuned using the built in CCD 
camera of the microscope. This allowed us to identify the approximate Z-position of 
planar substrates. To fine-tune this position to the lipid bilayer, a Z-scan was then 
quickly performed to locate the point of highest fluorescence intensity due to the 
presence of fluorescently-labelled lipid within the bilayer. Due to drift within the 
system the Z-position was recalibrated between each point measurement.  
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4.2.7. Atomic Force Microscopy 
For AFM characterisation of the PDMS cavity arrays a Digital Instruments Bioscope II 
AFM system was utilised. For imaging, contact mode was used under dry conditions. 
To begin imaging a commercial Si3N4 cantilever tip with spring constants between 
0.04 and 0.08 N/m was inserted into the tip holder, placed into the prongs of the 
Bioscope II head, and the head was then positioned onto the EasyAlign base. The 
laser beam was positioned on the back of the cantilever where a sum signal of 
approximately 5 V was obtained. The exact value of this is dependent on the 
reflective properties of the material and the geometry of the probe. The position of 
the laser spot in the photodetector was adjusted using the adjustment knobs on the 
Bioscope II head where the red dot was centred in the BioScope head filter screen. 
The vertical position was set to -2 V and the horizontal position to 0 V. The PDMS 
cavity sample was placed on the Bioscope stage and clamped in place. The Bioscope 
head was then moved to the Bioscope stage above the sample. The cantilever was 
then lowered toward the sample until the tip was almost in contact with the PDMS. 
Before engagement the scan properties were set to their default values (Deflection 
gain of 0 V, integral gain of 0.5 V, proportional gain of 1, scan angle of 0 degrees, 
scan rate of 1 Hz). Following that the tip was slow engaged to the sample. Channel 1 
was used to monitor height while channel 2 was used to monitor deflection error. 
The scanning parameters of the experiment were optimised if necessary with 
particular attention placed on integral and proportional gain. Once imaging was 
complete the AFM tip was withdrawn and the images saved for analysis. 
 
4.2.8. Annexin V reconstitution 
For annexin V experiments, bilayers composed of 80% DOPC and 20% DOPS (molar 
percentages) were created via a combination of LB and vesicle deposition as used by 
Klab et al.157 Unlike integrin insertion in the literature, annexin V has been 
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membrane-reconstituted without the need for detergent-mediated insertion. The 
protocol we used was based on the technique used by Diaz et al.,181 with some 
modifications. Atto 547N-labelled annexin V (Enzo Life Sciences, Exeter, UK) in an 
insertion buffer of 10 mM sodium acetate, 100 mM NaCl, 1 mM CaCl2, pH 5.5 was 
injected into the flow cell and incubated at room temperature for 1 hour. At this pH 
and under these conditions the annexin V protein should insert itself into the 
bilayer. To remove any unincorporated protein, the cell was extensively flushed with 
a buffer of 10 mM sodium acetate, 100 mM NaCl, 5 mM EDTA, pH 5.5. Finally, the 
cell was injected with a working buffer of 10 mM sodium acetate, 100 mM NaCl, pH 
5.5 before FLCS measurements began. 
 
4.2.9. First integrin reconstitution method 
The initial protocol for the reconstitution of IIb3 in a supported lipid bilayer was 
based on Müller et al.34 Desired lipids were mixed and evaporated in a glass vial 
under a stream of nitrogen. The lipid, was completely solubilised in a HEPES 
reconstitution buffer (10 mM HEPES, 150 mM NaCl, 1 mM CaCl2, 0.1% Triton X-100 
(w/v), pH 7.4) with a final detergent:lipid ratio of 2:1 (w/w). The final lipid 
concentration was normally 1 mM. αIIbβ3 (Enzyme Research Laboratories, Swansea, 
UK) in HEPES reconstitution buffer was then added to the detergent-lipid solution at 
the required concentration, normally 1 integrin molecule for every 8000 lipid 
molecules. The protein-containing solution was shaken at room temperature for 30 
minutes to fully ensure that all lipid has been solubilised and that the solution was 
homogeneous. The solution was then incubated at 37 °C for 1 hour 30 minutes. 
Detergent was removed by the addition of 100 mg of bio-beads per ml of solution 
for 3 hours 30 minutes in a slow shaken vial. The biobeads were then removed and 
replaced by a fresh batch of 100 mg biobeads per ml of solution for 30 minutes 
(slowly shaken). In order to separate non-incorporated protein from the proteo-
liposomes ultracentrifugation across a four-step sucrose gradient was used. From 
bottom to top of the ultracentrifuge tube 0.8 ml of 2 M, 1.2 M, 0.8 M and 0.4 M 
sucrose was used. The proteoliposome solution was then stacked on top of the 0.4 
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mM solution and the tube was carefully loaded into the ultracentrifuge and 
centrifuged for 20 hours at 275,000 g. Following the centrifugation step the protein-
reconstituted vesicles could be visualised as a thin white layer within the tube. 
(Figure 60) The layer was carefully pipetted out of the tube and dialysed against a 
HEPES buffer (10 mM HEPES, 150 mM NaCl, 1 mM CaCl2, pH 7.4) to remove any 
remaining sucrose. The proteoliposomes were stored at 4 °C for up to a week. When 
an integrin-reconstituted bilayer was required the solution was added above the 
substrate, usually in a flow cell, and left to disrupt over a 30 minutes period as was 
the case with protein free vesicles. After flushing the cell with buffer the bilayer 
could be probed as required. 
 
 
Figure 60: Proteoliposomes separated from un-incorporated protein via sucrose gradient ultracentrifugation. 
The proteoliposomes were easily visible as thin white layer within the sucrose solution as shown by the blue 
arrows. 
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4.2.10. Alternative integrin reconstitution 
method 
A novel integrin insertion method was later developed to insert IIb3 into non-
DMPC-containing lipid compositions. The protocol began with the creation of 
integrin-reconstituted proteoliposomes as per the Müller method. Following 
detergent removal via bio-beads the vesicles were loaded into an ultracentrifuge 
tube and centrifuged at 100,000 g for 1 hour. This resulted in the pelleting of the 
protein-reconstituted liposomes. The supernatant was removed and the pellet was 
gently washed in dH2O to eliminate any remaining salts. This pellet was then re-
suspended in dH2O at a lipid concentration of 10 mM. The re-suspended vesicles 
could then be stored at -20 °C for a number of weeks. When required, the solution 
was thawed and 2 μl droplets were placed on the conductive side of an ITO glass 
slide of the Vesicle Prep Pro (VPP). The slides were placed in a vacuum desiccator in 
the presence of a saturated sodium chloride solution resulting in a relative air 
humidity of 73%. The lipid in buffer was left to partially dehydrate for between 2 and 
20 hours. Once complete the electroformation cell of the VPP was assembled as 
before, filled 100 mM sucrose in HEPES buffer, and the electroformation protocol 
was started. In order to successfully create GUVs in a salt buffer the voltage was 
ramped up over 1 hour from 0 to 1.2 V, before being held constant at 1.2 V for 13 
hours. This took place at 500 Hz in comparison to the frequency of between 2 and 
12 Hz normally used for electroformation in a salt free buffer. The voltage was then 
ramped down from 1.2 to 0 V over the final hour while the the frequency was held 
constant at 500 Hz. The electroformation process was carried out at room 
temperature. This process yield GUVs from a wide range of lipid compositions 
reconstituted with IIb3. These GUVs did not readily disrupt above planar 
substrates or lipid monolayers in contrast to smaller SUVs or LUVs. Therefore, to 
initiate vesicle rupture the GUVs had to be incubated in the presence of calcium. To 
do so, GUVs mixed with an equal volume of glucose-containing buffer (eg for GUVs 
in a buffer containing 10 mM HEPES, 150 mM NaCl, 1 mM CaCl2, pH 7.4, 100 mM 
sucrose the solution was mixed with 10 mM HEPES, 150 mM NaCl, 1 mM CaCl2, pH 
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7.4, 100 mM glucose). CaCl2 was then added to the buffer so that the final 
concentration was 30 mM. The solution was then injected into the desired flow cell, 
normally a PDMS cavity array, and the sucrose-containing GUVs were allowed to fall 
to the bottom of the cell. The cell was left at room temperature for 1 hour, which 
allowed for the GUVs to rupture above the substrate. When using PDMS arrays this 
disruption process took place an already created LB monolayer although the same 
process could also be done above a solid planar substrate. 
 
4.2.11. Determination of integrin orientation 
In order to determine the orientation of the reconstituted IIb3 within the bilayer a 
protein-cleaving enzyme was used. Proteinase K is a serine protease that 
predominantly cleaves peptide bonds adjacent to the carboxyl group of aliphatic and 
aromatic amino acids with blocked alpha amino groups. Due to the fact that the 
labelling ratio of IIb3 was 1:1 and this labelling took place in the integrin headpiece 
only properly orientated integrin proteins were physically available to larger 
molecules that were flushed across the bilayer. With a molecular weight of 28 kDa 
proteinase K only had access to the regions of the integrin protein facing away from 
the underlying substrate. Although both downwards and upward facing IIb3 
proteins were likely to be partially digested by the enzyme, only properly orientated 
integrins were likely to lose their fluorescently-labelled portion. Proteinase K was 
injected into the cell containing the already formed integrin reconstitution bilayer at 
a concentration of 0.01 mg/ml and incubated at room temperature for 2 hours. 
Once the digestion was complete the cell was then flushed with buffer to remove 
digested protein fragments. The bilayer was imaged for fluorescence before and 
after the digestion process and the mean fluorescence per pixel was compared. Any 
reduction in fluorescence would be due to cleavage of properly inserted integrin and 
this could be used to determine the percentage of IIb3 proteins that were properly 
or improperly orientated.  
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4.3. Results 
4.3.1. Creating a supported lipid bilayer on 
glass 
Before work began on our novel microcavity arrays, we first looked at forming SLBs 
on planar substrates. Using the vesicle disruption method, it was possible to 
routinely create a homogenous and laterally diffusing lipid bilayer on plasma-
cleaned glass. Initial experiments used DOPC as the primary lipid component with 
fluorescently labelled DOPE used as the probe at a concentration of approximately 
0.001 % (mol/mol). (Figure 61) Later experiments expanded on this composition to 
also include various combinations of DOPE, DOPS, DMPC, DMPG, cholesterol, and 
sphingomyelin, amongst others. We were particularly interested to use the Lentz 
Group’s nature’s own composition in our experiments. While we had previously 
created GUVs using this mixture, it had not been previously utilised to create SLBs. 
As with simple lipid compositions, it was also possible to create nature’s own SLBs 
on plasma-cleaned glass. (Figure 62) 
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Figure 61: A DOPC bilayer created above a plasma-cleaned planar glass substrate. 0.001 % of the lipid was 
made up of DOPE-Atto655 which allowed for fluorescence microscopy to be used to image the lipid bilayer. 
The completed bilayer was continuous and defect free. FCS and FCLS measurements could be subsequently 
carried out on the SLB. 
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Figure 62: A nature’s own bilayer created above a plasma-cleaned planar glass substrate. 0.001 % of the total 
lipid was made up of DOPE-Atto655 which allowed for fluorescence microscopy to be used to image the lipid 
bilayer. As was the case for less complex lipid compositions, the completed nature’s own bilayer was 
continuous and defect free. FCS and FCLS measurements could be subsequently carried out on the SLB. 
 
In order to demonstrate the temperature dependence of lipid diffusion, DOPC SLBs 
were created in a temperature controlled flow cell and FLCS measurements were 
performed at 21, 25, 30 and 37 C. As expected, increasing temperature leads to an 
increase in the lateral diffusion co-efficient of the lipid bilayer. As can be seen in 
Figure 63, increasing temperature leads to a shift in the ACF curve to the left 
indicting the fluorescently-labelled probe spends less time in the confocal volume 
and thus was diffusing faster than the same probe at lower temperatures. The 
diffusion co-efficient of a DOPC SLB on plasma-cleaned glass was found to be 3.72  
0.52 m2/s at 21 C. Increasing the temperature to 25 C resulted in a diffusion co-
efficient of 6.07  0.55 m2/s, while at 30 C the diffusion co-efficient was found to 
be 8.25  0.77 m2/s. Finally, at 37 C, the diffusion co-efficient of a DOPC bilayer 
was found to be 14.25  1.43 m2/s. These diffusion co-efficient are shown in Figure 
64. In all cases the alpha value was determined to be approximately 1, indicating 
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Brownian diffusion. Only when the underlying glass substrate was not plasma-
cleaned was the alpha value found to indicate hindered diffusion (0.6 – 0.9). 
 
 
Figure 63: Two-dimensional fits to the ACF trace of DOPE-Atto655 in a DOPC bilayer on plasma-cleaned glass 
at 21, 25, 30 and 37 C. As expected, increasing temperature leads to an increase in the lateral diffusion co-
efficient of SLBs. This can be seen where the fluorescent molecules spend less time within the focal volume 
and the ACF decays towards zero faster. 
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Figure 64: Diffusion of DOPE-Atto655 in a DOPC SLB on plasma-cleaned glass. Increasing temperature resulted 
in an increase in the determined diffusion co-efficient. Each point is a 60 – 180 seconds FLCS measurement of 
the lipid bilayer fitted to a two-dimensional model. Standard deviation was used to report the error. 
 
As well as temperature, another major influence on the lateral diffusion co-efficient 
of an SLB is the lipid composition. A wide variety of lipid compositions were used in 
SLB experiments but for comparison the diffusion co-efficient of a DOPC bilayer is 
contrasted with a nature’s own lipid bilayer below. Nature’s own contains both 
cholesterol and sphingomyelin leading to a more ordered and rigid lipid bilayer 
when compared with a pure DOPC bilayer. Thus, the diffusion co-efficient of 
nature’s own SLBs would be expected to be lower than DOPC at the same 
temperature. The diffusion co-efficient of a nature’s own SLB on plasma-cleaned 
glass was found to be 2.58  0.65 m2/s at 21 C. Increasing the temperature to 25 
C resulted in a diffusion co-efficient of 3.81  0.54 m2/s, while at 30 C the 
diffusion co-efficient was found to be 6.65  0.73 m2/s. Finally, at 37 C, the 
diffusion co-efficient of a nature’s own bilayer was found to be 12.43  0.90 m2/s. 
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As with the DOPC SLB, the alpha value was consistently found to be 1 as long as the 
plasma cleaning process was properly carried out on the underlying glass substrate. 
Thus, the diffusion of the nature’s own bilayer can also be described as Brownian. 
Nature’s own diffusion co-efficients are shown in Figure 65, while a comparison of 
the diffusion co-efficients of DOPC versus nature’s own SLBs at various temperatures 
are shown in Table 11. 
 
 
Figure 65: Diffusion of DOPE-Atto655 in a nature’s own SLB on plasma-cleaned glass. Increasing temperature 
resulted in an increase in the determined diffusion co-efficient. Due to the inclusion of ordered phase lipids, 
nature’s own was slightly less mobile than a DOPC bilayer. Each point is a 60 – 180 seconds FLCS measurement 
of the lipid bilayer fitted to a two-dimensional model. Standard deviation was used to report the error.  
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Table 11: The lateral diffusion co-efficient of DOPE-Atto655 in DOPC versus nature’s own bilayers on plasma-
cleaned glass at 21, 25, 30 and 37 C. Increasing the experimental temperature lead to an increase in the 
diffusion co-efficient of the lipid bilayer. The nature’s own lipid composition was slightly less mobile than a 
pure DOPC bilayer due to the inclusion of cholesterol and sphingomyelin. Standard deviation was used to 
report the error. 
Temperature (C) DOPC SLB diffusion  
co-efficient (m2/s) 
Nature’s own SLB 
diffusion co-efficient 
(m2/s) 
21 3.72  0.52 2.58  0.65 
25 6.07  0.55 3.81  0.54 
30 8.25  0.77 6.65  0.73 
37 14.25  1.43 12.43  0.90 
 
 
 
4.3.2. Integrin IIb3 in a DMPC-supported 
lipid bilayer 
 
Before moving onto our novel microcavity arrays, we first attempted to construct 
IIb3-reconstituted bilayers on planar glass substrates. This protocol was based on 
Müller et alia. work and therefore used DMPC:DMPG (1:1) as the lipid composition. 
This was in contrast to our ultimate goal of a reconstituting IIb3 into a 
physiologically-relevant composition, but nonetheless served as a useful starting 
point. The IIb3 proteoliposomes were formed as per the Müller method and then 
disrupted above plasma-cleaned glass to yield a DMPC:DMPG SLB. Using DOPE-
Atto532 as a lipid probe at 0.001 % (mol/mol)  it was possible to visualise the bilayer 
as shown in Figure 66. Within this bilayer, Atto655-labelled IIb3 can be seen in 
Figure 67. Due to the high phase transition temperature of DMPC and DMPG, all 
point measurement experiments were carried out at 25 C. It was found that the 
lipid bilayer (DOPE-Atto532) diffused at 4.2  0.51 m2/s, in line with the values 
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reported by Erb and Goennenwein for their DMPC/DMPG bilayers.30,31 However, the 
reconstituted IIb3 was found to be immobile on planar glass surface where 
photobleaching of the Atto655-labelled integrin was observed. This photo-bleaching 
is demonstrated in the MCS trace shown in figure Figure 68. This result is in contrast 
with observations by Erb where reconstituted integrin was found to laterally diffuse 
on a planar quartz substrate30 but in agreement with Goennenwein where integrin 
was found to be immobile above planar glass and quartz substrates. Only when 
Goennenwein utilised a cellulose cushion was integrin found to laterally diffuse. 
Indeed, even when using this cellulose cushion 75 % of integrin proteins remained 
immobile.31  This difficulty with not specific interaction between membrane proteins 
and the underlying substrate is the key problem that we hoped to target in the 
development of our upcoming microcavity arrays.    
 
 
Figure 66: A fluorescence image of an DOPE-Atto532 in an integrin-reconstituted DMPC/DMPG lipid bilayer. 
The bilayer appeared defect free and was identical to a DMPC/DMPG SLB created in the absence of IIb3. Due 
to the high phase transition temperature of DMPC and DMPG (approximately 21 C) the experiment was 
carried out at 25 C. 
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Figure 67: IIb3-Atto655 in DMPC/DMPG SLB created on glass via the disruption of integrin-reconstituted 
vesicles. Integrin was found well distributed throughout the SLB. However, point measurements found that 
the labelled integrin was immobile on the glass substrate as indicated by photobleaching of the lipid probe.   
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Figure 68: MCS trace of atto655 labelled IIb3 in a DMPC/DMPG (1:1) lipid bilayer above planar glass. 
Photobleaching was clearly visible over time indicating that the reconstituted integrin was immobilised on the 
glass surface. This photobleaching of a reconstituted transmembrane protein is a key drawback of membrane-
reconstituted SLB system. It was hoped that our PDMS arrays would eliminate this protein immobilisation.  
 
 
4.3.3. Lipid-spanning of cavities 
After construction of our PDMS microcavities (section 4.2.2) we next sought to 
creating a spanning lipid bilayer across the array. Due to the spherical porous nature 
of the cavities within the PDMS support as well as the significant refractive index 
mismatch between PDMS (n ≈ 1.45) and the buffer (n ≈ 1.33) it was possible to 
visualise the location of the cavities using reflectance imaging. The laser light 
scatters strongly within the buffer-filled cavities with the effect that filled cavities 
appear much brighter than the un-filled cavities or the surrounding planar regions of 
the PDMS support. A close-up image of the cavities suggests that that the aperture 
of the cavities is about 2 m across when constructed from polystyrene spheres 
with a diameter of 2.88 m. (Figure 69)  
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Figure 69: Close up reflectance imaging of the PDMS cavity array following sonication. Due to the scattering of 
the laser light buffer-filled cavities appear much brighter than the surrounding PDMS substrate. Measuring the  
diameter of the cavities using ImageJ suggest that the aperture of the cavities was approximately 2 m when 
constructed from 2.88 m polystyrene spheres.  
 
Unlike experiments that featured completely planar substrates, a continuous bilayer 
could not be formed across the PDMS cavity arrays using the standard vesicle 
disruption method that utilise, for example, sonicated SUVs or extruded LUVs. This is 
because the diameter of the cavity aperture exceeds the diameter of the SUVs or 
LUVs, and so the vesicles enter the cavities rather than span them. To combat this, it 
was instead hoped to form a continuous lipid bilayer across the cavities via the 
disruption of electroformed GUVs. Unlike smaller vesicles, GUVs do not readily 
rupture on planar substrates. In order to promote disruption GUVs were incubated 
in the presence of CaCl2 at 30 mM. This is because calcium increases the rate of 
vesicle fusion and has been shown to promote the tendency of vesicles to form 
SLBs.182 Figure 70 and Figure 71 shows attempts to span cavities using disruption of 
GUVs via the addition of CaCl2. As can be seen from the reflectance and fluorescence 
imaging, the lipid bilayer failed to span the cavities of the PDMS platform. Instead 
characteristic “halos” were observed around non-spanned cavities, while the 
cavities themselves were devoid of fluorescence. Backing up this imaging data, point 
measurements above the cavities showed no fluorescence intensity. This was in 
contrast to MCS point measurements on planar PDMS regions where fluorescence 
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intensity fluctuations over time showed the presence of a freely diffusing lipid 
bilayer.  
 
Figure 70: A reflectance image of a PDMS cavity array created with 2.88 m polystyrene spheres. Filled cavities 
are visible as bright white circles. In order to attempt to form a lipid bilayer above this PDMS array we used 
GUVs as the lipid source. The GUVs were disrupted via the use of calcium, with the hope the the ruptured 
vesicles would span the buffer-filled cavities. 
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Figure 71: A fluorescent image of the DOPC lipid bilayer formed via the disruption of GUVs. DOPE-Atto655 was 
included as a lipid probe for imaging. While the SLB formed on planar regions of the PDMS, no bilayer was 
present above cavities. Instead a characteristic fluorescent “halo” was visible around non-spanning pores 
where the labelled lipids were found at high concentrations.  
 
In order to circumvent the lack of cavity-spanning, an alternative method of bilayer 
formation was investigated. The chosen protocol was a combination of LB and 
vesicle disruption whereby the first monolayer was deposited by the LB and the 
bilayer was completed by the disruption of extruded LUVs Figure 72 shows the lipid 
bilayer across the same PDMS array, this time created via the two-step LB and 
vesicle disruption. In contrast to Figure 71, the lipid bilayer appeared continuous 
across the buffer-filled cavities. However, un-filled cavities did not appear to be 
traversed. To further investigate the continuity of the bilayer MCS point 
measurements were taken above buffer-filled cavities, above un-filled cavities, as 
well as on planar PDMS regions. In agreement with the imaging results, buffer-filled 
cavities and planar PDMS regions displayed fluorescence intensity fluctuations over 
time, indicating the presence of a freely diffusing lipid bilayer. MCS measurements 
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above un-filled cavities did not show any fluorescence intensity fluctuations 
indicating no bilayer was present. As such it was confirmed that buffer filling of our 
cavity system was a requirement for full lipid spanning.  
 
 
Figure 72: A fluorescent image of the DOPC lipid bilayer that was spanned across the PDMS cavity array. 
DOPE-Atto655 was included at 0.001 % for imaging and point measurements. Surface coverage of the bilayer 
is excellent and the bilayer trans-versed the buffer-filled cavities. Only un-filled cavities prevented bilayer 
coverage. 
 
Following the establishment of a protocol that allowed for the formation of a cavity-
spanning lipid bilayer, we were interested to know how the lipid diffusion coefficient 
of planar regions compared with the diffusion co-efficient above cavities. An 
example of the ACF traces and accompanying fits for FLCS measurements above 
planar regions and above cavities is shown in Figure 73. It is immediately evident 
that the lipid bilayer was diffusing faster above cavities (blue) when compared to 
above planar PDMS regions (red). Using a DOPC lipid bilayer it was found that the 
lipid probe DOPE-Atto655 diffused at 3.97  0.36 m2/s above planar PDMS regions. 
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The alpha value was found to be 1. These values are indistinguishable from diffusion 
measurements above plasma-cleaned glass for an identical lipid composition (3.72  
0.52 m2/s, alpha = 1). When diffusion measurements were performed above 2.88 
m cavities it was found that the lateral diffusion co-efficient of a DOPC bilayer was 
11.06  0.52 m2/s. Again the alpha value was determined to be 1. Importantly, 
these diffusion values above microcavities are approximately three-fold higher than 
diffusion values above planar substrates and are in line with our free-standing GUV 
values as described in chapter 3. This high lipid mobility shows that the bilayer has 
been decoupled from underlying substrate. This decoupling of the lipid bilayer from 
our PDMS arrays is the key feature of our platform. We hoped that this decoupling 
of the bilayer could be exploited in upcoming protein reconstitution experiments to 
allow for full protein mobility without the need for polymer cushions or other 
surface modifications.     
 
 
 
 
Figure 73: Representative ACFs of DOPE-Atto655 in a DOPC bilayer diffusing on planar PDMS (red) and above 
cavities (blue). It is apparent that lipid above cavities is much more mobile than lipid above a planar substrate. 
This is because the lipid bilayer has been decoupled from the PDMS and free-standing. As such these diffusion 
values above cavities are line line with GUV diffusion values. 
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In order to investigate the importance of positioning for point measurements, 
additional FLCS experiments took place whereby the cavities were approximately 
divided into different regions and point measurements undertaken. Figure 74 shows 
the areas in which cavities were divided. To perform these point measurements, 
close-up, high resolution images were taken of individual cavities in order to 
accurately position point measurements.  While at the centre of the cavities the 
lateral diffusion co-efficient was in agreement with our previous value for 2.88 m 
cavities, the diffusion co-efficient at “off-centre” regions was found to fall to 9.88  
1.12 m2. When point measurements were performed at “edge” regions where the 
cavities and planar regions converged the diffusion co-efficient was found to be 7.45 
 2.12 m2/s, although the data here appears bimodal, where some values reflect 
planar lipid regions and other values reflect free-standing lipid regions. This data is 
summarised in Figure 75. Using the centre position as the control, a one one-way 
ANOVA was performed to compare diffusion between here and the off centre and 
edge data. This data showed statistical significance, where F(2, 28) = 18.03 , p < 
0.001. A post-hoc Bonferroni test showed that this significance lay between the 
centre control and the edge regions. There was no significant difference between 
the centre control and off centre regions. Despite this statistical analysis we believed 
that failure to properly place point measurements at the centre of the cavities 
meant that a second component from the slower diffusing planar PDMS regions was 
present in the ACF trace and thus the apparent diffusion co-efficient was slower 
than the actual diffusion co-efficient of the lipid bilayer above cavities. This result 
was perhaps surprising given the dimensions of the cavity apertures according to 
reflectance imaging. With an elongated focal volume with a diameter of between 
600 – 700 nm, slight deviations from the centre of the cavity would not be expected 
to influence the measured diffusion co-efficient as the entire focal volume should be 
within the 2.88 m cavities.  
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Figure 74: To examine the influence of point measurement positioning within the cavities and experiment was 
designed whereby the cavities were roughly divided up into different regions, namely “centre”, “off-centre” 
and “edge”. High resolution images were taken of cavities that appeared to be approximately 2 m in 
diameter and point measurements were taken at the aforementioned regions. 
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Figure 75: Diffusion of a DOPE-Atto65 in a DOPC bilayer by position. Each point represents a 60 second 
measurement of the lipid bilayer at a particular location. Slight deviations from the centre of the cavities lead 
to a noticeable drop in the apparent diffusion co-efficient measured via FLCS. While large deviations from the 
centre of the cavities would be expected to alter the diffusion co-efficient, the ease at which this occurred was 
surprising given the width of the confocal volume at its widest point and the apparent dimensions of the 
cavities. Error was reported using standard deviation.  
 
 
Table 12: Summary of diffusion co-efficients obtained by positon. Slight deviations from the centre of cavities 
lead to a considerable fall in the apparent diffusion co-efficient owing to influence from the slower moving 
lipid above planar PDMS regions. This sudden fall off in diffusion co-efficients was unexpected in the “off-
centre” regions given the apparent dimensions of the cavities and the focal volume of the point 
measurements. Error was reported used standard deviation.   
Position Lateral Diffusion Co-efficient (m2/s) 
Centre 11.06  0.52 
Off-centre 9.88  1.12 
Edge 7.45  2.12 
Planar PDMS 3.97  0.36 
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4.3.4. Further characterisation of the PDMS 
arrays 
The apparent reduction in lipid diffusion co-efficients when performing point 
measurements slightly off centre was surprising given the apparent dimensions of 
the microcavities as observed via reflectance imaging (diameter of approximately 2 
m) and the area interrogated by point measurements (diameter of approximately 
600 nm).In order to investigate this result further it was decided to further 
characterise the PDMS surface further using AFM. Due to the fact that AFM is not 
diffraction limited the technique allows for much higher resolution imaging of the 
cavity dimensions when compared to reflectance imaging previously used. Figure 76 
shows AFM images of the PDMS cavity array made with 2.88 m polystyrene 
spheres. In contrast to the reflectance images which suggest a cavity diameter of 
approximately 2 m (Figure 69), AFM imaging shows that the cavities are in fact 
closer to 1 m in diameter. Therefore, it appears that reflectance imaging 
overestimates the size of the cavities, perhaps due the scattering of laser light within 
the cavities and below the cavity aperture. This examination of the PDMS surface 
and cavity size explains why slight deviations from the centre of the cavities lead to a 
reduction in the observed diffusion co-efficient during point measurements as the 
focal volume overlapped with the planar PDMS regions. As such it was noted that 
correct positioning of point measurements was a key requirement in obtaining 
accurate data. 
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Figure 76: AFM of PDMS cavity arrays constructed from 2.88 m polystyrene spheres. According to AFM the 
aperture of the cavities was about 1 m. This was in contrast to the apparent size of the aperture obtained via 
reflectance imaging which was approximately 2 m across. This difference in the apparent size as obtained via 
reflectance imaging and the actual size as obtained via AFM explained why lipid diffusion co-efficients were 
reduced when point measurements were performed slightly off-centre. 
 
 
 
Figure 77: Cavity diameter aperture as determined via AFM versus apparent diameter determined via 
reflectance imaging. AFM was used to shows the actual aperture of the cavities created with 2.88 m 
polystyrene spheres. AFM measurements show that reflectance imaging had been overestimating the size of 
the cavities due to light scattering within the buffer-filled cavities.    
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4.3.5. Insertion of Annexin V into cavity 
supported lipid bilayers 
After a reliable protocol was developed to construct continuous lipid bilayers across 
PDMS cavity arrays it was hoped to expand the complexity of our platform by 
inserting membrane proteins in the system. The first model protein to be 
successfully inserted into the platform was Annexin V. In comparison to other larger 
and more complex membrane residing proteins, Annexin V could be readily and 
easily inserted into a preformed cavity-spanning lipid bilayer. This protein insertion 
process (section 4.2.8) could be achieved without the need for detergent-mediated 
reconstitution, making it a straightforward process. For all Annexin V experiments 
the lipid bilayer was formed as normal using a combination of LB and extruded 
vesicle disruption, although the composition was always a mixture of DOPC (80 %) 
and DOPS (20 %). Figure 78 shows buffer-filled cavities of a PDMS array in which the 
lipid bilayer was formed across. Figure 79 is the accompanying fluorescence image 
of Atto547N labelled Annexin V inserted within the DOPC/DOPS bilayer. Following 
imaging of the cavity array, and in order to assess whether the Annexin V was 
mobile within the bilayer, we then performed FLCS measurements on the system. 
Firstly it was determined that above cavities, the lipid probe DOPE-Atto655 in the 
DOPC/DOPS (8:2) bilayer had a lateral diffusion co-efficient of 10.91  0.72 m2/s, a 
value indistinguishable from a pure DOPC bilayer. In comparison, it was determined 
that Annexin V-Atto547N had a lateral diffusion co-efficient of 7.10  0.80 m2/s in 
the DOPC/DOPS (8:2) bilayer. The alpha value was 1. Switching attention to the 
planar regions of the PDMS array, the DOPE-Atto655 lipid probe was found to 
diffuse at 3.96  0.77 m2/s in the DOPC/DOPS bilayer, again a value 
indistinguishable from a pure DOPC bilayer. The alpha value was 1. Although the 
bilayer was freely diffusing in these planar regions, point measurements of annexin 
V-Atto547N showed that the fluorescently probe was quickly photo-bleached. This 
photobleaching of the probe was due to the immobility of the protein planar PDMS 
regions owing to its bulky nature. An example of this photobleaching is given in the 
MCS trace shown in Figure 81. While of course this protein immobility is not ideal in 
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any protein-reconstituted system, this contrast with the readily mobile cavity data 
shows the power of our cavity-spanning bilayer system.   
 
 
Figure 78: PDMS cavities created using 2.88 m polystyrene spheres. Buffer-filled cavities were clearly visible 
on the PDMS surface. A lipid bilayer was transferred to this array using LB and vesicle rupture before annexin 
V was reconstituted within.   
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Figure 79: Atto547N-labelled annexin V in a DOPC:DOPS (8:2) lipid bilayer formed above the PDMS cavities 
shown in the previous figure. Annexin V appeared to aggregate at the locations of un-filled cavities but was 
also present above buffer-filled cavities on in planar PDMS regions. It was these locations that were probed 
with point measurements.  
 
 
Figure 80: An example of an ACF trace and it accompanying fit for annexin V-Atto547N above cavities when 
reconstituted into a DOPC/DOPS (8:2) lipid bilayer. A single component fit was used to determine that the 
protein had a diffusion co-efficient of  7.10  0.80 m2/s following reconstitution, a value substantially smaller 
than the lipid diffusion co-efficient at the same location.   
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Figure 81: An MCS trace of annexin V-Atto547N on planar PDMS regions when reconstituted into a 
DOPC/DOPS (8:2) lipid bilayer. While annexin V-Atto547N was mobile above cavities, it was completely 
immobile on planar regions of the substrate leading to bleaching of the probe during point measurements. 
This contrasting mobility shows the power of our PDMS cavity arrays. 
 
Table 13: Summary of diffusion co-efficients of components in a DOPC/DOPS (8:2) lipid bilayer reconstituted 
with annexin V. The protein was highly mobile above cavities although the diffusion co-efficient was below 
that found for lipid at the same location. On the other and, while the lipid was mobile on planar PDMS 
regions, annexin V was immobile at these locations where photo-bleaching was evident. Standard deviation 
was used to report the error. 
Component Lateral Diffusion Co-
efficient (m2/s) 
Alpha Value 
DOPC/DOPS bilayer above 
cavities 
10.91  0.72 0.98  0.01 
Annexin V above cavities 7.10  0.80 0.97  0.02 
DOPC/DOPS bilayer on 
planar PDMS 
3.96  0.77 0.98  0.03 
Annexin V on planar PDMS bleaching n/a 
 
 
To the best of our knowledge this is the first time that an annexin protein has been 
reconstituted into a cavity-spanning system such as this one. Previously a number of 
groups have, however, used polymer cushions to decouple annexin V from the 
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underlying substrate. For example, Diaz et al. found that in the absence of PEG 
cushion annexin V diffused at 0.3  0.1 m2/s. Using varying concentrations of PEG 
in a single cushioned set-up they were able to obtain a diffusion co-efficient of 
between 1 and 2 m2/s, while the use of a doubled cushioned set-up allowed for a 
diffusion co-efficient of between 0.4 and 3.5 m2/s. Of particular note was the 
percentage of mobile annexin V throughout their experiments where only between 
20 and 36 % of the protein was mobile in their PEG-containing systems.181 While we 
experienced this lack of annexin mobility on planar regions of PDMS, the freely 
diffusing environment present above buffer-filled cavities meant that no 
photobleaching was detectable in our cavity arrays. This shows the case for cavity 
supported bilayer systems as valuable tools for the biophysical study of membrane 
proteins. 
 
 
4.3.6. Insertion of integrin IIb3 into cavity 
supported lipid bilayers   
Using the protocol developed by Müller et al., we had earlier successfully inserted 
IIb3 into a DMPC/DMPG bilayer on glass (section 4.3.2). In order to expand on this 
work we wanted to insert IIb3 into a more physiologically-relevant compositions 
within our microcavity PDMS arrays. While previously we had observed that IIb3  
was immobile on planar glass, we hoped that these arrays we allow for full 
membrane protein mobility as had been shown in annexin V experiments (section 
4.3.5). Beginning with a pure DOPC system the Müller reconstitution protocol (with 
a different lipid composition) was used to create integrin-reconstituted vesicles. This 
protocol had been used in chapter 3 to produce proteoliposomes that were used to 
construct GUVs. However, here these proteoliposomes were disrupted above an 
already created lipid monolayer that had been transferred via LB. As such the bilayer 
creation process was similar to our previous 2-step cavity-spanning bilayer protocol, 
albeit utilising integrin-reconstituted vesicles rather than protein-free LUVs. Initial 
fluorescent imaging of the IIb3-containing bilayer was promising. Figure 83 shows 
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Atto655 labelled IIb3 within a DOPC bilayer that was spanned across cavities made 
using 2.88 m polystyrene beads. (Figure 82) As can be seen the labelled IIb3 
protein is well distributed throughout the lipid bilayer and appears to be membrane 
inserted. Figure 84 shows an ACF trace and it’s fit of IIb3-Atto655 in DOPC bilayer 
above cavities. While at first this protein mobility appeared to show that IIb3 had 
been successfully reconstituted within the bilayer, analysis of the ACF traces showed 
that IIb3-Atto655 was diffusing much faster than would be expected for our 
system. While DOPC had already been characterised to having a lateral diffusion co-
efficient of 11.06  0.52 m2/s above cavities, values for integrin showed that the 
protein was diffusing at between 16 and 30 m2/s. Likewise in planar regions where 
DOPC was known to diffuse at 3.97  0.36 m2/s, IIb3-Atto655 was found it diffuse 
much faster than the lipid with a diffusion co-efficient in excess of 8 m2/s. In 
further contrast to this value, IIb3 in DMPC above glass was previously found to be 
immobile. These diffusion values for the IIb3 protein which were consistently well 
above the reported lipid values suggested that the protein was not fully 
reconstituted into the lipid bilayer. Instead, it was believed, that the labelled IIb3 
was loosely attached to the bilayer and was membrane-associated rather than 
membrane-inserted.  
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Figure 82: Reflectance image of PDMS array used for lipid-spanning and integrin reconstitution experiment. 
Buffer-filled cavities were visible in white due to the scattering of light within the cavities. Un-filled cavities 
and planar regions did not scatter light and there was no refractive index mismatch, and as such, these regions 
were black. 
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Figure 83: Fluorescence image of atto655-labelled IIb3 reconstituted into a cavity-spanning DOPC bilayer. 
IIb3 was well distributed throughout the bilayer and present above the buffer-filled cavities. Fluorescent 
“halos” were evident around un-filled cavities where no lipid bilayer spanned the cavities. 
 
Figure 84: A representative ACF of integrin super-diffusion above buffer-filled cavities. Atto655 labelled IIb3 
was found to diffuse at between 16 and 30 m2/s, values way above the lipid diffusion co-efficient at the 
same location. This data suggests that the integrin protein was not fully inserted into the lipid bilayer. 
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Table 14: Summary of diffusion co-efficients in a DOPC lipid bilayer reconstituted with IIb3 using the Müller 
et al. method. The reconstituted IIb3 protein was found to have a diffusion co-efficient well in excess of the 
surrounding lipid phase indicating that protein was not properly inserted into the bilayer in our SLB system. 
This is in contrast to our GUV results were IIb3 was found to diffuse much slower than the lipid membrane. 
Standard deviation was used to report the error. 
Component Lateral Diffusion Co-efficient (m2/s) 
DOPC above cavities 11.06  0.52 
IIb3 above cavities 16 – 30 
DOPC on planar PDMS 3.97  0.36 
IIb3 on planar PDMS > 8 
 
 
This rate of integrin diffusion was perhaps in agreement with observations by a 
number of other groups which stated that DMPC-based lipid compositions were a 
requirement for proper IIb3 insertion into the membrane. For example, Müller 
reported “partial” insertion of IIb3 into POPC/POPS vesicles and stated that co-
location of lipid and integrin was not a reliable measure of correct incorporation, but 
instead a sign that αIIbβ3 had a tendency to strongly adhere to the lipid, an 
association that could not be removed by sucrose gradient centrifugation.34  Later, 
Erb et al. stated that integrin reconstitution was performed using lipid/lipid mixtures 
of “POPC, POPC/POPS (molar ratio 75:25), POPC/POPG (molar ratio 50:50), PC/PE 
(molar ratio 70:30), which did in neither case result in a good integrin 
reconstitution” while DMPC and an equimolar mixture of DMPG/DMPC did result in 
good integrin reconstitution.29 In agreement with this, the vast majority of paper 
that feature IIb3 reconstitution utilise a DMPC-based mixture.29–31,34,43–45 Many of 
these also perform diffusion-based measurements on the reconstituted IIb3. 
Perhaps somewhat tellingly, of the limited number of papers on IIb3 reconstitution 
into non-DMPC-based mixtures,42,46,47 none perform diffusion-based measurements. 
Given the apparent difficulties with proper IIb3 reconstitution in non-DMPC-
containing compositions it is therefore unclear whether the integrin protein is 
membrane-inserted or merely membrane-associated in these cases. 
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However, this requirement for DMPC-based compositions is in contrast to our 
earlier GUV results where reconstituted IIb3 was found to diffuse well below the 
lipid diffusion co-efficient in a range of DMPC-free compositions (3.3.5). While the 
reconstitution process in our GUV-based experiments shares a lot of similarities with 
the reconstitution process in our cavity-spanning experiments, the two protocols 
diverge after the formation of proteoliposomes precursors. In SLB-based 
experiments these proteoliposomes were directly disrupted above LB monolayer to 
form bilayers (section 4.2.9), while in GUV-based experiments these 
proteoliposomes were converted to giant vesicles (section 3.2.7). This conversion 
process involved the ultracentrifugation of the proteoliposomes to a lipid-protein 
pellet, and later electroformation of this pellet to form GUVs. We speculated that 
this two step ultracentrifugation and electroformation step somehow facilitated 
correct IIb3 insertion. We therefore proposed a new method of bilayer formation 
(section 4.2.10) that used these IIb3-reconstituted GUVs to complete the bilayer 
after LB monolayer transfer, rather than the use of smaller proteoliposomes. A 
schematic for the new insertion method is shown in Figure 85.   
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Figure 85: A schematic of the insertion protocol for GUVs and SLBs as well as the proposed new method of 
integrin reconstitution into an SLB (red). In all cases the initial protocol is the same whereby the protein is 
inserted into vesicles via the use of detergents to create proteoliposomes. These vesicles can then be used as 
the lipid course for electroformation (left), or as the lipid source for bilayer formation (right). Given the fact 
that direct disruption of the proteoliposomes to create an SLB did not result in integrin incorporation it was 
proposed that the successfully reconstituted GUVs be used as the lipid source for SLBs instead. 
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4.3.7. Alternative insertion method 
As described above, we had proposed a new method of IIb3 insertion into our 
PDMS cavity arrays based on the success we had achieved in our GUV-based 
experiments (Chapter 3). As before, a cavity-spanning lipid monolayer was 
transferred to the PDMS array using LB. Parallel to this, IIb3-containing integrin-
containing GUVs were also constructed from proteoliposomes precursors, as 
described in section 4.2.10. The GUVs were then flushed across the monolayer-
containing PDMS array in a buffer containing 30 mM CaCl2 in order to promote 
disruption of the giant vesicles. GUVs were incubated for 1 hour to allow for bilayer 
formation which yielded a continuous lipid bilayer with a well-distributed protein 
presence. In order to determine whether the protein was membrane inserted point 
measurements were required. Probing the cavities with FLCS measurements for 
IIb3-Atto655 showed that IIb3 was indeed mobile within the bilayer as expected 
(Figure 86). Fitting these traces yielded a diffusion co-efficient of 3.20  0.33 m2/s 
for IIb3-Atto655 in a DOPC bilayer above cavities. This figure is well below the 
values for IIb3 diffusion in an bilayer created from direct disruption of 
proteoliposomes. There IIb3 diffusion co-efficients were well in excess of the 
surrounding lipid values (4.3.6). Here, above cavities, the alpha value was found to 
be 1, showing the diffusion of IIb3 was unhindered. FLCS measurements were also 
performed for IIb3-Atto655 above planar PDMS regions. In contrast to the high 
diffusion co-efficients in SLBs created via direct proteoliposomes disruption, IIb3 
was found to be immobile on planar PDMS regions. This can be seen in MCS 
measurements where IIb3-Atto655 photo-bleaching was immediately evident 
(Figure 87). This result is in line with what would be expected of a large, membrane 
traversing, reconstituted protein. Therefore this result appears to confirm the 
insertion status of IIb3 in an SLB model system via GUV disruption. This 
immobilisation of the integrin protein is also in agreement with our earlier annexin V 
work where the annexin protein was highly mobile above buffer-filled cavities, yet 
immobile above planar PDMS regions (4.3.5). Again this contrast between locations 
highlights the power of our PDMS cavity-spanning bilayer system, when compared 
to standard SLB set-ups.  
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Table 15: Summary of diffusion co-efficients in a DOPC lipid bilayer reconstituted with IIb3 using the GUV 
intermediate method. In contrast to the high diffusion values witnessed using the original integrin insertion 
method, this new reconstitution method delivered IIb3 diffusion co-efficient well below the lipid diffusion 
co-efficient above cavities. On planar regions the integrin protein was immobile where bleaching was evident. 
Standard deviation was used to report the error. 
Component Lateral Diffusion Co-
efficient (m2/s) 
Alpha Value 
DOPC above cavities 11.06  0.52 1.01  0.02  
IIb3 above cavities 3.20  0.33 0.99  0.02 
DOPC on planar PDMS 3.97  0.36 0.98  0.02 
IIb3 on planar PDMS immobile n/a 
 
 
   
 
Figure 86: Representative ACF for atto655 labelled IIb3 inserted into a cavity-spanning lipid bilayer using 
integrin-containing GUVs as an intermediate. In contrast to the extremely high diffusion co-efficients 
witnessed using the original integrin reconstitution method, using GUVs as an intermediate resulted in a 
diffusion co-efficient of 3.20  0.33 m2/s above cavities. This value is well below the diffusion co-efficient of 
the surrounding lipid bilayer. 
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Figure 87: A representative MCS trace of atto655 labelled IIb3 on planar PDMS. Photobleaching of the probe 
is clearly evident over time showing that the labelled integrin is immobile above the substrate. This is in 
contrast to the original integrin reconstitution method where IIb3 diffused faster than the lipid bilayer at the 
same position due to loose association with SLB. Such protein immobility on planar regions appears to confirm 
that the use of GUVs as an intermediate lead to the proper reconstitution of the integrin protein. 
 
Having successfully inserted IIb3 into a non-DMPC-containing composition in the 
form of DOPC it was decided to expand the scope of the experiments by using a 
more complex and biomimetic lipid composition. Having previously successfully 
inserted IIb3 into GUVs composed of the nature’s own composition it was seen as 
the natural progression to use nature’s own in our PDMS cavity arrays. The use of a 
biometic composition in combination with IIb3 reconstitution emphasises the 
power of the PDMS cavity arrays in developing a powerful cell membrane mimic. As 
before, integrin-containing GUVs were formed from detergent-reconstituted 
proteoliposomes and disrupted to complete a lipid bilayer. The surface was then 
imaged and later probed via point measurements in order to determine diffusion co-
efficients. FLCS showed that IIb3-Atto655 diffused at 2.80 ± 0.59 m2/s above 
cavities, with an alpha value of 1. This integrin diffusion co-efficient was slightly 
below the value for a pure DOPC bilayer. This was to be expected given the presence 
of liquid ordered phase lipids in cholesterol and sphingomyelin within the nature’s 
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own composition. For example, previously the nature’s own bilayer itself was shown 
to diffuse slightly slower than a pure DOPC bilayer on planar glass across a range of 
temperatures (Figure 64 and Figure 65). Positioning point measurements above 
planar PDMS regions, again it was found that the labelled integrin protein was 
readily photobleached. This shows that IIb3 was immobile above planar PDMS 
regardless of lipid composition. This was to be expected given the bulky nature of 
bilayer-spanning lipid membrane proteins, such as integrin IIb3, above a planar 
substrate, and mirrors our earlier results for annexin V, where it too was immobile 
above PDMS. Once again this contrast between the high mobility of proteins above 
buffer-filled cavities and the immobility of proteins above planar regions shows the 
power of our novel PDMS array set-up. 
 
Table 16: A summary of diffusion co-efficients in a Nature’s own lipid bilayer reconstituted with IIb3 using 
the GUV intermediate method. As with a pure DOPC bilayer the IIb3 diffused much slower than the lipid 
value above cavities. Likewise the IIb3 was immobile above planar PDMS. Of particular note is that the 
integrin protein diffused slower in this composition than in a pure DOPC bilayer. Standard deviation was used 
to report the error. 
Component Lateral Diffusion Co-
efficient (m2/s) 
Alpha Value 
Nature’s own above 
cavities 
9.12  0.67 0.99  0.02 
IIb3 above cavities 2.80  0.59 0.97  0.02 
Nature’s own on planar 
PDMS 
2.98  0.32 1.00  0.03 
IIb3 on planar PDMS immobile n/a 
 
4.3.8. Integrin orientation in the bilayer 
In order to determine the orientation of IIb3 in the lipid bilayer proteinase K was 
flushed into the PDMS cell at 0.01 mg/ml and incubated at room temperature for 2 
hours. During this time the enzyme could digest any exposed regions of the integrin 
protein it had access to. Given that IIb3 was only labelled once per protein and this 
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was located on the extracellular head region, the probe could only be removed from 
integrin molecules that were “correctly” orientated with their extracellular domain 
pointed away from the PDMS substrate surface. Previously, a similar set-up had 
shown that, in GUVs, the ratio between outwards and inwardly orientated IIb3 was 
1:1, meaning the insertion process was completely random. We were keen to see 
whether this ratio was maintained during the SLB formation step, or whether the 
process changed the orientation of the integrin proteins. Experimentally, the 
nature’s own bilayer was imaged for IIb3-Atto655 fluorescence and the mean pixel 
intensity was determined for the 80 x 80 m image. Across 5 different locations the 
mean pixel intensity of the integrin-reconstituted bilayer was 56.25  9.99 counts 
per pixel. Following proteinase K incubation and subsequent removal via a buffer 
flush the mean pixel intensity had been reduced to 23.50  4.24 counts per pixel 
based on the imaging of 5 new locations. (Figure 89) A two-tailed unpaired t-test 
was performed where the difference between the two data sets was found to be 
significant, t(14) = 8.53, p < 0.001. As the average average count per pixel fell to 
approximately 40 % of its original value. This suggets that approximately 60 % of the 
integrin proteins were available for digestion at their fluorescently labelled 
terminus. As such, it can be said that the SLB system slightly favoured “correctly” 
orientated IIb3, ie integrin molecules with their extracellular domain pointing away 
from the PDMS substrate.   
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Figure 88: Atto655 labelled IIb3 in a nature’s own bilayer before (left) and after (right) proteinase K addition. 
Following 2 hours of proteinase K incubation, the cell was flushed with buffer to leave behind a bilayer where 
many of the extracellular integrin domains have been digested by the enzyme. Only labelled integrin 
molecules with their headpiece orientated towards the PDMS remained. (n=8) 
 
Figure 89: Average count per pixel before (left) and after (right) proteinase K incubation. Following incubation 
and buffer flushing the average count per pixel was fell to approximately 40 % of its original value, indicating 
that the system slightly favoured “correctly” orientated integrin, with their extracellular domain pointed 
outwards. A two-tailed unpaired t-test was performed where the difference between the two data sets was 
found to be significant, t(14) = 8.53, p < 0.001. 
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4.3.9. Addition of integrin ligands 
In complimentary experiments to the addition of integrin ligands to GUVs, we 
examined how integrin activation and ligand-binding influenced IIb3 behaviour 
within the cavity-spanning bilayer. As with the GUV experiments, DTT and Mn2+ 
were used as integrin activators.  DTT or Mn2+ in buffer were injected into the PDMS 
cell at concentrations ranging from 500 nM to 5 mM and the cell was incubated at 
room temperature for 1 hour. Point measurements were then performed at the 
bilayer above cavities and the ACFs compared to an un-activated control. Where no 
integrin activators were present, the lateral diffusion co-efficient of IIb3-Atto655 
was found to be 2.80  0.59 m2/s. Upon addition of 5 mM DTT and 5 mM Mn2+, the 
lateral diffusion co-efficient of IIb3-Atto655 was found to be 2.76  0.44 m2/s and 
2.95  0.46 m2/s respectively. A one-way ANOVA with post-hoc Bonferroni test 
between the three data sets showed no statistically significant difference between 
the activation states of the integrin protein, where F(2, 98) = 3.07, p > 0.05. 
Therefore, consistent with the results observed for GUVs, (section 3.3.6) structural 
changes induced by integrin activators alone were not sufficient to alter the mobility 
of IIb3 above cavities where the diffusion co-efficient remained unchanged. (Table 
17) 
 
Table 17: The influence of integrin activators alone on the diffusion co-efficient of IIb3 above cavities in a 
nature’s own bilayer. No change in the mobility of the integrin protein was recorded as confirmed via ANOVA 
analysis. This was to be expected given our results in GUVs. Standard deviation was used to display the error.  
Activator Lateral Diffusion Co-
efficient (m2/s) 
Alpha value 
No activator 2.80  0.59 1.00  0.01 
5 mM DTT 2.76  0.44 0.99  0.02 
5 mM Mn2+ 2.95  0.46 0.98  0.02 
 
The unchanged lateral diffusion co-efficient for activated IIb3 was expected given 
our results when working with IIb3 in GUVs, where conformational changes alone 
that were brought about by DTT and Mn2+ were not sufficient to bring about a 
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measurable change in the lateral mobility of of IIb3. On the other-hand, the co-
inclusion of fibrinogen with activated IIb3 did bring about a change in the lateral 
mobility of IIb3 in our integrin-reconstituted GUV system. Thus, it would be 
expected that the application of fibrinogen would also reduce the mobility of pre-
activated IIb3 in our cavity supported bilayer system. To explore this integrin-
containing bilayer was formed above a PDMS array as before and the cell was 
flushed with DTT or Mn2+ (500 nM to 5 mM) as well as fibrinogen (at 0.1 mg/ml) and 
the system was left to equilibrate for 1 hour at room temperature. Following the 
incubation period, the integrin-containing bilayer was probed with point 
measurements above the location of the cavities. Surprisingly, fitting of the ACF 
traces did not show any change in the lateral diffusion co-efficient of IIb3-atto655 
where the protein did not appear to alter its rate of diffusion, remaining near the 
2.80 m2/s value recorded with the un-activated, unliganded form of IIb3. (Table 
18) A one-way ANOVA with post-hoc  Bonferroni test confirmed this to be non-
significant, where F(2, 114), p > 0.05. The alpha value also remained at 1, consistent 
with unhindered diffusion.  
 
This was in contrast to our GUV system where fibrinogen binding resulted in 
anomalous sub-diffusion represented by a reduction in the recorded alpha value. 
Another characteristic of integrin-fibrinogen binding in our GUV system was the 
movement of large integrin clusters through the focal volume in large fluorescent 
bursts as visible in the MCS trace. Therefore, the MCS trace was examined for similar 
traits in our cavity supported lipid bilayer system. Figure 90 shows a representative 
MCS trace before and after DTT-mediated activation of IIb3 in the presence of 
fibrinogen. In contrast to our GUV-based results (Figure 53) but in agreement with 
the unchanged diffusion and alpha values in our cavity supported lipid bilayer 
system, the MCS trace appeared unaffected when its characteristics were compared 
before and after integrin activation in the presence of fibrinogen. As displayed in the 
MCS trace, the atto655-labelled IIb3 proteins transitioned through the focal 
volume at regular intervals throughout the length of the point measurement under 
all conditions.  No major changed in the number of fluorescent molecules present in 
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the focal volume during measurements was obvious (N). Taken together these three 
unchanged variables (diffusion co-efficient, alpha value, and MCS trace) suggest that 
the integrin IIb3 proteins present above cavities were not fibrinogen bound and/or 
aggregated above cavities, in contrast to the free standing GUV system (section 
3.3.6).  
 
Table 18: The influence of integrin activators in the presence of the integrin ligand fibrinogen. No change in 
the mobility of the integrin protein was detected. This was shown via one-way ANOVA analysis. This was 
unexpected given our results in GUVs where the use of an integrin activator in the presence of fibrinogen lead 
to measureable reduction in the mobility of IIb3. Standard deviation was used to display the error. 
Activator Lateral Diffusion 
Co-efficient (m2/s) 
Alpha value N value 
No activator 2.80  0.59 1.00  0.01 1.58  0.41 
5 mM DTT + 
fibrinogen 
2.85  0.71 1.01  0.03 1.77  0.56 
5 mM Mn2++ 
fibrinogen 
2.69  0.33 0.99  0.02 1.49  0.62 
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Figure 90: MCS trace before (blue) and after (red) ligand addition. No major changes in the characteristics of 
the time-trace were evident. This is in contrast to the findings in our GUV studies before and after fibrinogen 
addition where large fluorescently labelled aggregates were found to diffuse through the focal volume. 
 
The absence of fibrinogen binding to DTT and Mn2+ activated IIb3 above buffer-
filled cavities was surprising given the earlier GUV-based results. This suggests that 
here the IIb3 proteins had an altered affinity for their ligands when compared to 
GUV-reconstituted IIb3. Therefore, in order to gain more insight, confocal 
microscopy was also carried out on the system. Interestingly, it was noted that after 
the addition of fibrinogen to DTT or Mn2+ activated IIb3, integrin aggregation 
began to become evident on planar PDMS regions over time. Also of note was the 
fact that neither the use of activators nor fibrinogen caused integrin aggregation 
over the time course of an experiment (up to 8 hours). Figure 91 shows the PDMS 
array over which a  nature’s own SLB was formed, as well as the spanning nature’s 
own SLB. Before the addition of activators or ligands the atto655-labelled IIb3 was 
homogenously distributed within the bilayer. Figure 92 shows atto655-labelled IIb3 
after DTT-mediated activation and incubation with fibrinogen, as well as the labelled 
fibrinogen itself. After addition of DTT and incubation with fibrinogen, large integrin 
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clusters became visible. Importantly these aggregates were co-localised with 
fluorescently-labelled fibrinogen clusters. This shows that the large scale integrin 
aggregation was mediated by fibrinogen. Importantly, this aggregation was only 
witnessed when both an activator (DTT or Mn2+) and fibrinogen were co-incubated 
together above the IIb3-reconstituted bilayer. The ability of an activator and 
fibrinogen to bring about integrin clustering was surprising given that earlier 
experiments had shown that IIb3  was immobile on planar PDMS regions. This was 
shown in MCS traces where fluorescently labelled integrin readily photobleached 
during point measurements. The reason for this ability of  IIb3  to form aggregates 
is therefore unclear but we speculate that the slow moving (below the limits of 
FLCS) integrin protein at the planar PDMS surface is preferentially aggregating and 
binding to fibrinogen. Such slow diffusing labelled IIb3  would be susceptible to 
photobleaching due to the length of time they remain in the focal volume during 
point measurement, and therefore give the impression of complete immobility. 
Therefore, it is only over the length scales of these confocal images that the mobility 
of IIb3 becomes apparent. Another aspect of the results that is not immediately 
obvious is why the ability of IIb3 to bind fibrinogen and aggregate in GUVs and on 
planar regions of PDMS is not replicated above buffer-filled cavities. Again we can 
only speculate why this is the case. For example, perhaps the IIb3  located on 
planar PDMS regions has more affinity for its ligand, fibrinogen. This could be due its 
slower diffusive properties when compared with the highly mobile IIb3 found 
above cavities. Or perhaps it can be speculated that the planar substrate has a direct 
influence on the structure and conformation of the integrin IIb3 protein increasing 
its affinity for fibrinogen binding.  
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Figure 91: Left) Reflectance image of a PDMS cavity array. The majority of cavities are buffer-filled and appear 
as a bright white circle due to light scatter. Right) An integrin-containing nature’s own lipid bilayer was 
constructed across the the PDMS array. IIb3  was labelled with atto655 to allow for imaging of the bilayer. 
The reconstituted integrin protein was well-distributed throughout the bilayer with no defects visible. Un-
filled on non spanned cavities were highlighted by a fluorescent halo. 
 
Figure 92: Left) Atto655-labelled IIb3  after DTT activation and fibrinogen incubation. Activation and ligand 
addition lead to large integrin aggregates to form on planar regions of the PDMS. Right) The use of atto655-
labelled fibrinogen showed that fibrinogen appeared to cluster in the same location as integrin aggregates. 
This shows that fibrinogen was mediating the aggregation process.  
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Overall the creation and use of our PDMS cavity supported lipid bilayer system has 
provided a novel method of decoupling both the lipid bilayer, and more importantly, 
membrane-reconstituted proteins from the underlying substrate. Importantly, our 
PDMS cavity arrays are cost effective, simple to fabricate, and easy to produce on a 
large scale. The use of such arrays also avoids the use of extensive surface31 or lipid 
modifications183 used be other groups.  
 
The substrates themselves were stable for an indefinite period of time and the 
cavity-spanning bilayers were capable of producing reliable diffusion data for up to 5 
days after spanning. The PDMS arrays were also extremely well suited to single 
particle measurements such FCS and FLCS-based experiments owing to the large 
cavity diameter. Many existing cavity systems utilise nanometer scale pores where 
such diffusional measurements would not be possible.167,169  The use of such single 
molecule techniques to obtain diffusion data is also relatively unique within the 
existing SLB models. For, example the majority of the literature has utilised FRAP to 
obtain diffusional characteristics of fluorescently labelled molecules within planar 
systems and these have been characterised by large scale protein immobility even 
where polymers cushions or tethers have been included.29–31,34,43,44,163,181,183–186  
 
As such FCS and FLCS measurements of membrane proteins have generally been the 
preserve of free-standing GUV-based systems. Here we have been able to provide 
GUV-comparable diffusion co-efficients in conjunction with 100 % protein 
mobility36,41,142,144, with the spatial stability of an SLB system. This meant that point 
measurements could easily be carried out at carefully defined locations. In 
comparison, point measurements in GUVs may be particularly difficult and time 
consuming due to the mobility of the vesicles within the buffer, where even slight 
fluctuations of GUV membranes within the focal volume may render FCS data 
useless.  
 
Another major advantage of our PDMS arrays is the fact that the set-up is chip-
based, with an inlet and outlet available for buffer flow. Therefore, different 
proteins, drugs, buffers, etc. can be brought in contact with the bilayer for a defined 
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period of time before being flushed from the cell. For example, this was exploited 
during the annexin V insertion protocol (section 4.2.8) whereby the protein was 
membrane-reconstituted using a calcium-containing insertion buffer before being 
flushed with an EDTA-containing buffer to remove non-incorporated protein.  
 
Another feature of our cavity arrays is the fact that the buffer-filled cavities provide 
access to both side of the lipid bilayer and this both the intracellular and 
extracellular domains of any membrane-reconstituted proteins. It is hoped to take 
advantage of this feature in future experiments. For example, through the 
controlled release of integrin interacting cytoplasmic proteins such as talin to the 
tails of membrane-reconstituted IIb3, in conjunction with extracellular ligands such 
as fibrinogen, fibronectin, vitronectin, etc. It is also clear from the fibrinogen binding 
studies that the cavity top surface is not innocent in these studies, this may be an 
exploitable feature depending on the process under study but for integrins, reducing 
the relative amount of area of top surface may be a useful way to reduce its 
influence. 
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5. Cytoskeletal Mimics  
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5.1. Introduction 
Much of this thesis has been devoted to modelling the complexity of the cell 
membrane in a physiological manner. Starting with αIIbβ3 in the platelet membrane 
(chapter 2), we transferred this knowledge to liposome-based mimics of the cell 
membrane (chapter 3). There we expanded upon the existing literature in the search 
for physiologically-relevant lipid compositions in our GUV model, and studied the 
functional ability of αIIbβ3 within this system. This knowledge was later transferred to 
our novel PDMS arrays (chapter 4) where we were able to convert our 
physiologically-relevant, αIIbβ3-containing GUVs to a αIIbβ3-reconstituted planar 
bilayer that spanned the buffer-filled microcavities. This planar system combined 
the main advantages of vesicle-based systems (free-standing, no lipid-substrate or 
protein-substrate interaction) with the main advantages of planar SLBs (increased 
stability, flow-cell setup) to create a biologically-relevant mimic of the cell 
membrane. Here, in the quest to increase the physiological relevance even further, 
we explored the inclusion of cytoskeletal structures in SLB models. Such cytoskeletal 
structures have an important role in the localisation and clustering of 
transmembrane proteins, the formation and deformation of lipid domains as well as 
the rate of protein diffusion. As these subjects were of particular interest to us in 
previous chapters the inclusion of such cytoskeletal proteins within an artificial lipid 
platform was the natural progression. For example, it was hoped that the use of 
cytoskeletal fibres below and in contact with a spanning lipid bilayer would provide 
a physiologically-relevant environment for lipid and transmembrane protein 
diffusion and interaction and thus alter the diffusion of the bilayer to more 
accurately mimic the cell membrane. This use of a cytoskeletal cushion is in contrast 
to existing work within the literature where lipid bilayers tend to be in contact with 
buffers (eg GUVs or PEG cushions) or solid substrates (eg SLB above glass or mica).     
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5.1.1. The cytoskeleton 
The cytoskeleton is an interconnected network of filamentous polymers and 
regulatory proteins that underlies the cell membrane. It is a dynamic and adaptive 
structure whose constituents are in constant flux. It carries out three main 
functions, namely spatial organisation of the cell contents, connects the cell 
(physically and biochemically) to the external environment, and generates co-
ordinated forces that enable the cell to move and change shape.187 This involves the 
interactions of hundreds of associated proteins – molecular motors, crosslinkers, 
capping proteins and nucleation promoting factors.188 The cytoskeleton can be 
approximately divided into three different categories, namely microfilimants, 
microtubules, and intermediate filaments.  
 
Microfilaments, made from actin polymers, are the thinnest filaments of the 
cytoskeleton with a diameter of approximately 7 to 10 nm.189 Actin is the most 
abundant protein in the majority of eukaryotic cells. It exists as a globular 42 kDa 
monomer known as G-actin but has the ability to transition to a filamentous form 
known as F-actin induced by nucleotide hydrolysis, ions, and a large number of 
actin-binding proteins in a reversible manner.190 F-actin forms long linear structures 
of varying architecture and these different architectures support varying roles within 
the cell.  For example, bundled networks support filopodial protrusions that are 
involved in cell-cell communication, while branched networks support the leading 
edge of motile cells and generates the forces involved in morphological changes. 
One of filamentous actin’s key functions is to act as an intracellular train track for 
the movement of myosin, and thus enable muscle contraction.187 The formation of 
F-actin begins with the nucleation step where actin dimers and trimers are first 
formed. They elongate rapidly as a function of monomer availability. Polymerisation 
of actin monomers at the filament end followed by hydrolysis of ATP bound to the 
actin subunits inside the filaments as well as phosphate dissociation. Additionally, 
actin monomers bind divalent cations like calcium and magnesium which influence 
polymerisation dynamics.191 
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Figure 93: Actin networks may take different architectures, which in turn lends different functions. Red arrows 
show compression, while green arrows show tension. A) Branched actin networks push against the cell 
membrane and external barriers as they generate protrusons. B) Filopodia also generate protrusive forces as 
they extend from the cell. C) Cortical networks such as those involving filamin crosslinking carry tension loads 
in multiple directions. D) Stress fibres form bundled actin filaments and generate tension against cell 
adhesions to the extracellular matrix. Diagram from “Cell Mechanics and the Cytoskeleton”. 187  
 
The second category of cytoskeletal proteins; microtubules, are formed from tubulin 
proteins. They form hollow cylinders with a much larger diameter than actin 
filaments at approximately 23 nm. They are polymers of alpha and beta tubulin that 
combine to form stiff, relatively long networks. Microtubules are capable of rapidly 
disassembling and it is this dynamic instability that allows for quick cytoskeletal 
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reorganisation and their ability to quickly search the cellular space. They play a role 
in intracellular transport such as the movement of vesicles and mitochondria.187  
 
The third category of cytoskeletal proteins are intermediate filaments. They have 
diameters of approximately 10 nm. Intermediate filaments are found widely 
distributed throughout the intracellular space. This complex network ranges from 
the plasma membrane through to the nucleus, and includes association with both 
microfilaments and microtubules. Unlike microfilaments and microtubules, 
intermediate filaments are not directly involved in cell movement but appear to play 
a purely structural role organising the 3 dimensional cell structure as well as 
anchoring cell organelles. This fibre category includes a wide range of proteins (over 
50) and includes keratins, lamins and nerofilament proteins.192    
 
 
 
Figure 94: Microfilaments, microtubules and intermediate filaments within the cell. The cytoskeleton is a 
complex matrix of structures that combine to play a role in spatial organisation, while allowing changes in cell 
morphological in response to the external environment. This figure shows the approximate scale of 
microfilaments, microtubules and intermediate filaments, as well their position within the cell. Image from 
”Molecular Cell Biology”.193 
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5.1.2. Cytoskeletal interactions with lipids 
and proteins 
 
The cytoskeletal proteins provide a regulatory and functional role via their 
interaction with both lipids and other proteins. For example, there exists evidence 
for the role of actin in the formation and turnover of ordered lipid rafts, highly 
ordered cholesterol and sphingolipid rich nanodomains (previously discussed in 
section 1.1).194 In vivo experiments have shown that the formation of ordered 
domains can be controlled by actin polymerization. Inhibiting the polymerization 
process decreased the fraction of ordered domains in the cell membrane, while 
stabilizing actin filaments had the opposite effect. Therefore, it appears that lipid 
rafts form when actin filaments attach to the plasma membrane.195,196 In addition 
the reverse may also be true, wherein depletion of cholesterol from the cell 
membrane seems to result in actin disassembly.197 Therefore, the cytoskeletal-lipid 
raft relationship appears to be both complex and reciprocal in nature.  
 
The cytoskeleton is also recognised as the intracellular scaffold upon where 
extracellular ligand recognition and signal transduction takes place. Focal adhesions 
occur at sites where the cell membrane interacts with the ECM. Here, mechanical 
force and regulatory signals are transmitted between the actin cytoskeleton and the 
ECM via large macromolecular assemblies. More precisely, focal adhesions are the 
sub-cellular structures that mediate the regulatory effects (i.e., signalling events) of 
a cell in response to ECM adhesion. Focal adhesions serve as the mechanical linkages 
to the ECM, and as a biochemical signalling hub to concentrate and direct numerous 
signalling proteins often at sites of integrin binding and clustering. The assembly of 
focal adhesions is regulated by the GTP-binding protein Rho. Rho stimulates 
contractility which, in cells that are tightly adherent to the substrate, generates 
isometric tension. In turn, this leads to the bundling of actin filaments and the 
aggregation of integrins in the plane of the lipid membrane. The aggregation of 
integrins activates the focal adhesion kinase and leads to the assembly of a 
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multicomponent signaling complex including talin, filamin, tensin and vinculin.198 
The exact structure of these focal adhesions varies from cell to cell, as well as by 
location within the membrane but they can be roughly grouped into a number of 
categories. For example, focal complexes are small adhesions associated with 
spreading and migrating cells and usually concentrated within membrane 
protrusions. Over time they may mature into larger and more elongated structures. 
Larger adhesions are normally found in resting cells or within areas of low motility 
and act as attachment points between the cell membrane and actin stress fibres. 
Fibrillar adhesions are a type of focal adhesion where extracellular fibronectin fibrils 
are arranged in a parallel orientation with actin stress fibres. Fibrillar adhesions also 
lack proteins such as vinculin and paxillin, which are normally present in standard 
focal adhesions. Finally, podosomes are ring like assembles of matrix adhesion 
components surrounding an F-actin core and are involved in cell motility.199  
 
The complex interaction between the cell cytoskeleton, the lipid bilayer, and 
membrane proteins is perhaps summed up best by Head et al. where they stated 
that “The combination of lateral membrane movement and transmembrane 
interaction among integrins, membrane bilayer lipids, and membrane proteins 
within membrane lipid rafts, along with interaction of the actin/myosin cytoskeleton 
and cytoskeletal tethering partners, can contribute to cellular migration, mechano-
transduction, cell growth, endothelial and epithelial barrier formation, and immune 
cell activation—physiologically important responses and ones that can be altered in 
disease settings”.200 
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Figure 95: The nanoscale architecture of focal adhesions. The integrin proteins span the cell’s lipid membrane 
to provide a link between the ECM and the cell. This is mediated by a variety of intracellular proteins including 
focal adhesion kinase and paxillin in an integrin signalling layer, talin and vinculin in an intermediate force 
transduction layer, and an uppermost actin-regulatory layer containing zyxin, vasodilator-stimulated 
phosphoprotein and a-actinin. Image from “Nanoscale architecture of integrin-based cell adhesions”.107 
 
5.1.3. Actin in platelets 
Due to the morphological changes that platelets undergo during activation, as well 
as the importance of integrin αIIbβ3 in the aggregation process, the role of actin is 
particularly relevant in platelets. In fact, actin makes up approximately 20 % of the 
total protein found in platelets. In the resting platelet state 40 – 50 % of the actin is 
unpolymerised, much of it sequestered in protein complexes. The resting platelet 
cytoskeleton contains around 2000 F-actin filaments of approximately 1 m in 
length which are crosslinked by actin-binding proteins (ABP) and which bind to 
spectrin rich lamina. As the platelet becomes activated, the cell fragment undergoes 
morphological changes and this is driven by an increase in the fraction of polymeric 
actin as the platelet filopodia extend.201 For example, within 20 seconds of thrombin 
stimulation the percentage of polymerized actin has been shown to increase from 
40 – 50 % to 70 %.202  
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In their resting form, discoid platelets are thought to contain a trilaminar membrane 
shield made up of an outer membrane, a spectrin and ABP-rich inner membrane, 
and a cage of closely aligned actin filaments that connect to the central core via 
radiating spokes. Along these spokes the pro-polymerization protein VASP is found, 
while ABP, tropomyosin, and spectrin stabilise the filaments. Once activated many 
existing filaments are disassembled while new fibres form. The once discoid platelet 
begins to initially round as the connections between the core actin filaments and the 
membrane skeleton appear to be dissociated. Following this, the membrane 
skeleton is dismantled, and the core filaments contract in a myosin-mediated 
process into a microfilamentous shell, known as the contractile ring. This 
cytoskeletal reorganisation results in the platelet becoming less rigid as deformation 
allows the filopodial and lamellipodial protrusions to occur. New actin monomers 
become available as previously sequestered actin is released. This allows actin 
growth to be facilitated. Finally, receptors such as αIIbβ3, GP1b/IX and GPVI interact 
with their respective ligands as the adhesions mature and higher ordered actin-
based stress fibres begin to form.202 For example, Bennett et al. found a direct role 
for actin polymerization in αIIbβ3 activation. They found that inhibition of actin 
polymerisation within platelets mimicked the effects of platelet agonists and 
promoted fibrinogen binding to αIIbβ3. The reverse was also true where stabilizing 
actin filaments prevented agonist induced αIIbβ3 binding to fibrinogen. To explain 
this, they proposed that actin constrains αIIbβ3 in a low affinity state and that 
agonist-stimulation increases the concentration of cytosolic calcium in the platelet 
which in turn initiates actin filament turnover that leads to relief of cytoskeletal 
constraints on αIIbβ3, allowing it to assume the high affinity conformation required 
for ligand binding.203 
 
Integrin clustering within the platelet membrane is believed to instigate the 
formation of focal adhesions. Some focal adhesion proteins are known to be 
particularly important with regards to both integrin activation and actin interactions. 
For example, talin is a well recognized activator of integrin both in vivo204 and in 
vitro45. It is also an F-actin binding protein where it is involved in initiation of matrix 
adhesion formation and the linkage of integrin receptors to the actin cytoskeleton. It 
 262 
is vitally important in the first steps of focal complex formation and also the 
turnover of adhesions owing to its degradation. Talin can also bind to and activate 
vinculin which subsequently promotes and stabilises talin-mediated integrin 
clustering by providing additional F-actin crosslinks to the nascent focal complex. 
Furthermore, filamins are large (280 kDa) proteins with the ability to bind to both 
integrins and actin. Tensin is a 220 kDa protein which binds to F-actin via 3 actin 
binding domains. It is also capable of binding to 3, 5, 7, and more weakly, 1-
containing integrins. Finally, -actinins are F-actin crosslinkers that also possesses 
affinity for the cytoplasmic -tails of some integrins. It also has a considerable 
number of additional binding partners such as the aforementioned vinculin.199 As 
can be seen there exists a complex and multicomponent relationship between 
integrins, actins, and actin binding proteins during the αIIbβ3 activation process.   
 
5.1.4. Cytoskeletal mimics in artificial lipid 
systems 
In spite of the prevalence of fibrillar protein structures with cells, their interaction 
with the lipid membrane and associated proteins, and the wide range of model 
membrane systems reported, there is a limited body of work that combines these 
artificial model lipid systems with cytoskeletal structures. Instead most SLB and 
liposome models focus on the lipid itself or reconstituted membrane proteins. Yet 
model systems can extract useful insights into the influence of fibrullar protein 
structures on lipid dynamics, domain formation and on diffusion and clustering of 
reconstituted protein away from the complexity of the cell. 
 
In one example, Yi et al. attempted to mimic the cell cytoskeleton and lipid diffusion 
in contact with the cytoskeleton by creating nanofiber networks made from 
polycaprolactam which had been modified by coating it with silica in order for it to 
be highly hydrophilic. POPC lipid vesicles were then disrupted above the mesh and 
FRAP was used to characterise the bilayer fluidity in contact with the fibres. Above 
an aperture-spanning nanofiber network, the diffusion co-efficient was determined 
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to be 0.98 ± 0.15 m2/s. In contrast to this, the diffusion co-efficient over a glass 
substrate was determined to be 0.40 ± 0.09 m2/s.205 This shows how the diffusion 
co-efficient of lipid can be impacted by the construction of a substrate designed to 
mimic the cell cytoskeletal. 
 
In a paper titled “Minimal F-actin cytoskeletal system for planar supported 
phospholipid bilayers”, Barfoot et al. showed that is was possible to construct actin 
tethered lipid bilayers. While they did not study the actin’s influence on lipid 
diffusion, crucially they were able to show the ability to construct F-actin-spanning 
SLBs.189  Sterling et al. were able to construct an actin-spanning DMPC SLB although 
they utilised the globular form of actin (G-actin) immobilised on a glass surface as a 
protein cushion, rather than the polymerised F-actin form. Nonetheless, they were 
able to compare this lipid diffusion versus a glass substrate control across a range of 
temperatures from 20 to 44 °C. Above glass the diffusion co-efficient ranged from 
approximately 0.6 m2/s to 3 m2/s. In contrast, above G-actin this diffusion co-
efficient ranged from approximately 0.4 m2/s to 2 m2/s. Thus, although the lipid 
bilayer was still mobile above G-actin, the lateral diffusion co-efficient was notably 
reduced when compared to the glass substrate control. Also of interest was the 
increase in the phase transition temperature from 24.3 °C in the glass supported 
bilayer to to 32.7 °C for the actin supported bilayer.206 Our goal in this final 
experimental chapter was similar to this set-up with the key difference being the use 
of the filamentous form of actin, to mirror the cytoskeletal lipid membrane 
scaffolding of the cell, rather than the use of the globular form of actin.  
 
In a reversal of the above examples, some groups have added actin above SLBs 
rather than creating actin-spanning bilayers. For example, Heath et al. utilised a lipid 
bilayer to promote the self assembly of actin filaments. They found that when G-
actin was added to a buffer solution above a lipid bilayer containing a positively-
charged lipid; DOTAP, the globular actin began to adsorb at the SLB. At 15 % DOTAP, 
filamentous actin began to become obvious above the bilayer as the nucleation 
concentration threshold had been reached. In the case of fluid-phase lipid bilayers, 
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the actin adsorbed to form a uniform two-dimensional layer with complete surface 
coverage, whereas gel-phase bilayers induced a network of randomly oriented actin 
filaments, of lower coverage.207  
 
Honigmann et al. showed that membrane bound actin networks had an important 
influence on lipid phase separation. Here, actin was added above an 
ordered/disordered domain-forming ternary mixture of DOPC, DPPC and cholesterol 
and attached to the bilayer via a biotin-streptavidin linkage. It was found that actin 
prevented macroscopic liquid-ordered and liquid-disordered domain formation in 
this domain-forming membrane. Instead the disordered phase lipids appeared to 
associate with the actin filaments themselves. FCS measurements showed that the 
diffusion of the lipid bilayer was hindered under these conditions.208 
 
Thus, although there exists some SLB models that have incorporated cytoskeletal 
structures within, no literature exists where lipid diffusion has been examined as 
part of SLB above the filamentous form of actin as exists within the living cell. There 
are also no model studies investigating the influence of actin network on integrin 
diffusion and aggregation.  
 
This purpose of this chapter was to take the first steps toward building static actin 
structural analogues into the membrane model.  Herein we describe preliminary 
efforts to assemble actin and related fibrous proteins above or below the membrane 
in a supported lipid bilayer system, with the long term objective of translating these 
structures to our PDMS cavity arrays. It is eventually hoped that we can build these 
arrays in which actin is assembled across the cavity apertures in order to examine 
the impact of these proteins and other fibrillar structures on integrin (and other 
membrane protein) diffusion.   
 
Actin 
Here, we attempted to firstly create F-actin-spanning lipid bilayers, comparing 
assembly of bovine cardiac, rabbit skeletal, and human platelet actin to study lipid 
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diffusion in contact with each fibre. Although actin is often thought of as single 
protein, in mammals it actually consists of 6 different isoforms, each encoded by a 
different gene. The isoforms are remarkably similar to one another, with only slight 
variations in amino acid sequence.209 In vivo these different isoforms lend 
themselves to different actin binding proteins. Of the three different commercially 
available actins used, the primary difference is the isoform composition. Bovine 
cardiac actin is 84 % alpha cardiac and 16 % alpha skeletal actin. Rabbit skeletal actin 
is 99 % alpha skeletal. Human platelet actin is 85 % beta actin and 15 % gamma actin 
isoforms. Actins have a diameter of approximately between 7 and 10 nm and an 
isoelectric point of approximately 4.8.210 In vitro they form fibres up to 10 m long.  
 
Ryadnov group fibres 
As a comparison to actin, we also utilised fibre-forming peptide sequences that were 
designed and constructed by the Ryadnov group at the National Physical Laboratory 
in London. Dr Radnov’s group specialise in de novo biomolecular design and 
engineering functional nanostructured materials.211 In this case Dr Ryadnov 
provided us with three different self-assembling peptide-based nanofibres known as 
cyan(+)4, cyan(+)6 and SR_EDS_02.211 The objective of comparing these with the 
actin fibres was that they are synthesized, so that their fibres are of consistent and 
of controlled length and diameter.  According to data supplied by Dr Ryadnov’s 
group, cyan(+)4 fibres are composed of polymerised polypeptides, 28 amino acids in 
length with a molecular weight of 3069. The polymerised fibres are between 90 and 
500 nm in length, with a thickness of 5 – 25 nm. Cyan(+)6 fibres are composed of 
polymerised polypeptides, 42 amino acids in length with a molecular weight of 4573. 
They form fibres with a length between 70 and 90 nm and a thickness between 4 
and 6 nm. Finally, SR_EDS_02 polypeptides are 42 amino acids in length, with a 
molecular weight of 4713. Polymerised, the fibres are on the micrometre scale with 
an approximate width of 300 nm. The isoelectric points of these fibres ranges from 
7.1 to 9.5, much higher than the isoelectric point of actin. The SEM images, supplied 
by Dr Ryadnov’s group, of the formed fibres are given in Figure 96. The lengths and 
widths of the fibres were obtained from multiple SEM experiments and measured 
 266 
using Image J. Further detail on the structure of the polypeptides is given in Table 
19. Using these de novo nanofibers, alongside in vitro formed actin filaments, we 
sought to compare and contrast the influence of fibre dimension on the fluidity of 
an interfaced, supported lipid membrane. 
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Figure 96: SEM images of the three different fibres supplied by Dr Ryadnov’s group. According to their SEM 
data, cyan(+)4 fibres are between 90 and 500 nm in length, with a thickness of 5 – 25 nm. Cyan(+)6 has a 
length between 70 and 90 nm with a thickness of 4 – 6 nm. SR_EDS_02 has a length in the m range with a 
thickness of approximately 300 nm. This data was supplied by Dr Ryadnov’s group, as measured using imageJ 
from multiple SEM experiments.  
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Table 19: A table describing the characteristics of Dr Ryadnov’s group’s fibre-forming peptides. Three different 
self assembling peptides known as cyan(+)4, cyan(+)6, and SR_EDS_02 were provided. 
Peptide Amino acid composition Amino Acid 
Length 
 
Molecular 
Weight 
pI 
Cyan(+)4 A (8), E (4), K (5), L (4),Q (2), I 
(4), Y (1) 
28 3069 9.5 
Cyan(+)6 A (12), E (6), K (7), L (6),Q (4), 
I (6), Y (1) 
42 4573 9.4 
SR_EDS_02 A (12), E (6), K (6), L (12),Q 
(3), W (3) 
42 4713 7.1 
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5.2. Experimental 
5.2.1. FLCS measurements 
 
Before FLCS measurements, the substrate surface was fluorescently imaged to 
identify both the presence of the fluorescently-labelled lipid and fluorescently-
labelled fibres. The actin fibres were fluorescently-labelled with phalloidin-TRITC, 
while the Ryadnov group’s fibres were fluorescently-labelled with sulfo-rhodamine 
B. Confocal images were collected using a MicroTime 200 fluorescence lifetime 
microscope system. Fluorophores were excited with 532 nm PicoTA or 640 nm light 
from a LDH-P-C-640B diode laser. The laser was directed toward a z532/635rpc 
dichroic mirror and focused on a water immersion objective (NA 1.2 UPlanSApo 60 x 
1.2 water/ CC1.48, Olympus). The sample fluorescence was collected through the 
same objective and filtered by the aforementioned dichroic mirror, as well as by an 
HQ550lp AHF/Chroma filter (Olching, Germany) for the 532 nm laser, or a BLP01-
635R-25 Semrock filter (New York, USA) for the 640 nm laser. Finally, the sample 
fluorescence was passed through a 50 mm pinhole onto a MPD SPAD detector. The 
ability to locate the various filamentous proteins on the substrate surface allowed 
for the positioning of point measurements above both actin and Ryadnov group 
fibres. The Z-position was firstly roughly tuned using the built-in CCD camera of the 
microscope. This allowed us to identify the approximate Z-position of planar 
substrates. To fine-tune this position to the lipid bilayer, a Z-scan was then 
performed to locate the point of highest fluorescence intensity due to the presence 
of fluorescently-labelled lipid and protein. Due to drift within the system the Z-
position was recalibrated between each point measurement.  
 
Diffusion coefficients for labelled lipid or fibres were obtained using FLCS. The 
autocorrelation functions obtained using FLCS are less prone to noise and distortion 
caused by scattered excitation light, detector thermal noise and detector 
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afterpulsing than conventional FCS.67 FLCS measurements were performed using a 
MicroTime 200 confocal fluorescence lifetime microscope system. For FLCS 
experiments, the fluorophores were excited and the sample fluorescence was also 
collected as described for confocal microscopy. The autocorrelation functions (ACF) 
were fit using SymphoTime software (PicoQuant GmbH, Berlin, Germany): 
 
𝐺(𝜏) = 1 +  [
1
𝑁
] [
1
1 + (𝜏 𝜏𝐷⁄ )
𝛼
] 
 
For simple single component diffusion, or in the case of the presence of a triplet 
state: 
 
𝐺(𝜏) = 1 + [1 − 𝑇 + 𝑇𝑒𝑥𝑝(−𝜏 𝜏𝑇⁄ )] [
1
𝑁(1 − 𝑇)
] [
1
1 + (𝜏 𝜏𝐷⁄ )
𝛼
] 
 
where G(τ) is the autocorrelation function of fluorescence fluctuations; N is the 
number of fluorophores in the effective volume; T is the fraction of the molecules in 
the triplet state; τT is the relaxation time for the singlet–triplet crossing;  is the 
anomalous parameter; and τD is the diffusion time, which is related to the lateral 
diffusion coefficient (D) of the labelled tracer by the expression: 
 
τ𝐷  =  
ω2
4D
 
 
In the latter equation, the radius ω0 is the distance at which the excitation intensity 
profile decreases to e-2 of its maximum value. This parameter was determined 
experimentally, by measuring the translational diffusion of Rhodamine 6G (532 nm 
laser) and Atto655 (640 nm laser) in water at room temperature (approximately 21 
°C).137 These dyes, have well characterized diffusion coefficients and so were used as 
standards to determine the working confocal volume for FLCS measurements.  
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5.2.2. STED imaging 
STED imaging was performed with a Leica SP8 TCS STED 3X microscope using a Leica 
HC PL APO 100x/1.40 oil immersion objective designed for STED imaging. The 
labelled fibres were excited at the desired wavelength using the microscopes white 
light laser which had a tuning range between 470 and 670 nm in 1 nm intervals. 
Laser power and gain was adjusted as required. The instrument utilised hybrid 
detectors and/or PMTs to detect fluorescence. Again this detection window may be 
tuned to nanometer accuracy. Before STED imaging began, fibres were firstly 
identified via standard confocal microscopy. STED imaging was then performed at 
the same location using a suitable depletion laser (for example 660 nm for TRITC) to 
obtain a super resolution image.  
 
5.2.3. PDMS cell construction 
For these preliminary cytoskeleton-SLB-based experiments we utilised planar, super-
hydrophillic glass as the underlying substrate. This was achieved through the 
plasma-treatment of glass coverslips (Harrick PDC-002 plasma cleaner at 1000 mT 
for 5 minutes). In a similar set-up our group have previously shown that ozone 
treatment of glass reduced the contact angle of a water droplet from 50 to 0, thus 
rendering the glass superhydrophillic.137 The experiments were conducted using a 
simple PDMS flow cell constructed around the glass coverslip. The structure of the 
cell was a simplified version of the cavity array cell, but the lipid interface was built 
at glass. Briefly, 10 parts PDMS elastomer to 1 part PDMS curing agent (w/w) were 
mixed to form the PDMS solution. The PDMS was thoroughly mixed and then placed 
in a vacuum desiccator for 30 minutes to ensure that all air bubbles were removed. 
Meanwhile a thin piece of freshly cleaved mica was glued to a glass slide to provide 
a raised platform and an aluminium foil “boat” was folded around the mica-glass 
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slide platform. Once the PDMS solution was bubble free the solution was gently 
poured into the foil (approximately 3 g per aluminium foil “boat”). The array was 
then placed on hotplate which had been preheated to 150 °C and cured over a 15-
minute period. Once complete the PDMS piece was removed and left to cool before 
the aluminium foil was peeled from the substrate. Using a scalpel, the PDMS was 
then cut from the glass-mica platform to yield a PDMS piece with a lowered imprint 
which had been created by the raised mica. Two holes were punched at the 
extremities of the PDMS to provide an inlet and outlet for flow-through and Teflon 
tubing was attached to either end. Prior the beginning of an experiment, a glass 
coverslip was plasma treated in a Harrick PDC-002 plasma cleaner at 1000 mT for 5 
minutes. The coverslip was then glued to the PDMS piece to provide a sealed 
chamber for later experimentation. Figure 97 shows a schematic of the PDMS cell. In 
contrast to the majority of chapter 4, which primarily focused on bilayer formation 
on the PDMS side of a similar cell set-up, this chapter focused on the near glass side 
of the PDMS cell where bilayers and cytoskeletal proteins were examined. 
 
 
Figure 97: A schematic of the constructed PDMS cell used for cytoskeleton and SLB-based experiments. The 
glued PDMS cell provided a chamber containing inlets and outlets for flow through of buffers, lipids, and 
proteins used during the experiments. 
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5.2.4. Cytoskeletal fibres  
In order to create a cytoskeletal mimic for our SLB system, a number of filamentous 
structures were examined. The first category of these were the actins; bovine actin, 
rabbit actin, and human platelet actin. The second category of fibres were self-
assembling peptide fibres designed to mimic the cell cytoskeleton. These fibres were 
supplied by the Ryadnov group and known as cyan(+)4, cyan(+)6, and SR_EDS_02. 
 
Actin polymerization 
In order to form filamentous actin, frozen aliquots of actin (bovine, rabbit, or 
platelet) were thawed and placed on ice for 1 hour to depolymerize any F-actin 
filaments that may have been present. This defrosted actin was in general actin 
buffer of 5 mM Tris-HCl, 0.2 mM CaCl2, 0.2 mM ATP, pH 8. In order to polymerise 
actin, 1/10th of the volume of a 10x actin polymerization buffer was added to the 
globular actin. This 10x actin polymerization buffer was composed of 100 mM Tris, 
500 mM KCl, 20 mM MgCl2, 10 mM ATP, pH 7.5. The actin was incubated at room 
temperature for 1 hour to allow for F-actin to form. The concentration of actin was 
kept above 0.1 mg/ml throughout. This is because the propensity of actin to 
polymerize is dependent upon the affinity of actin monomers for filament ends. 
Thus, there is an actin monomer concentration below which actin will not 
polymerize. This value has been termed the Critical Concentration (CC). The exact CC 
varies with ionic type and strength. Keeping the actin concentration above 0.1 
mg/ml was suitable for the nucleation step to begin. In order to fluorescently stain 
actin filaments, phalloidin-TRITC was used. Phalloidin is a mushroom toxin with 
strong binding affinity for actin filaments and is thus an excellent marker for actin 
visualization when conjugated to a fluorescent probe. Stock solutions of phalloidin-
TRITC were stored in the fridge in methanol at 0.1 mg/ml. F-actin was diluted to 0.01 
mg/ml (approximately 240 nM). Phalloidin-TRITC was added at a final concentration 
of approximately 24 nM and left to incubate for 1 hour. Labelled F-actin was then 
flushed through the PDMS flow cell. 
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Ryadnov group’s fibres 
Peptides provided by Dr Ryadnov’s group are referred to as as cyan(+)4, cyan(+)6 
and SR_EDS_02 and were each provided as lyophilised powders and stored at – 20 
°C until required. Stock solutions were prepared to a concentration of 2 mM using 
dH2O. Working samples were prepared by diluting the peptides to 100 M using a 
buffer of 10 mM HEPES at pH7.4. It was important to limit the concentration of salts 
used as fibre assembly is stabilised by electrostatic interactions and thus improper 
buffer preparation could prevent assembly or promote disassembly. The thawed 
peptides were left to self-assemble overnight at room temperature. Before use, the 
fibres were gently mixed with a pipette to re-suspend them. In order to 
fluorescently label the fibres, the electrostatic dye sulfo-rhodamine B was used. 
Lyophilised sulfo-rhodamine B was re-suspended in methanol to make a stock 
concentration of 10 mM. This could be aliquoted and frozen for later use. For the 
working concentration this solution was diluted to 1 M in the working buffer, in 
this case 10 mM HEPES, pH 7.4. The dye was then added to the peptides at a final 
concentration of 100 nM and left to incubate at room temperature for one hour. 
The fibres were then flushed through the PDMS flow cell.     
 
 
5.2.5. Substrate Functionalization  
In later experiments we sought to increase the surface coverage of immobilised 
fibres via modification of the glass substrate. Two different methods were explored. 
Poly-L-Lysine coating 
Poly-L-Lysine is a positively-charged synthetic polymer that facilitates the 
attachment of proteins and cells to solid surfaces for biological applications. Here it 
was used to increase the surface coverage of F-actin on a glass substrate. Poly-L-
lysine (PLL) coating was carried out on the day of the experiment. The PLL was firstly 
diluted to 0.1 mg/ml in dH2O for the working concentration. It was then pipetted 
onto a plasma-cleaned glass coverslip and incubated for 1 hour at room 
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temperature. dH2O was then flushed across the coverslip to remove an excess PLL. 
This protocol was suitable to render the coverslip positively charged.  
 
APTMS/GA coating 
As an alternative to poly-L-lysine, a two-step functionalization of glass substrates 
was explored using 3-aminopropyl trimethoxysilane (APTMS) and glutaraldehyde 
(GA). Glass coverslips were firstly plasma-treated as normal. The surface was then 
modified with APTMS by attachment to the substrate’s hydroxyl functional groups. 
This was achieved by incubating the coverslips for 3 hours with 5 mM APTMS 
dissolved in acetone. The coverslips were then dried under nitrogen to remove any 
remaining solvent. Directly before use the coverslips were incubated in a 10 % GA in 
dH2O solution (v/v) for 1 hour. Following this the substrate was gently washed in 
dH2O to leave behind an amine-reactive surface. An F-actin-containing solution 
could then be flushed across the surface in order to yield an actin coated surface. 
This two-step coating process has previously been used in microfluidic cells for the 
immobilisation of proteins.212 
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5.3. Results  
5.3.1. Fibres below the SLB 
Initial experiments were designed to measure the diffusion dynamics of fibre-
spanning lipid membranes (Figure 98). Our objective was to investigate the relative 
ability of each actin and fibrous peptide type to form filaments at the glass interface, 
to investigate if the lipid bilayer spanned across these structures and to determine 
whether these filamentous structures were capable of altering the diffusion co-
efficient of the spanning lipid bilayer. The use of these filamentous proteins within 
the SLB system was designed to better mimic the environmental conditions 
encountered by the lipid membrane within the cell. To date, the majority of existing 
work within the literature, as well as the platforms used in this thesis, have utilised a 
lipid bilayer in contact with buffers or solid substrates rather than a cytoskeletal 
cushion found below the cell membrane. Therefore, our inclusion of cytoskeleton 
proteins aimed to create a more accurate biomimetic model than what currently 
exists within the literature. To act as cytoskeleton mimics we used 6 different fibres: 
bovine actin, rabbit actin, human platelet actin, cyan(+)4, cyan(+)6, and SR_EDS_02.  
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Figure 98: A schematic of the proposed system where a lipid bilayer is formed above nanometer wide and 
micrometer length polypeptide filaments. It was hoped that these fibres would act as a sufficient barrier to 
lipid mobility that would be reflected in the diffusional characteristics of the spanning lipid molecules.  
 
F-actin polymerisation above bare glass 
Following formation of F-actin according to the protocol described in experimental 
section, the labelled actin filaments were flushed across a superhydrophillic 
coverslip using the PDMS flow cell and imaged via confocal microscopy to determine 
whether actin fibres had formed and bound to the surface. Figure 99 demonstrates 
that using this approach we succeeded in achieving bovine F-actin polymerisation 
and that these filaments bind to the superhydrophillic glass slide. We therefore used 
analogous polymerisation conditions for the other actins as a routine method for 
formation of F-actin, and this lead to high levels of fibre assembly at the glass 
interface. The next step was to assemble a supported DOPC lipid bilayer above the 
actin modified interface. This was achieved via the addition of extruded DOPC LUVs 
which were introduced into the flow cell. Here the vesicles were left to disrupt over 
a 30-minute period in order to form a lipid bilayer above the actin filaments. 
Following SLB formation this cell was flushed with buffer to remove any loosely 
bound actin and undisrupted vesicles. The coverslip surface was once again imaged 
to locate the actin filaments. Figure 100 shows that following the various buffer 
flushes used in the bilayer formation step, much of the actin filaments had been 
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washed away from the surface narrowing the number of locations available for 
upcoming diffusion measurements. Nonetheless, enough F-actin remained below 
the lipid bilayer for some point measurements to be recorded. Figure 101 shows 
DOPE-Atto655 within a spanning DOPC bilayer. As can be seen, forming a spanning 
SLB above actin fibres did not result in any obvious defects to the lipid membrane 
where the SLB looked no different than the creation of a bilayer above plasma 
treated glass in the absence of actin. 
  
 
Figure 99: Phalloidin-TRITC stained bovine actin filaments assembled on a glass surface as seen via confocal 
microscopy. F-actin filaments readily formed under the polymerisation conditions used and surface coverage 
of the glass substrate was extremely good. The experiment was carried out at room temperature in a PDMS 
cell. Phalloidin TRITC labelled actin was excited by a 532 nm laser line and fluorescence was passed through a 
550LP filter onto the SPAD detectors. 
 
 279 
 
Figure 100: Bovine actin on plasma-treated glass following the addition and disruption of DOPC lipid vesicles. 
During the disruption process, which features a number of buffer flushes through the cell, the vast majority of 
actin was washed away from the glass. The experiment was carried out at room temperature in a PDMS cell. 
Phalloidin-TRITC labelled actin was excited by a 532 nm laser line and fluorescence was passed through a 
550LP filter onto the SPAD detectors.  
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Figure 101: A DOPC bilayer formed above F-actin filaments. DOPE-Atto655 was used as the lipid probe. The 
bilayer appeared formed homogeneously with no defects visible due undisrupted vesicles and no perturbation 
caused by the presence of some underlying actin filaments. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence was passed 
through a 635R filter onto the SPAD detectors.  
 
Following imaging of both the F-actin and the lipid bilayer it was possible to begin 
point measurements for lipid (DOPE-Atto655) diffusion directly above actin 
filaments using the confocal image of phalloidin-TRITC as a reference. A typical ACF 
trace of lipid diffusion above an actin filament is given in Figure 102. In all cases the 
diffusional data was easily obtained in the ACF traces where the data fit well to 
single component two-dimensional diffusional model. Point measurements were 
carried out for lipid diffusion above all three actin types; bovine, rabbit, and platelet. 
A control sample was prepared in the absence of actin to provide a baseline 
diffusion co-efficient. In the actin free control the calculated lipid diffusion co-
efficient (DOPE-Atto655) was found to be 3.82 ± 0.29 m2/s. Above bovine actin 
filaments this was found to be 3.92 ± 0.26 m2/s. Measurements above rabbit actin 
 281 
provided a lipid diffusion co-efficient of 4.00 ± 0.31 m2/s, while above human 
platelet actin the lipid diffusion co-efficient was found to be 3.99 ± 0.20 m2/s. A 
one-way ANOVA and post-hoc Bonferroni test was performed on all the data-sets 
which found that these diffusion co-efficients did not significantly differ from one 
another, where F(3, 76) = 1.71, p > 0.05. The alpha value was shown to be 1 in all 
cases, indicating Brownian diffusion. Based on this data, it can therefore be stated 
that actin filaments failed to alter the diffusion co-efficient of a spanning DOPC 
bilayer, indicating that they were not a sufficient barrier to membrane fluidity. 
Between 5 and 10 measurements were performed above 10 different actin 
filaments to obtain this diffusion data. This was repeated across 3 different flow 
cells. This diffusional data is summarised in Figure 103. 
 
 
Figure 102: A typical ACF of DOPE-Atto655 diffusion in a DOPC bilayer located above a filamentous bovine 
actin. The fits to a single component model were good, and no other diffusing species were evident within the 
trace. Analogous behaviour was observed for lipid above the other actin fibres in rabbit actin and human 
platelet actin, where ACF data could be routinely obtained. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence was passed 
through a 635R filter onto the SPAD detectors. Point measurements were performed for between 1 and 3 
minutes. 
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Figure 103: A summary of DOPE-Atto655 diffusion co-efficients in a DOPC bilayer above various actin filaments 
and a lipid only control fitted using a two-dimensional single species model. Diffusion of lipid above bovine, 
rabbit, or human platelet actin failed to alter the diffusion co-efficient when compared to lipid diffusion above 
plasma-cleaned glass. This was confirmed via a one-way ANOVA analysis. Each point refers to the average lipid 
diffusion co-efficient over an individual actin fibre, or in the case of the control, above planar glass. The 
experiment was repeated in triplicate using three separate PDMS flow cells. Standard deviation was used to 
represent the error. 
 
STED imaging of F-actin 
In order to identify actin fibres for point measurement experiments, standard 
confocal microscopy was described above. However, confocal microscopy is limited 
by the diffraction limit of light which means that structures separated by less than 
about 250 nm nm are not resolvable. Due to the fact that actin fibres have a 
diameter between 7 and 10 nm these filaments fall well below the diffraction limit. 
Indeed, if there are several filaments group together, for example, these cannot be 
distinguished from single fibres.189 Therefore, to ensure the positioning of the point 
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measurements to obtain diffusion data directly above individual filaments we use 
STED microscopy, which allows for the collection of super-resolution images with a 
resolution of approximately  20 to 50 nm. Phallodin-TRITC stained actin fibres were 
firstly imaged by standard confocal imaging before STED images were obtained 
using the 660 nm depletion laser. A typical confocal image and corresponding STED 
image is shown in Figure 104. STED imaging (right) shows a significant  increase in 
optical resolution when compared to confocal microscopy (left) under experimental 
conditions. Using this super-resolution image allowed us to better position the 
location of diffusion measurements to more accurately target actin filaments. These 
point measurements were carried out as before; however, again, no change in 
diffusion data was obtained when compared to using confocal microscopy images as 
reference.  
 
 
Figure 104: Confocal and STED imaging of phalloidin-TRITC labelled human-platelet actin. A) A standard 
confocal image which was routinely used to position point measurements above actin filaments. B) A 
complementary STED image of the same actin filaments. STED imaging provided an improvement in resolution 
when compared with confocal imaging. Increased accuracy in positioning point measurements above actin 
filaments did not alter obtained diffusion data. Phalloidin-TRITC was excited by the white light laser at 542 
nm. Fluorescence was detected between 560 and 700 nm. The experiment was carried out at room 
temperature in a PDMS flow cell. 
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F-actin polymerisation above PLL coated glass 
It was rather surprising that DOPC diffusion was unaffected by assembly over actin 
filaments. For example, Sterling et al. reported a reduction in the diffusion co-
efficient of a G-actin-spanning SLB.206 However in their experimental setup, their 
substrate surface was described as “fully coated with actin monomers”. We 
therefore speculated that our unchanged lipid diffusion co-efficients were a result of 
the low surface coverage of F-actin. For example, single actin filaments of between 7 
and 10 in diameter make up a relatively small barrier to diffusion of the lipid bilayer 
within the focal volume’s cross-sectional area.49,189 As such it was hoped that 
increasing the surface coverage of actin on the glass surface after bilayer formation 
would mean that multiple actin filaments would be present within the focal volume 
during point measurements. Thus, the actin bundles would be more likely to act as a 
hindrance to lipid bilayer mobility.  
 
The first and simplest method to increase actin surface coverage utilised the 
positively charged amino acid polymer poly-L-lysine. This polymer is widely used to 
promote cell adhesion to solid substrates and it was hoped that coating the the glass 
substrate with PLL prior to actin addition would promote immobilisation of the 
negatively charged cytoskeletal protein. The actins were polymerised as before and 
flushed across the PLL coated surface before being imaged by confocal microscopy. 
This is shown in Figure 105 where phalloidin-TRITC was used to stain bovine actin. It 
was immediately evident that the PLL-coating had dramatically improved the surface 
of coverage of actin before the lipid bilayer was formed (compared to Figure 99 on 
bare glass). Extruded DOPC LUVs were subsequently introduced to the cell and 
allowed to disrupt over a 30-minute period to yield an actin-spanning SLB. The 
surface was then flushed with buffer to remove excess lipid and the PLL-coated 
surface was once again imaged for actin via confocal microscopy. Figure 106 shows 
phalloidin-TRITC labelled bovine actin following the formation of the SLB. It can 
clearly be seen that much of the F-actin filaments remained on the PLL-coated 
surface after the bilayer formation process. This is in contrast to the earlier 
observations on bare glass where the SLB formation step washed the vast majority 
of actin filaments from the substrate (Figure 100). After establishing the presence of 
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actin on the surface, attention was turned to the spanning lipid bilayer itself, which 
after assembly was also imaged via confocal microscopy as can be seen in Figure 
107. Although the DOPE-Atto655 containing DOPC bilayer was definitely present and 
the surface coverage was good, careful examination of the bilayer shows that bilayer 
was not continuous. These defects are visible as fluorescently labelled lipid-free 
regions within the bilayer. This is in contrast to the construction of actin-spanning 
bilayer on bare glass as in Figure 101 where the bilayer appears homogeneous 
throughout.  
 
 
 
 
Figure 105: Phalloidin-TRITC stained bovine actin filaments on a PLL-coated glass coverslips before bilayer 
formation. The use of PLL coating massively increased the number of actin filaments present on the glass 
substrate when compared to bare glass. The experiment was carried out at room temperature in a PDMS cell. 
Phalloidin-TRITC-labelled actin was excited by a 532 nm laser line and fluorescence was passed through a 
550LP filter onto the SPAD detectors.  
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Figure 106: Phalloidin-TRITC-stained bovine actin filaments on a PLL-coated glass coverslips following the 
formation of a spanning DOPC SLB. Unlike non-PLL-coated glass the vast majority of the F-actin remained on 
the substrate following bilayer formation. The SLB was created via vesicle disruption. The experiment was 
carried out at room temperature in a PDMS cell. Phalloidin-TRITC-labelled actin was excited by a 532 nm laser 
line and fluorescence was passed through a 550LP filter onto the SPAD detectors.  
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Figure 107: DOPE-Atto655 in a DOPC bilayer that spanned PLL-immobilised F-actin filaments. The lipid 
coverage was high but relatively heterogeneous, as some lipid-free defects can be seen on the surface. It was 
hoped that these defects would not negatively influence the fluidity of the lipid bilayer. The experiment was 
carried out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and 
fluorescence was passed through a 635R filter onto the SPAD detectors.  
 
Despite the presence of these defects within the SLB, the high surface coverage of 
actin filaments provided an opportunity to attempt to study lipid diffusion above 
these fibres. To do so, further confocal images were taken at higher magnifications, 
in order to accurately position the point measurements directly above actin 
filaments. Once individual filaments or filamentous bundles were identified in the XY 
direction, and Z-scans performed to position the Z-direction, point measurements of 
the spanning lipid bilayer could be performed with accuracy. Figure 108 shows the 
location and MCS trace of a point measurement for the lipid bilayer above a single 
actin filament. Figure 109 shows the location and MCS trace of a point measurement 
for the lipid bilayer above a bundle of actin filaments. Interestingly in both cases it 
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was found that the lipid bilayer was immobile. This can be seen in the MCS traces 
where photobleaching is immediately evident. Thus no ACF trace of lipid diffusion 
could be calculated.  
 
 
 
Figure 108: MCS trace of lipid above an actin filament. The image on the left shows separate actin filaments 
immobilised on PLL-coated glass. The red dot shows the exact location of the point measurement. This point 
measurement was used to determine the diffusion co-efficient of the lipid bilayer above the actin filament. 
The MCS trace on the right shows the photobleaching of DOPE-Atto655 at this location showing that no lipid 
diffusion was apparent above this single actin filament. The experiment was carried out at room temperature 
in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence was passed through a 635R 
filter onto the SPAD detectors. 
 
 
Figure 109: MCS trace of lipid above an actin bundle. The image on the left shows a bundle of F-actin filaments 
immobilised on PLL-coated glass. The red dot shows the exact location of the point measurement. Again this 
point measurement was used to determine the diffusion co-efficient of the lipid bilayer above the actin 
filament. As was the case above a single actin filament, the MCS trace on the right shows that photobleaching 
of DOPE-Atto655 was occurring. Therefore, once again the lipid bilayer appeared to be immobile. The 
experiment was carried out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser 
line and fluorescence was passed through a 635R filter onto the SPAD detectors. 
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Thus, the defects visible in the confocal image of the actin-spanning bilayer on PLL 
glass were reflected in the point measurements, where no lipid mobility was 
present. It was initially unclear whether this lipid immobility was due to the actin 
filaments themselves or the PLL treatment of the glass substrate. In order to 
determine this, a control was prepared where a lipid bilayer was formed above PLL-
coated glass in the absence of actin filaments. A confocal image of this PLL-spanning 
bilayer is shown in Figure 110 where DOPE-Atto655 was included as lipid probe. As 
was the case of the PLL and F-actin sample, some defects are seen in the lipid bilayer 
where lipid free regions and lipid aggregates are visible within the SLB. This suggests 
that the lack of lipid fluidity in the previous sample as a result of the PLL coating 
rather than the high actin surface coverage. To confirm this, FLCS measurements 
were taken for the lipid bilayer at various locations in the bilayer. An MCS trace of 
one such point measurement is given in Figure 111. Again, photobleaching was 
observed showing that the lipid was immobile even in the absence of actin. Thus, it 
appeared that the PLL-coating was responsible for immobilising the lipid molecules 
on the surface. The PLL is expected to be polycationic at the pH used here and it is 
likely that they have a strong interaction with the anionic phosphates of the 
zwitterionic lipids used here.  PLL has been used to coat vesicles, and thereby 
stabilise them, though there are few reports on the mobility of the lipid in such 
work.  It has been been shown however that addition of PLL to SLBs comprised of 
DPPC, and particularly those of DOPS/DOPC leads to lipid removal and 
aggregation.213,214 Therefore, despite the excellent immobilisation of actin with high 
surface coverage on PLL, the immobility of the lipid bilayer meant that the polymer 
coating was unsuited for our spanning lipid bilayer experiments.  
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Figure 110: A DOPC bilayer formed above PLL coated glass. DOPE-Atto655 was used as the lipid probe. No 
actin was present these experiments. Despite this, the homogeneity of the bilayer is less than typically 
observed on glass alone and a number of defects were apparent in the bilayer. The experiment was carried 
out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence 
was passed through a 635R filter onto the SPAD detectors. 
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Figure 111: An MCS trace of DOPE-Atto655 in a DOPC bilayer on PLL-coated glass. As with the PLL immobilised 
actin on glass, photobleaching of lipid probe was evident. This data shows that PLL coating, while an excellent 
coating to increase actin surface coverage, was a poor choice of substrate for an SLB system. The experiment 
was carried out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and 
fluorescence was passed through a 635R filter onto the SPAD detectors. 
  
F-actin polymerisation above APTMS/GA-coated glass 
As an alternative to PLL coating, we modified the glass substrate with gluteraldehde 
(GA).  This was achieved in a two-step coating of (3-aminopropyl)trimethoxysilane 
(APTMS) followed by GA. This protocol has previously been used to modify glass 
surfaces with APTMS in order to provide an amine terminated group on the 
substrate, and then the use of GA as a crosslinker between the amine on the surface 
and amines of the protein.206,212 As previously described, F-actin was polymerised as 
normal and flushed across the APTMS/GA coated surface. The surface imaged for 
the phalloidin-TRITC stained F-actin via confocal microscopy as shown in Figure 112 
where rabbit actin was used. As was the case in PLL-coated glass, APTMS/GA 
provided excellent surface coverage of actin filaments. A spanning SLB was formed 
by flushing extruded DOPC LUVs across the substrate and incubating them for 30 
minutes to allow for a lipid bilayer to form from vesicle disruption. After the elapsed 
time the surface was once again imaged via confocal microscopy and a 
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representative image of the resulting surface is shown in Figure 113. This image 
clearly shows that the vast majority of rabbit actin filaments remained immobilised 
on the glass surface after SLB formation. This result is similar to observations with 
PLL-functionalised glass (Figure 106), but contrasts with bare glass, where few actin 
filaments remained adhered to the surface (Figure 100). A confocal image of the 
bilayer above F-actin on APTMS/GA glass is given in Figure 114 where DOPE-Atto655 
was used as the lipid probe. It can clearly be seen that the bilayer is very 
heterogeneous with both lipid aggregates and contrasting lipid free areas visible on 
the coverslip. For comparison, a defect-free bilayer can be seen in Figure 101. 
Despite the heterogeneity of bilayer assembly, the high surface coverage of actin 
provided an attempt to obtain point measurements for DOPE-Atto655 above 
filaments was made. Figure 115 shows an MCS trace of one such point 
measurement. Unfortunately, again, it is evident that the lipid bilayer was not 
mobile as evident from the photobleaching of the lipid probe within the focal 
volume, indicating, as was the case for PLL-coated glass, that lipid adsorption was 
occurring at the interface and a fluid bilayer was not being established (Figure 108 
and Figure 109). At this stage it was unclear whether the lack of bilayer fluidity was 
due to the high surface coverage of actin filaments themselves or instead due to the 
APTMS/GA coating.   
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Figure 112: Rabbit actin filaments on APTMS/GA-coated glass before the addition of extruded lipid vesicles in 
order to form a spanning lipid bilayer. As was the case with PLL coating, APTMS/GA massively increased the 
concentration of actin filaments present on the glass substrate when compared to bare glass. The experiment 
was carried out at room temperature in a PDMS cell. Phalloidin TRITC-labelled actin was excited by a 532 nm 
laser line and fluorescence was passed through a 550LP filter onto the SPAD detectors.  
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Figure 113: Rabbit actin filaments on APTMS/GA-coated glass directly after bilayer formation at the same 
location. Extruded DOPC vesicles were added to the cell and incubated above the actin covered glass substrate 
and allowed to rupture over a 30-minute period. The APTMS/GA coating meant that the majority of actin 
filaments remained adhered to the glass with little variation between the before and after bilayer formation 
images. The experiment was carried out at room temperature in a PDMS cell. Phalloidin TRITC-labelled actin 
was excited by a 532 nm laser line and fluorescence was passed through a 550LP filter onto the SPAD 
detectors.  
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Figure 114: Confocal luminescence image of DOPE-Atto655 in a DOPC bilayer formed above actin, immobilised 
on a APTMS/GA-coated glass substrate. In contrast to the formation of a lipid bilayer above plasma-cleaned 
glass, the emission was considerably less homogeneous. This can be seen where the lipid probe appears to be 
excluded from certain regions and aggregated in others in a patchwork fashion. The experiment was carried 
out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence 
was passed through a 635R filter onto the SPAD detectors. 
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Figure 115: Photobleaching of DOPE-Atto655 in a DOPC bilayer above actin immobilised on glass via an 
APTMS/GA coating. This bleaching means that the lipid bilayer was not diffusive in this sample. At this stage it 
was unclear whether this was due to the actin filaments or the APTMS/GA treatment. The experiment was 
carried out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and 
fluorescence was passed through a 635R filter onto the SPAD detectors. 
In order to determine whether the photobleaching was a result of the APTMS/GA 
coating (as was the case with PLL), or due to the actin filaments themselves, a 
control was setup whereby the glass substrate was coated with APTMS/GA and a 
bilayer assembled at this interface in the absence of actin above the functionalized 
surface. Figure 116 shows the confocal image of the resulting SLB where DOPE-
Atto655 was included as a lipid probe.  As for the PLL layer it is clear that the 
APTMS/GA coating prevented the formation of a continuous and defect free lipid 
bilayer. In fact, in this particular case the bilayer failed to form in large areas of the 
coverslip as can be seen in the lower right of image where the surface is devoid of 
DOPE-Atto655. Even where DOPE-Atto655 was present, such as the top left of the 
image, the bilayer appeared patchy and full of defects.  Thus, it appeared that the 
APTMS/GA coating was responsible for the failure of a continuous and fluid lipid 
bilayer to form. To confirm this, point measurements were undertaken in areas that 
did feature some degree of labelled lipid. Figure 117 shows an MCS trace of one 
such measurement. Once again bleaching of the lipid probe was evident suggesting 
the lipid was adsorbing onto the substrate. This bilayer immobility is perhaps 
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surprising given the fact that an APTMS/GA coating has previously been used below 
a lipid bilayer with not mention of lipid immobility.206 In that case Sterling et al. were 
able to produce a G-actin-coated (not F-actin) surface via APTMS/GA surface 
functionalization and subsequently create a spanning diffusive DMPC bilayer. 
However, in their case, they describe their glass surface as “fully coated with actin 
monomers” as described by immunochemical staining. This may suggest that their 
lipid bilayer is fully cushioned by G-actin monomers while our lipid bilayer is 
cushioned by a combination of narrow actin filaments and surrounding APTMS/GA 
coated glass.  
 
 
Figure 116: DOPE-Atto655 in a DOPC bilayer above APTMS/GA-coated glass. No actin filaments were present 
in this sample. The lipid bilayer was again not continuous. This can clearly be seen where much of the probe 
was excluded from the lower right of the image. Even where the probe was present in the upper left its 
coverage appears patchy when compared to plasma-cleaned glass. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence was passed 
through a 635R filter onto the SPAD detectors. 
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Figure 117: Photobleaching of DOPE-Atto655 in a DOPC bilayer above APTMS/GA coated glass. No actin was 
present in this sample, yet the lipid bilayer was not diffusive. This suggests that the APTMS/GA coating was 
responsible for the immobilisation of the lipid molecules. The experiment was carried out at room 
temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence was passed 
through a 635R filter onto the SPAD detectors. 
 
 
Ryadnov group fibre polymerisation on bare glass 
Under our experimental conditions, the isolated actin fibres (bovine, rabbit and 
human platelet) were not observed to hinder the diffusion of a lipid bilayer on bare 
glass. Furthermore, attempts to immobilize more densely packed actin on PLL or 
ATPMS/GA-coated glass rendered the lipid molecules immobile, indicating the 
lipid/dye was adsorbing onto the structures rather than forming a bilayer. 
Therefore, attention then turned to the peptide fibres supplied by the Ryadnov 
group. These fibres known as cyan(+)4, cyan(+)6 and SR_EDS_02 were formed in low 
salt buffers as described (section 5.2.4) and labelled with sulforhodmaine B, before 
being incubated with a plasma-cleaned glass coverslip. Each fibre possesses 
different dimensions and PI, and so we were interested to see if these parameters 
influenced lipid diffusion of lipid in contact with the fibres.  A lipid bilayer was 
formed as normal be injecting extruded DOPC LUVs across the surface and 
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incubating them for 30 minutes. After washing out excess lipid the fibres and bilayer 
were imaged via confocal microscopy. Figure 118 shows a representative image of 
sulfo-rhodmaine B labelled cyan(+)4 after the formation of a spanning DOPC SLB. As 
was the case with actin filaments the various wash steps involved in bilayer 
formation meant that high surface coverage of filaments was difficult to achieve. 
Nonetheless, a sufficient number of fibres remained on the surface for FCS point 
measurements to be undertaken. Figure 119 shows a corresponding confocal image 
of the bilayer itself at the same location where DOPE-Atto655 was used as a lipid 
dye. Consistent with SLB formation, the lipid bilayer appeared homogeneously 
fluorescent across the substrate with no evidence for lipid aggregates or 
luminophore (lipid bilayer) free regions. Using both images, from lipid and fibre 
fluorescence, in combination, it was possible to perform point measurements on 
lipid diffusing above the fibres. Figure 120 shows a typical ACF and its single 
component two-dimensional fit for lipid diffusion above a cyan(+)4 filament. The 
model fit well to the ACF trace with no obvious second component present in the 
data.     
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Figure 118: Sulfo-rhodamine B-labelled cyan(+)4 below a DOPC SLB. Some cyan(+)4 filaments remained 
adhered to the glass during the vesicle disruption process and thus were present below the lipid bilayer. This 
allowed the bilayer to be probed for changes in fluidity directly above individual fibres. The experiment was 
carried out at room temperature in a PDMS cell. Sulfo-rhodamine B-labelled cyan(+)4 was excited by a 532 nm 
laser line and fluorescence was passed through a 550LP filter onto the SPAD detectors.  
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Figure 119: DOPE-Atto655 in a DOPC bilayer-spanning above cyan(+)4 fibres on plasma-cleaned glass. The 
bilayer was formed by flushing extruded LUVs across the surface and allowing the vesicles to rupture over a 
30-minute period.  The resultant bilayer appeared to form without any defects. Knowing the locations of the 
fibres it was then possible to perform point measurements of the lipid bilayer above the peptides. The 
experiment was carried out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser 
line and fluorescence was passed through a 635R filter onto the SPAD detectors. 
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Figure 120: A typical ACF of DOPE-Atto655 diffusion in a DOPC bilayer above cyan(+)4. The fits to a single 
component model were good and no other species were obvious within the trace. The experiment was carried 
out at room temperature in a PDMS cell. DOPE-Atto655 was excited by a 640 nm laser line and fluorescence 
was passed through a 635R filter onto the SPAD detectors. Point measurements were carried out above 
filaments for between 1 and 3 minutes. 
 
The same protocol was also carried out for the other fibres supplied by the Ryadnov 
group. For example, Figure 121 shows polymerised cyan(+)6 on plasma-cleaned 
glass following the formation of a spanning DOPC SLB, while Figure 122 shows 
polymerised SR_EDS_02 on plasma-cleaned glass following the formation of a 
spanning DOPC SLB. Once again surface coverage of fibres was low after the 
formation of a traversing lipid bilayer. While cyan(+)6 size and surface coverage was 
comparable to that of cyan(+)4, SR_EDS_02 was difficult to form and was only found 
below the lipid bilayer on a single occasion, and at extremely sparse levels. 
Nonetheless, the identification of individual fibres allowed us to subsequently 
perform point measurements at these locations. As was the case with cyan(+)4 
experiments, the ACF trace fitted well to a its single-component two-dimensional fit 
with no obvious second component present in the data.  
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Figure 121: Sulfo-rhodamine B-labelled cyan(+)6 below a DOPC SLB. Some cyan(+)6 filaments remained 
adhered to the glass during the vesicle disruption process and thus were present below the lipid bilayer. This 
allowed the bilayer to be probed for changes in fluidity directly above individual fibres. The experiment was 
carried out at room temperature in a PDMS cell. Sulfo-rhodamine B labelled cyan(+)6 was excited by a 532 nm 
laser line and fluorescence was passed through a 550LP filter onto the SPAD detectors. Point measurements 
for the lipid diffusion co-efficients were then carried out above these filaments for between 1 and 3 minutes. 
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Figure 122: Sulfo-rhodamine B-labelled SR_EDS_02 below a DOPC SLB. SR_EDS_02 was extremely difficult to 
polymerise and was only once immobilised on a glass slide below a lipid bilayer. Despite this low surface 
coverage, this again allowed the bilayer to be probed for changes in fluidity directly above individual fibres. 
The experiment was carried out at room temperature in a PDMS cell. Sulfo-rhodamine B-labelled SR_EDS_02 
was excited by a 532 nm laser line and fluorescence was passed through a 550LP filter onto the SPAD 
detectors. Point measurements for the lipid diffusion co-efficients were then carried out above these 
filaments for between 1 and 3 minutes. 
 
 
It was calculated that DOPE-Atto655 in a DOPC bilayer above cyan(+)4 fibres 
diffused at 3.98 ± 0.28 m2/s. Above cyan(+)6, DOPE-Atto655 diffused at 3.84 ± 0.28 
m2/s, while above SR_EDS_02 the diffusion co-efficient was found to be 3.81 ± 0.17 
m2/s. Alongside these fibre-containing samples, a fibre free control was prepared 
that featured a DOPC bilayer with DOPE-Atto655 above plasma-cleaned glass. In this 
case the diffusion co-efficient was determined to be 3.81 ± 0.29 m2/s. This data is 
summarised in Figure 123. In all cases the alpha value was 1 showing that the 
diffusion was Brownian. A one-way ANOVA and post-hoc Bonferroni test was 
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performed on the diffusion values under each condition and found that there was 
no significant difference between each data set, where F(3, 73) = 2.40, p > 0.05. 
Therefore, this data shows that none of the Ryadnov group’s fibres, within 
experimental error affected diffusion of a spanning DOPC bilayer and this is line with 
our earlier actin-spanning results.   
 
 
Figure 123: A summary of DOPE-Atto655 diffusion co-efficients in a DOPC bilayer above cyan(+)4, cyan(+)6 and 
SR_EDS_02, as well a lipid only control. Data was fitted using a two-dimensional single species model. None of 
the fibres lead to a change in the diffusivity of the spanning lipid bilayer when compared to a fibre free 
control. This was confirmed by one-way ANOVA anlysis. Each point represents the average diffusion co-
efficient of 5 to 10 measurements above an individual filament. The experiment was performed in triplicate 
using three separate flow cells, except for SR_EDS_02 where data was obtained from a single experiment. 
Standard deviation was used to represent the error.  
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5.3.2. Fibres above the SLB 
Polymerized actin has been shown to bind to phospholipid monolayers and bilayers 
in liposomes at physiological pH. Binding occurs to a range of lipids irrespective of 
the charge at the lipid, which suggests the interactions are multi-sited and non-
specific.215  However, to date there have been no studies reported on the diffusion 
of actin filaments at fluid lipid bilayers so this was investigated here by reversing the 
previous setup and adding polymerised fibres above a pre-constructed lipid bilayer 
as shown in Figure 124. For comparison, we used the same actin filament structures 
in; bovine actin, rabbit actin, human platelet actin, as well as the synthetic fibrous 
peptides; cyan(+)4, cyan(+)6, and SR_EDS_02. 
 
Figure 124: In a reversal of the earlier experimental set-up, the various fibre-forming polypeptides were added 
above an already formed DOPC lipid bilayer. This was due to the fact that creating a lipid bilayer above 
immobilised fibres had failed to alter the diffusional characteristics of the SLB.  
 
Actin polymerisation above the lipid bilayer 
To investigate the binding of actins to a pre-assembled lipid bilayer polymerised 
actins; bovine, rabbit and human platelet were each separately studied by 
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incubating them with a DOPC SLB. The bilayer was formed, by flushing extruded 
DOPC LUVs above a plasma-cleaned glass coverslip, followed by 30-minute 
incubation, and then removing excess lipid via a buffer flush. The already 
polymerised F-actin was then flushed across the lipid membrane with the intention 
of performing point measurements for the lipid membrane at locations below these 
actin filaments. However, by collecting confocal images over time it was clear that 
the actin filaments themselves were highly mobile above the lipid. This mobility of 
actin can be seen in Figure 125 where pholloidin-TRITC-stained bovine actin which is 
shown at 5 minute intervals. Confocal images of pholloidin-TRITC-stained rabbit 
actin and human platelet actin are shown in Figure 126 and Figure 127, respectively. 
All of the actin filaments, regardless of origin were not only found to bind to the 
bilayer but also to be highly mobile at this bilayer.   
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Figure 125: Phalloidin-TRITC-labelled bovine actin above a DOPC bilayer on plasma-cleaned glass. Top shows 
the initial confocal image of the area. Bottom left shows the same area 5 minutes later, while bottom right 
shows the same area 10 minutes later. It can clearly be seen that the labelled actin is mobile atop the SLB. The 
experiment was carried out at room temperature in a PDMS cell. Phallodin-TRITC was excited by a 532 nm 
laser line and fluorescence was passed through a 550LP filter onto the SPAD detectors. Point measurements 
were performed for between 12 and 20 minutes to build ACF data. 
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Figure 126: Pholloidin-TRITC-labelled rabbit actin above a DOPC bilayer formed on plasma-cleaned glass. As 
was the case with bovine actin these actin filaments were mobile atop the SLB and thus only low resolution 
images could be obtained. The experiment was carried out at room temperature in a PDMS cell. Phallodin-
TRITC was excited by a 532 nm laser line and fluorescence was passed through a 550LP filter onto the SPAD 
detectors.  
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Figure 127: Pholloidin-TRITC-labelled human platelet actin above a DOPC bilayer formed on plasma-cleaned 
glass. In agreement with our bovine and rabbit actin results, human platelet F-actin was mobile on top of a 
SLB and once again only low resolution images could be obtained. The experiment was carried out at room 
temperature in a PDMS cell. Phalloidin-TRITC was excited by a 532 nm laser line and fluorescence was passed 
through a 550LP filter onto the SPAD detectors.  
 
To measure the diffusion of the actin filaments, point measurements were 
performed detecting at the wavelength of the TRITC-labelled actin filaments at 
random locations on the bilayer. Initially this proved difficult due to the sparse 
nature of the F-actin filaments atop the SLB and what was evidently relatively slow 
diffusion. In order to overcome this limitation, the concentration of the actin was 
increased and the length scale of the point measurements were increased to a 12 to 
20-minute window in order to gain diffusional data. A typical ACF of phalloidin-
TRITC-labelled rabbit actin diffusing atop a DOPC SLB is shown in Figure 128. Fitting 
of this ACF data was more challenging than unhindered Brownian diffusion for lipid 
diffusion. The most obvious feature of these fits for actin filament was the much 
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more gradual decay of the curve, an indication of a sub 1 alpha value and thus 
hindered diffusion.   
 
 
 
Figure 128: A representative ACF of phalloidin-TRIC-labelled rabbit actin diffusing above a DOPC bilayer. Fits to 
ACF trace were often difficult when compared to the ease at which lipid data was routinely fitted. 
Nonetheless diffusion co-efficients could be obtained for actin filaments above a DOPC bilayer. The 
experiment was carried out at room temperature in a PDMS cell. Phallodin-TRITC was excited by a 532 nm 
laser line and fluorescence was passed through a 550LP filter onto the SPAD detectors. Point measurements 
were performed for between 12 and 20 minutes to build ACF data. 
Fitting the ACF data to a two-dimensional model, the diffusion co-efficient was 
calculated for all three actin types as well as the underlying lipid bilayer. By this 
stage the lipid bilayer diffusive properties had been well characterised and this was 
not altered by the presence of mobile actin filaments above. Here the lipid diffusion 
co-efficient was determined to be 3.69 ± 0.22 m2/s and the alpha was 1. Fitting the 
bovine actin to a single-component two-dimensional model the diffusion co-efficient 
was determined to be 1.18 ± 0.43 m2/s, while the alpha value was 0.77 ± 0.11. 
Rabbit actin was found to diffuse at 1.54 ± 0.50 m2/s, while the alpha value was 
0.78 ± 0.09. Finally, human platelet actin was determined to diffuse at 1.26 ± 0.56 
m2/s, with an alpha value of 0.68 ± 0.12. These diffusion co-efficients are 
summarized in Figure 129. A one-way ANOVA found the difference between these 
diffusion co-efficients to be significant, where F(3, 60) = 128.50, < 0.001. A post-hoc 
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Bonferroni test found this significance to lie between the lipid value and all three 
actin fibres (p < 0.001). There are several points to note; firstly these diffusion co-
efficients are at least an order of magnitude lower than reported for actin filaments 
in free aqueous media.216 Secondly, these actin diffusion values are 2 to 3 times 
slower than the surrounding lipid values. Recalling our earlier integrin reconstitution 
data, we had previously seen that protein that was loosely associated with the lipid 
bilayer diffused faster than the bilayer itself (section 4.3.6). Only properly inserted 
integrin diffused slower than the surrounding lipid bilayer (section 4.3.7). Therefore 
the fact that the actin proteins diffused well below the lipid diffusion co-efficient 
suggests that the protein fibres are not merely loosely bound to the lipid membrane.  
This was the case for all three actin fibres. 
 
As seen in Figure 129, the distribution of the diffusion values varies widely, where 
the range of the values is used as the experimental standard deviation. However, 
this is probably not appropriate as the breadth of the SD, particularly compared with 
the lipid diffusion is likely due to variation in length distributions of the filaments 
which are evidently variable from visual examination of the confocal images. 
However, in two-dimensional diffusion, it is the membrane incorporated volume of 
the protein which is regarded to dictate the diffusion rate, and the slow rate of 
diffusion here suggests that there is either some intercalation of the actin filaments 
into the bilayer and that there is muli-point attachment of the actin to the bilayer.  
The actin, which has a PI of approximately 4.8210, is anionic at the pH used here, and 
zwitterionic, electrostatic interactions between the actin and ammonium group of 
DOPC may promote binding.  Furthermore, that the actin does diffuse indicates that 
it is not penetrating through the membrane, i.e. and interacting with the underlying 
substrate.  The alpha values are notable in that in all cases the filaments they are 
found to be below 0.80.  As described, where the anomalous exponent is below 1, 
this indicates that sub-diffusion is occurring. This value, not found in the lipid data, 
shows that the movement of the actin filaments is anomalous and thus hindered. 
Again multipoint attachment to the lipid is the most likely explanation for this 
behaviour. Overall, to our knowledge this is the first report on the interaction and 
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diffusion of actin filaments with the lipid bilayer and they may be a useful analogue 
for peripheral protein interactions with bilayers.  
 
 
Figure 129: A summary of actin diffusion co-efficients above a DOPC SLB. The actin was labelled with 
phalloidin-TRITC and flushed on top of a preformed lipid bilayer. Point measurements were then performed 
over a 12 to 20 minute period and the ACF data was fitted to a two-dimensional model. A lipid probe was also 
included in the form of DOPE-Atto655 to determine whether actin presence altered the bilayer’s diffusive 
properties. It was found that the actin filaments diffused much slower than the SLB, while the lipid itself 
behaved as normal with no change in the diffusion co-efficients when compared to previous actin free 
experiments. Standard deviation was used to represent the error.   
 
Ryadnov group fibre polymerisation above the lipid bilayer 
We then compared the interaction of the actin filaments with the filament forming 
peptides provided by Dr Ryadnov’s group. Here, the DOPC lipid bilayer was formed 
via the same method as before and self-assembled fibres (cyan(+)4, cyan(+)6 and 
SR_EDS_02) were each flushed across the SLB in separate experiments. The surface 
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was then imaged by confocal fluorescence microscopy to confirm assembly had 
occurred prior to the initiation of point FCS measurements. As before, cyan(+)4 
fibres could be routinely formed. However, interestingly, unlike the actin fibres 
above the lipid bilayer we observed that the cyan(+)4 fibres were completely 
immobilized at the bilayer. For reference, the lipid bilayer remained completely 
mobile. This fibre immobility is shown in Figure 130 where sulfo-rhodamine B 
labelled cyan(+)4 was was imaged three times over a 30 minute period at the same 
location. In contrast to the actin observations, the movement between frames was 
negligible showing that the fibres were stationary above the SLB. Owing to this 
immobility it was not possible to perform the anticipated diffusion measurements 
on the fluorescently labelled fibres as achieved in the actin-based experiments.  
 
This same protocol was repeated on the cyan(+)6 peptide where the self-assembled 
fibres were incubated with the pre-formed DOPC SLB. The sulfo-rhodamine B 
labelled fibres were then imaged via confocal microscopy to determine their 
polymerisation state, and subsequently imaged 10 and 30 minutes later to 
determine whether the fibres were mobile like actin, or stationary as in the case of 
cyan(+)4. A typical confocal image of cyan(+)6  is shown in Figure 131. Interestingly, 
it was evident that like cyan(+)4, cyan(+)6 was immobile over the time-course of the 
experiment.  
 
Finally, attempts were made to repeat this experiment with the final Ryadnov group 
fibre-forming peptide; SR_EDS_02. The fibre was allowed to self-assemble overnight 
as prescribed before being flushed across the pre-formed DOPC SLB. Previously we 
had found it difficult to assemble this fibre directly above a glass substrate and this 
difficulty continued where no SR_EDS_02 was successfully found atop the lipid 
bilayer despite multiple attempts.  
 
As a whole both cyan(+)4 and cyan(+)6 were found to be immobile over multiple 
measurements when introduced onto a DOPC SLB. This was unexpected given that 
the fibres were atop a mobile freely diffusing lipid plane and also given that their 
positive charge. Logically it would be expected that any fibres interacting with the 
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bilayer would also be mobile, as had been our experience with fluorescently labelled 
bovine, rabbit, and human platelet actin. This contrasting observation with these 
cytoskeletal mimics is an interesting feature of the Ryadnov group’s fibres. To help 
explain this, it is speculated that these cytoskeletal mimics are capable of 
penetrating though the lipid bilayer in order to interact with the underlying 
stationary glass substrate, giving the impression of immobility atop the SLB. 
However, to confirm such a hypothesis, further experimentation will be necessary.   
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Figure 130: Sulfo-rhodamine B-labelled cyan(+)4 on top of a DOPC SLB. Top shows cyan(+)4  after flushing the 
fibres across the bilayer. Bottom left shows the fibres 10 minutes later, while bottom right shows the fibres 30 
minutes later. The movement of the fibres was negligible over the course of the experiment. Sulfo-rhodamine 
B-labelled fibres were excited with a 532 nm laser line and fluorescence was passed through a 550LP filter 
onto the SPAD detectors. 
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Figure 131: Sulfo-rhodamine B-labelled cyan(+)6 on top of a DOPC SLB. Top shows cyan(+)6  after flushing the 
fibres across the bilayer. Bottom left shows the fibres 10 minutes later, while bottom right shows the fibres 30 
minutes later. As was the case with cyan(+)4, the movement of the cyan(+)6 was negligible over the course of 
the experiment. Sulfo-rhodamine B labelled fibres were excited with a 532 nm laser line and fluorescence was 
passed through a 550LP filter onto the SPAD detectors.   
 
Although it was not confirmed whether the Ryadnov group’s fibres had penetrated 
below the bilayer or were actually stationary above the SLB, we decided to carry out 
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point measurements on the under/overlying lipid regardless, to see whether the 
fibres had any influence on bilayer diffusion. We had previously carried out similar 
experiments where the Ryadnov group’s fibres were known to be below the bilayer 
(section 5.3.1). 
 
To examine the influence of overlying cyan(+)4 and cyan(+)6 on the DOPC SLB, 
confocal imaging was used to image the sulfo-rhodamine fibres and locate them for 
point measurements in order to determine whether the immobile fibres provided 
any barrier to the fluidity of the bilayer. A typical ACF of lipid diffusion below a 
stationary cyan(+)4 fibre is shown in Figure 132. In this case the data fitted well to a 
single-component two-dimensional fit with no obvious defects. The same protocol 
was also carried out for cyan(+)6 where similar ACF data was obtained. In order to 
provide a baseline diffusion rate, a fibre free control was prepared in tandem. Using 
DOPE-Atto655 as the lipid probe this control was determined to diffuse at 3.89 ± 
0.34 m2/s. Below cyan(+)4 the diffusion co-efficient was 3.91 ± 0.23 m2/s. Below 
cyan(+)6 the diffusion co-efficient was 3.92 ± 0.25 m2/s. In all cases the alpha value 
was determined to be 1, indicating unhindered Brownian diffusion. This data is 
summarised in Figure 133. As a whole this data shows that the addition of cyan(+)4 
and cyan(+)6 fibres above a DOPC SLB had no influence on the diffusion co-efficient 
of the lipid membrane. However, this observation presumes that fibres are 
stationary above the diffusing lipid membrane. This may suggest that the fibres are 
somehow immobilising a thin nanometer wide stretch of underlying lipid. On the 
other hand it can be speculated that the fibres are no longer situated above the lipid 
membrane but have penetrated through the lipid film to the underlying glass 
substrates. If this were the case then the previous lipid diffusion measurements 
were merely measuring the diffusional characteristics of the surrounding intact lipid 
membrane, rather than the influence of fibres on an underlying lipid bilayer.            
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Figure 132: A typical ACF and its two-dimensional single component fit for DOPE-Atto655 in a DOPC bilayer 
“below” a cyan(+)4 fibre. The immobility of the cyan(+)4 (and cyan(+)6) fibres may suggest that the filaments 
are not in fact resting above the lipid bilayer but rather have penetrated through the membrane to interact 
with the underlying glass substrate. On the other hand the fibres may immobilise a thin length of underlying 
lipid molecules to remain stationary above the SLB. 
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Figure 133: A summary of lipid diffusion co-efficients for DOPE-Atto655 in a DOPC SLB “below” cyan(+)4 and 
cyan(+) 6 fibres, as well as a fibre-free control. The fact that the fibres remained stationary rather than 
diffusion in tandem with the lipid suggests that the fibres have penetrated through the lipid bilayer to interact 
with the underlying substrate. Nonetheless the fibre’s presence does not appear to provide a sufficient barrier 
to lipid diffusion to alter DOPE-Atto655 mobility when compared to a lipid only control. 
 
This work highlights contrasting lipid-fibre interactions between actin filaments and 
the Rydnov group’s cytoskeletal mimics. Further work will be needed to characterise 
this contrasting interaction above the lipid bilayer. All of this work was carried out in 
pure DOPC membranes and in the future we would like to expand this to include a 
variety of lipid compositions to determine the controlling factor in these lipid-fibre 
interactions. For example, the inclusion of charged lipids (eg the negatively charged 
DOPS) at varying concentrations may provide alternative observations. Likewise, the 
use of ordered domain-forming lipids such as cholesterol and sphingomyelin is 
another avenue of approach. Furthermore, we have yet to incorporate these 
cytoskeletal mimics with our biologically-relevant nature’s own composition.  Ideally 
we would also like to combine this cytoskeletal work with our novel PDMS arrays 
(chapter 4). For example, by assembling both classes of filamentous mimics above 
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our microcavity-containing arrays we could eliminate the concern of the underlying 
stationary substrate. Our microcavity system has also been shown to be an ideal 
platform for the reconstitution of transmembrane proteins and given the role of 
actin in integrin function199,203,217 it would therefore be extremely desirable to 
combine these two proteins in a platform such as ours. For example, if F-actin could 
be formed across our mircocavities in a mesh we could monitor integrin diffusion 
and function while in contact with cytoskeletal proteins alone, away from the 
constraints of a planar substrate. This proposed experiment is sketched in Figure 
134. 
 
Figure 134: By combining cytoskeletal structures with our PDMS cavity arrays we would hope to more 
accurately reflect the cell membrane in an artificial lipid model. This top down sketch of one such proposed 
experiment would involve the formation of a cytoskeletal mesh (such as actin) across buffer-filled 
microcavites. By spanning a protein inserted (such as integrin) SLB across the microcavity we could better 
mimic the cell membrane. Here membrane proteins could be examined in a biologically-relevant environment. 
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6. Conclusions and future 
work 
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We have shown that artificial mimics of the cell membrane are insightful models to 
better understand the complex nature of the cell’s lipid bilayer and its interactions 
with transmembrane and membrane associating proteins. As described, these 
models may take various forms, each with their own advantages and disadvantages. 
These models can be roughly divided into two main categories, namely free-
standing vesicle systems and planar supported bilayers. This thesis has focused on 
both of these categories and has sought to advance upon what currently exists 
within the literature to better model the cell membrane. 
 
One of the main focuses of this thesis has been on a transmembrane protein 
integrin IIb3 within lipid bilayer models. Therefore, the study began with the 
characterisation of IIb3 in its native environment, the platelet (chapter 2). 
Physiologically IIb3 remains constrained in its low-affinity form within the resting 
discoid platelet. IIb3 activation to its high affinity ligand binding form occurs in 
response to platelet activation. Here, platelet agonists interact with their respective 
receptors leading to intracellular signalling processes and culminating in a pro-
aggregatory response. IIb3 is one of the key mediators of the response and its 
inside out activation leads to structural changes within the integrin protein which 
allow for ligand binding. While such an activation process is beyond the scope of an 
artificial membrane system it is possible to mimic this IIb3 activation process using 
artificial integrin activators. Therefore, before we began to investigate artificial 
integrin activation in our lipid vesicles and planar lipid bilayer, we first attempted to 
characterise activation in platelets. The two artificial integrin activators were DTT 
and Mn2+. Both have been widely used in the literature to initiate integrin-ligand 
binding both in vivo and in vitro.104,109,110,112,113,117,119,218,219 The investigation began 
with platelet aggregometry experiments, where the ability of DTT and Mn2+ to 
initiate platelet aggregation was examined. While TRAP, a physiological agonist and 
positive control was a potent activator, the platelet response to DTT and Mn2+ was 
noticeably different. Firstly, DTT was noted to have a concentration dependent lag 
time. For example, at 0.5 mM DTT, the lag-phase lasted over 13 minutes, while at 5 
mM, the lag phase lasted nearly 4 minutes. This was in contrast to the almost 
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immediate response using TRAP. On the other hand, Mn2+ initially appeared to have 
no ability to initiate platelet aggregation in a washed platelet population. In order to 
promote an aggregatory response it was required that the platelets were 
supplemented with additional fibrinogen to mediate platelet bridging. From this 
data we were able to conclude that Mn2+ was a weaker activator than DTT, but with 
the caveat that DTT possess an inherent lag-phase that must be taken into account 
for upcoming experiments (section 2.3.1). Flow cytometry was later used to 
characterise the influence of DTT and Mn2+ on IIb3 in isolation. Here we found that 
although both DTT and Mn2+ lead to a change in integrin conformation (PAC-1 
binding), only DTT lead to a measurable degree of fibrinogen binding (OgFg binding). 
This again highlights Mn2+ as a weak integrin activator (section 2.3.2). The 
bidirectional signalling ability of IIb3 was also taken into account where assays for 
alpha and dense granule release were performed. While, as expected, the positive 
control of TRAP lead to P-selectin presentation and ATP/ADP release, DTT and Mn2+ 
failed to initiate these responses. From this we were able to conclude that these 
artificial activators were unable to promote a whole-platelet response. Therefore, 
whatever activating ability possessed by DTT and Mn2+ is limited to the integrin 
protein (section 2.3.3). From this data we were able conclude that both of these 
activators were candidates for use in our upcoming reconstituted lipid systems, 
although DTT seemed a more potent activator as long as its lag-phase is accounted 
for. 
 
The next chapter focused on lipid vesicles and in particular GUVs as a model for 
studying reconstituted IIb3 (chapter 3). Here various methods of vesicle formation 
were explored and refined including sonication (SUVs), extrusion (LUVs), and 
electroformation (GUVs). While these techniques are relatively common, one of the 
striking features of the available literature is the reliance on relatively simple unary 
and binary lipid compositions.33,53,126,142,150,220 Therefore, one of the key goals of this 
refinement stage was the development of a more accurate physiological mimic of 
the cell membrane. To this end, we adopted a lipid composition known as nature’s 
own from the Lentz group at the University of North Carolina at Chapel Hill. The 
Lentz group had been using this composition for some time in their SUV-based 
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experiments, but the lipid mixture had yet to be used in larger vesicles or planar lipid 
bilayer systems. We found that the nature’s own composition was compatible with 
electroformation and could be routinely used to create complex and physiologically-
relevant GUVs (section 3.3.1). Parallel to this development process, we also explored 
methods of integrin IIb3 reconstitution into lipid vesicles. To do so, a number of 
approaches were possible, using varying vesicle sizes, detergents, and detergent 
removal methods. We utilised two separate insertion methods, one based on 
Dennison et al.27, and the other based on Müller et al.34 The Dennison method used 
partial solubilisation of sonicated SUVs and slow detergent removal, while the 
Müller method used complete solubilisation of extruded LUVs and fast detergent 
removal. Both of these methods yielded integrin-containing proteoliposomes 
(section 3.3.3). As our goal was to study IIb3 in GUVs, we then developed a method 
of converting these small proteoliposomes into giant vesicles, well suited to 
microscopy-based experiments. It was found that a two-step procedure of 1) 
ultracentrifugation, and 2) electroformation of a proteoliposomes pellet, could 
successfully produce such IIb3-reconstituted GUVs. Combining the two strands of 
the chapter it was therefore possible to produce nature’s own GUVs containing 
reconstituted IIb3 (section 3.3.4). FLCS was then used to examine the diffusion co-
efficients of the lipid and integrin molecules. The lipid diffusion co-efficients were in-
line with literature values for such free-standing structures.53 The IIb3 diffusion co-
efficient was found to be well below the lipid value, indicating that IIb3 had been 
fully inserted into the nature’s own GUVs and was not simply membrane-associated. 
This is particularly relevant given the fact that IIb3 has been highlighted as 
associating with the lipid bilayer in other reconstitution experiments, particularly in 
the absence of the lipid DMPC.29,34 Another key point is that GUV systems are free-
standing and are immune from the immobilisation of reconstituted proteins on a 
substrate surface, as is normally the case in planar bilayer systems.221 Therefore 
IIb3 was capable of diffusing freely without being encumbered, as has previously 
been the case in other IIb3-containing systems.31 This means that our GUV work is 
the first such setup to confirm full IIb3 insertion into a non DMPC-based 
composition, the first to provide diffusion co-efficients for IIb3 in a vesicle-based 
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system, and the first artificial lipid system to show fully mobile IIb3 (section 3.3.5). 
After establishing that IIb3 could be routinely inserted into GUVs we later sought 
to determine whether activation induced structural changes in the integrin protein 
would bring about a change in the diffusion co-efficient. The use of DTT and Mn2+ as 
integrin activators failed to alter the mobility of IIb3. However, when DTT and Mn2+ 
were used as integrin activators in the presence of fibrinogen, a large change in the 
mobility of IIb3 became apparent. Here the diffusion co-efficient of IIb3 fell to 
approximately 60 % of its original value. This reduction was identical for either 
activator. Importantly, the use of fibrinogen alone failed to alter the diffusion co-
efficient showing that the reconstituted IIb3 was in its resting low-affinity 
conformation following reconstitution. Such a large reduction in the diffusion co-
efficient could only be brought about massive integrin-fibrinogen conglomerates.55 
To the best of our knowledge this is the first work to show how protein-protein 
interaction may bring about a change in the diffusion co-efficient of protein in GUVs, 
and the first to utilise FLCS to show this in any artificial lipid system (section 3.3.6). 
We later used domain-forming GUVs to determine whether IIb3 had affinity for 
either the liquid order or liquid disordered phase of the giant vesicles. Here, we 
found that IIb3 preferentially associates with the phospholipid rich, cholesterol 
poor, liquid disordered phase of GUVs, regardless of activation state. Interestingly 
this is in contrast to other members of the integrin family (section 3.3.7).35    
 
Armed with the knowledge gained from GUV studies, we next sought to combine 
the advantages of free-standing vesicle systems with those of existing SLB models. 
To provide this platform our group has developed a novel cavity array system 
(chapter 4). This was achieved using polystyrene beads and PDMS to create optically 
transparent cavity arrays with pore sizes with well-defined dimensions.175 This was 
done using beads with diameters ranging from hundreds of nanometres to 8 m, 
although this thesis focuses on PDMS arrays constructed using 2.88 m spheres. 
Such beads were capable of constructing cavity sizes well suited to FLCS-based 
experiments. It was found that by plasma treating the PDMS surface to render it 
hydrophilic, and sonicating it in buffer, it was possible to produce buffer-filled 
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cavities. The next step was to form a spanning lipid bilayer across these cavities. It 
was immediately clear that SUVs and LUVs were too small to span the dimensions of 
our cavities and so GUVs were explored as the lipid source in our SLB system. Unlike 
smaller vesicles, GUVs do not readily rupture to form planar bilayer so this 
disruption was promoted by the use of high concentrations of calcium within the 
buffer. Via this method an SLB was formed, but the bilayer did not span the cavities. 
As such an alternative method to create a spanning bilayer was investigated. It was 
found that a two-step protocol of 1) LB transfer of a lipid monolayer, and 2) 
SUV/LUV rupture lead to formation of a lipid bilayer. Confocal microscopy and point 
measurements were able to show that this SLB spanned the buffer-filled 
microcavities. We were able to achieve this spanning with a multitude of lipid 
compositions, including the physiologically-relevant nature’s own mixture. 
Importantly, point measurements showed that the lipid diffused at values 
comparable with GUV systems and away from the non-specific interactions normally 
associated with SLBs. In fact, diffusion values above cavities were approximately 
three-fold higher than diffusion co-efficients on planar PDMS regions (section 4.3.3). 
The next step in our development of the PDMS array was to reconstitute membrane 
proteins into the SLB, with particular emphasis on integrin IIb3. Given that 
liposomes were required for completion of the lipid bilayer, and given the fact that 
we had already created IIb3-containing proteoliposomes in the previous chapter, it 
at first appeared straightforward to create an integrin-reconstituted cavity-spanning 
SLB. However, the disruption of the IIb3-containing proteoliposomes atop the LB 
monolayer yielded a lipid bilayer where reported integrin diffusion co-efficients 
were well in excess of lipid diffusion co-efficients. In fact, this protein value was 
approximately twice that of the lipid bilayer value (section 4.3.6). This was in 
contrast to our experience in IIb3-reconstituted GUVs. Combined with the 
knowledge IIb3 has a tendency to associate with lipid membranes in non-DMPC-
containing compositions, such high diffusion co-efficients suggested that IIb3 was 
not correctly inserted into the lipid bilayer in our cavity-spanning system. In the 
search for a solution we looked to our earlier GUV-based work. There, we had 
shown proper integrin reconstitution into GUVs. As such, we decided to utilise these 
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giant vesicles to complete the lipid bilayer in our cavity-spanning system, rather than 
the smaller proteoliposomes. Using these GUVs as an intermediate, and calcium to 
promote vesicle rupture, it was possible to create a cavity-spanning lipid bilayer. 
Under these conditions point measurements were able to show integrin diffusion 
co-efficients well below the lipid bilayer values and in line with our earlier 
experience in GUVs. From this we were able to conclude that the protein was 
properly inserted via this method. This suggests that the two-step combination of 
ultracentrifugation and electroformation was required to produce properly 
reconstituted IIb3 into DMPC-free lipid compositions (section 4.3.7). Interestingly, 
we were not able to accurately mirror ligand binding experiments when compared 
to our GUV system. In GUVs, the addition of fibrinogen leads to a measurable 
decrease in the diffusion co-efficient of the integrin protein. Here, above cavities, no 
such reduction in integrin diffusion was noted. However, we were able to observe 
large scale aggregation of IIb3 on planar regions of the PDMS. Dual colour 
experiments were able to show that these integrin clusters aligned with the 
locations of labelled fibrinogen molecules. This shows that fibrinogen was 
responsible for the aggregation process (section 4.3.9). As a whole, our PDMS arrays 
provide a low cost and straightforward means of creating cavity-spanning lipid 
bilayers that alleviate the primary drawback of planar systems, namely non-specific 
interactions between the bilayer and the underlying substrates. Much of the existing 
work in the literature that has attempted to do so has produced nanocavity scale 
systems unsuited to FCS-based measurements, or used complex surface 
modifications to improve bilayer mobility. Indeed, even these surface modifications 
do not fully decoupled the two interfaces, where lipid and, in particular, protein 
immobility is still observed. To the best of our knowledge this work is the first to 
fully reconstitute IIb3 into a DMPC-free planar bilayer system, and the first to 
measure IIb3 diffusion in any planar bilayer system via FCS. Another key aspect to 
our cavity system is the fact that 100 % of our IIb3 molecules were mobile. Existing 
setups within the literature have reported that 40 – 84 % of the integrin protein was 
immobile even where polymer cushions were utilised.30,31,43,44 This shows the power 
of our novel system. Furthermore, our system has been shown to be compatible 
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wide other membrane proteins such as annexin V and glycophorin.153 Such flexibility 
means that potentially any membrane protein could be studied using our platform. 
 
Much of the previous work had focused on the lipid bilayer and the membrane 
proteins within the bilayer but the final experimental chapter concentrated on the 
cell cytoskeleton, the protein backbone of the cell’s lipid membrane (chapter 5).191 
We had initially hoped that actin filaments or cytoskeletal mimics would be capable 
of bringing about a change in the diffusion co-efficient of a spanning lipid bilayer by 
acting as a barrier to lipid mobility. While it was possible to assemble these various 
actin proteins and cytoskeletal peptide mimics, we could not identify any alterations 
to the lipid bilayer’s diffusive properties. Much of this was put down to the low 
surface coverage of the fibres. While initially the concentration of said fibres on the 
substrate was good, the creation of a spanning lipid bilayer meant that much of 
these fibres were removed from the surface. While it was possible to vastly increase 
the surface coverage of the fibres by immobilising them on the substrate, this 
process had the unfortunate side-effect of also rendering the lipid bilayer immobile 
(section 5.3.1). Because of these difficulties, the experimental set-up was reversed 
and the fibres were instead added atop a pre-formed SLB. In this case we found two 
diverging observations between the actin proteins and the cytoskeletal mimics. 
While the actins were highly mobile above the lipid bilayer, the cytoskeletal mimics 
were completely immobile. Interestingly, the diffusion co-efficient of the actin 
proteins were well below the value for the supporting SLB. Additionally, this 
diffusion was hindered, as shown by the low alpha value. This data suggests that the 
actin proteins were not merely associated with the bilayer but rather embedded 
somehow within the SLB. On the other hand, the immobility of the cytoskeletal 
mimics when added above a mobile bilayer suggests that fibres were penetrating 
through the SLB and interacting with the stationary underlying substrates. Such 
differing protein-lipid interactions are sure to require further investigation (section 
5.3.2).  
 
Throughout this thesis, one of the main objectives has been to increase the 
complexity of existing artificial lipid bilayer systems to more accurately mimic the 
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native cell membrane environment. Both the platelet-based chapter and GUV-based 
chapter served as a precursor for our novel PDMS cavity arrays. Going forward, one 
of the key goals would be to combine our existing PDMS cavity arrays with 
cytoskeletal structures such as actin in order to achieve even more physiological 
relevance. While currently, our PDMS arrays allow for the diffusion of membrane 
proteins above buffer-filled cavities, in the future it would be desirable to examine 
diffusion values over an actin (or other cytoskeletal protein) mesh. The cytoskeleton 
is of course not merely an inert structure within the cell. Instead it provides a 
platform for cell-cell interactions and functions as a base for signal transduction. It is 
a dynamic assembly that interacts with a wide array of binding proteins as well as 
having a role in the formation of lipid rafts. The fact that our PDMS arrays facilitate 
access to the intracellular regions of any transmembrane protein means that these 
actin-transmembrane protein interactions can be studied in greater detail. Indeed, 
one of the avenues of investigation proposed has been the controlled release of 
transmembrane binding proteins from the inside of buffer-filled cavities. Using IIb3 
as a model protein, for example, this hypothetical experiment could involve the 
release of talin, or another intracellular protein with a role in integrin activation, to 
the cytoplasmic tail end of membrane-reconstituted IIb3. In such a set-up, this 
controlled release of binding proteins could perhaps be governed via electrorelease 
or the use of magnetically functionalised proteins. Perhaps the strongest feature of 
our PDMS array system is the fact that the platform may be applicable to a wide 
range of membrane proteins. It has already be used to host three un-related 
proteins (IIb3, annexin V, and glycophorin), each inserted via a different 
reconstitution method. This versatility is combined with a low cost, straightforward, 
highly reproducible means of creating cavity-containing arrays. The platform is ideal 
for studying biological molecules as the system is completely surrounded by buffer 
unlike many existing systems. It also allows for the study of membrane proteins 
away from harsh solvents, while their optical transparency is well suited to 
microscopy experiments. The PDMS arrays provide an extremely stable means of 
study where lipid bilayer diffusion values were unchanged days after construction. 
This stability is improved in comparison to GUVs. The other massive improvement 
when compared to GUV is the spatial stability of our cavity-spanning system. Due to 
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the free-standing nature of GUVs, vesicle movement meant that point 
measurements were often difficult to perform. The stationary nature of our PDMS 
arrays meant that the acquisition of data is greatly improved. Finally, the fact that 
our cavity arrays are part of a flow cell setup means that buffer, drugs, proteins, and 
other molecules may be freely exchanged. Therefore, our PDMS arrays provide an 
excellent and versatile means of mimicking the native cell environment. By 
combining this platform with cytoskeletal structure and other membrane and 
membrane interacting proteins we hope to further mimic the physiology of the cell.        
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